UFT	NN	nsubj	B-Simple_chemical
and	CC	cc	O
its	PRP$	nmod:poss	O
metabolites	NNS	conj	O
inhibit	VBP	ROOT	O
the	DT	det	O
angiogenesis	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
murine	JJ	amod	B-Organism
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
,	,	punct	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
a	DT	det	O
dorsal	NN	amod	B-Multi-tissue_structure
air	NN	compound	I-Multi-tissue_structure
sac	NN	compound	I-Multi-tissue_structure
assay	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

UFT	NN	nsubjpass	B-Simple_chemical
,	,	punct	O
an	DT	det	O
anticancer	NN	compound	B-Cancer
agent	NN	appos	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
composed	VBN	acl:relcl	O
of	IN	case	O
tegafur	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
FT	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
uracil	NN	conj	B-Simple_chemical
at	IN	case	O
a	DT	det	O
molar	JJ	amod	O
ratio	NN	nmod	O
of	IN	case	O
1	CD	nummod	O
:	:	punct	O
4	CD	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
widely	RB	advmod	O
used	VBN	ROOT	O
in	IN	prep	O
clinical	JJ	amod	O
practice	NN	pobj	O
in	IN	case	O
Japan	NNP	nmod	O
to	TO	mark	O
treat	VB	xcomp	O
cancer	NN	compound	B-Cancer
patients	NNS	dobj	B-Organism
requiring	VBG	acl	O
a	DT	det	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
chemotherapy	NN	dobj	O
,	,	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	conj	O
with	IN	case	O
few	JJ	amod	O
side	JJ	amod	O
effects	NNS	nmod	O
,	,	punct	O
if	IN	mark	O
any	DT	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
evaluated	VBN	ROOT	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
UFT	NN	nmod	B-Simple_chemical
against	IN	case	O
RENCA	NN	nmod:npmod	B-Cell
cell	NN	nmod:npmod	I-Cell
-	:	punct	O
induced	VBN	amod	O
angiogenesis	NN	nmod	O
by	IN	case	O
a	DT	det	O
dorsal	NN	amod	O
air	NN	compound	O
sac	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

Marked	JJ	amod	O
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
implantation	NN	nmod	O
of	IN	case	O
a	DT	det	O
chamber	NN	nmod	O
containing	VBG	acl	O
RENCA	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
into	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

In	IN	case	O
this	DT	det	O
model	NN	nmod	O
,	,	punct	O
UFT	NN	nsubj	B-Simple_chemical
showed	VBD	ROOT	O
a	DT	det	O
strong	JJ	amod	O
angiogenesis	NN	nmod:npmod	O
-	HYPH	punct	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
,	,	punct	O
whereas	IN	mark	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
fluorouracil	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
doxifluridine	NN	conj	B-Simple_chemical
were	VBD	cop	O
less	RBR	advmod	O
effective	JJ	advcl	O
.	.	punct	O

Additional	JJ	amod	O
experiments	NNS	nsubj	O
revealed	VBD	ROOT	O
FT	NN	dobj	B-Simple_chemical
to	TO	mark	O
be	VB	cop	O
effective	JJ	amod	O
component	NN	xcomp	O
of	IN	case	O
UFT	NN	nmod	B-Simple_chemical
;	:	punct	O
uracil	NN	nsubj	B-Simple_chemical
remained	VBD	parataxis	O
ineffective	JJ	xcomp	O
in	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
gamma	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
hydroxybutyric	JJ	amod	I-Simple_chemical
acid	NN	nsubj	I-Simple_chemical
and	CC	cc	O
gamma	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
butyrolactone	NN	conj	I-Simple_chemical
,	,	punct	O
the	DT	det	O
metabolites	NNS	appos	O
of	IN	case	O
FT	NN	nmod	B-Simple_chemical
,	,	punct	O
possess	VBP	ccomp	O
a	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
amplified	VBN	acl:relcl	O
when	WRB	advmod	O
the	DT	det	O
compounds	NNS	nsubjpass	O
are	VBP	auxpass	O
administered	VBN	advcl	O
by	IN	case	O
a	DT	det	O
continuous	JJ	amod	O
infusion	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
may	MD	aux	O
reflect	VB	ROOT	O
a	DT	det	O
transition	NN	dobj	O
in	IN	case	O
blood	NN	compound	B-Organism_substance
concentration	NN	nmod	O
of	IN	case	O
each	DT	det	O
metabolite	NN	nmod	O
resulting	VBG	acl	O
from	IN	case	O
the	DT	det	O
administration	NN	nmod	O
of	IN	case	O
UFT	NN	nmod	B-Simple_chemical
.	.	punct	O

Similar	JJ	amod	O
results	NNS	nsubjpass	O
were	VBD	auxpass	O
also	RB	advmod	O
obtained	VBN	ROOT	O
with	IN	case	O
respect	NN	dep	O
to	IN	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	nmod	I-Simple_chemical
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
UFT	NN	nsubj	B-Simple_chemical
has	VBZ	ccomp	O
a	DT	det	O
stronger	JJR	amod	O
angiogenesis	NN	compound	O
-	HYPH	punct	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
than	IN	mark	O
did	VBD	advcl	O
other	JJ	amod	O
fluorinated	JJ	amod	B-Simple_chemical
pyrimidines	NNS	dobj	I-Simple_chemical
,	,	punct	O
partly	RB	advmod	O
due	JJ	case	O
to	TO	case	O
its	PRP$	nmod:poss	O
pharmacokinetic	JJ	amod	O
properties	NNS	nmod	O
characterized	VBN	acl	O
by	IN	case	O
maintaining	VBG	nmod	O
of	IN	case	O
higher	JJR	amod	O
and	CC	cc	O
long	RB	conj	O
-	HYPH	punct	O
lasting	VBG	amod	O
blood	NN	compound	B-Organism_substance
levels	NNS	nmod	O
of	IN	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NN	nmod	I-Simple_chemical
and	CC	cc	O
partly	RB	advmod	O
due	JJ	case	O
the	DT	det	O
inhibitory	JJ	amod	O
effects	NNS	conj	O
derived	VBN	acl	O
from	IN	case	O
gamma	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
hydroxybutyric	JJ	amod	I-Simple_chemical
acid	NN	nmod	I-Simple_chemical
and	CC	cc	O
gamma	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
butyrolactone	NN	conj	I-Simple_chemical
,	,	punct	O
UFT	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
specific	JJ	amod	O
metabolites	NNS	conj	O
.	.	punct	O

Nitric	JJ	amod	B-Gene_or_gene_product0
oxide	NN	compound	I-Gene_or_gene_product0
synthase	NN	compound	I-Gene_or_gene_product0
inhibition	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
synergistic	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
tumour	NN	compound	B-Cancer
activity	NN	nmod	O
with	IN	case	O
melphalan	NN	nmod	B-Simple_chemical
and	CC	cc	O
tumour	NN	compound	B-Gene_or_gene_product0
necrosis	NN	compound	I-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
alpha	NN	conj	I-Gene_or_gene_product0
-	HYPH	punct	O
based	VBN	amod	O
isolated	VBN	amod	O
limb	NN	compound	B-Organism_subdivision
perfusions	NNS	conj	O
.	.	punct	O

Nitric	JJ	amod	B-Simple_chemical
oxide	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
NO	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
molecule	NN	ROOT	O
in	IN	mark	O
regulating	VBG	acl	O
tumour	NN	compound	B-Cancer
blood	NN	compound	B-Organism_substance
flow	NN	dobj	O
and	CC	cc	O
stimulating	VBG	conj	O
tumour	NN	compound	B-Cancer
angiogenesis	NN	dobj	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
NO	NN	compound	B-Gene_or_gene_product2
synthase	NN	nmod	I-Gene_or_gene_product2
by	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NAME	NNP	nmod	I-Simple_chemical
might	MD	aux	O
induce	VB	ROOT	O
an	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
tumour	NN	compound	B-Cancer
effect	NN	dobj	O
by	IN	case	O
limiting	VBG	amod	O
nutrients	NNS	nmod	O
and	CC	cc	O
oxygen	NN	conj	B-Simple_chemical
to	TO	mark	O
reach	VB	xcomp	O
tumour	NN	compound	B-Tissue
tissue	NN	dobj	I-Tissue
or	CC	cc	O
affecting	VBG	conj	O
vascular	JJ	amod	B-Multi-tissue_structure
growth	NN	dobj	O
.	.	punct	O

The	DT	det	O
anti	JJ	compound	O
-	HYPH	punct	O
tumour	NN	compound	B-Cancer
effect	NN	nsubjpass	O
of	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NAME	NN	nmod	I-Simple_chemical
after	IN	case	O
systemic	JJ	amod	O
administration	NN	nmod	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
renal	JJ	amod	B-Cancer
subcapsular	JJ	amod	I-Cancer
CC531	NN	compound	I-Cancer
adenocarcinoma	NN	compound	I-Cancer
model	NN	nmod	O
in	IN	case	O
rats	NNS	nmod	B-Organism
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
regional	JJ	amod	O
administration	NN	nsubjpass	O
of	IN	case	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NAME	NNP	nmod	I-Simple_chemical
,	,	punct	O
in	IN	case	O
combination	NN	nmod	O
with	IN	case	O
TNF	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
melphalan	NN	conj	B-Simple_chemical
,	,	punct	O
was	VBD	auxpass	O
studied	VBN	ROOT	O
in	IN	case	O
an	DT	det	O
isolated	VBN	amod	O
limb	NN	compound	B-Organism_subdivision
perfusion	NN	compound	O
(	-LRB-	punct	O
ILP	NN	appos	O
)	-RRB-	punct	O
model	NN	nmod	O
using	VBG	acl	O
BN175	NN	compound	B-Cancer
soft	JJ	amod	I-Cancer
-	HYPH	punct	I-Cancer
tissue	NN	compound	I-Cancer
sarcomas	NNS	dobj	I-Cancer
.	.	punct	O

Systemic	JJ	amod	O
treatment	NN	nsubj	O
with	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NAME	NNP	nmod	I-Simple_chemical
inhibited	VBD	ROOT	O
growth	NN	dobj	O
of	IN	case	O
adenocarcinoma	NN	nmod	B-Cancer
significantly	RB	advmod	O
but	CC	cc	O
was	VBD	auxpass	O
accompanied	VBN	conj	O
by	IN	case	O
impaired	JJ	amod	O
renal	JJ	amod	B-Organ
function	NN	nmod	O
.	.	punct	O

In	IN	case	O
ILP	NN	nmod	O
,	,	punct	O
reduced	VBD	amod	O
tumour	NN	compound	B-Cancer
growth	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
when	WRB	advmod	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NAME	NNP	nsubjpass	I-Simple_chemical
was	VBD	auxpass	O
used	VBN	advcl	O
alone	RB	advmod	O
.	.	punct	O

In	IN	case	O
combination	NN	nmod	O
with	IN	case	O
TNF	NN	nmod	B-Gene_or_gene_product1
or	CC	cc	O
melphalan	NN	conj	B-Simple_chemical
,	,	punct	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NAME	NN	nsubj	I-Simple_chemical
increased	VBD	ROOT	O
response	NN	compound	O
rates	NNS	dobj	O
significantly	RB	advmod	O
compared	VBN	advcl	O
to	TO	case	O
perfusions	NNS	nmod	O
without	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NAME	NNP	nmod	I-Simple_chemical
(	-LRB-	punct	O
0	CD	compound	O
-	SYM	punct	O
64	CD	nummod	O
%	NN	dep	O
and	CC	cc	O
0	CD	compound	O
-	SYM	punct	O
63	CD	nummod	O
%	NN	conj	O
respectively	RB	advmod	O
)	-RRB-	punct	O
.	.	punct	O

An	DT	det	O
additional	JJ	amod	O
anti	NN	compound	O
-	HYPH	punct	O
tumour	NN	compound	B-Cancer
effect	NN	nsubjpass	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
when	WRB	advmod	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NAME	NN	nsubjpass	I-Simple_chemical
was	VBD	auxpass	O
added	VBN	advcl	O
to	TO	case	O
the	DT	det	O
synergistic	JJ	amod	O
combination	NN	nmod	O
of	IN	case	O
melphalan	NN	nmod	B-Simple_chemical
and	CC	cc	O
TNF	NN	conj	B-Gene_or_gene_product1
(	-LRB-	punct	O
responses	NNS	nsubj	O
increased	VBD	advcl	O
from	IN	case	O
70	CD	compound	O
to	TO	dep	O
100	CD	nummod	O
%	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
NO	NN	compound	B-Gene_or_gene_product2
synthase	NN	nmod	I-Gene_or_gene_product2
reduces	VBZ	ROOT	O
tumour	NN	compound	B-Cancer
growth	NN	dobj	O
both	CC	cc:preconj	O
after	IN	case	O
systemic	JJ	amod	O
and	CC	cc	O
regional	JJ	conj	O
(	-LRB-	punct	O
ILP	NN	appos	O
)	-RRB-	punct	O
treatment	NN	nmod	O
.	.	punct	O

A	DT	det	O
synergistic	JJ	amod	O
anti	NN	compound	O
-	HYPH	punct	O
tumour	NN	compound	B-Cancer
effect	NN	nsubjpass	O
of	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NAME	NNP	nmod	I-Simple_chemical
is	VBZ	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
combination	NN	nmod	O
with	IN	case	O
melphalan	NN	nmod	B-Simple_chemical
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
TNF	NN	conj	B-Gene_or_gene_product1
using	VBG	acl	O
ILP	NN	dobj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
a	DT	det	O
possible	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NAME	NN	nmod	I-Simple_chemical
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
solid	JJ	amod	O
tumours	NNS	nmod	B-Cancer
in	IN	prep	O
a	DT	det	O
systemic	JJ	amod	O
or	CC	cc	O
regional	JJ	conj	O
setting	NN	pobj	O
.	.	punct	O

Apoptosis	NN	nsubj	O
induced	VBN	acl	O
by	IN	case	O
1	CD	nummod	B-Simple_chemical
'	''	punct	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
acetoxychavicol	NN	compound	I-Simple_chemical
acetate	NN	nmod	I-Simple_chemical
in	IN	case	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	ROOT	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
is	VBZ	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
modulation	NN	nmod	O
of	IN	case	O
polyamine	NN	compound	O
metabolism	NN	nmod	O
and	CC	cc	O
caspase	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
3	CD	nummod	I-Gene_or_gene_product3
activation	NN	conj	O
.	.	punct	O

The	DT	det	O
efficacy	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
antitumor	NN	compound	B-Cancer
activity	NN	nmod	O
of	IN	case	O
1	CD	nummod	B-Simple_chemical
'	''	punct	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
acetoxychavicol	NN	compound	I-Simple_chemical
acetate	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
ACA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
reported	VBN	acl	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
suppressor	NN	xcomp	O
of	IN	case	O
chemically	RB	advmod	O
induced	VBN	amod	O
carcinogenesis	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
in	IN	case	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	ccomp	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

ACA	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
changes	NNS	nmod	O
in	IN	case	O
morphology	NN	nmod	O
and	CC	cc	O
a	DT	det	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
suppression	NN	conj	O
of	IN	case	O
cell	NN	compound	B-Cell
viability	NN	nmod	O
.	.	punct	O

Apoptosis	NN	nsubjpass	O
,	,	punct	O
characterized	VBN	acl	O
by	IN	case	O
nuclear	JJ	amod	B-Cellular_component
condensation	NN	nmod	O
,	,	punct	O
membrane	NN	compound	B-Cellular_component
blebbing	NN	conj	O
,	,	punct	O
cell	NN	compound	B-Cell
shrinkage	NN	conj	O
and	CC	cc	O
a	DT	det	O
significant	JJ	amod	O
induction	NN	nsubjpass	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
3	CD	nummod	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
like	IN	dep	I-Gene_or_gene_product1
protease	NN	compound	I-Gene_or_gene_product1
activity	NN	nmod	O
at	IN	case	O
8	CD	nummod	O
h	NN	nmod	O
in	IN	case	O
a	DT	det	O
time	NN	compound	O
-	HYPH	punct	O
course	NN	amod	O
study	NN	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

Formation	NN	nsubjpass	O
of	IN	case	O
apoptotic	JJ	amod	B-Cellular_component
bodies	NNS	nmod	I-Cellular_component
was	VBD	auxpass	O
preceded	VBN	ROOT	O
by	IN	case	O
lowering	VBG	nmod	O
of	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
polyamines	NNS	nmod	O
,	,	punct	O
particularly	RB	advmod	O
putrescine	NN	appos	B-Simple_chemical
,	,	punct	O
and	CC	cc	O
both	DT	cc:preconj	O
dose	NN	conj	O
-	:	punct	O
and	CC	cc	O
time	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
inhibitory	JJ	conj	O
and	CC	cc	O
activation	NN	conj	O
effect	NN	dep	O
by	IN	case	O
ACA	NN	nmod	B-Simple_chemical
on	IN	case	O
ornithine	NN	compound	B-Gene_or_gene_product0
decarboxylase	NN	nmod	I-Gene_or_gene_product0
(	-LRB-	punct	O
ODC	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
and	CC	cc	O
spermidine	NN	compound	B-Gene_or_gene_product0
/	:	punct	I-Gene_or_gene_product0
spermine	NN	compound	I-Gene_or_gene_product0
N	NN	compound	I-Gene_or_gene_product0
(	-LRB-	punct	I-Gene_or_gene_product0
1	CD	nummod	I-Gene_or_gene_product0
)	-RRB-	punct	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
acetyltransferase	NN	conj	I-Gene_or_gene_product0
(	-LRB-	punct	O
SSAT	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Administration	NN	nsubj	O
of	IN	case	O
exogenous	JJ	amod	O
polyamines	NNS	nmod	O
prevented	VBD	ROOT	O
ACA	NNP	nmod:npmod	B-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
apoptosis	NN	dobj	O
represented	VBN	acl	O
by	IN	case	O
a	DT	det	O
reduction	NN	nmod	O
in	IN	case	O
the	DT	det	O
number	NN	nmod	O
of	IN	case	O
apoptotic	JJ	amod	B-Cellular_component
bodies	NNS	nmod	I-Cellular_component
and	CC	cc	O
also	RB	advmod	O
caused	VBD	conj	O
reduction	NN	dobj	O
in	IN	case	O
the	DT	det	O
induced	VBN	amod	O
caspase	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
3	CD	dep	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
like	IN	dep	I-Gene_or_gene_product1
protease	NN	compound	I-Gene_or_gene_product1
activity	NN	nmod	O
at	IN	case	O
8	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
anticarcinogenic	JJ	amod	O
effects	NNS	nsubj	O
of	IN	case	O
ACA	NN	nmod	B-Simple_chemical
might	MD	aux	O
be	VB	cop	O
partly	RB	advmod	O
due	JJ	case	O
to	TO	case	O
perturbation	NN	ccomp	O
of	IN	case	O
the	DT	det	O
polyamine	NN	compound	O
metabolic	JJ	amod	O
pathway	NN	nmod	O
and	CC	cc	O
triggering	NN	conj	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
3	CD	nummod	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
like	NN	case	I-Gene_or_gene_product2
activity	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
result	VBP	acl:relcl	O
in	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
B	NN	compound	I-Gene_or_gene_product0
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
C	NN	conj	I-Gene_or_gene_product0
expression	NN	ROOT	O
in	IN	case	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
:	:	punct	O
regulation	NN	dep	O
by	IN	case	O
the	DT	det	O
von	NN	compound	B-Gene_or_gene_product0
Hippel	NNP	compound	I-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
Lindau	NN	compound	I-Gene_or_gene_product0
gene	NN	nmod	O
and	CC	cc	O
hypoxia	NN	conj	O
.	.	punct	O

Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
numerous	JJ	amod	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
important	JJ	nmod	O
being	VBG	cop	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	nmod	I-Gene_or_gene_product0
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
.	.	punct	O

Recently	RB	advmod	O
VEGF	NNP	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
B	NNP	nsubjpass	I-Gene_or_gene_product0
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C	NNP	conj	I-Gene_or_gene_product0
,	,	punct	O
two	CD	nummod	O
new	JJ	amod	O
VEGF	NN	compound	B-Gene_or_gene_product1
family	NN	compound	O
members	NNS	appos	O
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
that	WDT	nsubj	O
bind	VBP	ccomp	O
to	TO	case	O
the	DT	det	O
tyrosine	NN	compound	O
kinase	NN	compound	O
receptors	NNS	nmod	O
flt	JJ	compound	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
1	CD	nmod	I-Gene_or_gene_product3
(	-LRB-	punct	O
VEGFR1	NN	appos	B-Gene_or_gene_product3
)	-RRB-	punct	O
,	,	punct	O
KDR	NN	conj	B-Gene_or_gene_product1
(	-LRB-	punct	O
VEGFR2	NN	appos	B-Gene_or_gene_product0
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
flt	JJ	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
4	CD	conj	I-Gene_or_gene_product3
(	-LRB-	punct	O
VEGFR3	NN	appos	B-Gene_or_gene_product0
)	-RRB-	punct	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
importance	NN	nsubjpass	O
of	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
A	NNP	nmod	I-Gene_or_gene_product1
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	advcl	O
in	IN	case	O
renal	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
the	DT	det	O
contribution	NN	nsubj	O
of	IN	case	O
these	DT	det	O
new	JJ	amod	O
ligands	NNS	nmod	O
in	IN	case	O
kidney	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
is	VBZ	cop	O
not	RB	neg	O
clear	JJ	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	ROOT	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
measured	VBD	parataxis	O
the	DT	det	O
mRNA	NN	compound	O
level	NN	dobj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
B	NNP	nmod	I-Gene_or_gene_product0
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C	NNP	conj	I-Gene_or_gene_product0
together	RB	advmod	O
with	IN	case	O
their	PRP$	nmod:poss	O
receptors	NNS	nmod	O
by	IN	case	O
RNase	NN	compound	B-Gene_or_gene_product2
protection	NN	compound	O
assay	NN	nmod	O
(	-LRB-	punct	O
RPA	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
26	CD	nummod	O
normal	JJ	amod	B-Multi-tissue_structure
kidney	NN	compound	I-Multi-tissue_structure
samples	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
45	CD	nummod	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
cancers	NNS	conj	I-Cancer
.	.	punct	O

We	PRP	nsubj	O
observed	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
up	RP	dep	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
B	NN	nmod	I-Gene_or_gene_product0
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
002	CD	dobj	O
)	-RRB-	punct	O
but	CC	cc	O
not	RB	neg	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C	NN	conj	I-Gene_or_gene_product0
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
3	LS	ROOT	O
)	-RRB-	punct	O
in	IN	case	O
neoplastic	JJ	amod	B-Organ
kidney	NN	nmod	I-Organ
compared	VBN	case	O
with	IN	case	O
normal	JJ	amod	B-Tissue
tissues	NNS	nmod	I-Tissue
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
although	IN	mark	O
VEGF	NN	compound	B-Gene_or_gene_product0
receptors	NNS	nsubj	I-Gene_or_gene_product0
were	VBD	cop	O
higher	JJR	advcl	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
than	IN	case	O
normal	JJ	amod	O
kidney	NN	nmod	B-Organ
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
up	RP	dep	O
-	HYPH	punct	O
regulation	NN	nsubj	O
of	IN	prep	O
only	RB	advmod	O
flt	JJ	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	pobj	I-Gene_or_gene_product3
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
003	CD	nsubj	O
)	-RRB-	punct	O
but	CC	cc	O
not	RB	neg	O
KDR	NN	conj	B-Gene_or_gene_product1
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
12	CD	ROOT	O
)	-RRB-	punct	O
or	CC	cc	O
flt	JJ	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
4	CD	conj	I-Gene_or_gene_product3
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
09	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
also	RB	advmod	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
C	NN	nmod	I-Gene_or_gene_product1
and	CC	cc	O
both	DT	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
receptors	NNS	nmod	O
flt	IN	compound	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
4	CD	attr	I-Gene_or_gene_product3
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
006	CD	attr	O
)	-RRB-	punct	O
and	CC	cc	O
KDR	NN	conj	B-Gene_or_gene_product1
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
03	CD	attr	O
)	-RRB-	punct	O
but	CC	cc	O
no	DT	neg	O
association	NN	conj	O
between	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
B	NNP	nmod	I-Gene_or_gene_product0
and	CC	cc	O
its	PRP$	nmod:poss	O
receptor	NN	conj	O
flt	NN	compound	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
23	CD	attr	O
)	-RRB-	punct	O
.	.	punct	O

A	DT	det	O
significant	JJ	amod	O
increase	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
flt	NNP	compound	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
1	CD	nmod	I-Gene_or_gene_product3
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	nmod	O
)	-RRB-	punct	O
,	,	punct	O
KDR	NN	nmod	B-Gene_or_gene_product1
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
02	CD	nummod	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
flt	JJ	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
4	CD	nummod	I-Gene_or_gene_product3
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	conj	O
0	CD	dobj	O
.	.	punct	O
01	CD	dep	O
)	-RRB-	punct	O
but	CC	cc	O
not	RB	neg	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
B	NN	conj	I-Gene_or_gene_product0
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
82	CD	dep	O
)	-RRB-	punct	O
or	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C	NN	conj	I-Gene_or_gene_product0
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
52	CD	dep	O
)	-RRB-	punct	O
expression	NN	ROOT	O
in	IN	case	O
clear	JJ	amod	B-Cell
cell	NN	nmod	I-Cell
compared	VBN	case	O
with	IN	case	O
chromophil	NN	compound	B-Cancer
(	-LRB-	punct	I-Cancer
papillary	JJ	appos	I-Cancer
)	-RRB-	punct	I-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
association	NN	nsubjpass	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
between	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
B	NNP	nmod	I-Gene_or_gene_product0
,	,	punct	O
VEGF	NN	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
C	NNP	conj	I-Gene_or_gene_product3
,	,	punct	O
flt	NNP	conj	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	dep	I-Gene_or_gene_product3
,	,	punct	O
KDR	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
and	CC	cc	O
flt	NNP	conj	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
4	CD	nummod	I-Gene_or_gene_product1
with	IN	case	O
patient	NN	compound	B-Organism
sex	NN	nmod	O
,	,	punct	O
patient	NN	compound	B-Organism
age	NN	conj	O
,	,	punct	O
or	CC	cc	O
tumor	NN	compound	B-Cancer
size	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
greater	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
effect	NN	nsubjpass	O
of	IN	case	O
von	NN	compound	B-Gene_or_gene_product0
Hippel	NNP	compound	I-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
Lindau	NNP	compound	I-Gene_or_gene_product0
(	-LRB-	punct	O
VHL	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
gene	NN	nmod	O
and	CC	cc	O
hypoxia	NN	conj	O
on	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
B	NNP	compound	I-Gene_or_gene_product0
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C	NN	conj	I-Gene_or_gene_product0
expression	NN	nmod	O
in	IN	case	O
the	DT	det	O
renal	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
786	CD	nummod	I-Cell
-	SYM	punct	I-Cell
0	CD	nummod	I-Cell
transfected	VBN	acl	O
with	IN	prep	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	pobj	O
and	CC	cc	O
mutant	JJ	amod	O
VHL	NN	conj	B-Gene_or_gene_product1
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
growing	VBG	amod	O
cells	NNS	nmod	B-Cell
under	IN	case	O
21	CD	compound	O
%	NN	compound	O
O2	CD	nmod	O
-	:	punct	O
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
1	CD	nummod	O
%	NN	compound	O
O2	CD	ROOT	O
.	.	punct	O

In	IN	case	O
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
VHL	NN	compound	B-Gene_or_gene_product1
cells	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
VEGF	NNP	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
A	NN	nsubjpass	I-Gene_or_gene_product0
was	VBD	auxpass	O
significantly	RB	advmod	O
up	RB	advmod	O
-	HYPH	punct	O
regulated	VBN	ROOT	O
under	IN	case	O
hypoxic	JJ	nmod	O
compared	VBN	case	O
with	IN	case	O
normoxic	JJ	amod	O
conditions	NNS	advcl	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
001	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
expression	NN	nsubjpass	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C	NN	nmod	I-Gene_or_gene_product0
was	VBD	auxpass	O
reduced	VBN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
002	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Nevertheless	RB	advmod	O
,	,	punct	O
the	DT	det	O
repression	NN	nsubjpass	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
C	NN	nmod	I-Gene_or_gene_product1
was	VBD	auxpass	O
lost	VBN	ROOT	O
in	IN	case	O
mutant	JJ	amod	O
VHL	NN	compound	B-Gene_or_gene_product1
cell	NN	compound	O
lines	NNS	nmod	O
under	IN	case	O
hypoxia	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
VEGF	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
B	NN	nsubjpass	I-Gene_or_gene_product1
was	VBD	auxpass	O
not	RB	neg	O
regulated	VBN	ROOT	O
by	IN	case	O
VHL	NN	nmod	B-Gene_or_gene_product1
despite	IN	case	O
clear	JJ	amod	O
up	RP	dep	O
-	HYPH	punct	O
regulation	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
strongly	RB	advmod	O
support	VBP	ROOT	O
an	DT	det	O
enhanced	VBN	amod	O
role	NN	dobj	O
for	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
in	IN	case	O
clear	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
by	IN	mark	O
regulating	VBG	advcl	O
angiogenesis	NN	dobj	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
lymphangiogenesis	NN	conj	O
.	.	punct	O

The	DT	det	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
clear	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
tumors	NNS	nsubj	I-Cancer
are	VBP	cop	O
able	JJ	ccomp	O
to	TO	mark	O
up	RB	dep	O
-	HYPH	punct	O
regulate	VB	xcomp	O
angiogenic	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
receptors	NNS	dobj	O
more	RBR	advmod	O
efficiently	RB	advmod	O
than	IN	case	O
chromophil	NN	nmod	B-Cancer
(	-LRB-	punct	O
papillary	JJ	appos	B-Cancer
)	-RRB-	punct	O
,	,	punct	O
that	WDT	mark	O
clear	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
tumors	NNS	nsubj	I-Cancer
can	MD	aux	O
use	VB	ccomp	O
pathways	NNS	dobj	O
independent	JJ	amod	O
of	IN	case	O
VHL	NN	nmod	B-Gene_or_gene_product1
to	TO	mark	O
regulate	VB	xcomp	O
angiogenesis	NN	dobj	O
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
combined	JJ	amod	O
regulation	NN	nsubj	O
may	MD	aux	O
account	VB	conj	O
for	IN	case	O
their	PRP$	nmod:poss	O
more	RBR	advmod	O
aggressive	JJ	amod	O
phenotype	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
suggests	VBZ	acl:relcl	O
that	IN	mark	O
targeting	VBG	csubj	O
VEGFR1	NN	dobj	B-Gene_or_gene_product3
(	-LRB-	punct	O
flt	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
l	NN	appos	I-Gene_or_gene_product2
)	-RRB-	punct	O
may	MD	aux	O
be	VB	cop	O
particularly	RB	advmod	O
effective	JJ	ccomp	O
in	IN	case	O
these	DT	det	O
tumor	NN	compound	B-Cancer
types	NNS	nmod	O
.	.	punct	O

Glucose	NN	compound	B-Simple_chemical
catabolism	NN	ROOT	O
in	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
:	:	punct	O
identification	NN	dep	O
and	CC	cc	O
characterization	NN	conj	O
of	IN	case	O
a	DT	det	O
marked	JJ	amod	O
activation	NN	compound	O
response	NN	nmod	O
of	IN	case	O
the	DT	det	O
type	NN	compound	B-Gene_or_gene_product2
II	CD	nummod	I-Gene_or_gene_product2
hexokinase	NN	compound	I-Gene_or_gene_product2
gene	NN	nmod	O
to	TO	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
signatures	NNS	nmod	O
of	IN	case	O
highly	RB	advmod	O
malignant	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
is	VBZ	cop	O
their	PRP$	nmod:poss	O
capacity	NN	ROOT	O
to	TO	mark	O
metabolize	VB	acl	O
more	JJR	amod	O
glucose	NN	dobj	B-Simple_chemical
to	TO	case	O
lactic	JJ	amod	B-Simple_chemical
acid	NN	nmod	I-Simple_chemical
than	IN	case	O
their	PRP$	nmod:poss	O
tissues	NNS	nmod	B-Tissue
of	IN	case	O
origin	NN	nmod	O
.	.	punct	O

Hepatomas	NNS	nsubj	B-Cancer
exhibiting	VBG	acl	O
this	DT	det	O
phenotype	NN	dobj	O
are	VBP	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
the	DT	det	O
high	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
type	NN	compound	B-Gene_or_gene_product2
II	CD	nummod	I-Gene_or_gene_product2
hexokinase	NN	nmod	I-Gene_or_gene_product2
,	,	punct	O
which	WDT	nsubj	O
supplies	VBZ	acl:relcl	O
such	JJ	amod	O
tumors	NNS	dobj	B-Cancer
with	IN	case	O
abundant	JJ	amod	O
amounts	NNS	nmod	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
6	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phosphate	NN	dep	I-Simple_chemical
,	,	punct	O
a	DT	det	O
significant	JJ	amod	O
carbon	NN	appos	B-Simple_chemical
and	CC	cc	O
energy	NN	compound	O
source	NN	conj	O
especially	RB	advmod	O
under	IN	prep	O
hypoxic	JJ	amod	O
conditions	NNS	pobj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
distal	JJ	amod	O
region	NN	nsubj	O
of	IN	case	O
the	DT	det	O
hepatoma	NN	compound	B-Cancer
type	NN	compound	B-Gene_or_gene_product2
II	CD	nummod	I-Gene_or_gene_product2
hexokinase	NN	compound	I-Gene_or_gene_product2
promoter	NN	nmod	O
displays	VBZ	ccomp	O
consensus	NN	compound	O
motifs	NNS	dobj	O
for	IN	case	O
hypoxia	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
inducible	JJ	amod	I-Gene_or_gene_product1
factor	NN	nmod	I-Gene_or_gene_product1
(	-LRB-	punct	O
HIF	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
)	-RRB-	punct	O
that	WDT	nsubj	O
overlap	VBP	acl:relcl	O
E	NN	compound	O
-	HYPH	punct	O
box	NN	compound	O
sequences	NNS	dobj	O
known	VBN	acl	O
to	TO	mark	O
be	VB	cop	O
related	JJ	xcomp	O
in	IN	case	O
other	JJ	amod	O
gene	NN	compound	O
promoters	NNS	nmod	O
to	TO	case	O
glucose	NN	compound	B-Simple_chemical
response	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
subjecting	VBG	csubj	O
transfected	VBN	amod	O
hepatoma	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
to	TO	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
activates	VBZ	ccomp	O
the	DT	det	O
type	NN	compound	B-Gene_or_gene_product2
II	CD	nummod	I-Gene_or_gene_product2
hexokinase	NN	compound	I-Gene_or_gene_product2
promoter	NN	dobj	O
almost	RB	advmod	O
3	CD	nummod	O
-	HYPH	punct	O
fold	NN	dep	O
,	,	punct	O
a	DT	det	O
value	NN	appos	O
that	WDT	nsubj	O
approaches	NNS	relcl	O
7	CD	nummod	O
-	HYPH	punct	O
fold	JJ	dobj	O
in	IN	prep	O
the	DT	det	O
presence	NN	pobj	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
these	DT	det	O
findings	NNS	nmod	O
is	VBZ	cop	O
the	DT	det	O
induction	NN	ROOT	O
under	IN	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
of	IN	case	O
the	DT	det	O
HIF	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
protein	NN	nmod	O
.	.	punct	O

Reporter	NN	compound	O
gene	NN	nsubj	O
analyses	NNS	nsubj	O
with	IN	case	O
a	DT	det	O
series	NN	nmod	O
of	IN	case	O
nested	JJ	amod	O
deletion	NN	compound	O
mutants	NNS	nmod	O
of	IN	case	O
the	DT	det	O
hepatoma	NN	compound	B-Cancer
type	NN	compound	B-Gene_or_gene_product2
II	CD	nummod	I-Gene_or_gene_product2
hexokinase	NN	compound	I-Gene_or_gene_product2
promoter	NN	nmod	O
show	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
significant	JJ	amod	O
fraction	NN	nsubj	O
of	IN	case	O
the	DT	det	O
total	JJ	amod	O
activation	NN	nmod	O
observed	VBN	acl	O
under	IN	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
localizes	VBZ	ccomp	O
to	TO	case	O
the	DT	det	O
distal	JJ	amod	O
region	NN	nmod	O
where	WRB	advmod	O
the	DT	det	O
overlapping	VBG	amod	O
HIF	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
/	SYM	punct	O
E	NNP	compound	O
-	HYPH	punct	O
box	NN	compound	O
sequences	NNS	nsubj	O
are	VBP	cop	O
located	JJ	acl:relcl	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
DNase	NN	compound	B-Gene_or_gene_product2
I	CD	nummod	I-Gene_or_gene_product2
footprint	NN	compound	O
analysis	NN	nsubj	O
with	IN	case	O
a	DT	det	O
segment	NN	nmod	O
of	IN	case	O
the	DT	det	O
promoter	NN	nmod	O
containing	VBG	acl	O
these	DT	det	O
elements	NNS	dobj	O
reveals	VBZ	ROOT	O
the	DT	det	O
binding	NN	dobj	O
of	IN	case	O
several	JJ	amod	O
nuclear	JJ	amod	B-Cellular_component
proteins	NNS	nmod	O
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
these	DT	det	O
novel	JJ	amod	O
studies	NNS	nsubj	O
identify	VBP	ROOT	O
and	CC	cc	O
characterize	VBP	conj	O
a	DT	det	O
marked	JJ	amod	O
glucose	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
modulated	VBN	amod	O
activation	NN	compound	O
response	NN	dobj	O
of	IN	case	O
the	DT	det	O
type	NN	compound	B-Gene_or_gene_product2
II	CD	nummod	I-Gene_or_gene_product2
hexokinase	NN	compound	I-Gene_or_gene_product2
gene	NN	nmod	O
to	TO	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
within	IN	case	O
highly	RB	advmod	O
glycolytic	JJ	amod	O
hepatoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
a	DT	det	O
property	NN	appos	O
that	WDT	nsubj	O
may	MD	aux	O
help	VB	acl:relcl	O
assure	VB	dobj	O
that	IN	mark	O
such	JJ	amod	O
cells	NNS	nsubj	B-Cell
exhibit	VBP	ccomp	O
a	DT	det	O
growth	NN	compound	O
and	CC	cc	O
survival	NN	conj	O
advantage	NN	dobj	O
over	IN	case	O
their	PRP$	nmod:poss	O
parental	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
origin	NN	nmod	O
.	.	punct	O

Membrane	NNP	npadvmod	O
-	HYPH	punct	O
anchored	VBN	amod	O
Cbl	NN	nsubj	B-Gene_or_gene_product1
suppresses	VBZ	ROOT	O
Hck	NN	compound	B-Gene_or_gene_product1
protein	NN	compound	O
-	HYPH	punct	O
tyrosine	NN	compound	B-Amino_acid
kinase	NN	nmod:npmod	O
mediated	JJ	amod	O
cellular	JJ	amod	B-Cell
transformation	NN	dobj	O
.	.	punct	O

The	DT	det	O
mammalian	JJ	amod	B-Organism
proto	NN	compound	O
-	:	punct	O
oncogene	NN	compound	O
Cbl	NN	nsubj	B-Gene_or_gene_product1
and	CC	cc	O
its	PRP$	nmod:poss	O
cellular	JJ	amod	B-Cell
homologues	NNS	conj	O
in	IN	case	O
Caenorhabditis	NN	compound	B-Organism
elegans	NNS	nmod	I-Organism
(	-LRB-	punct	O
Sli	NN	compound	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
)	-RRB-	punct	O
and	CC	cc	O
Drosophila	NN	conj	B-Organism
(	-LRB-	punct	O
D	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
Cbl	NN	appos	I-Gene_or_gene_product1
)	-RRB-	punct	O
are	VBP	cop	O
negative	JJ	amod	O
regulators	NNS	ROOT	O
of	IN	case	O
some	DT	det	O
growth	NN	compound	B-Gene_or_gene_product2
factor	NN	compound	I-Gene_or_gene_product2
receptor	NN	compound	I-Gene_or_gene_product2
signaling	NN	compound	O
pathways	NNS	nmod	O
.	.	punct	O

Herein	RB	advmod	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
Cbl	NN	nsubj	B-Gene_or_gene_product1
can	MD	aux	O
negatively	RB	advmod	O
regulate	VB	ccomp	O
another	DT	det	O
signaling	VBG	compound	O
molecule	NN	dobj	O
,	,	punct	O
namely	RB	advmod	O
theSrc	NN	amod	B-Gene_or_gene_product2
-	HYPH	punct	O
family	NN	compound	O
kinase	NN	compound	O
Hck	NN	appos	B-Gene_or_gene_product2
by	IN	mark	O
targeting	VBG	advcl	O
it	PRP	dobj	O
for	IN	prep	O
degradation	NN	pobj	O
.	.	punct	O

Hck	NNP	npadvmod	B-Gene_or_gene_product1
-	HYPH	punct	O
mediated	VBN	amod	O
cellular	JJ	amod	B-Cell
transformation	NN	nsubjpass	O
of	IN	case	O
murine	JJ	amod	B-Organism
fibroblasts	NNS	nmod	B-Cell
is	VBZ	auxpass	O
reverted	VBN	ROOT	O
by	IN	case	O
ectopic	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
a	DT	det	O
membrane	NN	nmod:npmod	B-Cellular_component
-	HYPH	punct	O
anchored	VBN	amod	O
allele	NN	nmod	O
of	IN	case	O
Cbl	NN	nmod	B-Gene_or_gene_product1
as	IN	mark	O
assessed	VBN	advcl	O
by	IN	case	O
the	DT	det	O
cellular	JJ	amod	B-Cell
morphology	NN	nmod	O
,	,	punct	O
suppression	NN	appos	O
of	IN	case	O
anchorage	JJ	amod	O
independent	JJ	amod	O
growth	NN	nmod	O
,	,	punct	O
and	CC	cc	O
an	DT	det	O
overall	JJ	amod	O
reduction	NN	conj	O
in	IN	case	O
the	DT	det	O
total	JJ	amod	O
tyrosine	NN	compound	B-Amino_acid
phosphorylation	NN	compound	O
levels	NNS	nmod	O
within	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
Cbl	NN	nmod	B-Gene_or_gene_product1
at	IN	case	O
the	DT	det	O
plasma	NN	compound	B-Cellular_component
membrane	NN	compound	I-Cellular_component
targets	NNS	ROOT	O
both	CC	cc:preconj	O
Hck	NNP	dobj	B-Gene_or_gene_product2
and	CC	cc	O
itself	PRP	conj	O
for	IN	case	O
ubiquitination	NN	nmod	O
and	CC	cc	O
degradation	NN	conj	O
,	,	punct	O
requiring	VBG	advcl	O
an	DT	det	O
intact	JJ	amod	O
RING	NN	compound	O
finger	NN	dobj	O
.	.	punct	O

Pharmacological	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proteasome	NN	nmod	O
prevents	VBZ	ROOT	O
the	DT	det	O
degradation	NN	dobj	O
of	IN	case	O
Hck	NNP	compound	B-Gene_or_gene_product1
correlating	NN	nmod	O
with	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
phosphotyrosine	NN	compound	B-Amino_acid
levels	NNS	nmod	O
within	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Activated	VBN	amod	O
Hck	NN	nsubj	B-Gene_or_gene_product2
and	CC	cc	O
membrane	NN	npadvmod	B-Cellular_component
-	HYPH	punct	O
anchored	VBN	amod	O
Cbl	NN	conj	B-Gene_or_gene_product1
are	VBP	cop	O
present	JJ	ROOT	O
in	IN	case	O
similar	JJ	amod	O
subcellular	JJ	amod	B-Cellular_component
localizations	NNS	nmod	O
and	CC	cc	O
co	NN	compound	O
-	HYPH	punct	O
immunoprecipitate	NN	conj	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
their	PRP$	nmod:poss	O
interaction	NN	nsubjpass	O
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
subsequent	JJ	amod	O
ubiquitination	NN	nmod	O
and	CC	cc	O
degradation	NN	conj	O
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
both	DT	cc:preconj	O
constitutively	RB	advmod	O
active	JJ	amod	O
and	CC	cc	O
kinase	NN	nmod:npmod	O
-	HYPH	punct	O
inactive	JJ	conj	O
Hck	NNP	nsubj	B-Gene_or_gene_product1
interact	VBP	ROOT	O
with	IN	prep	O
and	CC	cc	O
are	VBP	auxpass	O
targeted	VBN	conj	O
for	IN	case	O
degradation	NN	nmod	O
by	IN	case	O
Cbl	NN	nmod	B-Gene_or_gene_product1
.	.	punct	O

This	DT	det	O
work	NN	nsubj	O
illustrates	VBZ	ROOT	O
alternate	JJ	amod	O
means	NNS	dobj	O
to	TO	aux	O
regulate	VB	xcomp	O
Src	NNP	compound	B-Gene_or_gene_product2
-	HYPH	punct	O
family	NN	compound	O
kinases	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
suggests	VBZ	conj	O
that	IN	mark	O
Cbl	NN	nsubj	B-Gene_or_gene_product1
may	MD	aux	O
be	VB	cop	O
able	JJ	ccomp	O
to	TO	mark	O
suppress	VB	xcomp	O
many	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	dobj	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
activated	VBN	acl:relcl	O
in	IN	case	O
various	JJ	amod	O
proliferative	JJ	amod	O
syndromes	NNS	nmod	O
including	VBG	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

Multiple	JJ	amod	O
stages	NNS	ROOT	O
of	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
modelled	VBN	acl	O
by	IN	case	O
co	NN	compound	O
-	HYPH	punct	O
expression	NN	nmod	O
of	IN	case	O
telomerase	NN	compound	B-Gene_or_gene_product0
reverse	JJ	amod	I-Gene_or_gene_product0
transcriptase	NN	nmod	I-Gene_or_gene_product0
,	,	punct	O
SV40	NN	compound	B-Gene_or_gene_product2
T	NN	compound	I-Gene_or_gene_product2
antigen	NN	conj	I-Gene_or_gene_product2
and	CC	cc	O
oncogenic	JJ	amod	O
N	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	conj	I-Gene_or_gene_product2
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
modelled	VBN	ROOT	O
multiple	JJ	amod	O
stages	NNS	dobj	O
of	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
ECs	NNS	appos	B-Cell
)	-RRB-	punct	O
by	IN	mark	O
overexpressing	VBG	advcl	O
the	DT	det	O
catalytic	JJ	amod	O
subunit	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
telomerase	NN	nmod	B-Gene_or_gene_product0
(	-LRB-	punct	O
hTERT	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
,	,	punct	O
together	RB	advmod	O
with	IN	case	O
SV40	NN	compound	B-Organism
T	NN	compound	B-Gene_or_gene_product2
antigen	NN	advcl	I-Gene_or_gene_product2
(	-LRB-	punct	O
SV40T	NN	appos	B-Gene_or_gene_product2
)	-RRB-	punct	O
and	CC	cc	O
oncogenic	JJ	amod	O
N	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	conj	I-Gene_or_gene_product2
.	.	punct	O

Transfection	NN	nsubj	O
with	IN	case	O
hTERT	NN	nmod	B-Gene_or_gene_product1
alone	RB	advmod	O
,	,	punct	O
led	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
immortalization	NN	nmod	O
of	IN	case	O
two	CD	compound	O
out	IN	advmod	O
of	IN	advmod	O
three	CD	nummod	O
cultures	NNS	nmod	O
of	IN	case	O
bone	NN	compound	B-Cell
marrow	NN	nmod:npmod	I-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
ECs	NNS	nmod	I-Cell
(	-LRB-	punct	O
BMECs	NNS	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

One	CD	nummod	O
hTERT	NN	compound	B-Gene_or_gene_product1
transduced	VBD	amod	O
BMEC	NN	compound	B-Cell
culture	NN	nsubj	O
underwent	VBD	ROOT	O
a	DT	det	O
long	JJ	amod	O
proliferative	JJ	amod	O
lag	NN	dobj	O
before	IN	mark	O
resuming	VBG	advcl	O
proliferation	NN	dobj	O
.	.	punct	O

BMECs	NNS	nsubj	B-Cell
transfected	VBN	acl	O
with	IN	case	O
hTERT	NN	nmod	B-Gene_or_gene_product1
alone	RB	advmod	O
were	VBD	cop	O
functionally	RB	advmod	O
and	CC	advmod	O
phenotypically	RB	advmod	O
normal	JJ	ROOT	O
.	.	punct	O

BMECs	NNS	nsubj	B-Cell
transfected	VBN	acl	O
with	IN	case	O
SV40T	NN	nmod	B-Gene_or_gene_product2
(	-LRB-	punct	O
BMSVTs	NNS	appos	B-Cell
)	-RRB-	punct	O
had	VBD	ROOT	O
an	DT	det	O
extended	VBN	amod	O
lifespan	NN	dobj	O
,	,	punct	O
but	CC	cc	O
eventually	RB	advmod	O
succumbed	VBN	conj	O
to	TO	case	O
crisis	NN	nmod	O
.	.	punct	O

BMSVTs	NNS	nsubj	B-Cell
exhibited	VBD	ROOT	O
a	DT	det	O
partially	RB	advmod	O
transformed	VBN	amod	O
phenotype	NN	dobj	O
,	,	punct	O
demonstrating	VBG	advcl	O
growth	NN	compound	O
factor	NN	compound	O
independence	NN	dobj	O
,	,	punct	O
altered	JJ	amod	O
antigen	NN	compound	O
expression	NN	conj	O
and	CC	cc	O
forming	VBG	conj	O
tiny	JJ	amod	O
,	,	punct	O
infrequent	NN	amod	O
colonies	NNS	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Transduction	NN	nsubj	O
of	IN	case	O
BMSVTs	NNS	nmod	B-Cell
with	IN	case	O
hTERT	NNS	nmod	B-Gene_or_gene_product1
resulted	VBD	ROOT	O
in	IN	case	O
immortalization	NN	nmod	O
of	IN	case	O
4	CD	compound	O
out	IN	advmod	O
of	IN	advmod	O
4	CD	nummod	O
cultures	NNS	nmod	B-Cell
.	.	punct	O

BMSVTs	NNS	nsubj	B-Cell
immortalized	VBN	acl	O
with	IN	case	O
hTERT	NN	nmod	B-Gene_or_gene_product1
formed	VBD	ROOT	O
large	JJ	amod	O
colonies	NNS	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
small	JJ	amod	O
transient	JJ	amod	O
tumours	NNS	conj	B-Cancer
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

BMECs	NNS	compound	B-Cell
co	NN	compound	O
-	HYPH	punct	O
expressing	VBG	amod	O
SV40T	NN	nsubj	B-Gene_or_gene_product2
,	,	punct	O
hTERT	NN	appos	B-Gene_or_gene_product1
and	CC	cc	O
N	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	conj	I-Gene_or_gene_product2
exhibited	VBD	ROOT	O
an	DT	det	O
overtly	RB	advmod	O
transformed	VBN	amod	O
phenotype	NN	dobj	O
;	:	punct	O
forming	VBG	advcl	O
very	RB	advmod	O
large	JJ	amod	O
colonies	NNS	dobj	O
with	IN	case	O
an	DT	det	O
altered	JJ	amod	O
morphology	NN	nmod	O
and	CC	cc	O
generating	VBG	conj	O
rapidly	RB	advmod	O
growing	VBG	amod	O
tumours	NNS	dobj	B-Cancer
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

These	DT	det	O
investigations	NNS	nsubj	O
demonstrate	VBP	ROOT	O
transformation	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
ECs	NNS	nmod	B-Cell
to	TO	case	O
an	DT	det	O
overtly	RB	advmod	O
malignant	JJ	amod	O
phenotype	NN	nmod	O
.	.	punct	O

This	DT	det	O
model	NN	nsubj	O
will	MD	aux	O
be	VB	cop	O
useful	JJ	ROOT	O
for	IN	mark	O
understanding	NN	advcl	O
mechanisms	NNS	dobj	O
underlying	VBG	acl	O
vascular	JJ	amod	B-Pathological_formation
and	CC	cc	O
angiogenic	JJ	conj	B-Pathological_formation
neoplasias	NNS	dobj	I-Pathological_formation
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
for	IN	case	O
testing	VBG	amod	O
drugs	NNS	conj	O
designed	VBN	acl	O
to	TO	mark	O
curtail	VB	xcomp	O
aberrant	JJ	amod	O
EC	NN	compound	B-Cell
growth	NN	dobj	O
.	.	punct	O

Retinal	JJ	amod	B-Multi-tissue_structure
microangiopathies	NNS	nsubj	O
overlying	VBG	ROOT	O
pigment	NN	amod	B-Tissue
epithelial	JJ	amod	I-Tissue
detachment	NN	dobj	O
in	IN	prep	O
age	NN	npadvmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	pobj	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
evaluate	VB	dep	O
alterations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
retinal	JJ	amod	B-Multi-tissue_structure
vasculature	NN	nmod	I-Multi-tissue_structure
overlying	NN	acl	O
pigment	NN	amod	B-Pathological_formation
epithelial	JJ	amod	I-Pathological_formation
detachments	NNS	dobj	I-Pathological_formation
(	-LRB-	punct	O
PED	NN	appos	B-Pathological_formation
)	-RRB-	punct	O
in	IN	case	O
exudative	JJ	amod	O
age	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	nmod	O
(	-LRB-	punct	O
ARMD	NN	appos	O
)	-RRB-	punct	O
using	VBG	acl	O
indocyanine	NN	amod	B-Simple_chemical
green	JJ	amod	I-Simple_chemical
and	CC	cc	O
fluorescein	NN	conj	B-Simple_chemical
angiography	NN	dobj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Forty	CD	compound	O
-	HYPH	punct	O
one	CD	nummod	O
patients	NNS	nsubj	B-Organism
(	-LRB-	punct	O
41	CD	nummod	O
eyes	NNS	appos	B-Organ
)	-RRB-	punct	O
with	IN	case	O
a	DT	det	O
clinical	JJ	amod	O
diagnosis	NN	nmod	O
of	IN	case	O
exudative	JJ	amod	O
ARMD	NN	nmod	O
with	IN	case	O
PED	NN	nmod	B-Pathological_formation
underwent	VBD	appos	O
simultaneous	JJ	amod	O
fluorescein	NN	dobj	B-Simple_chemical
and	CC	cc	O
indocyanine	NN	amod	B-Simple_chemical
green	JJ	amod	I-Simple_chemical
angiography	NN	conj	O
,	,	punct	O
also	RB	advmod	O
under	IN	case	O
high	JJ	amod	O
(	-LRB-	punct	O
10	CD	nummod	O
degrees	NNS	dep	O
)	-RRB-	punct	O
magnification	NN	nmod	O
.	.	punct	O

Vascular	JJ	amod	B-Multi-tissue_structure
abnormalities	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
retina	NN	nmod	B-Multi-tissue_structure
were	VBD	auxpass	O
compared	VBN	ROOT	O
between	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
vascularized	JJ	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
34	CD	dobj	O
,	,	punct	O
group	NN	appos	O
1	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
nonvascularized	VBN	conj	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
7	CD	dep	O
,	,	punct	O
group	NN	appos	O
2	CD	nummod	O
)	-RRB-	punct	O
PED	NN	dep	B-Pathological_formation
on	IN	case	O
indocyanine	NN	amod	B-Simple_chemical
green	JJ	amod	I-Simple_chemical
angiography	NN	nmod	O
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
the	DT	det	O
size	NN	nmod	O
of	IN	case	O
the	DT	det	O
PED	NN	nmod	B-Pathological_formation
and	CC	cc	O
the	DT	det	O
presence	NN	conj	O
of	IN	case	O
serous	JJ	amod	B-Multi-tissue_structure
retinal	JJ	amod	I-Multi-tissue_structure
detachment	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
In	IN	case	O
all	DT	nmod	O
,	,	punct	O
67	CD	nummod	O
vascular	JJ	amod	B-Multi-tissue_structure
abnormalities	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	dep	O
by	IN	case	O
indocyanine	NN	amod	B-Simple_chemical
green	JJ	amod	I-Simple_chemical
angiography	NN	nmod	O
and	CC	cc	O
only	RB	advmod	O
22	CD	conj	O
by	IN	case	O
fluorescein	NN	compound	B-Simple_chemical
angiography	NN	nmod	O
;	:	punct	O
this	DT	det	O
finding	NN	nsubj	O
was	VBD	cop	O
statistically	RB	advmod	O
significant	JJ	appos	O
(	-LRB-	punct	O
P	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
0001	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
finding	NN	nsubjpass	O
of	IN	case	O
retinal	JJ	amod	B-Multi-tissue_structure
vasculopathy	NN	nmod	O
(	-LRB-	punct	O
32	CD	nummod	O
patients	NNS	dep	B-Organism
in	IN	case	O
group	NN	nmod	O
1	CD	nummod	O
and	CC	cc	O
two	CD	nummod	O
patients	NNS	conj	B-Organism
in	IN	case	O
group	NN	nmod	O
2	CD	nummod	O
)	-RRB-	punct	O
was	VBD	auxpass	O
directly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
choroidal	JJ	amod	B-Multi-tissue_structure
neovascularizations	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
002	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
also	RB	advmod	O
a	DT	det	O
direct	JJ	amod	O
correlation	NN	attr	O
between	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
choroidal	JJ	amod	B-Multi-tissue_structure
neovascularization	NN	nmod	O
and	CC	cc	O
size	NN	conj	O
of	IN	case	O
the	DT	det	O
PED	NN	nmod	B-Pathological_formation
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
03	CD	attr	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
retinal	JJ	amod	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
findings	NNS	nmod	O
was	VBD	auxpass	O
not	RB	neg	O
significantly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
serous	JJ	amod	B-Organism_substance
elevation	NN	nmod	O
of	IN	case	O
the	DT	det	O
retina	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Retinal	JJ	amod	B-Multi-tissue_structure
vasculopathies	NNS	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
observed	VBN	dep	O
in	IN	case	O
eyes	NNS	nmod	B-Organ
with	IN	case	O
PED	NN	nmod	B-Pathological_formation
and	CC	cc	O
are	VBP	cop	O
detectable	JJ	conj	O
by	IN	case	O
indocyanine	NN	amod	B-Simple_chemical
green	JJ	amod	I-Simple_chemical
and	CC	cc	O
fluorescein	NN	conj	B-Simple_chemical
angiography	NN	nmod	O
.	.	punct	O

Fas	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	O
Fas	NN	compound	B-Gene_or_gene_product0
ligand	NN	compound	I-Gene_or_gene_product0
signaling	NN	compound	O
pathway	NN	nsubj	O
mediates	VBZ	ROOT	O
an	DT	det	O
interleukin	NN	nmod:npmod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
12	CD	npadvmod	I-Gene_or_gene_product2
-	HYPH	punct	O
induced	VBN	amod	O
rejection	NN	dobj	O
of	IN	case	O
a	DT	det	O
murine	JJ	amod	B-Organism
prostate	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
system	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	dep	O
:	:	punct	O
Recent	JJ	amod	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
anti	JJ	amod	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
activities	NNS	nsubj	O
of	IN	case	O
interleukin	NN	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
12	CD	nummod	I-Gene_or_gene_product3
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
12	CD	nmod	I-Gene_or_gene_product2
)	-RRB-	punct	O
involve	VBP	ccomp	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Fas	NN	nsubj	B-Gene_or_gene_product2
(	-LRB-	punct	O
APO	NN	compound	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
/	:	punct	O
CD95	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
type	NN	compound	O
I	CD	nummod	O
membrane	NN	compound	B-Cellular_component
protein	NN	ROOT	O
that	WDT	nsubj	O
is	VBZ	cop	O
capable	JJ	acl:relcl	O
of	IN	mark	O
initiating	VBG	advcl	O
an	DT	det	O
apoptosis	NN	compound	O
signaling	NN	compound	O
pathway	NN	dobj	O
when	WRB	advmod	O
bound	VBN	advcl	O
to	TO	case	O
its	PRP$	nmod:poss	O
ligand	NN	nmod	O
(	-LRB-	punct	O
FasL	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
undertook	VBD	ROOT	O
this	DT	det	O
study	NN	dobj	O
to	TO	mark	O
test	VB	xcomp	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
Fas	NN	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
FasL	NN	nmod:npmod	B-Gene_or_gene_product1
-	:	punct	O
mediated	VBN	amod	O
apoptosis	NN	nsubj	O
plays	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
IL	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
12	CD	nummod	I-Gene_or_gene_product2
-	HYPH	punct	O
induced	VBN	amod	O
tumor	NN	compound	B-Cancer
regression	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
An	DT	det	O
mIL	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
12	CD	nummod	I-Gene_or_gene_product2
expression	NN	compound	O
vector	NN	nsubjpass	O
driven	VBN	acl	O
by	IN	case	O
cytomegalovirus	NN	compound	B-Organism
promoter	NN	nmod	O
was	VBD	auxpass	O
used	VBN	dep	O
to	TO	mark	O
express	VB	xcomp	O
murine	JJ	amod	B-Organism
IL	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
12	CD	nummod	I-Gene_or_gene_product2
cDNA	NN	dobj	O
in	IN	case	O
the	DT	det	O
RM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
9	CD	nummod	I-Cell
murine	JJ	amod	I-Cell
prostate	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
.	.	punct	O

Control	NNP	amod	O
RM	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
9	CD	nummod	I-Cell
cells	NNS	nsubjpass	I-Cell
and	CC	cc	O
RM	NN	compound	B-Cell
-	:	punct	I-Cell
9	CD	nummod	I-Cell
cells	NNS	conj	I-Cell
stably	RB	advmod	O
transfected	VBN	acl	O
with	IN	case	O
IL	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
12	CD	nummod	I-Gene_or_gene_product2
gene	NN	nmod	O
(	-LRB-	punct	O
RM	NN	compound	O
-	:	punct	O
9	CD	dep	O
-	HYPH	punct	O
IL12	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
were	VBD	auxpass	O
inoculated	VBN	ROOT	O
subcutaneously	RB	advmod	B-Immaterial_anatomical_entity
in	IN	case	O
4	CD	nummod	O
-	HYPH	punct	O
to	TO	dep	O
6	CD	pobj	O
-	HYPH	punct	O
week	NN	npadvmod	O
-	HYPH	punct	O
old	JJ	amod	O
male	JJ	amod	O
C57BL	NN	nmod	B-Organism
/	:	punct	I-Organism
J6	NN	compound	I-Organism
mice	NNS	dep	I-Organism
.	.	punct	O

Tumor	NN	compound	B-Cancer
size	NN	nsubjpass	O
was	VBD	auxpass	O
measured	VBN	ROOT	O
every	DT	det	O
3	CD	nummod	O
days	NNS	dobj	O
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
and	CC	cc	O
immunohistochemical	JJ	conj	O
assays	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
Fas	NN	compound	B-Gene_or_gene_product1
and	CC	cc	O
FasL	NN	compound	B-Gene_or_gene_product1
protein	NN	compound	O
expression	NN	dobj	O
.	.	punct	O

In	FW	amod	O
situ	FW	dep	O
fluorescent	NN	amod	O
end	NN	compound	O
labeling	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
label	VB	xcomp	O
apoptotic	JJ	amod	O
cells	NNS	dobj	B-Cell
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
IL	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
12	CD	nummod	I-Gene_or_gene_product2
-	HYPH	punct	O
expressing	VBG	amod	O
RM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
9	CD	nummod	I-Cell
prostate	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
transplanted	VBN	acl	O
into	IN	case	O
C57BL	NN	nmod	B-Organism
/	:	punct	I-Organism
J6	NN	compound	I-Organism
mice	NNS	nsubj	I-Organism
grew	VBD	ROOT	O
more	RBR	advmod	O
slowly	RB	advmod	O
than	IN	case	O
control	JJ	amod	O
RM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
9	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
vector	NN	conj	O
control	NN	amod	O
RM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
9	CD	compound	I-Cell
-	HYPH	punct	I-Cell
Luc	NN	compound	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

The	DT	det	O
average	JJ	amod	O
survival	NN	compound	O
time	NN	nsubj	O
of	IN	case	O
the	DT	det	O
RM	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
9	CD	nummod	I-Organism
-	HYPH	punct	I-Organism
IL12	NN	compound	I-Organism
mice	NNS	nmod	I-Organism
was	VBD	cop	O
longer	JJR	advmod	O
than	IN	quantmod	O
53	CD	nummod	O
days	NNS	ROOT	O
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
mean	NN	amod	O
survival	NN	nsubj	O
for	IN	case	O
mice	NNS	nmod	B-Organism
transplanted	VBN	acl	O
with	IN	case	O
control	JJ	amod	O
RM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
9	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
was	VBD	cop	O
only	RB	advmod	O
16	CD	nummod	O
days	NNS	parataxis	O
.	.	punct	O

Apoptotic	JJ	amod	O
cells	NNS	nsubj	B-Cell
were	VBD	cop	O
more	RBR	advmod	O
numerous	JJ	ROOT	O
in	IN	case	O
RM	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
9	CD	nummod	I-Cancer
-	HYPH	punct	I-Cancer
IL12	NN	compound	I-Cancer
tumors	NNS	dobj	I-Cancer
:	:	punct	O
10	CD	dep	O
.	.	punct	O
3	CD	nummod	O
%	NN	ROOT	O
vs	CC	cc	O
.	.	punct	O
1	LS	ROOT	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
in	IN	case	O
control	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
001	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Fas	NN	compound	B-Gene_or_gene_product2
and	CC	cc	O
FasL	NN	conj	B-Gene_or_gene_product1
proteins	NNS	nsubjpass	O
were	VBD	auxpass	O
increased	VBN	ROOT	O
approximately	RB	advmod	O
twofold	RB	advmod	O
in	IN	case	O
the	DT	det	O
RM	NNP	compound	B-Cancer
-	HYPH	punct	I-Cancer
9	CD	nummod	I-Cancer
-	HYPH	punct	I-Cancer
IL12	NN	compound	I-Cancer
tumors	NNS	nmod	I-Cancer
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
RM	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
9	CD	nummod	I-Cancer
control	NN	compound	I-Cancer
tumors	NNS	nmod	I-Cancer
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
Western	NN	compound	O
blot	NN	nmod	O
and	CC	cc	O
immunohistochemical	JJ	amod	O
analyses	NNS	conj	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
The	DT	det	O
Fas	NN	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
FasL	NN	npadvmod	B-Gene_or_gene_product1
-	:	punct	O
mediated	VBN	amod	O
apoptosis	NN	compound	O
pathway	NN	nsubj	O
may	MD	aux	O
contribute	VB	appos	O
to	TO	case	O
the	DT	det	O
IL	NN	nmod:npmod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
12	CD	npadvmod	I-Gene_or_gene_product2
-	HYPH	punct	O
induced	VBN	amod	O
rejection	NN	nmod	O
of	IN	case	O
prostate	NN	compound	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Adaptor	NN	compound	O
protein	NN	compound	O
Crk	NN	nsubjpass	B-Gene_or_gene_product1
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
ephrin	NN	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
B1	NN	nmod:npmod	I-Gene_or_gene_product3
-	HYPH	punct	O
induced	VBN	dep	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	nmod	O
and	CC	cc	O
focal	JJ	amod	B-Cellular_component
complex	NN	compound	I-Cellular_component
assembly	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nsubj	O
is	VBZ	cop	O
an	DT	det	O
essential	JJ	amod	O
step	NN	ROOT	O
in	IN	case	O
vasculogenesis	NN	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
,	,	punct	O
in	IN	case	O
which	WDT	nmod	O
receptor	NN	compound	B-Gene_or_gene_product0
tyrosine	NN	compound	I-Gene_or_gene_product0
kinases	NNS	nsubj	I-Gene_or_gene_product0
play	VBP	acl:relcl	O
a	DT	det	O
pivotal	JJ	amod	O
role	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
ephrin	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
B1	NN	nsubj	I-Gene_or_gene_product3
promotes	VBZ	acl:relcl	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
because	IN	mark	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	compound	O
heralds	VBZ	compound	O
cell	NN	compound	B-Cell
body	NN	compound	I-Cell
migration	NN	advcl	O
.	.	punct	O

We	PRP	nsubj	O
especially	RB	advmod	O
focused	VBD	ROOT	O
on	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
Crk	NN	compound	B-Gene_or_gene_product1
adaptor	NN	compound	O
protein	NN	nmod	O
in	IN	case	O
EphB	NN	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
mediated	VBN	amod	O
signaling	NN	nmod	O
.	.	punct	O

Using	VBG	advcl	O
DsRed	NNP	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
tagged	VBN	amod	O
Crk	NNP	dobj	B-Gene_or_gene_product1
and	CC	cc	O
a	DT	det	O
fluorescent	JJ	amod	O
time	NN	npadvmod	O
-	HYPH	punct	O
lapse	NN	compound	O
microscope	NN	conj	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
Crk	NN	nsubjpass	B-Gene_or_gene_product1
was	VBD	auxpass	O
recruited	VBN	ccomp	O
to	TO	case	O
the	DT	det	O
nascent	JJ	amod	B-Cellular_component
focal	JJ	amod	I-Cellular_component
complex	NN	nmod	I-Cellular_component
after	IN	case	O
ephrin	NN	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
B1	NN	compound	I-Gene_or_gene_product3
stimulation	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
p130	NN	nsubj	B-Gene_or_gene_product1
(	-LRB-	punct	I-Gene_or_gene_product1
Cas	NN	appos	I-Gene_or_gene_product1
)	-RRB-	punct	I-Gene_or_gene_product1
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
paxillin	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
recruited	VBD	ccomp	O
Crk	NNP	dobj	B-Gene_or_gene_product1
to	TO	case	O
the	DT	det	O
nascent	JJ	amod	B-Cellular_component
focal	JJ	amod	I-Cellular_component
complex	NN	nmod	I-Cellular_component
.	.	punct	O

The	DT	det	O
necessity	NN	nsubjpass	O
of	IN	prep	O
Crk	NN	pobj	B-Gene_or_gene_product1
in	IN	case	O
ephrin	NN	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
B1	NN	nmod:npmod	I-Gene_or_gene_product3
-	HYPH	punct	O
induced	VBN	amod	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	nmod	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
both	CC	cc:preconj	O
by	IN	case	O
the	DT	det	O
overexpression	NN	nmod	O
of	IN	case	O
dominant	JJ	amod	O
negative	JJ	amod	O
Crk	NN	compound	B-Gene_or_gene_product1
mutants	NNS	nmod	O
and	CC	cc	O
by	IN	case	O
the	DT	det	O
depletion	NN	conj	O
of	IN	case	O
Crk	NN	nmod	B-Gene_or_gene_product1
by	IN	mark	O
using	VBG	advcl	O
RNA	NN	compound	O
interference	NN	dobj	O
.	.	punct	O

Then	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
two	CD	nummod	O
major	JJ	amod	O
downstream	JJ	amod	O
molecules	NNS	nmod	O
of	IN	case	O
Crk	NN	nmod	B-Gene_or_gene_product1
,	,	punct	O
Rac1	NN	conj	B-Gene_or_gene_product3
and	CC	cc	O
Rap1	NN	conj	B-Gene_or_gene_product1
.	.	punct	O

The	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
mutant	NN	nsubj	O
of	IN	case	O
Rac1	NN	nmod	B-Gene_or_gene_product3
completely	RB	advmod	O
inhibited	VBD	ROOT	O
ephrin	NN	amod	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
B1	NN	nmod:npmod	I-Gene_or_gene_product3
-	HYPH	punct	O
induced	VBN	amod	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	dobj	O
and	CC	cc	O
focal	JJ	amod	B-Cellular_component
complex	NN	compound	I-Cellular_component
assembly	NN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
rap1GAPII	NN	nsubj	B-Gene_or_gene_product2
,	,	punct	O
a	DT	det	O
negative	JJ	amod	O
regulator	NN	appos	O
of	IN	case	O
Rap1	NN	nmod	B-Gene_or_gene_product3
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
inhibit	VB	ROOT	O
ephrin	NN	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
B1	NN	nmod:npmod	I-Gene_or_gene_product3
-	HYPH	punct	O
induced	VBN	amod	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
rap1GAPII	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	nmod	O
,	,	punct	O
ephrin	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
B1	NN	nsubj	I-Gene_or_gene_product3
did	VBD	aux	O
not	RB	neg	O
induce	VB	ROOT	O
membrane	NN	compound	B-Cellular_component
spreading	NN	dobj	O
,	,	punct	O
probably	RB	advmod	O
due	JJ	case	O
to	TO	case	O
instability	NN	nmod	O
of	IN	case	O
the	DT	det	O
focal	JJ	amod	B-Cellular_component
complex	NN	nmod	I-Cellular_component
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
Crk	NN	nsubj	B-Gene_or_gene_product1
plays	VBZ	ccomp	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
Rac1	NN	nmod:npmod	B-Gene_or_gene_product1
-	:	punct	O
induced	VBN	amod	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	nmod	O
and	CC	cc	O
Rap1	NN	compound	B-Gene_or_gene_product2
-	:	punct	O
mediated	VBN	amod	O
nascent	JJ	amod	B-Cellular_component
focal	JJ	amod	I-Cellular_component
complex	NN	compound	I-Cellular_component
stabilization	NN	conj	O
contributing	VBG	acl	O
to	TO	case	O
ephrin	NN	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
B1	NN	nmod:npmod	I-Gene_or_gene_product3
-	HYPH	punct	O
induced	VBN	amod	O
human	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	compound	I-Cell
migration	NN	nmod	O
.	.	punct	O

Postoperative	JJ	amod	O
progression	NN	ROOT	O
of	IN	case	O
pulmonary	JJ	amod	B-Organ
metastasis	NN	nmod	O
in	IN	case	O
osteosarcoma	NN	nmod	B-Cancer
.	.	punct	O

Early	JJ	amod	O
relapse	NN	nsubjpass	O
with	IN	case	O
distant	JJ	amod	O
metastasis	NN	nmod	O
often	RB	advmod	O
is	VBZ	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
cancer	NN	nmod	B-Cancer
after	IN	case	O
resection	NN	nmod	O
of	IN	case	O
the	DT	det	O
primary	JJ	amod	O
tumor	NN	nmod	B-Cancer
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
considered	VBN	ROOT	O
that	IN	mark	O
resection	NN	nsubj	O
of	IN	case	O
the	DT	det	O
primary	JJ	amod	O
tumor	NN	nmod	B-Cancer
induces	VBZ	ccomp	O
activation	NN	dobj	O
of	IN	case	O
systemic	JJ	amod	O
angiogenesis	NN	nmod	O
and	CC	cc	O
enhances	VBZ	conj	O
progression	NN	dobj	O
of	IN	case	O
remote	JJ	amod	O
metastasis	NN	nmod	O
.	.	punct	O

The	DT	det	O
authors	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
resection	NN	nsubj	O
of	IN	case	O
the	DT	det	O
primary	JJ	amod	O
osteosarcoma	NN	compound	B-Cancer
tumor	NN	nmod	I-Cancer
enhances	VBZ	ccomp	O
progression	NN	dobj	O
of	IN	case	O
pulmonary	JJ	amod	B-Organ
metastasis	NN	nmod	O
in	IN	case	O
animal	NN	compound	O
osteosarcoma	NN	compound	B-Cancer
models	NNS	nmod	O
.	.	punct	O

Matrigel	NN	compound	O
plug	NN	compound	O
neovascularization	NN	compound	O
assay	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
systemic	JJ	amod	O
angiogenic	JJ	amod	O
activity	NN	nsubj	O
was	VBD	auxpass	O
elevated	JJ	ccomp	O
after	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
removal	NN	nmod	O
(	-LRB-	punct	O
tumor	NN	compound	B-Cancer
intact	JJ	amod	O
group	NN	dep	O
,	,	punct	O
1	CD	appos	O
.	.	punct	O
61	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
21	CD	nummod	O
g	NN	ROOT	O
/	:	punct	O
dL	NN	appos	O
;	:	punct	O
tumor	NN	nsubj	B-Cancer
removed	VBN	amod	O
group	NN	dep	O
,	,	punct	O
4	CD	dep	O
.	.	punct	O
92	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
0	CD	dep	O
.	.	punct	O
35	CD	nummod	O
g	NN	ROOT	O
/	:	punct	O
dL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
serum	NN	compound	B-Organism_substance
concentration	NN	nsubj	O
of	IN	case	O
the	DT	det	O
angiogenesis	NN	compound	O
inhibitor	NN	nmod	O
,	,	punct	O
endostatin	NN	appos	B-Gene_or_gene_product0
,	,	punct	O
decreased	VBD	ROOT	O
significantly	RB	advmod	O
after	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
removal	NN	nmod	O
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
the	DT	det	O
antiangiogenic	JJ	amod	O
reagent	NN	compound	O
TNP	NNP	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
470	CD	nmod	I-Simple_chemical
suppressed	VBD	ROOT	O
postoperative	JJ	amod	O
progression	NN	dobj	O
of	IN	case	O
pulmonary	JJ	amod	B-Organ
metastasis	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
angiogenic	JJ	amod	O
activity	NN	nmod	O
after	IN	case	O
resection	NN	nmod	O
of	IN	case	O
osteosarcoma	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
enhances	VBZ	ccomp	O
progression	NN	dobj	O
of	IN	case	O
pulmonary	JJ	amod	B-Organ
metastasis	NN	nmod	O
.	.	punct	O

The	DT	det	O
current	JJ	amod	O
data	NNS	nsubj	O
also	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
administration	NN	nsubj	O
of	IN	case	O
antiangiogenic	JJ	amod	O
reagents	NNS	nmod	O
can	MD	aux	O
prevent	VB	ccomp	O
progression	NN	dobj	O
of	IN	case	O
pulmonary	JJ	amod	B-Organ
metastasis	NN	nmod	O
in	IN	case	O
osteosarcoma	NN	nmod	B-Cancer
postoperatively	RB	advmod	O
.	.	punct	O

Antiapoptotic	JJ	amod	O
effect	NN	ROOT	O
of	IN	case	O
coagulation	NN	compound	B-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
VIIa	NN	nmod	I-Gene_or_gene_product0
.	.	punct	O

Binding	NN	nsubjpass	O
of	IN	case	O
factor	NN	compound	B-Gene_or_gene_product2
VIIa	NN	nmod	I-Gene_or_gene_product2
(	-LRB-	punct	O
FVIIa	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
to	TO	case	O
its	PRP$	nmod:poss	O
cellular	JJ	amod	B-Cell
receptor	NN	compound	O
tissue	NN	compound	B-Gene_or_gene_product0
factor	NN	nmod	I-Gene_or_gene_product0
(	-LRB-	punct	O
TF	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
was	VBD	auxpass	O
previously	RB	advmod	O
shown	VBN	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
various	JJ	amod	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
signaling	NN	compound	O
events	NNS	dobj	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
thought	VBN	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
responsible	JJ	xcomp	O
for	IN	case	O
TF	NN	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
mediated	VBN	amod	O
biologic	JJ	amod	O
effects	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
tumor	NN	compound	B-Cancer
metastasis	NN	conj	O
,	,	punct	O
and	CC	cc	O
restenosis	NN	conj	O
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
behind	IN	case	O
these	DT	det	O
processes	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
FVIIa	NN	nmod	B-Gene_or_gene_product1
on	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Serum	NN	compound	B-Organism_substance
deprivation	NN	npadvmod	O
-	:	punct	O
induced	VBN	amod	O
apoptosis	NN	nsubjpass	O
of	IN	case	O
BHK	NN	compound	B-Cell
(	-LRB-	punct	I-Cell
+	CC	cc	I-Cell
TF	NN	conj	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nmod	I-Cell
was	VBD	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
apoptotic	JJ	amod	O
blebs	NNS	nmod	B-Cellular_component
,	,	punct	O
nuclei	NNS	conj	B-Cellular_component
with	IN	case	O
chromatin	NN	npadvmod	B-Cellular_component
-	HYPH	punct	O
condensed	VBN	amod	O
bodies	NNS	nmod	O
,	,	punct	O
DNA	NN	compound	B-Cellular_component
degradation	NN	conj	O
,	,	punct	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
caspase	NN	nmod	B-Gene_or_gene_product2
3	CD	nummod	I-Gene_or_gene_product2
.	.	punct	O

FVIIa	NN	nsubj	B-Gene_or_gene_product1
markedly	RB	advmod	O
decreased	VBD	ROOT	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
with	IN	case	O
apoptotic	JJ	amod	O
morphology	NN	nmod	O
and	CC	cc	O
prevented	VBD	conj	O
the	DT	det	O
DNA	NN	compound	B-Cellular_component
degradation	NN	dobj	O
as	IN	mark	O
measured	VBN	advcl	O
by	IN	case	O
means	NNS	nmod	O
of	IN	case	O
TdT	NN	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
mediated	VBN	amod	O
dUTP	NN	compound	B-Simple_chemical
nick	NN	compound	O
end	VBP	compound	O
labeling	NN	nmod	O
(	-LRB-	punct	O
TUNEL	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
antiapoptotic	JJ	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
FVIIa	NN	nmod	B-Gene_or_gene_product1
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
observation	NN	nmod	O
that	IN	mark	O
FVIIa	NN	nsubj	B-Gene_or_gene_product1
attenuated	VBD	ccomp	O
caspase	NN	compound	B-Gene_or_gene_product2
3	CD	nummod	I-Gene_or_gene_product2
activation	NN	dobj	O
.	.	punct	O

FVIIa	NN	nsubj	B-Gene_or_gene_product2
-	HYPH	punct	O
induced	VBN	amod	O
antiapoptotic	JJ	amod	O
effect	NN	nsubj	O
was	VBD	cop	O
dependent	JJ	ROOT	O
on	IN	case	O
its	PRP$	nmod:poss	O
proteolytic	JJ	amod	O
activity	NN	nmod	O
and	CC	cc	O
TF	NN	conj	B-Gene_or_gene_product1
but	CC	cc	O
independent	JJ	conj	O
of	IN	case	O
factor	NN	compound	B-Gene_or_gene_product1
Xa	NN	nmod	I-Gene_or_gene_product1
and	CC	cc	O
thrombin	NN	conj	B-Gene_or_gene_product0
.	.	punct	O

FVIIa	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
survival	NN	nsubj	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
Akt	NNP	nmod	B-Gene_or_gene_product1
and	CC	cc	O
was	VBD	auxpass	O
inhibited	VBN	conj	O
markedly	RB	advmod	O
by	IN	case	O
the	DT	det	O
specific	JJ	amod	O
PI3	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
kinase	NN	compound	I-Gene_or_gene_product1
inhibitor	NN	nmod	O
,	,	punct	O
LY294002	NN	appos	B-Simple_chemical
.	.	punct	O

Blocking	VBG	csubj	O
the	DT	det	O
activation	NN	dobj	O
of	IN	case	O
p44	NN	nmod	B-Gene_or_gene_product1
/	:	punct	I-Gene_or_gene_product1
42	CD	nummod	I-Gene_or_gene_product1
mitogen	NN	nmod:npmod	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
activated	VBN	amod	I-Gene_or_gene_product1
protein	NN	compound	I-Gene_or_gene_product1
kinase	NN	conj	I-Gene_or_gene_product1
(	-LRB-	punct	O
MAPK	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
by	IN	case	O
the	DT	det	O
specific	JJ	amod	O
mitogen	NN	nmod:npmod	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
induced	VBD	amod	I-Gene_or_gene_product2
extracellular	JJ	amod	I-Gene_or_gene_product2
kinase	NN	compound	I-Gene_or_gene_product2
(	-LRB-	punct	O
MEK	NN	compound	B-Gene_or_gene_product2
)	-RRB-	punct	O
inhibitor	NN	nmod	O
,	,	punct	O
U0126	NN	appos	B-Simple_chemical
,	,	punct	O
impaired	VBD	ROOT	O
modestly	RB	advmod	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
FVIIa	NN	nmod	B-Gene_or_gene_product1
to	TO	mark	O
promote	VB	acl	O
cell	NN	compound	B-Cell
survival	NN	dobj	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
FVIIa	NN	nsubj	B-Gene_or_gene_product1
binding	VBG	acl	O
to	TO	case	O
TF	NN	nmod	B-Gene_or_gene_product1
provided	VBD	ROOT	O
protection	NN	dobj	O
against	IN	case	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
growth	NN	compound	O
factor	NN	compound	O
deprivation	NN	nmod	O
,	,	punct	O
primarily	RB	advmod	O
through	IN	case	O
activation	NN	nmod	O
of	IN	case	O
PI3	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
kinase	NN	compound	I-Gene_or_gene_product1
/	:	punct	O
Akt	NN	compound	B-Gene_or_gene_product1
pathway	NN	nmod	O
,	,	punct	O
and	CC	cc	O
to	TO	case	O
a	DT	det	O
lesser	JJR	amod	O
extent	NN	conj	O
,	,	punct	O
p44	NN	compound	B-Gene_or_gene_product1
/	:	punct	I-Gene_or_gene_product1
42	CD	nummod	I-Gene_or_gene_product1
MAPK	NN	compound	I-Gene_or_gene_product1
pathway	NN	appos	O
.	.	punct	O

Cloning	NN	ROOT	O
and	CC	cc	O
characterization	NN	conj	O
of	IN	case	O
the	DT	det	O
latent	JJ	amod	B-Gene_or_gene_product2
membrane	NN	compound	I-Gene_or_gene_product2
protein	NN	nmod	I-Gene_or_gene_product2
(	-LRB-	punct	O
LMP	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
of	IN	case	O
a	DT	det	O
specific	JJ	amod	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	compound	I-Organism
variant	NN	nmod	O
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
nasopharyngeal	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
in	IN	case	O
the	DT	det	O
Taiwanese	JJ	amod	O
population	NN	nmod	O
.	.	punct	O

A	DT	det	O
DNA	NN	compound	O
fragment	NN	nsubjpass	O
containing	VBG	acl	O
Epstein	NNP	compound	B-Organism
-	HYPH	punct	I-Organism
Barr	NN	compound	I-Organism
virus	NN	compound	I-Organism
(	-LRB-	punct	O
EBV	NN	compound	B-Organism
)	-RRB-	punct	O
terminal	JJ	amod	O
fragment	NN	compound	O
sequence	NN	dobj	O
was	VBD	auxpass	O
obtained	VBN	ROOT	O
from	IN	case	O
a	DT	det	O
genomic	JJ	amod	O
library	NN	nmod	O
of	IN	case	O
nasopharyngeal	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
NPC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

One	CD	nsubj	O
of	IN	case	O
the	DT	det	O
clones	NNS	nmod	O
(	-LRB-	punct	O
clone	NN	appos	O
1510	CD	nummod	O
)	-RRB-	punct	O
contained	VBD	ROOT	O
the	DT	det	O
gene	NN	dobj	O
encoding	VBG	acl	O
latent	JJ	amod	B-Gene_or_gene_product2
membrane	NN	compound	I-Gene_or_gene_product2
protein	NN	dobj	I-Gene_or_gene_product2
(	-LRB-	punct	O
LMP	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
.	.	punct	O

Sequence	NN	compound	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
this	DT	det	O
gene	NN	nsubj	O
had	VBD	ccomp	O
95	CD	nummod	O
%	NN	compound	O
homology	NN	dobj	O
with	IN	case	O
the	DT	det	O
LMP	NN	compound	B-Gene_or_gene_product1
sequence	NN	nmod	O
of	IN	case	O
the	DT	det	O
B95	NN	compound	B-Organism
-	HYPH	punct	I-Organism
8	CD	nummod	I-Organism
strain	NN	nmod	O
.	.	punct	O

Among	IN	case	O
the	DT	det	O
sequence	NN	compound	O
variations	NNS	nmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
change	NN	nsubj	O
from	IN	case	O
G	NN	nmod	O
to	TO	case	O
T	NN	nmod	O
at	IN	case	O
nucleotide	NN	compound	O
position	NN	nmod	O
169	CD	nummod	O
,	,	punct	O
426	CD	appos	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
the	DT	det	O
loss	NN	nmod	O
of	IN	case	O
an	DT	det	O
XhoI	NN	compound	B-Gene_or_gene_product2
site	NN	nmod	O
in	IN	case	O
exon	NN	nmod	O
1	CD	nummod	O
of	IN	case	O
the	DT	det	O
LMP	NN	compound	B-Gene_or_gene_product1
gene	NN	nmod	O
.	.	punct	O

A	DT	det	O
pair	NN	nsubjpass	O
of	IN	prep	O
primers	NNS	pobj	O
bracketing	VBG	acl	O
the	DT	det	O
XhoI	NN	compound	B-Gene_or_gene_product1
site	NN	dobj	O
were	VBD	auxpass	O
designed	VBN	ROOT	O
to	TO	mark	O
synthesize	VB	xcomp	O
the	DT	det	O
EBV	NN	compound	B-Organism
DNA	NN	compound	B-Cellular_component
fragment	NN	dobj	O
from	IN	case	O
nucleotides	NNS	nmod	O
169	CD	nummod	O
,	,	punct	O
081	CD	nummod	O
-	SYM	punct	O
169	CD	dobj	O
,	,	punct	O
577	CD	npadvmod	O
by	IN	mark	O
using	VBG	advcl	O
the	DT	det	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	compound	O
(	-LRB-	punct	O
PCR	NN	appos	O
)	-RRB-	punct	O
method	NN	dobj	O
.	.	punct	O

The	DT	det	O
PCR	NN	compound	O
products	NNS	nsubj	O
were	VBD	cop	O
then	RB	advmod	O
subject	JJ	ROOT	O
to	TO	case	O
XhoI	NN	compound	B-Gene_or_gene_product1
digestion	NN	nmod	O
and	CC	cc	O
to	TO	case	O
DNA	NN	compound	B-Cellular_component
sequencing	NN	compound	O
analysis	NN	conj	O
.	.	punct	O

This	DT	det	O
restriction	NN	compound	O
enzyme	NN	compound	O
site	NN	compound	O
polymorphism	NN	nsubjpass	O
along	IN	case	O
with	IN	case	O
the	DT	det	O
sequence	NN	compound	O
variations	NNS	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
50	CD	nummod	O
biopsy	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
the	DT	det	O
throat	NN	compound	B-Organism_subdivision
washings	NNS	conj	O
of	IN	case	O
6	CD	compound	O
out	IN	advmod	O
of	IN	advmod	O
20	CD	nummod	O
healthy	JJ	amod	O
individuals	NNS	nmod	B-Organism
that	WDT	dobj	O
we	PRP	nsubj	O
examined	VBD	acl:relcl	O
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
EBV	NN	compound	B-Organism
strain	NN	nsubj	O
predominantly	RB	advmod	O
existing	VBG	nsubj	O
in	IN	case	O
these	DT	det	O
biopsy	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
was	VBD	cop	O
different	JJ	ccomp	O
from	IN	case	O
strains	NNS	nmod	O
of	IN	case	O
B95	NN	nmod	B-Organism
-	SYM	punct	I-Organism
8	CD	nummod	I-Organism
,	,	punct	O
Jijoye	NN	conj	B-Organism
or	CC	cc	O
nude	JJ	conj	B-Organism
mouse	NN	compound	I-Organism
passaged	JJ	amod	O
cells	NNS	conj	B-Cell
(	-LRB-	punct	O
C15	NN	appos	B-Cell
)	-RRB-	punct	O
with	IN	case	O
an	DT	det	O
African	JJ	amod	O
origin	NN	nmod	O
,	,	punct	O
but	CC	cc	O
closely	RB	advmod	O
resembled	VBD	amod	O
other	JJ	amod	O
nude	JJ	amod	B-Organism
mouse	NN	compound	I-Organism
passaged	JJ	amod	O
CAO	NN	compound	B-Cell
cells	NNS	conj	I-Cell
which	WDT	nsubjpass	O
were	VBD	auxpass	O
originally	RB	advmod	O
derived	VBN	acl:relcl	O
from	IN	prep	O
China	NNP	pobj	O
.	.	punct	O

Balb	NN	compound	B-Cell
/	:	punct	I-Cell
c	NN	compound	I-Cell
3T3	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
carrying	VBG	acl	O
this	DT	det	O
NPC	NN	compound	B-Cancer
-	HYPH	punct	O
LMP	NN	compound	B-Gene_or_gene_product1
gene	NN	dobj	O
showed	VBD	ROOT	O
a	DT	det	O
transformed	VBN	amod	O
cell	NN	compound	B-Cell
morphology	NN	dobj	O
and	CC	cc	O
were	VBD	cop	O
tumorigenic	JJ	conj	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

The	DT	det	O
relationship	NN	nsubj	O
between	IN	case	O
this	DT	det	O
unique	JJ	amod	O
type	NN	nmod	O
of	IN	case	O
EBV	NN	nmod	B-Organism
and	CC	cc	O
NPC	NN	conj	B-Cancer
has	VBZ	ROOT	O
yet	RB	advmod	O
to	TO	mark	O
be	VB	auxpass	O
established	VBN	xcomp	O
.	.	punct	O

Angiopoietin	NNP	compound	B-Gene_or_gene_product0
/	:	punct	O
tie	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
2	CD	ROOT	I-Gene_or_gene_product2
as	IN	case	O
mediators	NNS	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
:	:	punct	O
a	DT	det	O
role	NN	dep	O
in	IN	case	O
congestive	JJ	amod	O
heart	NN	compound	B-Organ
failure	NN	nmod	O
?	.	punct	O

Angiogenic	JJ	compound	O
factors	NNS	nsubj	O
,	,	punct	O
in	IN	case	O
particular	JJ	amod	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	nmod	I-Gene_or_gene_product0
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
angiopoietins	NNS	conj	B-Gene_or_gene_product0
,	,	punct	O
Ang	NNP	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	appos	I-Gene_or_gene_product3
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product2
2	CD	conj	I-Gene_or_gene_product2
,	,	punct	O
have	VBP	aux	O
recently	RB	advmod	O
generated	VBN	ROOT	O
significant	JJ	amod	O
interest	NN	dobj	O
,	,	punct	O
especially	RB	advmod	O
in	IN	case	O
oncology	NN	nmod	O
.	.	punct	O

The	DT	det	O
process	NN	nsubjpass	O
of	IN	case	O
angiogenesis	NN	nmod	O
is	VBZ	auxpass	O
also	RB	advmod	O
thought	VBN	ROOT	O
to	TO	mark	O
occur	VB	xcomp	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
ischaemic	JJ	amod	O
conditions	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
lie	VBP	acl:relcl	O
at	IN	case	O
the	DT	det	O
core	NN	nmod	O
of	IN	case	O
cardiovascular	JJ	amod	B-Anatomical_system
disease	NN	compound	O
states	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
coronary	JJ	amod	B-Multi-tissue_structure
artery	NN	compound	I-Multi-tissue_structure
disease	NN	nmod	O
and	CC	cc	O
congestive	JJ	amod	O
heart	NN	compound	B-Organ
failure	NN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
current	JJ	amod	O
data	NNS	nsubj	O
do	VBP	aux	O
not	RB	neg	O
conclusively	RB	advmod	O
show	VB	ROOT	O
evidence	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
per	FW	compound	O
se	FW	nmod	O
in	IN	case	O
these	DT	det	O
conditions	NNS	nmod	O
,	,	punct	O
despite	IN	case	O
(	-LRB-	punct	O
for	IN	case	O
example	NN	dep	O
)	-RRB-	punct	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
Ang	NN	compound	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
2	CD	conj	I-Gene_or_gene_product3
.	.	punct	O

High	JJ	amod	O
levels	NNS	nsubj	O
of	IN	case	O
these	DT	det	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
in	IN	case	O
heart	NN	compound	B-Organ
disease	NN	nmod	O
also	RB	advmod	O
have	VBP	aux	O
not	RB	neg	O
translated	VBN	ROOT	O
into	IN	case	O
clinically	RB	advmod	O
significant	JJ	amod	O
new	JJ	amod	O
vessel	NN	compound	B-Multi-tissue_structure
formation	NN	nmod	O
,	,	punct	O
as	IN	case	O
in	IN	case	O
accelerated	VBN	amod	O
cancer	NN	compound	B-Cancer
growth	NN	advcl	O
or	CC	cc	O
proliferative	JJ	amod	O
retinopathy	NN	conj	O
.	.	punct	O

Indeed	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
would	MD	aux	O
hypothesize	VB	ROOT	O
that	IN	mark	O
these	DT	det	O
angiogenic	JJ	amod	O
markers	NNS	nsubj	O
-	:	punct	O
-	:	punct	O
especially	RB	advmod	O
the	DT	det	O
angiopoietins	NNS	appos	B-Gene_or_gene_product0
-	HYPH	punct	O
-	HYPH	punct	O
do	VBP	aux	O
not	RB	neg	O
necessarily	RB	advmod	O
translate	VB	ccomp	O
into	IN	case	O
new	JJ	amod	O
vessel	NN	compound	B-Multi-tissue_structure
formation	NN	nmod	O
in	IN	case	O
congestive	JJ	amod	O
heart	NN	compound	B-Organ
failure	NN	nmod	O
(	-LRB-	punct	O
CHF	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
but	CC	cc	O
may	MD	aux	O
well	RB	advmod	O
reflect	VB	conj	O
disturbances	NNS	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Tissue
integrity	NN	nmod	O
in	IN	case	O
CHF	NN	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Correlation	NN	ROOT	O
between	IN	case	O
expression	NN	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
C	NN	nmod	I-Gene_or_gene_product0
in	IN	case	O
tumor	NN	nmod:npmod	B-Cell
-	HYPH	punct	I-Cell
associated	VBN	amod	I-Cell
macrophages	NNS	nmod	I-Cell
and	CC	cc	O
lymphatic	JJ	amod	B-Organ
metastasis	NN	conj	O
in	IN	case	O
oral	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
]	-RRB-	punct	O
.	.	punct	O

BACKGROUND	NN	nsubj	O
&	CC	cc	O
#	$	advmod	O
38	CD	conj	O
;	:	punct	O
OBJECTIVE	NN	appos	O
:	:	punct	O
Previous	JJ	amod	O
study	NN	nsubj	O
shows	VBZ	ROOT	O
that	IN	mark	O
both	CC	cc:preconj	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
C	NN	compound	I-Gene_or_gene_product0
(	-LRB-	punct	O
VEGF	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
C	NN	nsubj	I-Gene_or_gene_product3
)	-RRB-	punct	O
and	CC	cc	O
tumor	NN	compound	B-Cell
-	HYPH	punct	I-Cell
associated	VBN	amod	I-Cell
macrophages	NNS	conj	I-Cell
(	-LRB-	punct	O
TAMs	NNS	appos	B-Cell
)	-RRB-	punct	O
are	VBP	cop	O
related	JJ	ccomp	O
to	TO	case	O
lymphatic	JJ	amod	B-Organ
metastasis	NN	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
aimed	VBD	ROOT	O
to	TO	mark	O
explore	VB	xcomp	O
the	DT	det	O
correlation	NN	dobj	O
between	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
C	NN	nmod	I-Gene_or_gene_product1
in	IN	case	O
TAMs	NN	nmod	B-Cell
and	CC	cc	O
lymphatic	JJ	amod	B-Organ
metastasis	NN	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
(	-LRB-	punct	O
OSCC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	nsubjpass	O
:	:	punct	O
After	IN	case	O
immunohistochemical	JJ	amod	O
staining	NN	nmod	O
,	,	punct	O
light	JJ	amod	O
microscope	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	dep	O
for	IN	case	O
counting	VBG	amod	O
macrophages	NNS	nmod	B-Cell
and	CC	cc	O
automated	VBN	amod	O
image	NN	compound	O
analysis	NN	compound	O
quantification	NN	conj	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
VEGF	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
C	NN	compound	I-Gene_or_gene_product1
expression	NN	dobj	O
,	,	punct	O
which	WDT	nsubjpass	O
was	VBD	auxpass	O
reflected	VBN	acl:relcl	O
by	IN	case	O
positive	JJ	amod	O
index	NN	nmod	O
(	-LRB-	punct	O
PI	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
double	JJ	amod	O
staining	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
used	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
VEGF	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
C	NN	compound	I-Gene_or_gene_product1
expression	NN	dobj	O
in	IN	case	O
TAMs	NN	nmod	B-Cell
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
C	NN	compound	I-Gene_or_gene_product1
expression	NN	nsubj	O
was	VBD	cop	O
higher	JJR	appos	O
in	IN	case	O
lymphatic	JJ	amod	B-Organ
metastasis	NN	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
PI	NN	dep	O
=	JJ	amod	O
12	CD	dobj	O
.	.	punct	O
169	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
2	CD	nummod	O
.	.	punct	O
778	CD	ROOT	O
)	-RRB-	punct	O
than	IN	case	O
in	IN	case	O
no	DT	nummod	O
-	HYPH	punct	O
metastasis	NN	compound	O
group	NN	advcl	O
(	-LRB-	punct	O
PI	NN	dep	O
=	JJ	amod	O
8	CD	dobj	O
.	.	punct	O
498	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
2	CD	ROOT	O
.	.	punct	O
674	CD	dep	O
,	,	punct	O
P	NN	compound	O
<	-LRB-	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

TAMs	NN	compound	B-Cell
counts	NNS	nsubj	O
was	VBD	cop	O
related	JJ	ROOT	O
to	TO	case	O
VEGF	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
C	NN	compound	I-Gene_or_gene_product1
expression	NN	nmod	O
in	IN	case	O
OSCC	NN	nmod	B-Cancer
(	-LRB-	punct	O
r	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
370	CD	nummod	O
,	,	punct	O
P	NN	compound	O
<	-LRB-	appos	O
0	CD	nummod	O
.	.	punct	O
05	CD	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
result	NN	nsubj	O
of	IN	case	O
double	JJ	amod	O
staining	NN	nmod	O
indicated	VBD	ROOT	O
that	IN	mark	O
macrophage	NN	nsubj	B-Cell
with	IN	case	O
positive	JJ	amod	O
VEGF	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
C	NN	compound	I-Gene_or_gene_product1
expression	NN	nmod	O
accounted	VBD	ccomp	O
for	IN	case	O
about	RB	advmod	O
22	CD	nmod	O
.	.	punct	O
8	CD	nummod	O
%	NN	ROOT	O
of	IN	prep	O
the	DT	det	O
total	NN	pobj	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
Not	RB	neg	O
only	RB	cc:preconj	O
tumor	NN	compound	B-Cell
cells	NNS	appos	I-Cell
but	CC	cc	O
also	RB	advmod	O
TAMs	NNS	nsubj	B-Cell
secrete	VBP	ROOT	O
the	DT	det	O
VEGF	NNP	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
C	NN	dobj	I-Gene_or_gene_product1
in	IN	case	O
OSCC	NN	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
TAMs	NN	nsubj	B-Cell
may	MD	aux	O
play	VB	conj	O
a	DT	det	O
major	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
peritumoral	JJ	amod	B-Multi-tissue_structure
lymphatic	JJ	amod	I-Multi-tissue_structure
neoangiogenesis	NN	nmod	O
and	CC	cc	O
lymphatic	JJ	amod	B-Organ
metastasis	NN	conj	O
.	.	punct	O

Hypothesis	NN	ROOT	O
:	:	punct	O
Induced	VBN	amod	O
angiogenesis	NN	nsubj	O
after	IN	case	O
surgery	NN	nmod	O
in	IN	case	O
premenopausal	JJ	amod	O
node	NN	compound	O
-	HYPH	punct	O
positive	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
underlying	JJ	amod	O
reason	NN	dep	O
why	WRB	advmod	O
adjuvant	JJ	amod	O
chemotherapy	NN	nsubj	O
works	VBZ	ccomp	O
particularly	RB	advmod	O
well	RB	advmod	O
for	IN	case	O
those	DT	det	O
patients	NNS	nmod	B-Organism
.	.	punct	O

BACKGROUND	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
surgical	JJ	amod	O
extirpation	NN	nsubj	O
of	IN	case	O
primary	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
among	IN	case	O
other	JJ	amod	O
effects	NNS	nmod	O
accelerates	VBZ	ccomp	O
relapse	NN	dobj	O
for	IN	case	O
some	DT	det	O
premenopausal	JJ	amod	O
node	NN	nmod:npmod	O
-	HYPH	punct	O
positive	JJ	amod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

These	DT	det	O
accelerated	VBN	amod	O
relapses	NNS	nsubj	O
occur	VBP	ROOT	O
within	IN	case	O
10	CD	nummod	O
months	NNS	nmod	O
of	IN	case	O
surgery	NN	nmod	O
for	IN	case	O
untreated	JJ	amod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubj	O
proposed	VBN	acl	O
is	VBZ	cop	O
a	DT	det	O
stimulation	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
for	IN	case	O
distant	JJ	amod	B-Cancer
dormant	JJ	amod	I-Cancer
micrometastases	NNS	nmod	I-Cancer
.	.	punct	O

This	DT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
as	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
mechanisms	NNS	nmod	O
to	TO	mark	O
explain	VB	acl	O
the	DT	det	O
mammography	NN	compound	O
paradox	NN	dobj	O
for	IN	case	O
women	NNS	nmod	B-Organism
aged	JJ	amod	O
40	CD	compound	O
-	SYM	punct	O
49	CD	nummod	O
years	NNS	dobj	O
.	.	punct	O

We	PRP	nsubj	O
could	MD	aux	O
imagine	VB	ROOT	O
that	IN	mark	O
it	PRP	nsubj	O
also	RB	advmod	O
plays	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
adjuvant	JJ	amod	O
chemotherapy	NN	compound	O
effectiveness	NN	nmod	O
since	IN	advmod	O
,	,	punct	O
perhaps	RB	advmod	O
not	RB	neg	O
coincidentally	RB	advmod	O
,	,	punct	O
this	DT	nsubj	O
is	VBZ	cop	O
most	RBS	advmod	O
beneficial	JJ	ccomp	O
for	IN	case	O
premenopausal	JJ	amod	O
node	NN	nmod:npmod	O
-	HYPH	punct	O
positive	JJ	amod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

HYPOTHESIS	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
speculate	VBP	ROOT	O
that	IN	mark	O
there	EX	expl	O
is	VBZ	ccomp	O
a	DT	det	O
burst	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
of	IN	case	O
distant	JJ	amod	B-Cancer
dormant	JJ	amod	I-Cancer
micrometastases	NNS	nmod	I-Cancer
after	IN	case	O
surgery	NN	nmod	O
in	IN	case	O
approximately	RB	advmod	O
20	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
premenopausal	JJ	amod	O
node	NN	nmod:npmod	O
-	HYPH	punct	O
positive	JJ	amod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
speculate	VBP	ROOT	O
that	IN	mark	O
this	DT	nsubj	O
synchronizes	VBZ	ccomp	O
them	PRP	dobj	O
into	IN	prep	O
a	DT	det	O
temporal	JJ	amod	O
highly	RB	advmod	O
chemosensitive	JJ	amod	O
state	NN	pobj	O
and	CC	cc	O
is	VBZ	conj	O
the	DT	det	O
underlying	JJ	amod	O
reason	NN	attr	O
why	WRB	advmod	O
adjuvant	JJ	amod	O
chemotherapy	NN	nsubj	O
works	VBZ	relcl	O
particularly	RB	advmod	O
well	RB	advmod	O
for	IN	prep	O
that	DT	det	O
patient	NN	compound	B-Organism
category	NN	pobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
this	DT	nsubj	O
may	MD	aux	O
explain	VB	ROOT	O
why	WRB	advmod	O
cancer	NN	nsubj	B-Cancer
in	IN	case	O
younger	JJR	amod	O
patients	NNS	nmod	B-Organism
is	VBZ	cop	O
more	RBR	advmod	O
often	RB	advmod	O
'	``	punct	O
aggressive	JJ	advcl	O
'	''	punct	O
.	.	punct	O

TESTING	VBG	compound	O
THE	DT	compound	O
HYPOTHESIS	NN	dep	O
:	:	punct	O
Stimulation	NN	nsubjpass	O
of	IN	case	O
dormant	JJ	amod	B-Cancer
micrometastases	NNS	nmod	I-Cancer
by	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
removal	NN	nmod	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
occur	VB	xcomp	O
in	IN	case	O
animal	NN	compound	O
models	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
need	VBP	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
it	PRP	nsubj	O
happens	VBZ	ccomp	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Transient	JJ	amod	O
circulating	VBG	amod	O
levels	NNS	nsubj	O
of	IN	case	O
angioactive	JJ	amod	O
molecules	NNS	nmod	O
and	CC	cc	O
serial	JJ	amod	O
high	JJ	amod	O
-	HYPH	punct	O
resolution	NN	compound	O
imaging	NN	amod	O
studies	NNS	conj	O
of	IN	case	O
focal	JJ	amod	O
angiogenesis	NN	nmod	O
might	MD	aux	O
help	VB	ROOT	O
.	.	punct	O

IMPLICATIONS	NNS	nsubj	O
:	:	punct	O
Short	JJ	amod	O
-	HYPH	punct	O
course	NN	amod	O
cytotoxic	JJ	amod	O
chemotherapy	NN	appos	O
after	IN	case	O
surgery	NN	nmod	O
has	VBZ	aux	O
probably	RB	advmod	O
reached	VBN	ROOT	O
its	PRP$	poss	O
zenith	NN	dobj	O
,	,	punct	O
and	CC	cc	O
other	JJ	amod	O
strategies	NNS	conj	O
,	,	punct	O
perhaps	RB	advmod	O
antiangiogenic	JJ	amod	O
methods	NNS	appos	O
,	,	punct	O
are	VBP	auxpass	O
needed	VBN	conj	O
to	TO	mark	O
successfully	RB	advmod	O
treat	VB	xcomp	O
more	JJR	amod	O
patients	NNS	dobj	B-Organism
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
hypothesis	NN	compound	O
predicts	VBZ	ROOT	O
that	IN	mark	O
early	JJ	amod	O
detection	NN	nsubj	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
designed	VBN	acl:relcl	O
to	TO	mark	O
find	VB	xcomp	O
more	JJR	amod	O
patients	NNS	dobj	B-Organism
without	IN	case	O
involved	VBN	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
may	MD	aux	O
not	RB	neg	O
be	VB	cop	O
a	DT	det	O
synergistic	JJ	amod	O
strategy	NN	ccomp	O
with	IN	case	O
adjuvant	JJ	amod	O
chemotherapy	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
works	VBZ	acl:relcl	O
best	RB	advmod	O
with	IN	case	O
positive	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
patients	NNS	nmod	B-Organism
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	ROOT	I-Gene_or_gene_product0
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
in	IN	case	O
seizures	NNS	nmod	O
:	:	punct	O
a	DT	det	O
double	JJ	amod	O
-	HYPH	punct	O
edged	VBN	amod	O
sword	NN	dep	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	nsubj	I-Gene_or_gene_product0
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
vascular	JJ	amod	O
growth	NN	compound	O
factor	NN	ROOT	O
which	WDT	nsubj	O
induces	VBZ	acl:relcl	O
angiogenesis	NN	dobj	O
(	-LRB-	punct	O
the	DT	det	O
development	NN	dep	O
of	IN	case	O
new	JJ	amod	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
)	-RRB-	punct	O
,	,	punct	O
vascular	JJ	amod	B-Multi-tissue_structure
permeability	NN	conj	O
,	,	punct	O
and	CC	cc	O
inflammation	NN	conj	O
.	.	punct	O

In	IN	case	O
brain	NN	nmod	B-Organ
,	,	punct	O
receptors	NNS	nsubj	O
for	IN	case	O
VEGF	NNS	nmod	B-Gene_or_gene_product1
have	VBP	aux	O
been	VBN	auxpass	O
localized	JJ	ROOT	O
to	TO	case	O
vascular	JJ	amod	B-Tissue
endothelium	NN	nmod	I-Tissue
,	,	punct	O
neurons	NNS	conj	B-Cell
,	,	punct	O
and	CC	cc	O
glia	NN	conj	B-Cell
.	.	punct	O

VEGF	NN	nsubjpass	B-Gene_or_gene_product1
is	VBZ	auxpass	O
upregulated	VBN	ROOT	O
after	IN	case	O
hypoxic	JJ	amod	O
injury	NN	nmod	O
to	TO	case	O
the	DT	det	O
brain	NN	nmod	B-Organ
,	,	punct	O
which	WDT	nsubj	O
can	MD	aux	O
occur	VB	acl:relcl	O
during	IN	case	O
cerebral	JJ	amod	B-Organ
ischemia	NN	nmod	O
or	CC	cc	O
high	JJ	amod	O
-	HYPH	punct	O
altitude	NN	compound	O
edema	NN	conj	B-Pathological_formation
,	,	punct	O
and	CC	cc	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	conj	O
in	IN	case	O
the	DT	det	O
blood	NN	compound	B-Multi-tissue_structure
-	HYPH	punct	I-Multi-tissue_structure
brain	NN	compound	I-Multi-tissue_structure
barrier	NN	amod	I-Multi-tissue_structure
breakdown	NN	nmod	O
associated	VBN	acl	O
with	IN	prep	O
these	DT	det	O
conditions	NNS	pobj	O
.	.	punct	O

Given	VBN	case	O
its	PRP$	nmod:poss	O
recently	RB	advmod	O
-	HYPH	punct	O
described	VBN	amod	O
role	NN	nmod	O
as	IN	case	O
an	DT	det	O
inflammatory	JJ	amod	O
mediator	NN	nmod	O
,	,	punct	O
VEGF	NN	nsubj	B-Gene_or_gene_product1
could	MD	aux	O
also	RB	advmod	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
inflammatory	JJ	amod	O
responses	NNS	nmod	O
observed	VBN	acl	O
in	IN	case	O
cerebral	JJ	amod	B-Organ
ischemia	NN	nmod	O
.	.	punct	O

After	IN	prep	O
seizures	NNS	pobj	O
,	,	punct	O
blood	NN	compound	B-Multi-tissue_structure
-	HYPH	punct	I-Multi-tissue_structure
brain	NN	compound	I-Multi-tissue_structure
barrier	NN	amod	I-Multi-tissue_structure
breakdown	NN	nsubjpass	O
and	CC	cc	O
inflammation	NN	conj	O
is	VBZ	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
brain	NN	nmod	B-Organ
,	,	punct	O
albeit	IN	mark	O
on	IN	case	O
a	DT	det	O
lower	JJR	amod	O
scale	NN	advcl	O
than	IN	case	O
that	DT	nmod	O
observed	VBN	acl	O
after	IN	prep	O
stroke	NN	pobj	O
.	.	punct	O

Recent	JJ	amod	O
evidence	NN	nsubj	O
has	VBZ	aux	O
suggested	VBN	ROOT	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
inflammation	NN	nmod	O
in	IN	case	O
seizure	JJ	amod	O
disorders	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
described	VBN	ROOT	O
striking	JJ	amod	O
increases	NNS	dobj	O
in	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product1
protein	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
neurons	NNS	nmod	B-Cell
and	CC	cc	O
glia	NN	conj	B-Cell
after	IN	case	O
pilocarpine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
status	NN	compound	O
epilepticus	NN	nmod	O
in	IN	case	O
the	DT	det	O
brain	NN	nmod	B-Organ
.	.	punct	O

Increases	NNS	nsubj	O
in	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product1
could	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
blood	NN	compound	B-Multi-tissue_structure
-	HYPH	punct	I-Multi-tissue_structure
brain	NN	compound	I-Multi-tissue_structure
barrier	NN	amod	I-Multi-tissue_structure
breakdown	NN	nmod	O
and	CC	cc	O
inflammation	NN	conj	O
observed	VBN	acl	O
after	IN	case	O
seizures	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
VEGF	NNP	nsubjpass	B-Gene_or_gene_product1
has	VBZ	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
neuroprotective	JJ	xcomp	O
across	IN	case	O
several	JJ	amod	O
experimental	JJ	amod	O
paradigms	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
hence	RB	advmod	O
could	MD	aux	O
potentially	RB	advmod	O
protect	VB	conj	O
vulnerable	JJ	amod	O
cells	NNS	dobj	B-Cell
from	IN	case	O
damage	NN	nmod	O
associated	VBN	acl	O
with	IN	prep	O
seizures	NNS	pobj	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product1
after	IN	case	O
seizures	NNS	nmod	O
could	MD	aux	O
be	VB	cop	O
either	CC	cc:preconj	O
protective	JJ	ROOT	O
or	CC	cc	O
destructive	JJ	conj	O
.	.	punct	O

Although	IN	mark	O
only	RB	advmod	O
further	JJ	amod	O
research	NN	nsubj	O
will	MD	aux	O
determine	VB	advcl	O
the	DT	det	O
exact	JJ	amod	O
nature	NN	dobj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product1
'	POS	punct	O
s	VBZ	compound	O
role	NN	nmod	O
after	IN	case	O
seizures	NNS	nmod	O
,	,	punct	O
preliminary	JJ	amod	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
VEGF	NN	nsubj	B-Gene_or_gene_product1
plays	VBZ	ccomp	O
a	DT	det	O
protective	JJ	amod	O
role	NN	dobj	O
after	IN	case	O
seizures	NNS	nmod	O
.	.	punct	O

Safety	NN	ROOT	O
of	IN	case	O
verteporfin	NN	nmod	B-Simple_chemical
for	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
subfoveal	JJ	amod	B-Multi-tissue_structure
choroidal	NN	amod	I-Multi-tissue_structure
neovascular	JJ	amod	I-Multi-tissue_structure
membranes	NNS	nmod	I-Multi-tissue_structure
associated	VBN	acl	O
with	IN	case	O
age	NN	nmod:npmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	nmod	O
.	.	punct	O

Photodynamic	JJ	amod	O
therapy	NN	nsubj	O
(	-LRB-	punct	O
PDT	NN	appos	O
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
treatment	NN	compound	O
entity	NN	ROOT	O
that	WDT	nsubj	O
exploits	VBZ	acl:relcl	O
the	DT	det	O
photophysical	JJ	amod	O
properties	NNS	dobj	O
of	IN	case	O
various	JJ	amod	O
photosensitive	JJ	amod	O
chemical	JJ	amod	O
entities	NNS	nmod	O
which	WDT	nsubj	O
,	,	punct	O
upon	IN	case	O
light	JJ	amod	O
activation	NN	nmod	O
,	,	punct	O
results	VBZ	acl:relcl	O
in	IN	case	O
targeted	VBN	amod	O
photooxidation	NN	nmod	O
and	CC	cc	O
subsequent	JJ	amod	O
tissue	NN	compound	B-Tissue
destruction	NN	conj	O
.	.	punct	O

The	DT	det	O
antiangiogenic	JJ	amod	O
properties	NNS	nsubjpass	O
of	IN	case	O
PDT	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
adapted	VBN	ROOT	O
for	IN	case	O
treatment	NN	nmod	O
of	IN	case	O
subfoveal	JJ	amod	B-Multi-tissue_structure
choroidal	NN	amod	I-Multi-tissue_structure
neovascular	JJ	amod	I-Multi-tissue_structure
membranes	NNS	nmod	I-Multi-tissue_structure
due	JJ	case	O
to	TO	mwe	O
disease	NN	compound	O
states	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
age	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	nmod	O
(	-LRB-	punct	O
AMD	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Historically	RB	advmod	O
,	,	punct	O
PDT	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
limited	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
lack	NN	nmod	O
of	IN	case	O
suitable	JJ	amod	O
photosensitive	JJ	amod	O
dyes	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
agents	NNS	nsubj	O
such	JJ	case	O
as	IN	mwe	O
verteporfin	NN	nmod	B-Simple_chemical
,	,	punct	O
a	DT	det	O
second	JJ	amod	O
-	HYPH	punct	O
generation	NN	compound	O
benzoporphyrin	NN	compound	B-Simple_chemical
derivative	NN	appos	O
,	,	punct	O
appear	VBP	ROOT	O
to	TO	aux	O
be	VB	xcomp	O
free	JJ	acomp	O
from	IN	prep	O
the	DT	det	O
extensive	JJ	amod	O
phototoxicity	NN	pobj	O
that	WDT	nsubj	O
limited	VBD	relcl	O
the	DT	det	O
success	NN	dobj	O
of	IN	case	O
previous	JJ	amod	O
agents	NNS	nmod	O
.	.	punct	O

Verteporfin	NNP	nsubj	B-Simple_chemical
has	VBZ	ROOT	O
a	DT	det	O
high	JJ	amod	O
affinity	NN	dobj	O
for	IN	case	O
choroidal	JJ	amod	B-Multi-tissue_structure
neovascular	JJ	amod	I-Multi-tissue_structure
membranes	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
typically	RB	advmod	O
found	VBN	advcl	O
with	IN	case	O
exudative	JJ	amod	O
AMD	NN	nmod	O
,	,	punct	O
and	CC	cc	O
upon	IN	case	O
photoactivation	NN	nmod	O
results	VBZ	conj	O
in	IN	case	O
targeted	VBN	amod	O
microvascular	JJ	amod	B-Tissue
damage	NN	nmod	O
and	CC	cc	O
thrombus	NN	compound	B-Pathological_formation
formation	NN	conj	O
with	IN	case	O
resultant	JJ	amod	O
vessel	NN	compound	B-Multi-tissue_structure
occlusion	NN	nmod	O
.	.	punct	O

Scrutiny	NN	nsubj	O
of	IN	case	O
diagnostic	JJ	amod	O
indicators	NNS	nmod	O
for	IN	case	O
verteporfin	NN	compound	B-Simple_chemical
administration	NN	nmod	O
,	,	punct	O
including	VBG	case	O
critical	JJ	amod	O
angiographic	JJ	amod	O
evaluation	NN	nmod	O
of	IN	case	O
lesion	NN	compound	B-Pathological_formation
size	NN	nmod	O
and	CC	cc	O
visual	JJ	amod	O
acuity	NN	conj	O
,	,	punct	O
is	VBZ	cop	O
essential	JJ	ROOT	O
to	TO	case	O
treatment	NN	compound	O
success	NN	nmod	O
.	.	punct	O

Large	JJ	amod	O
lesions	NNS	nsubj	B-Pathological_formation
with	IN	case	O
relatively	RB	advmod	O
good	JJ	amod	O
visual	JJ	amod	O
acuity	NN	nmod	O
(	-LRB-	punct	O
20	CD	nummod	O
/	SYM	punct	O
50	CD	dep	O
or	CC	cc	O
better	JJR	conj	O
)	-RRB-	punct	O
may	MD	aux	O
be	VB	cop	O
at	IN	case	O
particular	JJ	amod	O
risk	NN	ROOT	O
for	IN	case	O
marked	JJ	amod	O
vision	NN	compound	O
loss	NN	nmod	O
following	VBG	prep	O
verteporfin	NN	compound	B-Simple_chemical
administration	NN	pobj	O
.	.	punct	O

Lesion	NN	compound	B-Pathological_formation
composition	NN	nsubj	O
also	RB	advmod	O
appears	VBZ	ROOT	O
to	TO	mark	O
influence	VB	xcomp	O
visual	JJ	amod	O
outcome	NN	dobj	O
with	IN	case	O
verteporfin	NN	compound	B-Simple_chemical
use	NN	nmod	O
.	.	punct	O

The	DT	det	O
safety	NN	nsubj	O
of	IN	prep	O
verteporfin	NN	pobj	B-Simple_chemical
is	VBZ	cop	O
directly	RB	advmod	O
dependent	JJ	ROOT	O
upon	IN	case	O
the	DT	det	O
appropriate	JJ	amod	O
integration	NN	nmod	O
of	IN	case	O
dosage	NN	nmod	O
,	,	punct	O
infusion	NN	conj	O
and	CC	cc	O
light	JJ	amod	O
activation	NN	conj	O
required	VBN	acl	O
for	IN	case	O
a	DT	det	O
suitable	JJ	amod	O
pharmacotherapeutic	JJ	amod	O
outcome	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
used	VBN	advcl	O
appropriately	RB	advmod	O
,	,	punct	O
and	CC	cc	O
with	IN	case	O
adequate	JJ	amod	O
patient	NN	compound	B-Organism
education	NN	conj	O
regarding	NN	case	O
photosensitivity	NN	nmod	O
,	,	punct	O
the	DT	det	O
risk	NN	compound	O
-	HYPH	punct	O
benefit	NN	nsubj	O
of	IN	prep	O
verteporfin	NN	pobj	B-Simple_chemical
for	IN	case	O
the	DT	det	O
medical	JJ	amod	O
treatment	NN	nmod	O
of	IN	case	O
neovascular	JJ	amod	O
AMD	NN	nmod	O
is	VBZ	cop	O
favourable	JJ	ROOT	O
.	.	punct	O

Retrospective	JJ	amod	O
case	NN	compound	O
series	NN	ROOT	O
of	IN	case	O
juxtafoveal	NN	amod	B-Multi-tissue_structure
choroidal	NN	amod	I-Multi-tissue_structure
neovascularization	NN	nmod	O
treated	VBN	acl	O
with	IN	case	O
photodynamic	JJ	amod	O
therapy	NN	nmod	O
with	IN	case	O
verteporfin	NN	nmod	B-Simple_chemical
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
describe	VB	dep	O
visual	JJ	amod	O
acuity	NN	dobj	O
and	CC	cc	O
angiographic	JJ	amod	O
outcomes	NNS	conj	O
of	IN	case	O
juxtafoveal	NN	amod	B-Multi-tissue_structure
choroidal	NN	amod	I-Multi-tissue_structure
neovascularization	NN	nmod	O
(	-LRB-	punct	O
CNV	NN	appos	O
)	-RRB-	punct	O
treated	VBN	acl	O
with	IN	case	O
photodynamic	JJ	amod	O
therapy	NN	nmod	O
and	CC	cc	O
verteporfin	NN	conj	B-Simple_chemical
(	-LRB-	punct	O
PDT	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	nsubjpass	O
:	:	punct	O
Four	CD	compound	O
hundred	CD	nummod	O
eighty	CD	compound	O
-	HYPH	punct	O
four	CD	nummod	O
consecutive	JJ	amod	O
eyes	NNS	appos	B-Organ
of	IN	case	O
446	CD	nummod	O
patients	NNS	nmod	B-Organism
treated	VBN	acl	O
with	IN	case	O
PDT	NN	nmod	O
from	IN	case	O
January	NNP	nmod	O
1	CD	nummod	O
,	,	punct	O
2001	CD	nummod	O
,	,	punct	O
to	IN	prep	O
June	NNP	pobj	O
30	CD	nummod	O
,	,	punct	O
2002	CD	nummod	O
,	,	punct	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
from	IN	prep	O
billing	VBG	compound	O
records	NNS	pobj	O
.	.	punct	O

Fluorescein	NN	compound	B-Simple_chemical
angiograms	NNS	nsubjpass	O
were	VBD	auxpass	O
reviewed	VBN	ROOT	O
retrospectively	RB	advmod	O
to	TO	mark	O
identify	VB	xcomp	O
juxtafoveal	NN	amod	B-Immaterial_anatomical_entity
CNV	NN	dobj	O
.	.	punct	O

Eligible	JJ	amod	O
patients	NNS	nsubj	B-Organism
had	VBD	ROOT	O
CNV	NN	nsubj	O
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
central	JJ	amod	O
boundary	NN	nsubj	O
of	IN	prep	O
the	DT	det	O
lesion	NN	pobj	B-Pathological_formation
was	VBD	cop	O
between	IN	case	O
1	CD	nummod	O
and	CC	cc	O
199	CD	conj	O
microm	NN	dobj	O
from	IN	case	O
the	DT	det	O
geometric	JJ	amod	O
center	NN	nmod	O
of	IN	case	O
the	DT	det	O
foveal	JJ	amod	B-Tissue
avascular	JJ	amod	I-Tissue
zone	NN	nmod	I-Tissue
(	-LRB-	punct	O
FAZ	NN	appos	B-Tissue
)	-RRB-	punct	O
.	.	punct	O

Patient	NN	compound	B-Organism
charts	NNS	nsubjpass	O
were	VBD	auxpass	O
reviewed	VBN	ROOT	O
for	IN	case	O
visual	JJ	amod	O
acuity	NN	nmod	O
of	IN	case	O
the	DT	det	O
treated	VBN	amod	O
eye	NN	nmod	B-Organ
before	IN	case	O
PDT	NN	nmod	O
and	CC	cc	O
at	IN	case	O
6	CD	nummod	O
-	HYPH	punct	O
and	CC	cc	O
12	CD	nummod	O
-	HYPH	punct	O
month	NN	compound	O
follow	NN	dep	O
-	HYPH	punct	O
up	RP	prt	O
examinations	NNS	conj	O
.	.	punct	O

Presence	NN	nsubjpass	O
of	IN	case	O
subfoveal	JJ	amod	O
CNV	NN	nmod	O
at	IN	case	O
6	CD	nummod	O
and	CC	cc	O
12	CD	conj	O
months	NNS	nmod	O
of	IN	case	O
follow	NN	compound	O
-	HYPH	punct	O
up	NN	nmod	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
review	NN	nmod	O
of	IN	case	O
fluorescein	NN	compound	B-Simple_chemical
angiograms	NNS	nmod	O
.	.	punct	O

A	DT	det	O
lesion	NN	nsubjpass	B-Pathological_formation
was	VBD	auxpass	O
considered	VBN	ROOT	O
subfoveal	JJ	oprd	O
if	IN	mark	O
it	PRP	nsubj	O
extended	VBD	advcl	O
underneath	IN	prep	O
the	DT	det	O
geometric	JJ	amod	O
center	NN	pobj	O
of	IN	prep	O
the	DT	det	O
FAZ	NN	pobj	B-Tissue
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Twenty	CD	compound	O
-	HYPH	punct	O
one	CD	nummod	O
eyes	NNS	nsubj	B-Organ
had	VBD	aux	O
juxtafoveal	JJ	ROOT	B-Immaterial_anatomical_entity
CNV	NN	dobj	O
.	.	punct	O

Median	JJ	amod	O
change	NN	nsubj	O
in	IN	case	O
visual	JJ	amod	O
acuity	NN	nmod	O
both	CC	cc:preconj	O
6	CD	nummod	O
and	CC	cc	O
12	CD	conj	O
months	NNS	nmod	O
after	IN	case	O
the	DT	det	O
initial	JJ	amod	O
PDT	NN	nmod	O
was	VBD	cop	O
0	CD	nummod	O
lines	NNS	ROOT	O
(	-LRB-	punct	O
n	NN	nsubj	O
=	JJ	amod	O
18	CD	dobj	O
at	IN	case	O
6	CD	nummod	O
months	NNS	nmod	O
,	,	punct	O
range	NN	dep	O
-	HYPH	punct	O
14	CD	nummod	O
to	TO	dep	O
+	CC	cc	O
8	CD	conj	O
lines	NNS	dobj	O
;	:	punct	O
n	NN	nsubj	O
=	JJ	parataxis	O
17	CD	dobj	O
at	IN	case	O
12	CD	nummod	O
months	NNS	nmod	O
,	,	punct	O
range	NN	conj	O
-	HYPH	punct	O
18	CD	nummod	O
to	TO	dep	O
+	CC	cc	O
7	CD	nummod	O
lines	NNS	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Eleven	CD	amod	O
lesions	NNS	nsubj	B-Pathological_formation
progressed	VBN	ROOT	O
to	TO	case	O
a	DT	det	O
subfoveal	JJ	amod	O
location	NN	nmod	O
by	IN	prep	O
12	CD	nummod	O
months	NNS	pobj	O
.	.	punct	O

Visual	JJ	amod	O
acuity	NN	nsubj	O
in	IN	case	O
eyes	NNS	nmod	B-Organ
with	IN	case	O
progressive	JJ	amod	O
lesions	NNS	nmod	B-Pathological_formation
decreased	VBD	ROOT	O
a	DT	det	O
median	NN	dobj	O
of	IN	case	O
4	CD	nummod	O
lines	NNS	nmod	O
of	IN	prep	O
vision	NN	pobj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Despite	IN	case	O
a	DT	det	O
small	JJ	amod	O
sample	NN	compound	O
size	NN	nmod	O
and	CC	cc	O
limited	JJ	amod	O
length	NN	conj	O
of	IN	prep	O
follow	NN	compound	O
-	HYPH	punct	O
up	RP	pobj	O
,	,	punct	O
this	DT	det	O
study	NN	nsubj	O
shows	VBZ	appos	O
that	IN	mark	O
visual	JJ	amod	O
acuity	NN	nsubj	O
on	IN	case	O
average	JJ	nmod	O
can	MD	aux	O
remain	VB	ccomp	O
stable	JJ	xcomp	O
for	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
12	CD	nummod	O
months	NNS	nmod	O
after	IN	prep	O
PDT	NN	pobj	O
of	IN	prep	O
juxtafoveal	JJ	amod	B-Pathological_formation
lesions	NNS	pobj	I-Pathological_formation
.	.	punct	O

Growth	NN	nsubj	O
through	IN	prep	O
the	DT	det	O
foveal	JJ	amod	B-Tissue
center	NN	pobj	I-Tissue
still	RB	advmod	O
can	MD	aux	O
occur	VB	ROOT	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
and	CC	cc	O
this	DT	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
associated	VBN	conj	O
with	IN	case	O
substantial	JJ	amod	O
visual	JJ	amod	O
loss	NN	nmod	O
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
DCC	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
netrin	NN	conj	B-Gene_or_gene_product3
-	,	punct	I-Gene_or_gene_product3
1	CD	dep	I-Gene_or_gene_product3
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
endometrium	NN	nmod	B-Multi-tissue_structure
and	CC	cc	O
its	PRP$	nmod:poss	O
implication	NN	conj	O
in	IN	case	O
endometrial	JJ	amod	B-Multi-tissue_structure
carcinogenesis	NN	nmod	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
Although	IN	mark	O
DCC	NN	nsubjpass	B-Gene_or_gene_product1
has	VBZ	aux	O
been	VBN	auxpass	O
considered	VBN	advcl	O
as	IN	case	O
a	DT	det	O
candidate	NN	compound	O
tumor	NN	compound	B-Cancer
suppressor	NN	nmod	O
,	,	punct	O
the	DT	det	O
roles	NNS	nsubj	O
it	PRP	nsubj	O
plays	VBZ	acl:relcl	O
in	IN	case	O
the	DT	det	O
uterine	JJ	amod	B-Multi-tissue_structure
endometrium	NN	nmod	I-Multi-tissue_structure
and	CC	cc	O
in	IN	case	O
the	DT	det	O
carcinogenic	JJ	amod	O
process	NN	nmod	O
remains	VBZ	dep	O
unclear	JJ	xcomp	O
.	.	punct	O

To	TO	mark	O
define	VB	advcl	O
these	DT	det	O
roles	NNS	dobj	O
more	RBR	advmod	O
clearly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
DCC	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
its	PRP$	nmod:poss	O
ligand	NN	conj	O
,	,	punct	O
netrin	NN	appos	B-Gene_or_gene_product3
-	,	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
,	,	punct	O
in	IN	case	O
the	DT	det	O
normal	JJ	amod	O
endometrium	NN	nmod	B-Multi-tissue_structure
and	CC	cc	O
in	IN	case	O
endometrial	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
DCC	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
netrin	NN	conj	B-Gene_or_gene_product3
-	,	punct	I-Gene_or_gene_product3
1	CD	dep	I-Gene_or_gene_product3
in	IN	case	O
normal	JJ	amod	O
endometrial	JJ	amod	B-Multi-tissue_structure
glands	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
in	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
was	VBD	auxpass	O
examined	VBN	dep	O
by	IN	case	O
RT	NN	nmod	O
-	HYPH	punct	O
PCR	NN	dep	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
exogenous	JJ	amod	O
DCC	NN	compound	B-Gene_or_gene_product1
and	CC	cc	O
netrin	NN	conj	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
expression	NN	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
together	RB	advmod	O
with	IN	case	O
the	DT	det	O
respective	JJ	amod	O
expression	NN	compound	O
vector	NN	compound	O
transfection	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Endometrial	JJ	amod	B-Multi-tissue_structure
glands	NNS	nsubj	I-Multi-tissue_structure
in	IN	case	O
the	DT	det	O
proliferative	JJ	amod	O
and	CC	cc	O
early	JJ	conj	O
secretory	JJ	amod	O
phase	NN	nmod	O
expressed	VBD	appos	O
both	CC	cc:preconj	O
DCC	NN	dobj	B-Gene_or_gene_product1
and	CC	cc	O
netrin	NN	conj	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	conj	I-Gene_or_gene_product3
,	,	punct	O
but	CC	cc	O
glands	NNS	conj	B-Multi-tissue_structure
in	IN	case	O
the	DT	det	O
late	JJ	amod	O
-	HYPH	punct	O
secretory	JJ	amod	O
phase	NN	nmod	O
tended	VBD	conj	O
to	TO	mark	O
silence	VB	xcomp	O
DCC	NN	compound	B-Gene_or_gene_product1
expression	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
all	DT	nsubj	O
of	IN	case	O
the	DT	det	O
endometrial	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
lost	VBD	ROOT	O
normal	JJ	amod	O
DCC	NN	compound	B-Gene_or_gene_product1
expression	NN	dobj	O
.	.	punct	O

Restored	VBN	amod	O
DCC	NN	compound	B-Gene_or_gene_product1
expression	NN	ROOT	O
in	IN	case	O
the	DT	det	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
netrin	NN	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
induced	VBD	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
no	DT	neg	O
changes	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
netrin	NN	nmod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
observations	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
DCC	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
netrin	NN	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
signaling	NN	nsubj	O
may	MD	aux	O
commit	VB	ccomp	O
cells	NNS	dobj	B-Cell
to	TO	case	O
the	DT	det	O
transition	NN	nmod	O
of	IN	case	O
endometrial	JJ	amod	B-Multi-tissue_structure
gland	NN	compound	I-Multi-tissue_structure
architecture	NN	nmod	O
or	CC	cc	O
function	NN	conj	O
from	IN	case	O
a	DT	det	O
proliferating	VBG	nmod	O
to	TO	case	O
a	DT	det	O
secretory	JJ	amod	O
phase	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
silencing	NN	nsubj	O
of	IN	case	O
DCC	NN	compound	B-Gene_or_gene_product1
expression	NN	nmod	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
escape	NN	nmod	O
of	IN	case	O
endometrial	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
a	DT	det	O
DCC	NN	npadvmod	B-Gene_or_gene_product1
-	HYPH	punct	O
regulated	VBN	amod	O
apoptotic	JJ	amod	O
program	NN	nmod	O
,	,	punct	O
thereby	RB	advmod	O
promoting	VBG	advcl	O
malignant	JJ	amod	O
phenotypes	NNS	dobj	O
.	.	punct	O

An	DT	det	O
evaluation	NN	ROOT	O
of	IN	case	O
low	JJ	amod	B-Simple_chemical
molecular	JJ	amod	I-Simple_chemical
weight	NN	compound	I-Simple_chemical
heparin	NN	nmod	I-Simple_chemical
and	CC	cc	O
hyperbaric	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
treatment	NN	conj	O
in	IN	case	O
the	DT	det	O
prevention	NN	nmod	O
of	IN	prep	O
intra	JJ	amod	O
-	HYPH	punct	O
abdominal	JJ	amod	O
adhesions	NNS	pobj	O
and	CC	cc	O
wound	NN	compound	B-Pathological_formation
healing	NN	conj	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Abdominal	JJ	amod	O
surgery	NN	nsubj	O
can	MD	aux	O
lead	VB	appos	O
to	TO	case	O
intra	JJ	amod	O
-	HYPH	punct	O
abdominal	JJ	amod	O
adhesions	NNS	nmod	O
with	IN	case	O
significant	JJ	amod	O
morbidity	NN	nmod	O
and	CC	cc	O
mortality	NN	conj	O
.	.	punct	O

To	TO	mark	O
prevent	VB	advcl	O
adhesions	NNS	dobj	O
,	,	punct	O
an	DT	det	O
experimental	JJ	amod	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
planned	VBN	ROOT	O
to	TO	mark	O
designate	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
low	JJ	amod	B-Simple_chemical
molecular	JJ	amod	I-Simple_chemical
weight	NN	compound	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
LMW	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
heparins	NNS	nmod	I-Simple_chemical
and	CC	cc	O
hyperbaric	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
HBO	NN	compound	B-Simple_chemical
)	-RRB-	punct	O
therapy	NN	conj	O
both	CC	cc:preconj	O
on	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
adhesions	NNS	nmod	O
and	CC	cc	O
wound	NN	compound	B-Pathological_formation
healing	NN	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Thirty	CD	compound	O
-	HYPH	punct	O
eight	CD	nummod	O
Wistar	NNP	compound	B-Organism
albino	NN	compound	I-Organism
rats	NNS	nsubj	I-Organism
underwent	VBD	appos	O
laparotomy	NNS	dobj	O
to	TO	mark	O
cause	VB	xcomp	O
intra	JJ	amod	O
-	HYPH	punct	O
abdominal	JJ	amod	O
adhesions	NNS	dobj	O
by	IN	case	O
mechanical	JJ	amod	O
abrasion	NN	nmod	O
of	IN	case	O
the	DT	det	O
cecum	NN	compound	B-Multi-tissue_structure
and	CC	cc	O
ethanol	NN	conj	B-Simple_chemical
application	NN	nmod	O
.	.	punct	O

The	DT	det	O
rats	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
divided	VBN	ROOT	O
into	IN	case	O
4	CD	nummod	O
groups	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
group	NN	appos	O
1	CD	nummod	O
)	-RRB-	punct	O
no	DT	neg	O
further	JJ	amod	O
management	NN	nsubjpass	O
was	VBD	auxpass	O
undertaken	VBN	ROOT	O
.	.	punct	O

Group	NN	nsubjpass	O
2	CD	nummod	O
was	VBD	auxpass	O
treated	VBN	ROOT	O
by	IN	case	O
Enoxaparine	NNP	compound	B-Simple_chemical
Na	NN	nmod	I-Simple_chemical
,	,	punct	O
group	NN	appos	O
3	CD	nummod	O
received	VBD	amod	O
HBO	NN	compound	B-Simple_chemical
therapy	NN	nmod	O
,	,	punct	O
and	CC	cc	O
group	NN	nsubjpass	O
4	CD	nummod	O
was	VBD	auxpass	O
given	VBN	conj	O
both	CC	cc:preconj	O
enoxaparine	NN	compound	B-Simple_chemical
Na	NN	dobj	I-Simple_chemical
and	CC	cc	O
HBO	NN	compound	B-Simple_chemical
treatment	NN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
There	EX	expl	O
was	VBD	appos	O
a	DT	det	O
statistically	RB	advmod	O
significant	JJ	amod	O
difference	NN	nsubj	O
between	IN	case	O
the	DT	det	O
control	NN	nmod	O
and	CC	cc	O
enoxaparine	NN	compound	B-Simple_chemical
Na	NN	compound	I-Simple_chemical
groups	NNS	conj	O
regarding	VBG	case	O
adhesions	NNS	nmod	O
.	.	punct	O

Statistically	RB	advmod	O
significant	JJ	amod	O
differences	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
between	IN	case	O
groups	NNS	nmod	O
1	CD	nummod	O
and	CC	cc	O
4	CD	conj	O
and	CC	cc	O
between	IN	case	O
groups	NNS	conj	O
1	CD	nummod	O
and	CC	cc	O
3	CD	nummod	O
regarding	VBG	case	O
the	DT	det	O
hydroxyproline	NN	compound	O
content	NN	nmod	O
of	IN	prep	O
the	DT	det	O
abdominal	JJ	amod	B-Pathological_formation
wounds	NNS	pobj	I-Pathological_formation
.	.	punct	O

In	IN	case	O
the	DT	det	O
pathologic	JJ	amod	O
analysis	NN	nmod	O
of	IN	prep	O
the	DT	det	O
abdominal	JJ	amod	B-Pathological_formation
wounds	NNS	pobj	I-Pathological_formation
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
statistically	RB	advmod	O
significant	JJ	amod	O
difference	NN	nsubj	O
between	IN	case	O
any	DT	nmod	O
of	IN	case	O
the	DT	det	O
groups	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
,	,	punct	O
regarding	VBG	advcl	O
inflammation	NN	dobj	O
.	.	punct	O

Statistically	RB	advmod	O
significant	JJ	amod	O
differences	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
regarding	VBG	case	O
angiogenesis	NN	nmod	O
between	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
and	CC	cc	O
groups	NNS	conj	O
3	CD	nummod	O
and	CC	cc	O
4	CD	conj	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
also	RB	advmod	O
a	DT	det	O
statistically	RB	advmod	O
significant	JJ	amod	O
difference	NN	attr	O
regarding	VBG	case	O
fibrosis	NN	nmod	O
between	IN	case	O
groups	NNS	nmod	O
1	CD	nummod	O
and	CC	cc	O
4	CD	conj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Enoxaparine	NN	compound	B-Simple_chemical
Na	NN	nsubj	I-Simple_chemical
decreased	VBD	appos	O
intra	JJ	amod	O
-	HYPH	punct	O
abdominal	JJ	amod	O
adhesions	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
HBO	NN	compound	B-Simple_chemical
therapy	NN	nsubj	O
had	VBD	conj	O
no	DT	neg	O
beneficial	JJ	amod	O
effect	NN	dobj	O
on	IN	case	O
adhesions	NNS	nmod	O
.	.	punct	O

Enoxaparine	NNP	compound	B-Simple_chemical
Na	NNP	nsubj	I-Simple_chemical
had	VBD	ROOT	O
no	DT	neg	O
harmful	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
,	,	punct	O
and	CC	cc	O
HBO	NN	compound	B-Simple_chemical
therapy	NN	nsubj	O
increased	VBD	conj	O
the	DT	det	O
process	NN	dobj	O
of	IN	case	O
wound	NN	compound	B-Pathological_formation
healing	NN	nmod	O
.	.	punct	O

VEGF	NNP	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
targeted	VBN	amod	O
therapy	NN	ROOT	O
:	:	punct	O
therapeutic	JJ	amod	O
potential	JJ	dep	O
and	CC	cc	O
recent	JJ	amod	O
advances	NNS	conj	O
.	.	punct	O

After	IN	prep	O
over	IN	advmod	O
30	CD	nummod	O
years	NNS	pobj	O
of	IN	prep	O
theorizing	NN	pobj	O
,	,	punct	O
the	DT	det	O
use	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	compound	O
inhibitors	NNS	nmod	O
as	IN	case	O
anticancer	NN	compound	B-Cancer
therapy	NN	nmod	O
has	VBZ	aux	O
finally	RB	advmod	O
moved	VBN	ROOT	O
from	IN	prep	O
the	DT	det	O
realm	NN	pobj	O
of	IN	prep	O
research	NN	pobj	O
to	IN	prep	O
reality	NN	pobj	O
.	.	punct	O

Normal	JJ	amod	O
adult	JJ	amod	O
vasculature	NN	nsubj	B-Anatomical_system
is	VBZ	cop	O
generally	RB	advmod	O
quiescent	JJ	ROOT	O
in	IN	case	O
nature	NN	nmod	O
,	,	punct	O
with	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
dividing	VBG	acl	O
approximately	RB	advmod	O
every	DT	det	O
10	CD	nummod	O
years	NNS	dobj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
growth	NN	nsubj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
requires	VBZ	ROOT	O
constant	JJ	amod	O
vascular	JJ	amod	B-Multi-tissue_structure
growth	NN	dobj	O
and	CC	cc	O
remodeling	NN	conj	O
in	IN	case	O
order	NN	nmod	O
for	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
to	TO	mark	O
grow	VB	xcomp	O
beyond	IN	case	O
1	CD	nummod	O
-	SYM	punct	O
2	CD	nummod	O
mm	NN	nmod	O
(	-LRB-	punct	O
3	CD	appos	O
)	-RRB-	punct	O
in	IN	case	O
size	NN	nmod	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	nsubj	I-Gene_or_gene_product0
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
receptors	NNS	conj	O
are	VBP	cop	O
key	JJ	amod	O
regulators	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
makes	VBZ	acl:relcl	O
them	PRP	nsubj	O
attractive	JJ	amod	O
therapeutic	JJ	amod	O
targets	NNS	dobj	O
.	.	punct	O

A	DT	det	O
multitude	NN	nsubjpass	O
of	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product1
-	HYPH	punct	O
targeted	VBN	amod	O
inhibitory	JJ	amod	O
agents	NNS	nmod	O
are	VBP	auxpass	O
currently	RB	advmod	O
being	VBG	auxpass	O
investigated	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

This	DT	det	O
review	NN	compound	O
article	NN	nsubj	O
focuses	VBZ	ROOT	O
on	IN	prep	O
recent	JJ	amod	O
developments	NNS	pobj	O
in	IN	prep	O
the	DT	det	O
use	NN	pobj	O
of	IN	case	O
angiogenesis	NN	compound	O
inhibitors	NNS	nmod	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
breast	NN	nmod	B-Cancer
,	,	punct	O
lung	NN	conj	B-Cancer
,	,	punct	O
and	CC	cc	O
colorectal	JJ	amod	B-Cancer
cancers	NNS	conj	I-Cancer
.	.	punct	O

MDM2	NN	ROOT	B-Gene_or_gene_product1
as	IN	case	O
a	DT	det	O
predictor	NN	nmod	O
of	IN	case	O
prostate	NN	compound	B-Cancer
carcinoma	NN	compound	I-Cancer
outcome	NN	nmod	O
:	:	punct	O
an	DT	det	O
analysis	NN	dep	O
of	IN	case	O
Radiation	NN	compound	O
Therapy	NNP	compound	O
Oncology	NNP	compound	O
Group	NNP	compound	O
Protocol	NNP	nmod	O
8610	CD	nummod	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
MDM2	NN	compound	B-Gene_or_gene_product1
oncoprotein	NN	nsubj	O
promotes	VBZ	dep	O
p53	NN	compound	B-Gene_or_gene_product1
degradation	NN	dobj	O
via	IN	case	O
ubiquitin	NN	nmod	B-Gene_or_gene_product0
,	,	punct	O
establishing	VBG	advcl	O
negative	JJ	amod	O
feedback	NN	compound	O
control	NN	dobj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
consequently	RB	advmod	O
affecting	VBG	conj	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

The	DT	det	O
authors	NNS	nsubj	O
evaluated	VBD	ROOT	O
the	DT	det	O
association	NN	dobj	O
between	IN	case	O
MDM2	NN	compound	B-Gene_or_gene_product1
expression	NN	nmod	O
and	CC	cc	O
local	JJ	amod	O
failure	NN	conj	O
,	,	punct	O
distant	JJ	amod	O
metastasis	NN	conj	O
(	-LRB-	punct	O
DM	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
cause	NN	conj	O
-	HYPH	punct	O
specific	JJ	amod	O
mortality	NN	dobj	O
,	,	punct	O
and	CC	cc	O
overall	JJ	amod	O
mortality	NN	conj	O
in	IN	prep	O
men	NNS	pobj	B-Organism
treated	VBN	acl	O
in	IN	case	O
Radiation	NNP	compound	O
Therapy	NNP	compound	O
Oncology	NNP	compound	O
Group	NNP	nmod	O
8610	CD	nummod	O
with	IN	case	O
radiotherapy	NN	nmod	O
,	,	punct	O
with	IN	prep	O
or	CC	cc	O
without	IN	conj	O
androgen	NN	compound	B-Simple_chemical
deprivation	NN	pobj	O
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
Of	IN	case	O
the	DT	dep	O
456	CD	nummod	O
eligible	JJ	dep	O
and	CC	cc	O
analyzable	JJ	conj	O
patients	NNS	dep	B-Organism
(	-LRB-	punct	O
parent	NN	compound	O
cohort	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
adequate	JJ	amod	O
archival	NN	compound	O
diagnostic	JJ	amod	O
tissue	NN	compound	B-Tissue
specimens	NNS	nsubj	I-Tissue
from	IN	case	O
108	CD	nummod	O
patients	NNS	nmod	B-Organism
were	VBD	cop	O
available	JJ	ROOT	O
for	IN	case	O
MDM2	NN	compound	B-Gene_or_gene_product1
analysis	NN	nmod	O
(	-LRB-	punct	O
MDM2	NN	compound	B-Gene_or_gene_product1
cohort	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Cox	NN	compound	O
proportional	JJ	amod	O
hazards	NNS	compound	O
multivariate	JJ	amod	O
analysis	NN	nsubjpass	O
(	-LRB-	punct	O
MVA	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
the	DT	det	O
relation	NN	dobj	O
of	IN	case	O
MDM2	NN	nmod	B-Gene_or_gene_product1
to	TO	case	O
the	DT	det	O
endpoints	NNS	nmod	O
.	.	punct	O

MDM2	NN	compound	B-Gene_or_gene_product1
overexpression	NN	nsubjpass	O
was	VBD	auxpass	O
manually	RB	advmod	O
classified	VBN	ROOT	O
as	IN	case	O
>	NN	amod	O
5	CD	nummod	O
%	NN	amod	O
nuclear	JJ	amod	B-Cellular_component
staining	NN	nmod	O
.	.	punct	O

An	DT	det	O
image	NN	amod	O
analysis	NN	compound	O
system	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
used	VBN	ROOT	O
to	TO	mark	O
quantify	VB	xcomp	O
the	DT	det	O
proportion	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
nuclei	NNS	nmod	B-Cellular_component
with	IN	case	O
MDM2	NN	compound	B-Gene_or_gene_product1
staining	NN	nmod	O
(	-LRB-	punct	O
ACIS	NN	compound	O
index	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
staining	VBG	compound	O
intensity	NN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Overexpression	NN	nsubjpass	O
of	IN	case	O
MDM2	NN	nmod	B-Gene_or_gene_product1
by	IN	case	O
manual	JJ	amod	O
counts	NNS	nmod	O
was	VBD	auxpass	O
seen	VBN	dep	O
in	IN	case	O
44	CD	nummod	O
%	NN	nmod	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
47	CD	dep	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
patients	NNS	nmod	B-Organism
.	.	punct	O

In	IN	prep	O
the	DT	det	O
manual	JJ	amod	O
count	NN	compound	O
analysis	NN	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
significant	JJ	amod	O
relation	NN	nsubj	O
between	IN	case	O
MDM2	NN	compound	B-Gene_or_gene_product1
overexpression	NN	nmod	O
and	CC	cc	O
outcome	NN	conj	O
.	.	punct	O

The	DT	det	O
ACIS	NN	compound	O
index	NN	nsubj	O
,	,	punct	O
using	VBG	acl	O
a	DT	det	O
cutoff	NN	compound	O
point	NN	dobj	O
defined	VBN	acl	O
by	IN	agent	O
the	DT	det	O
median	JJ	amod	O
value	NN	pobj	O
,	,	punct	O
<	ADD	appos	O
or	CC	cc	O
=	JJ	conj	O
3	CD	nummod	O
%	NN	conj	O
versus	CC	cc	O
>	NN	conj	O
3	CD	nummod	O
%	NN	conj	O
,	,	punct	O
was	VBD	aux	O
related	JJ	ROOT	O
to	IN	case	O
5	CD	nummod	O
-	HYPH	punct	O
year	NN	compound	O
DM	NN	compound	O
rates	NNS	dobj	O
in	IN	case	O
univariate	JJ	amod	O
analyses	NNS	nmod	O
(	-LRB-	punct	O
32	CD	nummod	O
.	.	punct	O
6	CD	nummod	O
%	NN	npadvmod	O
vs	CC	cc	O
.	.	punct	O
45	CD	ROOT	O
.	.	punct	O
8	CD	nummod	O
%	NN	ROOT	O
;	:	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
057	CD	ROOT	O
)	-RRB-	punct	O
and	CC	cc	O
MVA	NN	nsubj	O
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	conj	O
0	CD	dobj	O
.	.	punct	O
06	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
intensity	NN	nsubj	O
of	IN	case	O
MDM2	NN	compound	B-Gene_or_gene_product1
staining	NN	nmod	O
was	VBD	cop	O
not	RB	neg	O
significant	JJ	ROOT	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
MDM2	NN	compound	B-Gene_or_gene_product1
expression	NN	nsubjpass	O
quantified	VBN	acl	O
by	IN	case	O
image	NN	compound	O
analysis	NN	nmod	O
was	VBD	auxpass	O
weakly	RB	advmod	O
associated	VBN	dep	O
with	IN	case	O
DM	NN	nmod	O
.	.	punct	O

The	DT	det	O
cohort	NN	nsubj	O
examined	VBN	acl	O
was	VBD	advcl	O
relatively	RB	advmod	O
small	JJ	acomp	O
and	CC	cc	O
with	IN	case	O
larger	JJR	amod	O
patient	NN	compound	B-Organism
numbers	NNS	nmod	O
,	,	punct	O
MDM2	NN	compound	B-Gene_or_gene_product1
overexpression	NN	nsubj	O
may	MD	aux	O
emerge	VB	ROOT	O
as	IN	case	O
a	DT	det	O
more	RBR	advmod	O
significant	JJ	amod	O
covariate	NN	nmod	O
.	.	punct	O

Thrombospondins	NNS	ROOT	B-Gene_or_gene_product0
,	,	punct	O
metallo	NN	compound	B-Gene_or_gene_product0
proteases	NNS	appos	I-Gene_or_gene_product0
and	CC	cc	O
thrombospondin	NN	compound	B-Gene_or_gene_product0
receptors	NNS	conj	I-Gene_or_gene_product0
messenger	NN	compound	O
RNA	NN	conj	O
and	CC	cc	O
protein	NN	compound	O
expression	NN	conj	O
in	IN	case	O
different	JJ	amod	O
tumour	NN	compound	B-Cancer
sublines	NNS	nmod	I-Cancer
of	IN	case	O
the	DT	det	O
Dunning	VBG	compound	B-Cancer
prostate	NN	compound	I-Cancer
cancer	NN	compound	I-Cancer
model	NN	nmod	O
.	.	punct	O

Thrombospondin	NN	nsubj	B-Gene_or_gene_product0
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
inhibitor	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
might	MD	aux	O
therefore	RB	advmod	O
be	VB	cop	O
important	JJ	conj	O
in	IN	mark	O
controlling	VBG	advcl	O
tumour	NN	compound	B-Cancer
growth	NN	dobj	O
.	.	punct	O

TSP	NN	nsubj	B-Gene_or_gene_product1
interacts	VBZ	ROOT	O
with	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
proteases	NNS	nmod	O
and	CC	cc	O
receptors	NNS	conj	O
and	CC	cc	O
in	IN	case	O
this	DT	det	O
way	NN	conj	O
inhibits	VBZ	conj	O
stimulation	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

An	DT	det	O
earlier	RBR	amod	O
study	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
thrombospondin	NN	nsubjpass	B-Gene_or_gene_product0
is	VBZ	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
benign	JJ	amod	B-Pathological_formation
prostatic	JJ	amod	I-Pathological_formation
hyperplasia	NN	nmod	I-Pathological_formation
(	-LRB-	punct	O
BPH	NN	appos	B-Pathological_formation
)	-RRB-	punct	O
and	CC	cc	O
high	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
prostatic	JJ	amod	B-Pathological_formation
intraepithelial	JJ	amod	I-Pathological_formation
neoplasia	NN	conj	I-Pathological_formation
(	-LRB-	punct	O
PIN	NN	appos	B-Pathological_formation
)	-RRB-	punct	O
but	CC	cc	O
is	VBZ	cop	O
absent	JJ	conj	O
in	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
therefore	RB	advmod	O
designed	VBN	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
thrombospondin	NN	nmod	B-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
and	CC	cc	O
2	CD	conj	B-Gene_or_gene_product0
(	-LRB-	punct	O
TSP	NN	appos	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	dep	I-Gene_or_gene_product3
,	,	punct	O
TSP	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
2	CD	appos	I-Gene_or_gene_product3
)	-RRB-	punct	O
,	,	punct	O
TSP	NN	compound	B-Gene_or_gene_product2
receptors	NNS	conj	O
CD36	NN	dep	B-Gene_or_gene_product1
and	CC	cc	O
CD47	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
and	CC	cc	O
matrix	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
metalloproteases	NNS	conj	I-Gene_or_gene_product2
2	CD	dep	I-Gene_or_gene_product2
and	CC	cc	O
9	CD	conj	B-Gene_or_gene_product2
(	-LRB-	punct	O
MMP	NN	dep	B-Gene_or_gene_product1
-	:	punct	O
,	,	punct	O
MMP	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
9	CD	appos	I-Gene_or_gene_product3
)	-RRB-	punct	O
in	IN	case	O
a	DT	det	O
rat	NN	compound	B-Organism
prostate	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
model	NN	nmod	O
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
immunohistochemistry	NN	dobj	O
,	,	punct	O
Western	NN	compound	O
blot	NN	conj	O
,	,	punct	O
and	CC	cc	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
PCR	NN	conj	O
the	DT	det	O
expression	NN	compound	O
patterns	NNS	nsubjpass	O
of	IN	prep	O
TSP	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	dep	I-Gene_or_gene_product3
,	,	punct	O
TSP	NN	appos	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
2	CD	nummod	I-Gene_or_gene_product3
,	,	punct	O
CD36	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
CD47	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
MMP	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
2	CD	conj	I-Gene_or_gene_product2
,	,	punct	O
and	CC	cc	O
MMP	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
9	CD	conj	I-Gene_or_gene_product2
were	VBD	auxpass	O
investigated	VBN	ROOT	O
in	IN	case	O
normal	JJ	amod	O
rat	NN	compound	B-Organism
prostate	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
and	CC	cc	O
five	CD	nummod	O
malignant	JJ	amod	B-Tissue
Dunning	NN	compound	I-Tissue
sublines	NNS	compound	I-Tissue
tissue	NN	conj	I-Tissue
.	.	punct	O

TSP	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
mRNA	NN	compound	O
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
decreased	VBN	ROOT	O
in	IN	case	O
all	DT	det	O
tumours	NNS	nmod	B-Cancer
compared	VBN	case	O
with	IN	case	O
normal	JJ	amod	O
prostate	NN	nmod	B-Organ
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
difference	NN	nsubj	O
in	IN	case	O
expression	NN	nmod	O
of	IN	case	O
TSP	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
2	CD	nummod	I-Gene_or_gene_product3
and	CC	cc	O
CD36	NN	conj	B-Gene_or_gene_product1
mRNA	NN	nmod	O
in	IN	case	O
these	DT	det	O
samples	NNS	nmod	O
.	.	punct	O

MMP	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
2	CD	nsubjpass	I-Gene_or_gene_product2
was	VBD	auxpass	O
increased	VBN	ROOT	O
with	IN	case	O
malignancy	NN	nmod	O
,	,	punct	O
but	CC	cc	O
no	DT	neg	O
expression	NN	nsubjpass	O
of	IN	case	O
MMP	NN	nmod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
9	CD	nsubjpass	I-Gene_or_gene_product2
was	VBD	auxpass	O
seen	VBN	conj	O
.	.	punct	O

The	DT	det	O
CD47	NN	compound	B-Gene_or_gene_product1
receptor	NN	nsubj	I-Gene_or_gene_product1
did	VBD	aux	O
slightly	RB	advmod	O
increase	VB	ROOT	O
with	IN	case	O
malignancy	NN	nmod	O
except	IN	case	O
for	IN	case	O
H3327	NN	nmod	B-Cancer
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
thrombospondin	NN	nsubjpass	B-Gene_or_gene_product0
is	VBZ	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
normal	JJ	amod	O
prostate	NN	nmod	B-Organ
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
prostate	NN	compound	B-Cancer
tumours	NNS	conj	I-Cancer
in	IN	case	O
a	DT	det	O
rat	NN	compound	B-Organism
model	NN	nmod	O
.	.	punct	O

Simultaneously	RB	advmod	O
,	,	punct	O
MMP	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
expression	NN	nsubj	O
increases	VBZ	ROOT	O
with	IN	case	O
malignancy	NN	nmod	O
.	.	punct	O

Bovine	JJ	amod	B-Organism
papillomavirus	NN	compound	I-Organism
E7	NN	compound	B-Gene_or_gene_product1
transformation	NN	compound	O
function	NN	nsubj	O
correlates	VBZ	ROOT	O
with	IN	case	O
cellular	JJ	amod	B-Cell
p600	NN	compound	B-Gene_or_gene_product1
protein	NN	compound	O
binding	NN	nmod	O
.	.	punct	O

The	DT	det	O
E7	NN	compound	B-Gene_or_gene_product1
oncoprotein	NN	nsubjpass	O
of	IN	case	O
bovine	JJ	amod	B-Organism
papillomavirus	NN	compound	I-Organism
type	NN	nmod	I-Organism
1	CD	nummod	I-Organism
(	-LRB-	punct	O
BPV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	appos	I-Organism
)	-RRB-	punct	O
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
full	JJ	amod	O
transformation	NN	compound	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
virus	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanism	NN	nsubj	O
by	IN	case	O
which	WDT	nmod	O
E7	NN	nsubj	B-Gene_or_gene_product1
contributes	VBZ	acl:relcl	O
to	TO	case	O
cellular	JJ	amod	B-Cell
transformation	NN	nmod	O
is	VBZ	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

To	TO	mark	O
address	VB	advcl	O
this	DT	det	O
question	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
the	DT	det	O
proteomic	JJ	amod	O
approach	NN	dobj	O
of	IN	case	O
tandem	JJ	amod	O
affinity	NN	compound	O
purification	NN	nmod	O
to	TO	mark	O
identify	VB	advcl	O
cellular	JJ	amod	B-Cell
proteins	NNS	dobj	O
that	WDT	nsubj	O
are	VBP	cop	O
in	IN	case	O
complex	NN	acl:relcl	O
with	IN	case	O
E7	NN	nmod	B-Gene_or_gene_product1
,	,	punct	O
and	CC	cc	O
identified	VBD	conj	O
the	DT	det	O
600	CD	compound	O
-	HYPH	punct	O
kDa	NN	compound	O
protein	NN	dobj	O
,	,	punct	O
p600	NN	appos	B-Gene_or_gene_product1
,	,	punct	O
as	IN	case	O
a	DT	det	O
binding	VBG	amod	O
partner	NN	nmod	O
of	IN	case	O
E7	NN	nmod	B-Gene_or_gene_product1
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
E7	NN	nmod	B-Gene_or_gene_product1
to	TO	case	O
complex	NN	nmod	O
with	IN	case	O
p600	NN	nmod	B-Gene_or_gene_product1
correlated	VBD	ROOT	O
with	IN	case	O
its	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
enhance	VB	acl	O
anchorage	JJ	amod	O
independence	NN	dobj	O
of	IN	case	O
BPV	NN	compound	B-Organism
-	:	punct	O
1	CD	nummod	O
E6	NN	dep	B-Gene_or_gene_product1
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
E7	NN	compound	B-Gene_or_gene_product1
mutant	JJ	amod	O
proteins	NNS	nsubj	O
impaired	JJ	acl	O
in	IN	case	O
their	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
bind	VB	acl	O
p600	NN	dobj	B-Gene_or_gene_product1
were	VBD	cop	O
transformation	NN	nmod:npmod	O
defective	JJ	ROOT	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
knockdown	NN	nsubj	O
of	IN	case	O
p600	NN	nmod	B-Gene_or_gene_product1
reduced	VBD	amod	O
transformation	NN	ROOT	O
of	IN	case	O
cells	NNS	nmod	B-Cell
expressing	VBG	acl	O
both	CC	cc:preconj	O
BPV	NN	compound	B-Organism
-	:	punct	I-Organism
1	CD	nummod	I-Organism
E6	NN	dobj	B-Gene_or_gene_product1
and	CC	cc	O
E7	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
E6	NN	conj	B-Gene_or_gene_product1
alone	RB	advmod	O
,	,	punct	O
suggesting	VBG	acl	O
that	IN	mark	O
the	DT	det	O
ability	NN	nsubjpass	O
of	IN	case	O
E7	NN	nmod	B-Gene_or_gene_product1
to	TO	case	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
is	VBZ	auxpass	O
mediated	VBN	ccomp	O
,	,	punct	O
at	IN	advmod	O
least	JJS	mwe	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
through	IN	case	O
its	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
bind	VB	acl	O
p600	NN	dobj	B-Gene_or_gene_product1
.	.	punct	O

These	DT	det	O
data	NNS	compound	O
complement	NN	compound	O
work	NN	ROOT	O
that	WDT	nsubj	O
shows	VBZ	acl:relcl	O
that	IN	mark	O
HPV16	NN	compound	B-Organism
E7	NN	nsubj	B-Gene_or_gene_product1
also	RB	advmod	O
interacts	VBZ	ccomp	O
with	IN	case	O
p600	NN	nmod	B-Gene_or_gene_product1
,	,	punct	O
and	CC	cc	O
that	IN	mark	O
this	DT	det	O
interaction	NN	nsubj	O
correlates	VBZ	conj	O
with	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
HPV16	NN	compound	B-Organism
E7	NN	nmod	B-Gene_or_gene_product1
to	TO	mark	O
transform	NN	acl	O
cells	NNS	dobj	B-Cell
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
thus	RB	advmod	O
identify	VBP	ROOT	O
p600	NN	dobj	B-Gene_or_gene_product1
as	IN	case	O
a	DT	det	O
shared	JJ	amod	O
target	NN	nmod	O
of	IN	case	O
the	DT	det	O
E7	NN	compound	B-Gene_or_gene_product1
proteins	NNS	nmod	O
of	IN	case	O
multiple	JJ	amod	O
papillomaviruses	NNS	nmod	B-Organism
.	.	punct	O

Molecular	JJ	amod	O
requirements	NNS	ROOT	O
for	IN	case	O
epithelial	JJ	amod	B-Cell
-	HYPH	punct	O
mesenchymal	JJ	dep	B-Cell
transition	NN	nmod	O
during	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

Epithelial	JJ	amod	B-Cell
-	HYPH	punct	O
mesenchymal	JJ	amod	B-Cell
transitions	NNS	nsubj	O
(	-LRB-	punct	O
EMTs	NNS	appos	O
)	-RRB-	punct	O
occur	VBP	ROOT	O
as	IN	case	O
key	JJ	amod	O
steps	NNS	nmod	O
during	IN	case	O
embryonic	JJ	amod	B-Developing_anatomical_structure
morphogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
are	VBP	auxpass	O
now	RB	advmod	O
implicated	VBN	conj	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
primary	JJ	amod	O
tumors	NNS	nmod	B-Cancer
towards	IN	case	O
metastases	NNS	nmod	O
.	.	punct	O

Recent	JJ	amod	O
advances	NNS	nsubj	O
have	VBP	aux	O
fostered	VBN	ROOT	O
a	DT	det	O
more	RBR	advmod	O
detailed	JJ	amod	O
understanding	NN	dobj	O
of	IN	case	O
molecular	JJ	amod	O
mechanisms	NNS	nmod	O
and	CC	cc	O
networks	NNS	conj	O
governing	VBG	acl	O
EMT	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
.	.	punct	O

Besides	IN	case	O
TGFbeta	NN	compound	B-Gene_or_gene_product1
and	CC	cc	O
RTK	NN	conj	B-Gene_or_gene_product1
/	:	punct	O
Ras	NN	compound	B-Gene_or_gene_product2
signaling	NN	conj	O
,	,	punct	O
autocrine	JJ	amod	O
factors	NNS	conj	O
and	CC	cc	O
Wnt	NN	compound	B-Gene_or_gene_product2
-	:	punct	O
,	,	punct	O
Notch	NNP	conj	B-Gene_or_gene_product2
-	HYPH	punct	O
,	,	punct	O
Hedgehog	NNP	nmod:npmod	B-Gene_or_gene_product2
-	HYPH	punct	O
and	CC	cc	O
NF	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
kappaB	NN	nmod:npmod	I-Gene_or_gene_product2
-	HYPH	punct	O
dependent	JJ	conj	O
pathways	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
contribute	VB	xcomp	O
to	TO	case	O
EMT	NN	nmod	B-Gene_or_gene_product1
.	.	punct	O

Repression	NN	ROOT	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
cadherin	NN	nmod	I-Gene_or_gene_product0
by	IN	case	O
transcriptional	JJ	amod	O
regulators	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
Snail	NNP	nmod	B-Gene_or_gene_product2
or	CC	cc	O
Twist	NNP	conj	B-Gene_or_gene_product2
emerges	VBZ	dep	O
as	IN	case	O
one	CD	nummod	O
critical	JJ	amod	O
step	NN	nmod	O
driving	VBG	acl	O
EMT	NN	dobj	O
,	,	punct	O
and	CC	cc	O
this	DT	det	O
stage	NN	nsubjpass	O
is	VBZ	auxpass	O
currently	RB	advmod	O
being	VBG	auxpass	O
molecularly	RB	advmod	O
linked	VBN	conj	O
with	IN	case	O
many	JJ	nmod	O
of	IN	prep	O
the	DT	det	O
new	JJ	amod	O
players	NNS	pobj	O
.	.	punct	O

Increasing	VBG	amod	O
evidence	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
EMT	NN	nsubj	O
plays	VBZ	ccomp	O
a	DT	det	O
specific	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
migration	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	B-Cell
from	IN	case	O
a	DT	det	O
primary	JJ	amod	O
tumor	NN	nmod	B-Cancer
into	IN	case	O
the	DT	det	O
circulation	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
provide	VB	conj	O
a	DT	det	O
rationale	NN	dobj	O
for	IN	mark	O
developing	VBG	acl	O
more	RBR	advmod	O
effective	JJ	amod	O
cancer	NN	compound	B-Cancer
therapies	NNS	dobj	O
.	.	punct	O

Minimal	JJ	amod	O
contribution	NN	ROOT	O
of	IN	case	O
marrow	NN	nmod:npmod	B-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
endothelial	JJ	amod	I-Cell
precursors	NNS	nmod	I-Cell
to	TO	case	O
tumor	NN	compound	B-Multi-tissue_structure
vasculature	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

During	IN	case	O
embryogenesis	NN	nmod	O
,	,	punct	O
vascular	JJ	amod	B-Cell
and	CC	cc	O
hemopoietic	JJ	conj	B-Cell
cells	NNS	nsubj	I-Cell
originate	VBP	ROOT	O
from	IN	case	O
a	DT	det	O
common	JJ	amod	O
precursor	NN	nmod	O
,	,	punct	O
the	DT	det	O
hemangioblast	NN	appos	B-Cell
.	.	punct	O

Recent	JJ	amod	O
evidence	NN	nsubj	O
suggests	VBZ	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
precursors	NNS	nmod	I-Cell
in	IN	case	O
adult	JJ	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
it	PRP	nsubj	O
is	VBZ	cop	O
unclear	JJ	conj	O
whether	IN	mark	O
those	DT	det	O
precursors	NNS	nsubj	O
have	VBP	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
neovascularization	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
murine	JJ	amod	B-Organism
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nsubj	I-Multi-tissue_structure
contains	VBZ	ccomp	O
endothelial	JJ	amod	B-Cell
progenitors	NNS	dobj	I-Cell
,	,	punct	O
which	WDT	nsubj	O
arise	VBP	acl:relcl	O
from	IN	case	O
a	DT	det	O
cell	NN	nmod	B-Cell
with	IN	case	O
self	NN	npadvmod	O
-	HYPH	punct	O
renewing	VBG	amod	O
capacity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
can	MD	aux	O
integrate	VB	conj	O
into	IN	case	O
tumor	NN	compound	B-Tissue
microvasculature	NN	nmod	I-Tissue
,	,	punct	O
albeit	IN	mark	O
at	IN	case	O
a	DT	det	O
very	RB	advmod	O
low	JJ	amod	O
frequency	NN	nmod	O
.	.	punct	O

A	DT	det	O
transgenic	JJ	amod	O
double	JJ	amod	O
-	HYPH	punct	O
reporter	NN	compound	O
strategy	NN	nsubj	O
allowed	VBD	ROOT	O
us	PRP	dobj	O
to	TO	mark	O
demonstrate	VB	xcomp	O
definitively	RB	advmod	O
that	IN	mark	O
tumor	NN	compound	B-Cell
bone	NN	compound	I-Cell
marrow	NN	nmod:npmod	I-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nsubj	I-Cell
arise	VBP	ccomp	O
by	IN	case	O
transdifferentiation	NN	nmod	O
of	IN	case	O
marrow	JJ	compound	B-Cell
progenitors	NNS	nmod	I-Cell
rather	RB	cc	O
than	IN	mwe	O
by	IN	case	O
cell	NN	compound	B-Cell
fusion	NN	conj	O
.	.	punct	O

Single	JJ	amod	O
cell	NN	compound	B-Cell
transplants	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
common	JJ	amod	O
precursor	NN	nsubj	O
contributes	VBZ	ccomp	O
to	TO	case	O
both	CC	cc:preconj	O
the	DT	dep	O
hemopoietic	JJ	amod	B-Cell
and	CC	cc	O
endothelial	JJ	conj	B-Cell
lineages	NNS	nmod	I-Cell
,	,	punct	O
thus	RB	advmod	O
demonstrating	VBG	advcl	O
the	DT	det	O
presence	NN	dobj	O
of	IN	case	O
an	DT	det	O
adult	JJ	amod	O
hemangioblast	NN	nmod	B-Cell
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
increased	VBN	amod	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
(	-LRB-	punct	I-Gene_or_gene_product0
VEGF	NN	appos	I-Gene_or_gene_product0
)	-RRB-	punct	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
A	NN	compound	I-Gene_or_gene_product0
secretion	NN	nsubj	O
by	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
activation	NN	conj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product0
receptor	NN	nmod	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
2	CD	nummod	I-Gene_or_gene_product0
in	IN	case	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
does	VBZ	aux	O
not	RB	neg	O
alter	VB	ccomp	O
the	DT	det	O
mobilization	NN	dobj	O
and	CC	cc	O
incorporation	NN	conj	O
of	IN	case	O
marrow	NN	nmod:npmod	B-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
endothelial	JJ	amod	I-Cell
progenitors	NNS	nmod	I-Cell
into	IN	case	O
tumor	NN	compound	B-Tissue
vasculature	NN	nmod	I-Tissue
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
in	IN	case	O
human	JJ	amod	B-Organism
umbilical	JJ	amod	B-Cell
cord	NN	compound	I-Cell
blood	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
endothelial	JJ	amod	B-Cell
precursors	NNS	nsubj	I-Cell
make	VBP	ccomp	O
up	RB	advmod	O
only	RB	advmod	O
approximately	RB	advmod	O
1	CD	nummod	O
in	IN	case	O
10	CD	nummod	O
(	-LRB-	punct	O
7	CD	dep	O
)	-RRB-	punct	O
mononuclear	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
but	CC	cc	O
are	VBP	auxpass	O
highly	RB	advmod	O
enriched	VBN	conj	O
in	IN	case	O
the	DT	det	O
CD133	NN	compound	B-Gene_or_gene_product2
+	CC	cc	O
cell	NN	conj	O
population	NN	nmod	O
.	.	punct	O

By	IN	mark	O
ruling	VBG	advcl	O
out	RP	prt	O
cell	NN	compound	B-Cell
fusion	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
clearly	RB	advmod	O
demonstrate	VBP	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
an	DT	det	O
adult	JJ	amod	O
hemangioblast	NN	nmod	B-Cell
,	,	punct	O
but	CC	cc	O
the	DT	det	O
differentiation	NN	nsubj	O
of	IN	case	O
marrow	JJ	compound	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
toward	IN	case	O
the	DT	det	O
endothelial	JJ	amod	B-Cell
lineage	NN	nmod	I-Cell
is	VBZ	cop	O
an	DT	det	O
extremely	RB	advmod	O
rare	JJ	amod	O
event	NN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
VEGF	NNP	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
A	NN	compound	I-Gene_or_gene_product1
stimulation	NN	nsubj	O
of	IN	case	O
hemopoietic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
does	VBZ	aux	O
not	RB	neg	O
significantly	RB	advmod	O
alter	VB	ccomp	O
this	DT	det	O
process	NN	dobj	O
.	.	punct	O

Histopathological	JJ	amod	O
development	NN	ROOT	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
induced	VBN	acl	O
by	IN	case	O
N	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
'	''	punct	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitro	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitrosoguanidine	NN	nmod	I-Simple_chemical
in	IN	case	O
rats	NNS	nmod	B-Organism
.	.	punct	O

The	DT	det	O
development	NN	nsubjpass	O
of	IN	case	O
carcinoma	NN	nmod	B-Cancer
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
male	JJ	amod	O
Wistar	NNP	compound	B-Organism
rats	NNS	nmod	I-Organism
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
120	CD	dep	O
)	-RRB-	punct	O
exposed	VBN	acl	O
to	TO	case	O
N	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
'	''	punct	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitro	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitrosoguanidine	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
MNNG	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
drinking	VBG	amod	O
water	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
83	CD	nummod	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
16	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

After	IN	case	O
MNNG	NN	compound	B-Simple_chemical
administration	NN	nmod	O
,	,	punct	O
rats	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
investigated	VBN	ROOT	O
by	IN	case	O
endoscopic	JJ	amod	O
observation	NN	nmod	O
,	,	punct	O
visualization	NN	appos	O
of	IN	case	O
microvascular	JJ	amod	B-Tissue
structure	NN	nmod	O
,	,	punct	O
and	CC	cc	O
estimation	NN	conj	O
of	IN	case	O
lectin	NN	compound	B-Gene_or_gene_product0
binding	NN	compound	O
sites	NNS	nmod	O
.	.	punct	O

Changes	NNS	nsubjpass	O
of	IN	prep	O
bile	JJ	amod	B-Organism_substance
reflux	NN	pobj	O
to	IN	prep	O
the	DT	det	O
stomach	NN	pobj	B-Organ
was	VBD	auxpass	O
observed	VBN	ROOT	O
endoscopically	RB	advmod	O
at	IN	case	O
24	CD	nummod	O
weeks	NNS	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
development	NN	conj	O
of	IN	case	O
gastric	JJ	amod	B-Pathological_formation
mucosal	JJ	amod	I-Pathological_formation
erosions	NNS	nmod	I-Pathological_formation
.	.	punct	O

Protruding	NN	nsubj	O
and	CC	cc	O
expansive	JJ	amod	O
ulcerating	VBG	amod	B-Cancer
carcinomas	NNS	conj	I-Cancer
developed	VBD	ROOT	O
at	IN	case	O
36	CD	nummod	O
weeks	NNS	nmod	O
and	CC	cc	O
had	VBD	conj	O
a	DT	det	O
microvascular	JJ	amod	B-Tissue
pattern	NN	dobj	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
adenocarcinoma	NN	nmod	B-Cancer
.	.	punct	O

Estimation	NN	nsubj	O
of	IN	case	O
lectin	NN	compound	B-Gene_or_gene_product0
binding	NN	compound	O
site	NN	nmod	O
and	CC	cc	O
pattern	NN	conj	O
was	VBD	cop	O
useful	JJ	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
malignant	JJ	amod	O
potential	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
proliferation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
postulate	VBP	ROOT	O
that	IN	mark	O
endoscopic	JJ	amod	O
observation	NN	nsubj	O
is	VBZ	cop	O
valuable	JJ	ccomp	O
in	IN	mark	O
investigating	VBG	advcl	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
microvascular	JJ	amod	B-Tissue
structure	NN	nsubj	O
and	CC	cc	O
lectin	NN	compound	B-Gene_or_gene_product0
binding	NN	compound	O
pattern	NN	conj	O
may	MD	aux	O
be	VB	cop	O
useful	JJ	conj	O
to	TO	mark	O
demonstrate	VB	xcomp	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
growth	NN	nmod	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

Decrease	NN	nsubj	O
in	IN	case	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
Myc	NN	compound	I-Gene_or_gene_product1
activity	NN	nmod	O
enhances	VBZ	ROOT	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
sensitivity	NN	dobj	O
to	TO	case	O
vinblastine	NN	nmod	B-Simple_chemical
.	.	punct	O

The	DT	det	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
myc	NN	compound	I-Gene_or_gene_product1
oncogene	NN	nsubj	O
encodes	VBZ	ROOT	O
for	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	O
factor	NN	nmod	O
involved	VBN	acl	O
in	IN	case	O
many	JJ	amod	O
cellular	JJ	amod	B-Cell
processes	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
proliferation	NN	nmod	O
,	,	punct	O
differentiation	NN	conj	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

According	VBG	prep	O
to	IN	prep	O
these	DT	det	O
different	JJ	amod	O
functions	NNS	pobj	O
,	,	punct	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
Myc	NN	compound	I-Gene_or_gene_product1
protein	NN	nmod	O
in	IN	case	O
cellular	JJ	amod	B-Cell
sensitivity	NN	nmod	O
to	TO	case	O
anti	VB	amod	O
-	HYPH	punct	O
cancer	NN	compound	B-Cancer
drugs	NNS	nmod	O
is	VBZ	cop	O
controversial	JJ	ROOT	O
.	.	punct	O

We	PRP	nsubj	O
defined	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
Myc	NNP	nmod	I-Gene_or_gene_product1
in	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
sensitivity	NN	nmod	O
to	TO	case	O
vinblastine	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
VLB	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
using	VBG	acl	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
:	:	punct	O
LoVo	NN	compound	B-Cell
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	dobj	O
or	CC	cc	O
transfected	VBN	conj	O
with	IN	case	O
a	DT	det	O
plasmid	NN	nmod	O
containing	VBG	acl	O
the	DT	det	O
human	JJ	amod	B-Organism
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
myc	NN	compound	I-Gene_or_gene_product1
gene	NN	dobj	O
in	IN	case	O
antisense	JJ	amod	O
orientation	NN	nmod	O
(	-LRB-	punct	O
LoVo	NN	compound	B-Cell
-	:	punct	I-Cell
mycANS	NN	appos	I-Cell
)	-RRB-	punct	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
VLB	NN	compound	B-Simple_chemical
cytotoxicity	NN	nmod	O
demonstrated	VBD	ROOT	O
a	DT	det	O
3	CD	nummod	O
-	HYPH	punct	O
fold	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
VLB	NN	compound	B-Simple_chemical
sensitivity	NN	nmod	O
in	IN	case	O
LoVo	NN	compound	B-Cell
-	HYPH	punct	I-Cell
mycANS	CD	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Comparison	NN	nsubj	O
between	IN	case	O
cells	NNS	nmod	B-Cell
revealed	VBD	ROOT	O
different	JJ	amod	O
apoptosis	NN	compound	O
kinetics	NNS	dobj	O
:	:	punct	O
accumulation	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
in	IN	case	O
sub	NN	compound	O
-	HYPH	punct	O
G1	NN	compound	O
phase	NN	nmod	O
and	CC	cc	O
poly	NN	amod	B-Gene_or_gene_product1
(	-LRB-	punct	I-Gene_or_gene_product1
ADP	NN	compound	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
ribose	NN	dep	I-Gene_or_gene_product1
)	-RRB-	punct	I-Gene_or_gene_product1
polymerase	NN	compound	I-Gene_or_gene_product1
cleavage	NN	conj	O
occurred	VBD	parataxis	O
earlier	RBR	advmod	O
in	IN	case	O
LoVo	NN	compound	B-Cell
-	HYPH	punct	I-Cell
mycANS	NN	nmod	I-Cell
.	.	punct	O

Then	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrated	VBD	ROOT	O
a	DT	det	O
mitochondrial	JJ	amod	B-Cellular_component
membrane	NN	compound	I-Cellular_component
potential	JJ	amod	O
disruption	NN	dobj	O
followed	VBN	acl	O
by	IN	case	O
cytochrome	NN	compound	B-Gene_or_gene_product0
c	NN	compound	I-Gene_or_gene_product0
release	NN	nmod	O
that	WDT	nsubj	O
indicates	VBZ	acl:relcl	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
mitochondria	NN	nmod	B-Cellular_component
in	IN	case	O
this	DT	det	O
apoptotic	JJ	amod	O
signaling	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

This	DT	det	O
earlier	JJR	amod	O
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
accompanied	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
Bcl	NN	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
2	CD	nummod	I-Gene_or_gene_product3
decrease	NN	nmod	O
and	CC	cc	O
a	DT	det	O
p53	NN	compound	B-Gene_or_gene_product1
increase	NN	conj	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
the	DT	det	O
decrease	NN	nsubj	O
in	IN	case	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
Myc	NN	compound	I-Gene_or_gene_product1
expression	NN	nmod	O
enhanced	VBD	ROOT	O
the	DT	det	O
VLB	NN	compound	B-Simple_chemical
sensitivity	NN	dobj	O
,	,	punct	O
triggering	VBG	advcl	O
earlier	JJR	amod	O
apoptosis	NN	dobj	O
through	IN	case	O
induction	NN	nmod	O
of	IN	case	O
the	DT	det	O
intrinsic	JJ	amod	O
pathway	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
myc	NN	compound	I-Gene_or_gene_product1
induction	NN	nsubj	O
is	VBZ	ROOT	O
a	DT	det	O
resistance	NN	compound	O
factor	NN	attr	O
and	CC	cc	O
our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
suggest	VBP	conj	O
that	IN	mark	O
tumors	NNS	nsubj	B-Cancer
carrying	VBG	acl	O
low	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
Myc	NN	compound	I-Gene_or_gene_product1
protein	NN	nmod	O
could	MD	aux	O
be	VB	cop	O
more	RBR	advmod	O
responsive	JJ	ccomp	O
to	TO	case	O
vinca	VB	amod	B-Simple_chemical
alkaloids	NNS	compound	I-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
downregulation	NN	nsubj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
myc	NN	compound	I-Gene_or_gene_product1
oncogene	NN	nmod	O
by	IN	case	O
an	DT	det	O
antisense	JJ	amod	O
strategy	NN	nmod	O
might	MD	aux	O
represent	VB	ROOT	O
a	DT	det	O
useful	JJ	amod	O
goal	NN	dobj	O
for	IN	mark	O
improving	VBG	advcl	O
the	DT	det	O
efficacy	NN	dobj	O
of	IN	case	O
this	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
neoplastic	JJ	amod	O
drug	NN	compound	O
family	NN	nmod	O
.	.	punct	O

Alteration	NN	ROOT	O
of	IN	case	O
homeobox	NN	compound	B-Gene_or_gene_product2
gene	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
N	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	compound	I-Gene_or_gene_product2
transformation	NN	nmod	O
of	IN	case	O
PA	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
human	JJ	amod	I-Cell
teratocarcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
used	VBD	ROOT	O
a	DT	det	O
series	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
clones	NNS	nmod	I-Cell
from	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
teratocarcinoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
PA	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	appos	I-Cell
,	,	punct	O
to	TO	mark	O
study	VB	advcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
transformation	NN	nmod	O
by	IN	case	O
an	DT	det	O
activated	VBN	amod	O
N	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	compound	I-Gene_or_gene_product2
oncogene	NN	nmod	O
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
retinoic	JJ	amod	B-Simple_chemical
acid	NN	intj	I-Simple_chemical
(	-LRB-	punct	O
RA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
-	:	punct	O
induced	VBN	amod	O
differentiation	NN	dobj	O
and	CC	cc	O
growth	NN	compound	O
regulation	NN	conj	O
.	.	punct	O

Recently	RB	advmod	O
,	,	punct	O
it	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
expression	NN	nsubjpass	O
of	IN	case	O
human	JJ	amod	B-Organism
HOX	NN	compound	B-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
genes	NNS	nmod	O
is	VBZ	auxpass	O
sequentially	RB	advmod	O
activated	VBN	ccomp	O
by	IN	case	O
RA	NN	nmod	B-Simple_chemical
beginning	VBG	acl	O
from	IN	case	O
Hox	NN	nmod	B-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
.	.	punct	I-Gene_or_gene_product2
9	CD	ROOT	I-Gene_or_gene_product2
at	IN	case	O
the	DT	det	O
3	CD	nummod	O
'	``	punct	O
end	NN	nmod	O
of	IN	case	O
the	DT	det	O
HOX	NN	compound	B-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
cluster	NN	nmod	O
(	-LRB-	punct	O
A	NN	dep	O
.	.	punct	O
Simeone	NN	compound	O
,	,	punct	O
D	NN	ROOT	O
.	.	punct	O
Acampora	NNP	advmod	O
,	,	punct	O
L	NNP	ROOT	O
.	.	punct	O
Arcioni	RB	advmod	O
,	,	punct	O
P	NN	ROOT	O
.	.	punct	O
W	NNP	ROOT	O
.	.	punct	O
Andrews	NNP	ROOT	O
,	,	punct	O
E	NNP	appos	O
.	.	punct	O
Boncinelli	NNP	ROOT	O
,	,	punct	O
and	CC	cc	O
F	NNP	conj	O
.	.	punct	O
Mavilio	NNP	advmod	O
,	,	punct	O
Nature	NNP	nmod	O
[	-LRB-	punct	O
London	NNP	nmod	O
]	-RRB-	punct	O
346	CD	ROOT	O
:	:	punct	O
763	CD	compound	O
-	SYM	punct	O
766	CD	appos	O
,	,	punct	O
1990	CD	conj	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
report	VBP	ROOT	O
that	IN	mark	O
six	CD	nummod	O
different	JJ	amod	O
genes	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
cluster	NN	compound	O
HOX	NN	nmod	B-Gene_or_gene_product2
1	CD	nummod	I-Gene_or_gene_product2
are	VBP	auxpass	O
sequentially	RB	advmod	O
induced	VBN	ccomp	O
by	IN	case	O
RA	NN	nmod	B-Simple_chemical
in	IN	case	O
a	DT	det	O
similar	JJ	amod	O
temporal	JJ	amod	O
pattern	NN	nmod	O
,	,	punct	O
beginning	VBG	advcl	O
with	IN	case	O
genes	NNS	nmod	O
at	IN	case	O
the	DT	det	O
3	CD	nummod	O
'	``	punct	O
end	NN	nmod	O
of	IN	case	O
the	DT	det	O
cluster	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
N	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	nmod:npmod	I-Gene_or_gene_product2
-	HYPH	punct	O
transformed	VBN	amod	O
cell	NN	compound	B-Cell
clones	NNS	nmod	I-Cell
,	,	punct	O
RA	NN	nmod:npmod	B-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
homeobox	NN	compound	B-Gene_or_gene_product2
genes	NNS	nmod	O
is	VBZ	auxpass	O
delayed	VBN	ROOT	O
.	.	punct	O

Hox	NN	ROOT	B-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
.	.	punct	I-Gene_or_gene_product3
4	CD	nummod	I-Gene_or_gene_product3
and	CC	cc	O
Hox	NN	conj	B-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
.	.	punct	I-Gene_or_gene_product3
3	CD	nummod	I-Gene_or_gene_product3
,	,	punct	O
genes	NNS	nsubjpass	O
abundantly	RB	advmod	O
induced	VBN	acl	O
in	IN	case	O
nontransformed	JJ	amod	O
clones	NNS	nmod	B-Cell
after	IN	case	O
3	CD	nummod	O
days	NNS	nmod	O
of	IN	case	O
RA	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
,	,	punct	O
are	VBP	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
N	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	nmod:npmod	I-Gene_or_gene_product2
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
only	RB	advmod	O
after	IN	case	O
10	CD	nummod	O
days	NNS	nmod	O
of	IN	case	O
RA	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

At	IN	prep	O
this	DT	det	O
time	NN	pobj	O
,	,	punct	O
the	DT	det	O
cells	NNS	poss	B-Cell
'	POS	case	O
growth	NN	nsubjpass	O
is	VBZ	auxpass	O
arrested	VBN	ROOT	O
at	IN	prep	O
very	RB	advmod	O
high	JJ	amod	O
density	NN	pobj	O
,	,	punct	O
and	CC	cc	O
no	DT	neg	O
differentiated	VBN	amod	O
morphologic	JJ	amod	O
characteristics	NNS	nsubjpass	O
are	VBP	auxpass	O
observed	VBN	conj	O
.	.	punct	O

Constitutive	JJ	amod	O
expression	NN	ROOT	O
of	IN	case	O
a	DT	det	O
transfected	VBN	amod	O
Hox	NN	nmod	B-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
.	.	punct	I-Gene_or_gene_product3
4	CD	nummod	I-Gene_or_gene_product3
gene	NN	nsubj	O
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
a	DT	det	O
simian	JJ	amod	B-Organism
virus	NN	compound	I-Organism
40	CD	nummod	I-Organism
promotor	NN	nmod	O
leads	VBZ	ROOT	O
to	TO	case	O
differentiated	VBN	amod	O
cell	NN	compound	B-Cell
morphology	NN	nmod	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
the	DT	det	O
RA	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
phenotype	NN	nmod	O
and	CC	cc	O
restores	VBZ	conj	O
the	DT	det	O
growth	NN	nmod:npmod	O
-	HYPH	punct	O
inhibitory	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
RA	NN	nmod	B-Simple_chemical
in	IN	case	O
N	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	nmod:npmod	I-Gene_or_gene_product2
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
enhanced	VBN	amod	O
proliferation	NN	nsubj	O
in	IN	case	O
N	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	nmod:npmod	I-Gene_or_gene_product2
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
compromises	NNS	ccomp	O
teratocarcinoma	VBP	compound	B-Cell
cell	NN	compound	I-Cell
differentiation	NN	dobj	O
by	IN	case	O
a	DT	det	O
mechanism	NN	nmod	O
that	WDT	nsubj	O
transiently	RB	advmod	O
suppresses	VBZ	acl:relcl	O
homeobox	NN	compound	B-Gene_or_gene_product2
gene	NN	compound	O
induction	NN	dobj	O
and	CC	cc	O
implies	VBZ	conj	O
a	DT	det	O
central	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
homeobox	NN	compound	B-Gene_or_gene_product2
genes	NNS	nmod	O
in	IN	case	O
RA	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
differentiation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	mark	O
stimulation	NN	nsubj	O
of	IN	case	O
a	DT	det	O
putative	JJ	amod	O
growth	NN	compound	O
factor	NN	compound	O
signal	NN	compound	O
pathway	NN	nmod	O
,	,	punct	O
associated	VBN	acl	O
with	IN	case	O
ras	NN	nmod:npmod	B-Gene_or_gene_product2
-	HYPH	punct	O
induced	VBN	amod	O
proliferation	NN	nmod	O
,	,	punct	O
transiently	RB	advmod	O
suppresses	VBZ	ccomp	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
transcription	NN	compound	O
factors	NNS	nmod	O
functionally	RB	advmod	O
involved	VBN	acl	O
in	IN	case	O
cell	NN	nmod	B-Cell
growth	NN	dep	O
and	CC	cc	O
differentiation	NN	conj	O
.	.	punct	O

High	NNP	compound	O
-	HYPH	punct	O
Dose	NNP	compound	O
celecoxib	NN	nsubj	B-Simple_chemical
and	CC	cc	O
metronomic	JJ	amod	O
"	``	punct	O
low	JJ	amod	O
-	HYPH	punct	O
dose	NN	conj	O
"	''	punct	O
cyclophosphamide	NN	appos	B-Simple_chemical
is	VBZ	cop	O
an	DT	det	O
effective	JJ	amod	O
and	CC	cc	O
safe	JJ	conj	O
therapy	NN	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
relapsed	JJ	amod	O
and	CC	cc	O
refractory	JJ	conj	O
aggressive	JJ	amod	O
histology	NN	nmod	O
non	NN	amod	B-Cancer
-	HYPH	punct	I-Cancer
Hodgkin	NNP	dep	I-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
lymphoma	NN	dep	I-Cancer
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
Angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
increased	VBN	appos	O
in	IN	case	O
aggressive	JJ	amod	O
histology	NN	nmod	O
non	NN	amod	B-Cancer
-	HYPH	punct	I-Cancer
Hodgkin	NNP	compound	I-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
lymphoma	NN	dep	I-Cancer
and	CC	cc	O
may	MD	aux	O
be	VB	cop	O
a	DT	det	O
target	NN	conj	O
with	IN	case	O
selective	JJ	amod	O
cyclooxygenase	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
inhibition	NN	nmod	O
and	CC	cc	O
metronomic	JJ	amod	O
chemotherapy	NN	conj	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
assessed	VBD	ROOT	O
response	NN	dobj	O
,	,	punct	O
toxicity	NN	conj	O
,	,	punct	O
and	CC	cc	O
biomarkers	NNS	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
to	TO	case	O
low	JJ	amod	O
-	HYPH	punct	O
dose	NN	compound	O
cyclophosphamide	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
50	CD	compound	O
mg	NN	compound	O
p	NN	dep	O
.	.	punct	O
o	NN	ROOT	O
.	.	punct	O
o	LS	ROOT	O
.	.	punct	O
d	LS	ROOT	O
.	.	punct	O
)	-RRB-	punct	O
and	CC	cc	O
high	JJ	amod	O
-	HYPH	punct	O
dose	NN	compound	O
celecoxib	NN	conj	B-Simple_chemical
(	-LRB-	punct	O
400	CD	compound	O
mg	NN	compound	O
p	NN	nmod	O
.	.	punct	O
o	NN	ROOT	O
.	.	punct	O
b	LS	ROOT	O
.	.	punct	O
i	LS	ROOT	O
.	.	punct	O
d	XX	ROOT	O
.	.	punct	O
)	-RRB-	punct	O
in	IN	case	O
adult	JJ	amod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
relapsed	JJ	amod	O
or	CC	cc	O
refractory	JJ	conj	O
aggressive	JJ	amod	O
non	NN	amod	B-Cancer
-	HYPH	punct	I-Cancer
Hodgkin	NNP	poss	I-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
lymphoma	NN	nmod	I-Cancer
in	IN	case	O
a	DT	det	O
multicenter	NN	amod	O
phase	NN	compound	O
II	CD	nummod	O
prospective	JJ	amod	O
study	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Thirty	CD	compound	O
-	HYPH	punct	O
two	CD	nsubj	O
of	IN	case	O
35	CD	nummod	O
patients	NNS	nmod	B-Organism
(	-LRB-	punct	O
median	JJ	amod	O
age	NN	dep	O
,	,	punct	O
62	CD	nummod	O
years	NNS	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
evaluable	JJ	appos	O
for	IN	case	O
response	NN	nmod	O
.	.	punct	O

Patients	NNS	nsubj	B-Organism
had	VBD	aux	O
primarily	RB	advmod	O
relapsed	VBN	ROOT	O
diffuse	JJ	amod	O
large	JJ	amod	O
B	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphoma	NN	nsubjpass	I-Cancer
(	-LRB-	punct	O
63	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
heavily	RB	advmod	O
pretreated	VBN	advcl	O
(	-LRB-	punct	O
median	NN	dep	O
of	IN	case	O
three	CD	nummod	O
regimens	NNS	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
high	JJ	amod	O
risk	NN	conj	O
(	-LRB-	punct	O
79	CD	nummod	O
%	NN	compound	O
international	JJ	amod	O
prognostic	JJ	amod	O
index	NN	dep	O
,	,	punct	O
greater	JJR	amod	O
than	IN	prep	O
or	CC	cc	O
=	JJ	conj	O
2	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
34	CD	nummod	O
%	NN	nsubjpass	O
were	VBD	auxpass	O
relapsed	VBN	conj	O
after	IN	case	O
autologous	JJ	amod	O
stem	NN	compound	B-Cell
cell	NN	compound	I-Cell
transplant	JJ	nmod	O
.	.	punct	O

With	IN	ROOT	O
a	DT	det	O
median	JJ	amod	O
follow	NN	amod	O
-	HYPH	punct	O
up	NN	pobj	O
of	IN	prep	O
8	CD	pobj	O
.	.	punct	O
4	CD	nummod	O
months	NNS	npadvmod	O
,	,	punct	O
the	DT	det	O
overall	RB	amod	O
best	JJS	amod	O
response	NN	compound	O
rate	NN	nsubj	O
is	VBZ	ROOT	O
37	CD	nummod	O
%	NN	attr	O
(	-LRB-	punct	O
2	CD	nummod	O
complete	JJ	amod	O
clinical	JJ	amod	O
response	NN	appos	O
/	:	punct	O
complete	JJ	amod	O
clinical	JJ	amod	O
response	NN	conj	O
unconfirmed	JJ	amod	O
and	CC	cc	O
9	CD	nummod	O
partial	JJ	amod	O
response	NN	conj	O
)	-RRB-	punct	O
,	,	punct	O
with	IN	case	O
22	CD	nummod	O
%	NN	nmod	O
achieving	VBG	acl	O
stable	JJ	amod	O
disease	NN	dobj	O
.	.	punct	O

Median	JJ	amod	O
overall	JJ	amod	O
and	CC	cc	O
progression	NN	npadvmod	O
-	HYPH	punct	O
free	JJ	amod	O
survivals	NNS	nsubj	O
are	VBP	ROOT	O
14	CD	attr	O
.	.	punct	O
4	CD	ROOT	O
and	CC	cc	O
4	CD	conj	O
.	.	punct	O
7	CD	nummod	O
months	NNS	ROOT	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

The	DT	det	O
median	JJ	amod	O
response	NN	compound	O
duration	NN	nsubj	O
was	VBD	cop	O
8	CD	ROOT	O
.	.	punct	O
2	CD	nummod	O
months	NNS	ROOT	O
.	.	punct	O

The	DT	det	O
most	RBS	advmod	O
common	JJ	amod	O
toxicity	NN	nsubj	O
was	VBD	cop	O
skin	NN	compound	B-Organ
rash	NN	ROOT	O
(	-LRB-	punct	O
40	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
;	:	punct	O
myelosuppression	NN	nsubj	O
and	CC	cc	O
gastrointestinal	JJ	amod	B-Organism_subdivision
side	JJ	amod	O
effects	NNS	conj	O
were	VBD	cop	O
uncommon	JJ	parataxis	O
.	.	punct	O

Three	CD	nummod	O
patients	NNS	nsubj	B-Organism
developed	VBD	ROOT	O
deep	JJ	amod	B-Pathological_formation
vein	NN	compound	I-Pathological_formation
thromboses	NNS	dobj	I-Pathological_formation
and	CC	cc	O
two	CD	nummod	O
heavily	RB	advmod	O
pretreated	JJ	amod	O
patients	NNS	nsubj	B-Organism
developed	VBD	conj	O
treatment	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
acute	JJ	amod	B-Cancer
myelogenous	JJ	amod	I-Cancer
leukemia	NN	dobj	I-Cancer
or	CC	cc	O
myelodysplasia	NN	conj	B-Pathological_formation
after	IN	case	O
3	CD	nmod	O
.	.	punct	O
7	CD	nummod	O
and	CC	cc	O
12	CD	conj	O
months	NNS	ROOT	O
of	IN	case	O
therapy	NN	nmod	O
.	.	punct	O

Circulating	VBG	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
and	CC	cc	O
their	PRP$	nmod:poss	O
precursors	NNS	nsubj	O
declined	VBD	ROOT	O
and	CC	cc	O
remained	VBD	conj	O
low	JJ	xcomp	O
in	IN	case	O
responders	NNS	nmod	O
,	,	punct	O
whereas	IN	dep	O
plasma	NN	compound	B-Organism_substance
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	nsubj	I-Gene_or_gene_product0
trended	VBN	parataxis	O
to	TO	mark	O
decline	VB	xcomp	O
in	IN	case	O
responding	VBG	amod	O
patients	NNS	nmod	B-Organism
but	CC	cc	O
increase	VBP	conj	O
in	IN	case	O
nonresponders	NNS	nmod	O
.	.	punct	O

Trough	NN	compound	O
celecoxib	NN	compound	B-Simple_chemical
levels	NNS	nsubj	O
achieved	VBD	ROOT	O
targeted	VBN	amod	O
"	``	punct	O
antiangiogenic	JJ	amod	O
"	''	punct	O
levels	NNS	dobj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Low	JJ	amod	O
-	HYPH	punct	O
dose	NN	compound	O
cyclophosphamide	NN	appos	B-Simple_chemical
and	CC	cc	O
high	JJ	amod	O
-	HYPH	punct	O
dose	NN	compound	O
celecoxib	NN	nsubjpass	B-Simple_chemical
is	VBZ	auxpass	O
well	RB	advmod	O
tolerated	VBN	conj	O
and	CC	cc	O
active	JJ	conj	O
in	IN	case	O
pretreated	JJ	amod	O
aggressive	JJ	amod	O
non	NN	amod	B-Cancer
-	HYPH	punct	I-Cancer
Hodgkin	NNP	dep	I-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
lymphoma	NN	nmod	I-Cancer
.	.	punct	O

Close	JJ	amod	O
surveillance	NN	nsubjpass	O
for	IN	case	O
arterial	JJ	amod	B-Multi-tissue_structure
and	CC	cc	O
venous	JJ	conj	B-Multi-tissue_structure
thrombotic	JJ	amod	O
events	NNS	nmod	O
is	VBZ	auxpass	O
recommended	VBN	ROOT	O
.	.	punct	O

The	DT	det	O
decline	NN	nsubj	O
in	IN	case	O
circulating	VBG	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
their	PRP$	nmod:poss	O
precursors	NNS	conj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
this	DT	det	O
combination	NN	nsubj	O
may	MD	aux	O
be	VB	aux	O
working	VBG	ccomp	O
by	IN	mark	O
inhibiting	VBG	advcl	O
angiogenesis	NN	dobj	O
but	CC	cc	O
should	MD	aux	O
be	VB	auxpass	O
validated	VBN	conj	O
in	IN	case	O
a	DT	det	O
larger	JJR	amod	O
patient	NN	compound	B-Organism
sample	NN	nmod	O
.	.	punct	O

Photodynamic	JJ	amod	O
therapy	NN	ROOT	O
with	IN	case	O
verteporfin	NN	nmod	B-Simple_chemical
for	IN	case	O
subfoveal	JJ	amod	B-Multi-tissue_structure
choroidal	NN	amod	I-Multi-tissue_structure
neovascularization	NN	nmod	O
secondary	JJ	amod	O
to	TO	case	O
pathologic	JJ	amod	O
myopia	NN	nmod	O
:	:	punct	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
study	NN	dep	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
assess	VB	dep	O
the	DT	det	O
safety	NN	dobj	O
and	CC	cc	O
effectiveness	NN	conj	O
of	IN	case	O
photodynamic	JJ	amod	O
therapy	NN	nmod	O
(	-LRB-	punct	O
PDT	NN	appos	O
)	-RRB-	punct	O
with	IN	case	O
verteporfin	NN	nmod	B-Simple_chemical
for	IN	case	O
subfoveal	JJ	amod	B-Multi-tissue_structure
choroidal	NN	amod	I-Multi-tissue_structure
neovascularization	NN	nmod	O
(	-LRB-	punct	O
CNV	NN	appos	O
)	-RRB-	punct	O
secondary	JJ	amod	O
to	TO	case	O
pathologic	JJ	amod	O
myopia	NN	nmod	O
(	-LRB-	punct	O
PM	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Sixty	NNP	compound	O
-	HYPH	punct	O
two	CD	nummod	O
patients	NNS	nsubj	B-Organism
(	-LRB-	punct	O
62	CD	nummod	O
eyes	NNS	appos	B-Organ
)	-RRB-	punct	O
with	IN	case	O
PM	NN	nmod	O
underwent	VBD	appos	O
PDT	NN	dobj	O
according	VBG	prep	O
to	IN	prep	O
the	DT	det	O
guidelines	NNS	pobj	O
of	IN	prep	O
the	DT	det	O
Verteporfin	NNP	pobj	B-Simple_chemical
in	IN	prep	O
Photodynamic	NNP	compound	O
Therapy	NNP	compound	O
Study	NNP	pobj	O
.	.	punct	O

Clinical	JJ	amod	O
evaluations	NNS	nsubj	O
performed	VBN	acl	O
at	IN	case	O
all	DT	det	O
study	NN	compound	O
visits	NNS	nmod	O
included	VBD	ROOT	O
measurement	NN	dobj	O
of	IN	case	O
best	RBS	advmod	O
-	HYPH	punct	O
corrected	VBN	amod	O
Snellen	NNP	amod	O
visual	JJ	amod	O
acuity	NN	nmod	O
,	,	punct	O
slit	NNS	compound	O
-	HYPH	punct	O
lamp	NN	compound	O
biomicroscopy	NN	conj	O
,	,	punct	O
and	CC	cc	O
fundus	VB	compound	B-Multi-tissue_structure
fluorescein	NN	compound	B-Simple_chemical
angiography	NN	conj	O
.	.	punct	O

Patients	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
followed	VBN	ROOT	O
up	RP	prt	O
at	IN	case	O
1	CD	nummod	O
month	NN	nmod	O
and	CC	cc	O
3	CD	nummod	O
months	NNS	conj	O
after	IN	case	O
treatment	NN	conj	O
and	CC	cc	O
thereafter	RB	conj	O
at	IN	case	O
3	CD	nummod	O
-	HYPH	punct	O
month	NN	compound	O
intervals	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
final	JJ	amod	O
visual	JJ	amod	O
acuity	NN	appos	O
of	IN	case	O
the	DT	det	O
study	NN	compound	O
patients	NNS	nmod	B-Organism
,	,	punct	O
after	IN	case	O
a	DT	det	O
median	JJ	amod	O
follow	NN	amod	O
-	HYPH	punct	O
up	NN	quantmod	O
of	IN	advmod	O
31	CD	nummod	O
months	NNS	nmod	O
,	,	punct	O
improved	VBN	acl	O
by	IN	agent	O
greater	JJR	pobj	O
than	IN	prep	O
or	CC	cc	O
=	JJ	conj	O
1	CD	nummod	O
Snellen	JJ	compound	O
lines	NNS	nmod	O
in	IN	case	O
8	CD	nummod	O
patients	NNS	nmod	B-Organism
(	-LRB-	punct	O
13	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
deteriorated	VBN	acl	O
in	IN	case	O
20	CD	nummod	O
(	-LRB-	punct	O
32	CD	nummod	O
%	NN	nmod	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
remained	VBD	conj	O
stable	JJ	xcomp	O
in	IN	case	O
34	CD	nmod	O
(	-LRB-	punct	O
55	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
baseline	NN	compound	O
visual	JJ	amod	O
acuity	NN	nsubj	O
was	VBD	cop	O
similar	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
various	JJ	amod	O
study	NN	compound	O
groups	NNS	nmod	O
.	.	punct	O

The	DT	det	O
final	JJ	amod	O
mean	NN	amod	O
visual	JJ	amod	O
acuity	NN	nsubj	O
in	IN	case	O
group	NN	compound	O
A	NN	nmod	O
(	-LRB-	punct	O
55	CD	nummod	O
years	NNS	dep	O
of	IN	case	O
age	NN	nmod	O
or	CC	cc	O
younger	JJR	conj	O
)	-RRB-	punct	O
was	VBD	cop	O
20	CD	ROOT	O
/	SYM	punct	O
80	CD	conj	O
and	CC	cc	O
significantly	RB	conj	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
006	CD	dep	O
)	-RRB-	punct	O
better	JJR	amod	O
than	IN	case	O
that	DT	nmod	O
(	-LRB-	punct	O
20	CD	nummod	O
/	SYM	punct	O
138	CD	dep	O
)	-RRB-	punct	O
in	IN	case	O
group	NN	compound	O
B	NN	nmod	O
(	-LRB-	punct	O
older	JJR	dep	O
than	IN	case	O
55	CD	nummod	O
years	NNS	nmod	O
of	IN	case	O
age	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
mean	JJ	amod	O
final	JJ	amod	O
visual	JJ	amod	O
acuity	NN	nsubj	O
in	IN	case	O
eyes	NNS	nmod	B-Organ
with	IN	case	O
higher	JJR	amod	O
refractive	JJ	amod	O
error	NN	nmod	O
at	IN	case	O
baseline	NN	nmod	O
(	-LRB-	punct	O
greater	JJR	advmod	O
than	IN	quantmod	O
-	HYPH	punct	O
17	CD	nummod	O
diopters	NNS	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
significantly	RB	advmod	O
better	JJR	ROOT	O
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
014	CD	dobj	O
)	-RRB-	punct	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
eyes	NNS	nmod	B-Organ
with	IN	case	O
lower	JJR	amod	O
refractive	JJ	amod	O
error	NN	nmod	O
(	-LRB-	punct	O
-	SYM	punct	O
6	CD	compound	O
to	TO	quantmod	O
-	HYPH	punct	O
10	CD	nummod	O
diopters	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

CNV	NN	compound	O
size	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
visual	JJ	amod	O
outcomes	NNS	dobj	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
PDT	NN	nsubj	O
preserves	NNS	ROOT	O
vision	NN	dobj	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
CNV	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
PM	NN	nmod	O
.	.	punct	O

Younger	NN	amod	O
patients	NNS	nsubj	B-Organism
and	CC	cc	O
eyes	NNS	conj	B-Organ
with	IN	case	O
higher	JJR	amod	O
refractive	JJ	amod	O
error	NN	nmod	O
appear	VBP	ROOT	O
more	RBR	advmod	O
likely	JJ	advmod	O
to	TO	mark	O
benefit	VB	xcomp	O
from	IN	case	O
PDT	NN	nmod	O
with	IN	prep	O
verteporfin	NN	pobj	B-Simple_chemical
.	.	punct	O

Carcinogenesis	NN	ROOT	O
and	CC	cc	O
transcriptional	JJ	amod	O
regulation	NN	conj	O
through	IN	case	O
Maf	NN	compound	B-Gene_or_gene_product1
recognition	NN	compound	O
elements	NNS	nmod	O
.	.	punct	O

Many	JJ	amod	O
studies	NNS	nsubj	O
on	IN	case	O
carcinogenesis	NN	nmod	O
carried	VBD	ROOT	O
out	RP	prt	O
early	RB	advmod	O
in	IN	prep	O
the	DT	det	O
last	JJ	amod	O
century	NN	pobj	O
are	VBP	auxpass	O
united	VBN	conj	O
on	IN	case	O
the	DT	det	O
consensus	NN	nmod	O
that	IN	mark	O
cancer	NN	nsubj	B-Cancer
is	VBZ	cop	O
a	DT	det	O
genetic	JJ	amod	O
disease	NN	ccomp	O
.	.	punct	O

Cancer	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
typically	RB	advmod	O
display	VBP	ROOT	O
gene	NN	compound	O
dysfunction	NN	dobj	O
and	CC	cc	O
endogenous	JJ	amod	O
or	CC	cc	O
exogenous	JJ	conj	O
insults	NNS	conj	O
resulting	VBG	acl	O
in	IN	case	O
gene	NN	compound	O
dysfunction	NN	nmod	O
are	VBP	cop	O
often	RB	advmod	O
carcinogenic	JJ	conj	O
.	.	punct	O

Recent	JJ	amod	O
advances	NNS	nsubj	O
in	IN	case	O
stem	NN	compound	B-Cell
cell	NN	compound	I-Cell
biology	NN	nmod	O
added	VBD	ROOT	O
the	DT	det	O
new	JJ	amod	O
concept	NN	dobj	O
that	IN	mark	O
cancer	NN	nsubj	B-Cancer
originates	VBZ	ccomp	O
from	IN	case	O
a	DT	det	O
single	JJ	amod	O
cancer	NN	preconj	B-Cancer
-	HYPH	punct	O
initiating	VBG	amod	O
cell	NN	nmod	B-Cell
.	.	punct	O

To	TO	mark	O
understand	VB	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
basis	NN	dobj	O
of	IN	case	O
carcinogenesis	NN	nmod	O
from	IN	case	O
the	DT	det	O
beginning	NN	nmod	O
to	IN	prep	O
the	DT	det	O
full	JJ	amod	O
acquirement	NN	pobj	O
of	IN	prep	O
malignancy	NN	pobj	O
,	,	punct	O
factors	NNS	nsubjpass	O
concerned	VBN	acl	O
with	IN	case	O
carcinogenesis	NN	nmod	O
were	VBD	auxpass	O
categorized	VBN	parataxis	O
into	IN	case	O
three	CD	nummod	O
groups	NNS	nmod	O
:	:	punct	O
those	DT	det	O
guarding	NN	amod	O
and	CC	cc	O
stabilizing	NN	conj	O
genomes	NNS	dobj	B-Cellular_component
,	,	punct	O
those	DT	appos	O
regulating	VBG	acl	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
,	,	punct	O
and	CC	cc	O
those	DT	conj	O
conferring	VBG	acl	O
resistance	NN	dobj	O
to	TO	case	O
various	JJ	amod	O
micro	NN	npadvmod	O
-	HYPH	punct	O
environmental	JJ	amod	O
stresses	NNS	nmod	O
.	.	punct	O

One	CD	nummod	O
example	NN	nsubj	O
of	IN	prep	O
particular	JJ	amod	O
interest	NN	pobj	O
is	VBZ	ROOT	O
the	DT	det	O
Keap1	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	O
Nrf2	NN	compound	B-Gene_or_gene_product1
system	NN	attr	O
since	IN	prep	O
,	,	punct	O
according	VBG	prep	O
to	IN	prep	O
recent	JJ	amod	O
studies	NNS	pobj	O
,	,	punct	O
it	PRP	nsubj	O
has	VBZ	aux	O
turned	VBN	advcl	O
out	RP	prt	O
to	TO	aux	O
be	VB	xcomp	O
ambivalent	JJ	acomp	O
.	.	punct	O

Nrf2	NN	nsubj	B-Gene_or_gene_product2
heterodimerizes	VBZ	ROOT	O
with	IN	case	O
small	JJ	amod	O
Maf	NN	compound	B-Gene_or_gene_product1
protein	NN	nmod	O
to	TO	mark	O
strongly	RB	advmod	O
activate	VB	xcomp	O
transcription	NN	dobj	O
through	IN	case	O
the	DT	det	O
Maf	NN	compound	B-Gene_or_gene_product1
recognition	NN	compound	O
element	NN	nmod	O
(	-LRB-	punct	O
MARE	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
Keap1	NN	conj	B-Gene_or_gene_product1
is	VBZ	cop	O
an	DT	det	O
inhibitory	JJ	amod	O
regulator	NN	conj	O
of	IN	case	O
Nrf2	NN	nmod	B-Gene_or_gene_product1
.	.	punct	O

The	DT	det	O
genes	NNS	nsubj	O
regulated	VBN	acl	O
by	IN	case	O
Nrf2	NN	nmod	B-Gene_or_gene_product1
are	VBP	cop	O
very	RB	advmod	O
important	JJ	ROOT	O
for	IN	case	O
cellular	JJ	amod	B-Cell
protection	NN	nmod	O
of	IN	case	O
the	DT	det	O
genome	NN	nmod	B-Cellular_component
from	IN	case	O
xenobiotic	JJ	amod	O
and	CC	cc	O
oxidative	JJ	conj	O
stresses	NNS	nmod	O
and	CC	cc	O
,	,	punct	O
consequently	RB	advmod	O
,	,	punct	O
for	IN	mark	O
preventing	VBG	advcl	O
carcinogenesis	NN	dobj	O
.	.	punct	O

This	DT	nsubj	O
implies	VBZ	ROOT	O
that	IN	mark	O
enhancing	VBG	nsubj	O
Nrf2	NN	compound	B-Gene_or_gene_product1
activity	NN	dobj	O
is	VBZ	cop	O
a	DT	det	O
promising	JJ	amod	O
method	NN	ccomp	O
for	IN	prep	O
thwarting	VBG	pcomp	O
cancer	NN	dobj	B-Cancer
.	.	punct	O

On	IN	prep	O
the	DT	det	O
contrary	NN	pobj	O
,	,	punct	O
the	DT	det	O
constitutive	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
Nrf2	NN	nmod	B-Gene_or_gene_product1
due	JJ	case	O
to	TO	case	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
keap1	NN	compound	B-Gene_or_gene_product1
gene	NN	nmod	O
is	VBZ	auxpass	O
characteristically	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
lung	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
induced	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
Nrf2	NN	compound	B-Gene_or_gene_product1
target	NN	compound	O
genes	NNS	nmod	O
favors	VBZ	ccomp	O
the	DT	det	O
prevalence	NN	dobj	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Angiotensin	NN	nsubj	B-Gene_or_gene_product0
II	CD	nummod	I-Gene_or_gene_product0
induces	VBZ	ROOT	O
soluble	JJ	amod	O
fms	NN	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
Like	NN	case	I-Gene_or_gene_product3
tyrosine	NN	compound	I-Gene_or_gene_product3
kinase	NN	compound	I-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
release	NN	dobj	O
via	IN	case	O
calcineurin	NN	compound	B-Gene_or_gene_product0
signaling	NN	compound	O
pathway	NN	nmod	O
in	IN	case	O
pregnancy	NN	nmod	O
.	.	punct	O

Maternal	JJ	amod	O
endothelial	JJ	amod	B-Cell
dysfunction	NN	nsubjpass	O
in	IN	case	O
preeclampsia	NN	nmod	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
increased	VBN	amod	O
soluble	JJ	amod	O
fms	NN	nmod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
like	IN	dep	I-Gene_or_gene_product3
tyrosine	NN	compound	I-Gene_or_gene_product3
kinase	NN	compound	I-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	pobj	I-Gene_or_gene_product3
(	-LRB-	punct	O
sFlt	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	conj	I-Gene_or_gene_product3
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
circulating	VBG	amod	O
antagonist	NN	appos	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	nmod	I-Gene_or_gene_product0
and	CC	cc	O
placental	JJ	amod	B-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	conj	I-Gene_or_gene_product0
.	.	punct	O

Angiotensin	NN	nsubj	B-Gene_or_gene_product0
II	CD	nummod	I-Gene_or_gene_product0
(	-LRB-	punct	O
Ang	NN	appos	B-Gene_or_gene_product1
II	CD	nummod	I-Gene_or_gene_product1
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
vasoconstrictor	NN	ROOT	O
that	WDT	nsubj	O
increases	VBZ	acl:relcl	O
concomitant	JJ	dobj	O
with	IN	case	O
sFlt	JJ	nmod	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
during	IN	case	O
pregnancy	NN	nmod	O
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
speculated	VBD	ROOT	O
that	IN	mark	O
Ang	NN	nsubj	B-Gene_or_gene_product1
II	CD	nummod	I-Gene_or_gene_product1
may	MD	aux	O
promote	VB	ccomp	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
sFlt	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nmod	I-Gene_or_gene_product3
in	IN	case	O
pregnancy	NN	nmod	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
infusion	NN	nsubj	O
of	IN	case	O
Ang	NN	nmod	B-Gene_or_gene_product1
II	CD	nummod	I-Gene_or_gene_product1
significantly	RB	advmod	O
increases	VBZ	ccomp	O
circulating	VBG	amod	O
levels	NNS	dobj	O
of	IN	case	O
sFlt	NN	nmod	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
in	IN	case	O
pregnant	JJ	amod	O
mice	NNS	nmod	B-Organism
,	,	punct	O
thereby	RB	advmod	O
demonstrating	VBG	advcl	O
that	IN	mark	O
Ang	NN	nsubj	B-Gene_or_gene_product1
II	CD	nummod	I-Gene_or_gene_product1
is	VBZ	cop	O
a	DT	det	O
regulator	NN	ccomp	O
of	IN	case	O
sFlt	NNP	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
secretion	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
Ang	NN	nsubj	B-Gene_or_gene_product1
II	CD	nummod	I-Gene_or_gene_product1
stimulated	VBN	ROOT	O
sFlt	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
production	NN	dobj	O
in	IN	case	O
a	DT	det	O
dose	NN	compound	O
-	HYPH	punct	O
and	CC	cc	O
time	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
from	IN	case	O
human	JJ	amod	B-Organism
villous	JJ	amod	O
explants	NNS	nmod	O
and	CC	cc	O
cultured	VBN	amod	O
trophoblasts	NNS	conj	B-Cell
but	CC	cc	O
not	RB	neg	O
from	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
trophoblasts	NNS	nsubj	B-Cell
are	VBP	ccomp	O
the	DT	det	O
primary	JJ	amod	O
source	NN	attr	O
of	IN	prep	O
sFlt	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	pobj	I-Gene_or_gene_product3
during	IN	prep	O
pregnancy	NN	pobj	O
.	.	punct	O

As	IN	mark	O
expected	VBN	advcl	O
,	,	punct	O
Ang	NN	conj	B-Gene_or_gene_product1
II	CD	npadvmod	I-Gene_or_gene_product1
-	HYPH	punct	O
induced	VBN	amod	O
sFlt	NNP	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
secretion	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
tube	NN	compound	B-Tissue
formation	NN	conj	O
.	.	punct	O

In	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	amod	O
vivo	FW	dep	O
studies	NNS	nsubj	O
with	IN	case	O
losartan	NN	nmod	B-Simple_chemical
,	,	punct	O
small	JJ	amod	O
interfering	VBG	amod	O
RNA	NN	appos	O
specific	JJ	amod	O
for	IN	case	O
calcineurin	NN	nmod	B-Gene_or_gene_product0
and	CC	cc	O
FK506	NN	conj	B-Simple_chemical
demonstrated	VBD	ROOT	O
that	IN	mark	O
Ang	NN	amod	B-Gene_or_gene_product1
II	CD	nummod	I-Gene_or_gene_product1
-	HYPH	punct	O
mediated	VBN	amod	O
sFlt	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
release	NN	nsubj	O
was	VBD	cop	O
via	IN	case	O
Ang	NN	compound	B-Gene_or_gene_product0
II	CD	nummod	I-Gene_or_gene_product0
type	NN	compound	I-Gene_or_gene_product0
1	CD	nummod	I-Gene_or_gene_product0
receptor	NN	compound	I-Gene_or_gene_product0
activation	NN	ccomp	O
and	CC	cc	O
calcineurin	NN	compound	O
signaling	NN	conj	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
reveal	VBP	ROOT	O
a	DT	det	O
previously	RB	advmod	O
unrecognized	JJ	amod	O
regulatory	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
Ang	NN	nmod	B-Gene_or_gene_product1
II	CD	nummod	I-Gene_or_gene_product1
on	IN	case	O
sFlt	NNP	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
expression	NN	nmod	O
in	IN	case	O
murine	JJ	amod	B-Organism
and	CC	cc	O
human	JJ	conj	B-Organism
pregnancy	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
elevated	JJ	amod	O
sFlt	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
levels	NNS	nsubjpass	O
in	IN	case	O
preeclampsia	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
caused	VBN	ccomp	O
by	IN	case	O
a	DT	det	O
dysregulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
local	JJ	amod	O
renin	NN	compound	B-Gene_or_gene_product0
/	:	punct	O
angiotensin	NN	compound	B-Gene_or_gene_product0
system	NN	nmod	O
.	.	punct	O

p21	NN	nsubj	B-Gene_or_gene_product1
delays	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
onset	NN	dobj	O
by	IN	case	O
preservation	NN	nmod	O
of	IN	case	O
chromosomal	JJ	amod	B-Cellular_component
stability	NN	nmod	O
.	.	punct	O

The	DT	det	O
p53	NN	compound	B-Gene_or_gene_product1
protein	NN	nsubj	O
suppresses	VBZ	ROOT	O
tumorigenesis	NN	dobj	O
by	IN	mark	O
initiating	VBG	advcl	O
cellular	JJ	amod	B-Cell
functions	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
DNA	NN	compound	B-Cellular_component
damage	NN	nmod	O
.	.	punct	O

A	DT	det	O
p53	NN	compound	B-Gene_or_gene_product1
mutant	NN	nsubj	O
,	,	punct	O
p53R172P	NN	appos	B-Gene_or_gene_product1
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
deficient	JJ	acl:relcl	O
for	IN	case	O
apoptosis	NN	nmod	O
but	CC	cc	O
retains	VBZ	conj	O
a	DT	det	O
partial	JJ	amod	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	compound	O
function	NN	dobj	O
,	,	punct	O
delays	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
onset	NN	dobj	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Remarkably	RB	advmod	O
,	,	punct	O
lymphomas	NNS	nsubj	B-Cancer
arising	VBG	acl	O
in	IN	case	O
Trp53	NN	compound	B-Gene_or_gene_product1
(	-LRB-	punct	O
515C	NN	compound	O
/	:	punct	O
515C	NN	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
(	-LRB-	punct	O
encoding	VBG	acl	O
p53R172P	NNS	advmod	B-Gene_or_gene_product1
)	-RRB-	punct	O
retain	VBP	ROOT	O
stable	JJ	amod	O
genomes	NNS	dobj	O
.	.	punct	O

Given	VBN	case	O
the	DT	det	O
dominant	JJ	amod	O
role	NN	nmod	O
of	IN	case	O
p21	NN	nmod	B-Gene_or_gene_product1
in	IN	case	O
p53	NN	compound	B-Gene_or_gene_product1
cell	NN	compound	B-Cell
cycle	NN	compound	O
control	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
crossed	VBD	ROOT	O
Trp53	NN	compound	B-Gene_or_gene_product1
(	-LRB-	punct	O
515C	NN	compound	O
/	:	punct	O
515C	NN	appos	O
)	-RRB-	punct	O
mice	NNS	dobj	O
onto	IN	case	O
a	DT	det	O
p21	NN	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
null	NN	amod	O
background	NN	nmod	O
to	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
p21	NN	nsubjpass	B-Gene_or_gene_product1
was	VBD	auxpass	O
required	VBN	ccomp	O
for	IN	mark	O
maintaining	VBG	advcl	O
chromosomal	JJ	amod	B-Cellular_component
stability	NN	dobj	O
and	CC	cc	O
delaying	VBG	conj	O
tumor	NN	compound	B-Cancer
onset	NN	conj	O
.	.	punct	O

Loss	NN	nsubj	O
of	IN	case	O
p21	NN	nmod	B-Gene_or_gene_product1
completely	RB	advmod	O
abolished	VBD	ROOT	O
the	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	compound	O
function	NN	dobj	O
of	IN	case	O
p53R172P	NNS	nmod	B-Gene_or_gene_product1
and	CC	cc	O
accelerated	VBD	conj	O
tumor	NN	compound	B-Cancer
onset	NN	dobj	O
in	IN	case	O
Trp53	NN	compound	B-Gene_or_gene_product1
(	-LRB-	punct	O
515C	NN	compound	O
/	:	punct	O
515C	NN	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
.	.	punct	O

Cytogenetic	JJ	amod	O
examination	NN	nsubj	O
of	IN	case	O
Trp53	NN	nmod	B-Gene_or_gene_product1
(	-LRB-	punct	O
515C	NN	compound	O
/	:	punct	O
515C	NN	intj	O
)	-RRB-	punct	O
p21	NN	dep	B-Gene_or_gene_product1
(	-LRB-	punct	O
-	:	punct	O
/	SYM	punct	O
-	:	punct	O
)	-RRB-	punct	O
sarcomas	NNS	dep	B-Cancer
and	CC	cc	O
lymphomas	NNS	conj	B-Cancer
revealed	VBD	ROOT	O
aneuploidy	NN	dobj	B-Pathological_formation
and	CC	cc	O
chromosomal	JJ	amod	B-Pathological_formation
aberrations	NNS	conj	I-Pathological_formation
that	WDT	nsubj	O
were	VBD	cop	O
absent	JJ	acl:relcl	O
in	IN	case	O
Trp53	NN	compound	B-Gene_or_gene_product1
(	-LRB-	punct	O
515C	NN	compound	O
/	:	punct	O
515C	NN	intj	O
)	-RRB-	punct	O
malignancies	NNS	nmod	B-Cancer
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
p21	NN	nsubj	B-Gene_or_gene_product1
coupled	JJ	amod	O
p53	NN	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
dependent	JJ	amod	O
checkpoint	NN	amod	O
control	NN	ROOT	O
and	CC	cc	O
preservation	NN	conj	O
of	IN	case	O
chromosomal	JJ	amod	B-Cellular_component
stability	NN	nmod	O
,	,	punct	O
and	CC	cc	O
cooperated	VBD	conj	O
with	IN	case	O
apoptosis	NN	nmod	O
in	IN	mark	O
suppressing	VBG	acl	O
tumor	NN	compound	B-Cancer
onset	NN	dobj	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Mechanisms	NNS	ROOT	O
for	IN	case	O
the	DT	det	O
magnolol	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
death	NN	nmod	O
of	IN	case	O
CGTH	NN	compound	B-Cell
W	NNP	compound	I-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
thyroid	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Magnolol	NNP	nsubj	B-Simple_chemical
,	,	punct	O
a	DT	det	O
substance	NN	appos	O
purified	VBN	acl	O
from	IN	prep	O
the	DT	det	O
bark	NN	pobj	B-Tissue
of	IN	prep	O
Magnolia	NNP	compound	B-Organism
officialis	NN	pobj	I-Organism
,	,	punct	O
inhibits	VBZ	ROOT	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
apoptosis	NN	dobj	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
study	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
magnolol	NN	nmod	B-Simple_chemical
on	IN	case	O
CGTH	NN	compound	B-Cell
W	NNP	compound	I-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
thyroid	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

After	IN	case	O
24	CD	nummod	O
h	NN	compound	O
treatment	NN	nmod	O
with	IN	case	O
80	CD	nummod	O
microM	NN	compound	O
magnolol	NN	nmod	B-Simple_chemical
in	IN	case	O
serum	NN	compound	B-Organism_substance
-	:	punct	O
containing	VBG	amod	O
medium	NN	nmod	O
,	,	punct	O
about	RB	advmod	O
50	CD	nummod	O
%	NN	nsubj	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
exhibited	VBD	ROOT	O
apoptotic	JJ	amod	O
features	NNS	dobj	O
and	CC	cc	O
20	CD	nummod	O
%	NN	amod	O
necrotic	JJ	amod	O
features	NNS	conj	O
.	.	punct	O

Cytochrome	NNP	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
c	NN	compound	I-Gene_or_gene_product1
staining	NN	nsubjpass	O
was	VBD	auxpass	O
diffused	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	nmod	B-Organism_substance
of	IN	case	O
the	DT	det	O
apoptotic	JJ	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
but	CC	cc	O
restricted	JJ	conj	O
to	TO	case	O
the	DT	det	O
mitochondria	NN	nmod	B-Cellular_component
in	IN	case	O
control	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Western	NN	compound	O
blot	NN	compound	O
analyses	NNS	nsubj	O
showed	VBD	ROOT	O
an	DT	det	O
increase	NN	dobj	O
in	IN	case	O
levels	NNS	nmod	O
of	IN	case	O
activated	VBN	amod	O
caspases	NNS	nmod	B-Gene_or_gene_product1
(	-LRB-	punct	O
caspase	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
3	CD	dep	I-Gene_or_gene_product3
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product2
7	CD	conj	I-Gene_or_gene_product2
)	-RRB-	punct	O
and	CC	cc	O
of	IN	case	O
cleaved	VBN	amod	O
poly	NN	conj	B-Gene_or_gene_product1
(	-LRB-	punct	I-Gene_or_gene_product1
ADP	NN	compound	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
ribose	NN	amod	I-Gene_or_gene_product1
)	-RRB-	punct	I-Gene_or_gene_product1
polymerase	NN	dep	I-Gene_or_gene_product1
(	-LRB-	punct	O
PARP	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
by	IN	case	O
magnolol	NN	nmod	B-Simple_chemical
.	.	punct	O

Concomitantly	RB	advmod	O
,	,	punct	O
immunostaining	NN	nsubj	O
for	IN	case	O
apoptosis	NN	nmod	B-Gene_or_gene_product1
inducing	VBG	acl	I-Gene_or_gene_product1
factor	NN	dobj	I-Gene_or_gene_product1
(	-LRB-	punct	O
AIF	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
showed	VBD	ROOT	O
a	DT	det	O
time	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
translocation	NN	dobj	O
from	IN	case	O
the	DT	det	O
mitochondria	NN	nmod	B-Cellular_component
to	TO	case	O
the	DT	det	O
nucleus	NN	nmod	B-Cellular_component
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
PARP	NN	nmod	B-Gene_or_gene_product1
or	CC	cc	O
caspase	NN	compound	B-Gene_or_gene_product1
activity	NN	conj	O
blocked	VBD	ROOT	O
magnolol	NN	amod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	dobj	O
,	,	punct	O
supporting	VBG	advcl	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
the	DT	det	O
caspases	NNS	nmod	B-Gene_or_gene_product2
and	CC	cc	O
PARP	NN	conj	B-Gene_or_gene_product1
.	.	punct	O

In	IN	case	O
addition	NN	ROOT	O
,	,	punct	O
magnolol	NN	amod	B-Simple_chemical
activated	VBD	amod	O
phosphatase	NN	intj	B-Gene_or_gene_product1
and	CC	cc	I-Gene_or_gene_product1
tensin	NN	compound	I-Gene_or_gene_product1
homolog	NN	conj	I-Gene_or_gene_product1
deleted	VBN	acl	I-Gene_or_gene_product1
on	IN	case	I-Gene_or_gene_product1
chromosome	NN	nmod	I-Gene_or_gene_product1
10	CD	nummod	I-Gene_or_gene_product1
(	-LRB-	punct	O
PTEN	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
and	CC	cc	O
inactivated	VBN	conj	O
Akt	NNP	dobj	B-Gene_or_gene_product1
by	IN	mark	O
decreasing	VBG	acl	O
levels	NNS	dobj	O
of	IN	case	O
phosphorylated	VBN	amod	O
PTEN	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
phosphorylated	VBN	amod	O
Akt	NNP	conj	B-Gene_or_gene_product1
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
magnolol	NN	nsubj	B-Simple_chemical
promoted	VBD	ccomp	O
apoptosis	NN	dobj	O
probably	RB	advmod	O
by	IN	mark	O
alleviating	VBG	advcl	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
Akt	NNP	nmod	B-Gene_or_gene_product1
on	IN	case	O
caspase	NN	nmod	B-Gene_or_gene_product2
9	CD	nummod	I-Gene_or_gene_product2
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
PARP	NN	compound	B-Gene_or_gene_product1
activity	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product1
activity	NN	conj	O
,	,	punct	O
completely	RB	advmod	O
prevented	VBD	ROOT	O
magnolol	NN	compound	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
necrosis	NN	dobj	O
,	,	punct	O
suggesting	VBG	advcl	O
the	DT	det	O
notion	NN	dobj	O
that	IN	mark	O
it	PRP	nsubjpass	O
might	MD	aux	O
be	VB	auxpass	O
caused	VBN	ccomp	O
by	IN	case	O
depletion	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
ATP	NN	compound	B-Simple_chemical
levels	NNS	nmod	O
due	JJ	case	O
to	TO	mwe	O
PARP	NN	compound	B-Gene_or_gene_product1
activation	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
magnolol	NN	nsubj	B-Simple_chemical
initiates	VBZ	ccomp	O
apoptosis	NN	dobj	O
via	IN	case	O
the	DT	dep	O
cytochrome	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
c	NN	compound	I-Gene_or_gene_product1
/	:	punct	O
caspase	NN	nmod	B-Gene_or_gene_product2
3	CD	nummod	I-Gene_or_gene_product2
/	:	punct	O
PARP	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
AIF	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
PTEN	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
Akt	NNP	compound	B-Gene_or_gene_product1
/	:	punct	O
caspase	NN	conj	B-Gene_or_gene_product3
9	CD	nummod	I-Gene_or_gene_product3
/	:	punct	O
PARP	NN	compound	B-Gene_or_gene_product1
pathways	NNS	conj	O
and	CC	cc	O
necrosis	NN	conj	O
via	IN	case	O
PARP	NN	compound	B-Gene_or_gene_product1
activation	NN	nmod	O
.	.	punct	O

Adaptive	JJ	amod	O
landscapes	NNS	nsubj	O
and	CC	cc	O
emergent	NN	amod	O
phenotypes	NNS	conj	O
:	:	punct	O
why	WRB	advmod	O
do	VBP	aux	O
cancers	NNS	nsubj	B-Cancer
have	VBP	ROOT	O
high	JJ	amod	O
glycolysis	NN	dobj	O
?	.	punct	O

Investigating	VBG	csubj	O
the	DT	det	O
causes	NNS	dobj	O
of	IN	case	O
increased	VBN	amod	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
(	-LRB-	punct	O
Warburg	NNP	compound	O
Effect	NNP	appos	O
)	-RRB-	punct	O
has	VBZ	aux	O
gone	VBN	ROOT	O
in	RB	prt	O
and	CC	cc	O
out	IN	conj	O
of	IN	prep	O
fashion	NN	pobj	O
many	JJ	amod	O
times	NNS	npadvmod	O
since	IN	mark	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
first	RB	advmod	O
described	VBN	advcl	O
almost	RB	advmod	O
a	DT	det	O
century	NN	npadvmod	O
ago	RB	advmod	O
.	.	punct	O

The	DT	det	O
field	NN	nsubj	O
is	VBZ	ROOT	O
currently	RB	advmod	O
in	IN	prep	O
ascendance	NN	pobj	O
due	JJ	case	O
to	TO	case	O
two	CD	nummod	O
factors	NNS	nmod	O
.	.	punct	O

Over	IN	case	O
a	DT	det	O
million	CD	nummod	O
FDG	NN	compound	O
-	HYPH	punct	O
PET	NN	compound	O
studies	NNS	nsubj	O
have	VBP	aux	O
unequivocally	RB	advmod	O
identified	VBN	ROOT	O
increased	VBN	amod	O
glucose	NN	compound	B-Simple_chemical
uptake	NN	dobj	O
as	IN	case	O
a	DT	det	O
hallmark	NN	nmod	O
of	IN	case	O
metastatic	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
in	IN	case	O
humans	NNS	nmod	B-Organism
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
,	,	punct	O
combined	VBN	acl	O
with	IN	case	O
new	JJ	amod	O
molecular	JJ	amod	O
insights	NNS	nmod	O
with	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1alpha	NN	nmod	I-Gene_or_gene_product3
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
myc	NN	conj	I-Gene_or_gene_product1
,	,	punct	O
have	VBP	aux	O
rekindled	VBN	ROOT	O
an	DT	det	O
interest	NN	dobj	O
in	IN	case	O
this	DT	det	O
important	JJ	amod	O
phenotype	NN	nmod	O
.	.	punct	O

A	DT	det	O
preponderance	NN	nsubjpass	O
of	IN	prep	O
work	NN	pobj	O
has	VBZ	aux	O
been	VBN	auxpass	O
focused	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
mechanisms	NNS	nmod	O
underlying	VBG	acl	O
this	DT	det	O
effect	NN	dobj	O
,	,	punct	O
with	IN	case	O
the	DT	det	O
expectation	NN	nmod	O
that	IN	mark	O
a	DT	det	O
mechanistic	JJ	amod	O
understanding	NN	nsubj	O
may	MD	aux	O
lead	VB	ccomp	O
to	TO	case	O
novel	JJ	amod	O
therapeutic	JJ	amod	O
approaches	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
also	RB	advmod	O
an	DT	det	O
implicit	JJ	amod	O
assumption	NN	attr	O
that	IN	mark	O
a	DT	det	O
mechanistic	JJ	amod	O
understanding	NN	nsubj	O
,	,	punct	O
although	IN	mark	O
fundamentally	RB	advmod	O
reductionist	NN	advcl	O
,	,	punct	O
will	MD	aux	O
nonetheless	RB	advmod	O
lead	VB	ccomp	O
to	TO	prep	O
a	DT	det	O
more	RBR	advmod	O
profound	JJ	amod	O
teleological	JJ	amod	O
understanding	NN	pobj	O
of	IN	prep	O
the	DT	det	O
need	NN	pobj	O
for	IN	case	O
altered	JJ	amod	O
metabolism	NN	nmod	O
in	IN	case	O
invasive	JJ	amod	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

In	IN	case	O
this	DT	det	O
communication	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
describe	VBP	ROOT	O
an	DT	det	O
alternative	JJ	amod	O
approach	NN	dobj	O
that	WDT	nsubj	O
begins	VBZ	acl:relcl	O
with	IN	case	O
teleology	NN	nmod	O
;	:	punct	O
i	LS	dep	O
.	.	punct	O
e	LS	intj	O
.	.	punct	O
adaptive	JJ	amod	O
landscapes	NNS	nsubj	O
and	CC	cc	O
selection	NN	conj	O
pressures	NNS	ROOT	O
that	WDT	nsubj	O
promote	VBP	acl:relcl	O
emergence	NN	dobj	O
of	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
during	IN	case	O
the	DT	det	O
somatic	JJ	amod	O
evolution	NN	nmod	O
of	IN	case	O
invasive	JJ	amod	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

Mathematical	JJ	amod	O
models	NNS	nsubjpass	O
and	CC	cc	O
empirical	JJ	amod	O
observations	NNS	conj	O
are	VBP	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
define	VB	xcomp	O
the	DT	det	O
adaptive	JJ	amod	O
advantage	NN	dobj	O
of	IN	case	O
aerobic	JJ	amod	O
glycolysis	NN	nmod	O
that	WDT	nsubj	O
would	MD	aux	O
explain	VB	acl:relcl	O
its	PRP$	nmod:poss	O
remarkable	JJ	amod	O
prevalence	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
.	.	punct	O

These	DT	det	O
studies	NNS	nsubj	O
have	VBP	aux	O
led	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
hypothesis	NN	nmod	O
that	IN	mark	O
increased	VBN	amod	O
consumption	NN	nsubjpass	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
in	IN	case	O
metastatic	JJ	amod	B-Cancer
lesions	NNS	nmod	I-Cancer
is	VBZ	auxpass	O
not	RB	neg	O
used	VBN	ccomp	O
for	IN	prep	O
substantial	JJ	amod	O
energy	NN	compound	O
production	NN	pobj	O
via	IN	case	O
Embden	NNP	compound	O
-	HYPH	punct	O
Meyerhoff	NNP	compound	O
glycolysis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
rather	RB	advmod	O
for	IN	case	O
production	NN	conj	O
of	IN	case	O
acid	NN	nmod	B-Simple_chemical
,	,	punct	O
which	WDT	nsubj	O
gives	VBZ	acl:relcl	O
the	DT	det	O
cancer	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
a	DT	det	O
competitive	JJ	amod	O
advantage	NN	dobj	O
for	IN	case	O
invasion	NN	nmod	O
.	.	punct	O

Alternative	JJ	amod	O
hypotheses	NNS	nsubj	O
,	,	punct	O
wherein	VB	nsubjpass	O
the	DT	det	O
glucose	NN	nsubjpass	B-Simple_chemical
is	VBZ	auxpass	O
used	VBN	ccomp	O
for	IN	case	O
generation	NN	nmod	O
of	IN	case	O
reducing	VBG	amod	O
equivalents	NNS	nmod	O
(	-LRB-	punct	O
NADPH	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
or	CC	cc	O
anabolic	JJ	amod	O
precursors	NNS	conj	O
(	-LRB-	punct	O
ribose	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
are	VBP	auxpass	O
also	RB	advmod	O
discussed	VBN	ROOT	O
.	.	punct	O

Ectopic	JJ	amod	O
decorin	NN	compound	B-Gene_or_gene_product0
expression	NN	nsubj	O
up	RB	advmod	O
-	:	punct	O
regulates	VBZ	ROOT	O
VEGF	NN	compound	B-Gene_or_gene_product1
expression	NN	dobj	O
in	IN	case	O
mouse	NN	compound	B-Organism
cerebral	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
via	IN	case	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
transcription	NN	compound	O
factors	NNS	nmod	O
Sp1	NN	dep	B-Gene_or_gene_product3
,	,	punct	O
HIF1alpha	NN	conj	B-Gene_or_gene_product3
,	,	punct	O
and	CC	cc	O
Stat3	NN	conj	B-Gene_or_gene_product1
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
proteoglycan	JJ	amod	O
decorin	NN	nsubj	B-Gene_or_gene_product0
(	-LRB-	punct	O
DCN	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
up	RB	advmod	O
-	:	punct	O
regulates	VBZ	ccomp	O
the	DT	det	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
expression	NN	dobj	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product1
regulating	VBG	acl	O
transcription	NN	compound	O
factors	NNS	dobj	O
Sp1	NN	dep	B-Gene_or_gene_product3
,	,	punct	O
hypoxia	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
inducible	JJ	amod	I-Gene_or_gene_product1
factor	NN	compound	I-Gene_or_gene_product1
1alpha	NN	conj	I-Gene_or_gene_product1
(	-LRB-	punct	O
HIF1alpha	NN	appos	B-Gene_or_gene_product3
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
signal	NN	compound	B-Gene_or_gene_product2
transducer	NN	conj	I-Gene_or_gene_product2
and	CC	cc	I-Gene_or_gene_product2
activator	NN	conj	I-Gene_or_gene_product2
of	IN	case	I-Gene_or_gene_product2
transcription	NN	nmod	I-Gene_or_gene_product2
3	CD	nummod	I-Gene_or_gene_product2
(	-LRB-	punct	O
Stat3	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
via	IN	case	O
epidermal	JJ	amod	B-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
receptor	NN	compound	I-Gene_or_gene_product0
(	-LRB-	punct	O
EGFR	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
,	,	punct	O
mitogen	NN	nmod:npmod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
activated	VBN	amod	I-Gene_or_gene_product2
protein	NN	compound	I-Gene_or_gene_product2
kinase	NN	compound	I-Gene_or_gene_product2
extracellular	JJ	amod	I-Gene_or_gene_product2
signal	NN	compound	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
regulated	VBN	amod	I-Gene_or_gene_product2
kinase	NN	conj	I-Gene_or_gene_product2
1	CD	nummod	I-Gene_or_gene_product2
/	SYM	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
(	-LRB-	punct	O
ERK1	NN	dep	B-Gene_or_gene_product2
/	:	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
protein	NN	compound	B-Gene_or_gene_product2
kinase	NN	compound	I-Gene_or_gene_product2
B	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
AKT	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
pathways	NNS	dobj	O
in	IN	case	O
DCN	NN	compound	B-Gene_or_gene_product
transfected	VBN	amod	O
mouse	NN	compound	B-Organism
cerebral	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
(	-LRB-	punct	I-Cell
MCE	NN	compound	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
pharmacological	JJ	amod	O
inhibitors	NNS	nmod	O
and	CC	cc	O
small	JJ	amod	O
interfering	VBG	amod	O
RNAs	NNS	conj	O
reveal	VBP	ROOT	O
that	IN	mark	O
induction	NN	nsubj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
Sp1	NN	nmod	B-Gene_or_gene_product3
,	,	punct	O
HIF1alpha	NN	conj	B-Gene_or_gene_product3
,	,	punct	O
and	CC	cc	O
Stat3	NN	conj	B-Gene_or_gene_product1
facilitate	VBP	ccomp	O
their	PRP$	nmod:poss	O
nuclear	JJ	amod	O
localization	NN	dobj	O
and	CC	cc	O
binding	VBG	conj	O
to	TO	case	O
their	PRP$	nmod:poss	O
specific	JJ	amod	O
motifs	NNS	nmod	O
of	IN	case	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product1
promoter	NN	nmod	O
and	CC	cc	O
induce	VB	conj	O
VEGF	NN	compound	B-Gene_or_gene_product1
expression	NN	dobj	O
via	IN	case	O
two	CD	nummod	O
independent	JJ	amod	O
pathways	NNS	nmod	O
,	,	punct	O
DCN	NN	appos	B-Gene_or_gene_product0
/	:	punct	O
EGFR	NN	appos	B-Gene_or_gene_product3
/	,	punct	O
phosphoinositide	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
3	CD	nummod	I-Gene_or_gene_product1
kinase	NN	conj	I-Gene_or_gene_product1
/	:	punct	O
AKT	NN	conj	B-Gene_or_gene_product2
and	CC	cc	O
DCN	NN	conj	B-Gene_or_gene_product0
/	:	punct	O
EGFR	NN	conj	B-Gene_or_gene_product3
/	:	punct	O
ERK1	NN	conj	B-Gene_or_gene_product2
/	:	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
in	IN	case	O
DCN	NN	nmod	B-Gene_or_gene_product0
synthesizing	NN	acl	O
MCE	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

The	DT	det	O
cell	NN	compound	B-Cell
type	NN	nmod:npmod	O
specific	JJ	amod	O
glycosylation	NN	nsubj	O
protects	VBZ	ROOT	O
Sp1	NN	dobj	B-Gene_or_gene_product3
and	CC	cc	O
HIF1alpha	NN	conj	B-Gene_or_gene_product3
from	IN	case	O
proteosome	NN	compound	O
degradation	NN	nmod	O
and	CC	cc	O
plays	VBZ	conj	O
an	DT	det	O
important	JJ	amod	O
and	CC	cc	O
novel	JJ	conj	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product1
in	IN	case	O
DCN	NN	compound	B-Gene_or_gene_product1
transfected	JJ	amod	O
MCE	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
gelatinases	NNS	nmod	O
(	-LRB-	punct	O
matrix	NN	compound	B-Gene_or_gene_product2
metalloproteinase	NN	appos	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
and	CC	cc	O
9	CD	conj	B-Gene_or_gene_product2
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
serine	NN	compound	O
protease	NN	compound	O
tissue	NN	compound	B-Gene_or_gene_product0
plasminogen	NN	compound	I-Gene_or_gene_product0
activator	NN	appos	I-Gene_or_gene_product0
and	CC	cc	O
plasmin	NN	conj	B-Gene_or_gene_product1
by	IN	case	O
DCN	NN	compound	B-Gene_or_gene_product1
transfection	NN	nmod	O
in	IN	case	O
MCE	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
leads	VBZ	ROOT	O
to	TO	case	O
extracellular	JJ	amod	B-Immaterial_anatomical_entity
proteolysis	NN	nmod	O
and	CC	cc	O
to	TO	case	O
release	VB	conj	O
of	IN	case	O
matrix	NN	nmod	O
-	HYPH	punct	O
bound	VBN	amod	O
VEGF	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
two	CD	nummod	O
independent	JJ	amod	O
downstream	JJ	amod	O
signal	NN	compound	O
pathways	NNS	nsubj	O
,	,	punct	O
DCN	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
EGFR	NN	appos	B-Gene_or_gene_product3
/	:	punct	O
ERK1	NN	conj	B-Gene_or_gene_product2
/	:	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
and	CC	cc	O
DCN	NN	conj	B-Gene_or_gene_product0
/	:	punct	O
EGFR	NN	compound	B-Gene_or_gene_product3
/	,	punct	O
phosphoinositide	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
3	CD	nummod	I-Gene_or_gene_product1
kinase	NN	conj	I-Gene_or_gene_product1
/	:	punct	O
AKT	NNP	conj	B-Gene_or_gene_product2
,	,	punct	O
mediate	VB	ccomp	O
up	RP	advmod	O
-	HYPH	punct	O
regulation	NN	dobj	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
transcription	NN	compound	O
factors	NNS	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product1
such	JJ	case	O
as	IN	mwe	O
HIF1alpha	NN	nmod	B-Gene_or_gene_product3
,	,	punct	O
Stat3	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
and	CC	cc	O
Sp1	NN	conj	B-Gene_or_gene_product3
and	CC	cc	O
increase	VB	conj	O
VEGF	NN	compound	B-Gene_or_gene_product1
transcription	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
in	IN	case	O
MCE	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Effects	NNS	ROOT	O
of	IN	case	O
spironolactone	NN	nmod	B-Simple_chemical
on	IN	case	O
corneal	NN	compound	B-Multi-tissue_structure
allograft	NN	compound	I-Multi-tissue_structure
survival	NN	nmod	O
in	IN	case	O
the	DT	det	O
rat	NN	nmod	B-Organism
.	.	punct	O

PURPOSE	NN	dep	O
:	:	punct	O
Spironolactone	NN	nsubjpass	B-Simple_chemical
has	VBZ	aux	O
recently	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
suppressive	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
several	JJ	amod	O
immunoactive	JJ	amod	O
and	CC	cc	O
proinflammatory	JJ	conj	O
cytokines	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
spironolactone	NN	nmod	B-Simple_chemical
on	IN	case	O
the	DT	det	O
prevention	NN	nmod	O
of	IN	case	O
corneal	NN	compound	B-Multi-tissue_structure
allograft	NN	compound	I-Multi-tissue_structure
rejection	NN	nmod	O
in	IN	case	O
a	DT	det	O
MHC	NN	compound	B-Gene_or_gene_product3
class	NN	compound	I-Gene_or_gene_product3
I	CD	nummod	I-Gene_or_gene_product3
/	SYM	punct	O
II	CD	nummod	B-Gene_or_gene_product2
mismatch	NN	compound	O
rat	NN	compound	B-Organism
corneal	NN	compound	B-Multi-tissue_structure
transplant	JJ	amod	O
model	NN	nmod	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Grafted	JJ	amod	O
animals	NNS	nsubjpass	O
for	IN	case	O
corneal	NN	compound	B-Multi-tissue_structure
survival	NN	compound	O
analysis	NN	nmod	O
were	VBD	auxpass	O
assigned	VBN	ROOT	O
to	TO	mark	O
receive	VB	xcomp	O
either	CC	cc:preconj	O
spironolactone	NN	compound	B-Simple_chemical
suspension	NN	dobj	O
(	-LRB-	punct	O
orally	RB	advmod	O
,	,	punct	O
100	CD	compound	O
mg	NN	nsubj	O
/	:	punct	O
kg	NN	dep	O
/	:	punct	O
day	NN	conj	O
,	,	punct	O
n	NN	nsubj	O
=	JJ	dep	O
7	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
phosphate	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
buffered	VBN	amod	I-Simple_chemical
saline	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
PBS	NN	appos	B-Simple_chemical
,	,	punct	O
orally	RB	advmod	O
,	,	punct	O
same	JJ	amod	O
volume	NN	appos	O
as	IN	case	O
spironolactone	NN	nmod	B-Simple_chemical
,	,	punct	O
n	NN	nsubj	O
=	JJ	parataxis	O
9	CD	dobj	O
)	-RRB-	punct	O
or	CC	cc	O
remained	VBD	conj	O
untreated	JJ	xcomp	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
16	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

Additional	JJ	amod	O
grafted	JJ	amod	O
rats	NNS	nsubjpass	B-Organism
treated	VBN	acl	O
with	IN	case	O
spironolactone	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
6	CD	dep	O
)	-RRB-	punct	O
or	CC	cc	O
PBS	NN	conj	B-Simple_chemical
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
8	CD	dep	O
)	-RRB-	punct	O
were	VBD	auxpass	O
sacrificed	VBN	ROOT	O
on	IN	case	O
day	NN	nmod	O
12	CD	nummod	O
for	IN	case	O
quantitative	JJ	amod	O
RT	NN	compound	O
-	HYPH	punct	O
PCR	NN	compound	O
analysis	NN	nmod	O
for	IN	case	O
mechanistic	JJ	amod	O
studies	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Mean	NN	compound	O
(	-LRB-	punct	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
SEM	NNP	appos	O
)	-RRB-	punct	O
graft	NN	compound	B-Multi-tissue_structure
survival	NN	nsubj	O
was	VBD	auxpass	O
significantly	RB	advmod	O
prolonged	JJ	appos	O
in	IN	case	O
animals	NNS	nmod	O
receiving	VBG	acl	O
spironolactone	NN	dobj	B-Simple_chemical
(	-LRB-	punct	O
14	CD	nummod	O
.	.	punct	O
9	CD	nmod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
2	CD	dep	O
.	.	punct	O
0	CD	nummod	O
days	NNS	ROOT	O
)	-RRB-	punct	O
compared	VBN	prep	O
with	IN	prep	O
both	DT	cc:preconj	O
PBS	NNP	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
(	-LRB-	punct	O
12	CD	nummod	O
.	.	punct	O
3	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
1	CD	intj	O
.	.	punct	O
2	CD	nummod	O
days	NNS	npadvmod	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	ROOT	O
0	CD	dobj	O
.	.	punct	O
007	CD	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
untreated	JJ	amod	O
controls	NNS	conj	O
(	-LRB-	punct	O
13	CD	dep	O
.	.	punct	O
0	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
1	CD	npadvmod	O
.	.	punct	O
0	CD	nummod	O
days	NNS	npadvmod	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	ROOT	O
0	CD	dobj	O
.	.	punct	O
01	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
a	DT	det	O
decrease	NN	dobj	O
in	IN	case	O
corneal	NN	compound	B-Multi-tissue_structure
neovascularization	NN	nmod	O
in	IN	case	O
spironolactone	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
rats	NNS	nmod	B-Organism
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
PBS	NNP	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
group	NN	advcl	O
,	,	punct	O
although	IN	mark	O
the	DT	det	O
difference	NN	nsubj	O
was	VBD	cop	O
not	RB	neg	O
statistically	RB	advmod	O
significant	JJ	advcl	O
.	.	punct	O

Spironolactone	NN	nsubj	B-Simple_chemical
affected	VBD	ROOT	O
both	CC	cc:preconj	O
systemic	JJ	amod	O
(	-LRB-	punct	O
down	RB	dep	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
CD25	NN	nmod	B-Gene_or_gene_product1
+	CC	cc	O
cells	NNS	conj	O
in	IN	case	O
spleen	NN	nmod	B-Organ
)	-RRB-	punct	O
and	CC	cc	O
local	JJ	amod	O
immune	JJ	amod	O
response	NN	conj	O
(	-LRB-	punct	O
up	RB	intj	O
-	HYPH	punct	O
regulation	NN	dep	O
of	IN	case	O
IL	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
10	CD	dep	I-Gene_or_gene_product2
in	IN	case	O
cornea	NN	nmod	B-Multi-tissue_structure
)	-RRB-	punct	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
present	VBP	dep	O
initial	JJ	amod	O
results	NNS	dobj	O
demonstrating	VBG	acl	O
anti	JJ	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
spironolactone	NN	nmod	B-Simple_chemical
.	.	punct	O

FAS	NNP	compound	B-Gene_or_gene_product2
-	:	punct	O
1377	CD	nummod	O
G	NN	compound	O
/	:	punct	O
A	DT	compound	O
polymorphism	NN	ROOT	O
and	CC	cc	O
the	DT	det	O
risk	NN	conj	O
of	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
in	IN	case	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Single	JJ	compound	O
-	HYPH	punct	O
nucleotide	NN	compound	O
polymorphisms	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
FAS	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	O
1377G	NN	compound	O
/	:	punct	O
A	NN	nmod	O
,	,	punct	O
FAS	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	O
670A	NN	compound	O
/	:	punct	O
G	NN	conj	O
,	,	punct	O
and	CC	cc	O
FASL	NN	compound	B-Gene_or_gene_product1
-	:	punct	O
844T	NNP	compound	O
/	:	punct	O
C	NN	compound	O
genes	NNS	conj	O
may	MD	aux	O
alter	VB	ROOT	O
transcriptional	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
.	.	punct	O

Recent	JJ	amod	O
evidence	NN	nsubj	O
suggests	VBZ	ROOT	O
an	DT	det	O
association	NN	dobj	O
of	IN	case	O
these	DT	det	O
polymorphisms	NNS	nmod	O
with	IN	case	O
an	DT	det	O
increased	VBN	amod	O
risk	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
so	CC	advmod	O
we	PRP	nsubj	O
explored	VBD	parataxis	O
this	DT	det	O
relationship	NN	dobj	O
.	.	punct	O

Genotypes	NNS	nsubjpass	O
of	IN	case	O
155	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
160	CD	nummod	O
healthy	JJ	amod	B-Organism
control	NN	compound	I-Organism
subjects	NNS	conj	I-Organism
were	VBD	auxpass	O
determined	VBN	ROOT	O
using	VBG	xcomp	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	compound	O
-	HYPH	punct	O
based	VBN	amod	O
restriction	NN	compound	O
fragment	NN	compound	O
length	NN	compound	O
polymorphism	NN	dobj	O
(	-LRB-	punct	O
PCR	NN	compound	O
-	HYPH	punct	O
RFLP	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

Associations	NNS	nsubjpass	O
with	IN	case	O
cancer	NN	compound	B-Cancer
risk	NN	nmod	O
were	VBD	auxpass	O
estimated	VBN	ROOT	O
using	VBG	xcomp	O
two	CD	nummod	O
-	HYPH	punct	O
sided	VBN	amod	O
logistic	JJ	amod	O
regression	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
observed	VBD	ROOT	O
a	DT	det	O
significantly	RB	advmod	O
increased	VBN	amod	O
risk	NN	dobj	O
of	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
associated	VBN	acl	O
with	IN	case	O
the	DT	det	O
FAS	NN	nmod	B-Gene_or_gene_product1
-	:	punct	O
1377	CD	nummod	O
GA	NNP	dep	O
or	CC	cc	O
AA	NN	conj	O
polymorphism	NN	conj	O
[	-LRB-	punct	O
odds	VBZ	compound	O
ratio	NN	dep	O
(	-LRB-	punct	O
OR	NN	appos	O
)	-RRB-	punct	O
=	JJ	amod	O
4	CD	dobj	O
.	.	punct	O
16	CD	nummod	O
,	,	punct	O
95	CD	nummod	O
%	NN	compound	O
confidence	NN	compound	O
interval	NN	dep	O
(	-LRB-	punct	O
CI	NN	appos	O
)	-RRB-	punct	O
=	JJ	amod	O
1	CD	dobj	O
.	.	punct	O
10	CD	compound	O
to	TO	dep	O
15	CD	ROOT	O
.	.	punct	O
74	CD	dep	O
;	:	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
036	CD	dobj	O
]	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
FAS	NN	compound	B-Gene_or_gene_product1
-	:	punct	O
670AG	NN	amod	O
or	CC	cc	O
GG	NN	conj	O
genotype	NN	nsubj	O
showed	VBD	ROOT	O
an	DT	det	O
increased	VBN	amod	O
incidence	NN	dobj	O
of	IN	case	O
node	NN	compound	B-Multi-tissue_structure
metastasis	NN	nmod	O
,	,	punct	O
but	CC	cc	O
these	DT	det	O
findings	NNS	nsubj	O
were	VBD	cop	O
not	RB	neg	O
statistically	RB	advmod	O
significant	JJ	conj	O
(	-LRB-	punct	O
OR	NN	nsubj	O
=	JJ	dep	O
3	CD	dobj	O
.	.	punct	O
67	CD	dep	O
,	,	punct	O
95	CD	nummod	O
%	NN	dep	O
CI	NN	nsubj	O
=	JJ	parataxis	O
0	CD	dobj	O
.	.	punct	O
96	CD	compound	O
-	SYM	punct	O
14	CD	nummod	O
.	.	punct	O
00	CD	dep	O
,	,	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
059	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
significant	JJ	amod	O
association	NN	nsubj	O
between	IN	case	O
an	DT	det	O
increased	VBN	amod	O
risk	NN	nmod	O
of	IN	case	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
polymorphisms	NNS	conj	O
of	IN	case	O
the	DT	det	O
death	NN	compound	O
pathway	NN	compound	O
genes	NNS	nmod	O
FAS	NN	dep	B-Gene_or_gene_product2
and	CC	cc	O
FASL	NN	conj	B-Gene_or_gene_product1
.	.	punct	O

None	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
polymorphisms	NNS	nmod	O
were	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
risk	NN	nmod	O
of	IN	case	O
advanced	JJ	amod	O
stage	NN	nmod	O
or	CC	cc	O
histologic	JJ	amod	O
subtype	NN	conj	O
of	IN	case	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
FAS	NN	compound	B-Gene_or_gene_product1
-	:	punct	O
1377	CD	nummod	O
G	NNP	compound	O
-	HYPH	punct	O
-	:	punct	O
>	NN	dep	O
A	NN	det	O
polymorphism	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
an	DT	det	O
increased	VBN	amod	O
risk	NN	nmod	O
of	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
in	IN	case	O
Korean	JJ	amod	O
cervical	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
.	.	punct	O

Detection	NN	ROOT	O
of	IN	case	O
lymphovascular	JJ	amod	B-Multi-tissue_structure
invasion	NN	nmod	O
in	IN	case	O
early	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
by	IN	case	O
D2	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
40	CD	nmod	I-Gene_or_gene_product2
(	-LRB-	punct	O
podoplanin	NN	appos	B-Gene_or_gene_product0
)	-RRB-	punct	O
:	:	punct	O
a	DT	det	O
clinically	RB	advmod	O
useful	JJ	amod	O
predictor	NN	dep	O
for	IN	case	O
axillary	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
The	DT	det	O
aim	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
use	NN	dobj	O
of	IN	case	O
D2	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
40	CD	nmod	I-Gene_or_gene_product2
for	IN	case	O
the	DT	det	O
detection	NN	nmod	O
of	IN	case	O
lymphovascular	JJ	amod	B-Multi-tissue_structure
invasion	NN	nmod	O
(	-LRB-	punct	O
LVI	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
node	NN	nmod:npmod	O
positive	JJ	amod	O
and	CC	cc	O
negative	JJ	conj	O
early	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

LVI	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
axillary	JJ	amod	B-Multi-tissue_structure
lymph	NN	compound	I-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
(	-LRB-	punct	O
ALNM	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
prognostic	JJ	amod	O
factor	NN	conj	O
.	.	punct	O

A	DT	det	O
precise	JJ	amod	O
identification	NN	nsubj	O
of	IN	case	O
LVI	NN	nmod	O
would	MD	aux	O
have	VB	ROOT	O
a	DT	det	O
strong	JJ	amod	O
clinical	JJ	dep	O
impact	NN	dobj	O
for	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Immunohistochemical	JJ	amod	O
staining	NN	nsubjpass	O
with	IN	case	O
D2	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
40	CD	nmod	I-Gene_or_gene_product2
and	CC	cc	O
CD34	NN	conj	B-Gene_or_gene_product1
was	VBD	auxpass	O
performed	VBN	dep	O
on	IN	case	O
formalin	NN	compound	O
-	HYPH	punct	O
fixed	VBN	amod	O
,	,	punct	O
paraffin	NN	npadvmod	O
-	HYPH	punct	O
embedded	JJ	amod	O
tissue	NN	compound	B-Tissue
sections	NNS	nmod	I-Tissue
of	IN	case	O
254	CD	nummod	O
invasive	JJ	amod	O
breast	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
of	IN	case	O
247	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
node	NN	nmod:npmod	O
negative	JJ	amod	O
and	CC	cc	O
node	NN	conj	O
positive	JJ	amod	O
early	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

All	DT	det	O
slides	NNS	nsubjpass	O
were	VBD	auxpass	O
screened	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
LVI	NN	nmod	O
.	.	punct	O

Correlation	NN	ROOT	O
with	IN	case	O
clinico	NN	nmod:npmod	O
-	HYPH	punct	O
pathological	JJ	amod	O
factors	NNS	nmod	O
including	VBG	case	O
LVI	NN	nmod	O
as	IN	mark	O
retrieved	VBN	advcl	O
by	IN	case	O
routine	NN	compound	O
haematoxylin	NN	nmod	B-Simple_chemical
and	CC	cc	O
eosin	NN	conj	B-Simple_chemical
(	-LRB-	punct	O
H	NN	dep	B-Simple_chemical
.	.	punct	I-Simple_chemical
E	NN	nsubj	I-Simple_chemical
.	.	punct	I-Simple_chemical
)	-RRB-	punct	O
stained	JJ	ROOT	O
sections	NNS	dobj	B-Tissue
and	CC	cc	O
the	DT	det	O
eligibility	NN	nsubjpass	O
for	IN	case	O
the	DT	det	O
prediction	NN	nmod	O
of	IN	case	O
ALNM	NN	nmod	O
was	VBD	auxpass	O
assessed	VBN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Using	VBG	dep	O
the	DT	det	O
D2	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
40	CD	nummod	I-Gene_or_gene_product2
antibody	NN	dobj	O
for	IN	case	O
immunostaining	NN	nmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
demonstrate	VBP	parataxis	O
a	DT	det	O
significant	JJ	amod	O
higher	JJR	amod	O
detection	NN	dobj	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
001	CD	appos	O
)	-RRB-	punct	O
of	IN	case	O
LVI	NN	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
routine	JJ	compound	O
H	NN	nmod	B-Simple_chemical
.	.	punct	I-Simple_chemical
E	NNP	compound	I-Simple_chemical
.	.	punct	I-Simple_chemical
-	HYPH	punct	O
staining	NN	ROOT	O
in	IN	case	O
early	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

LVI	NN	nsubjpass	O
was	VBD	auxpass	O
correctly	RB	advmod	O
identified	VBN	ROOT	O
by	IN	case	O
D2	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
40	CD	compound	I-Gene_or_gene_product2
(	-LRB-	punct	O
D2	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
40	CD	nmod	I-Gene_or_gene_product2
+	CC	cc	O
)	-RRB-	punct	O
in	IN	case	O
70	CD	nummod	O
out	IN	advmod	O
of	IN	advmod	O
254	CD	nummod	O
tumors	NNS	nmod	B-Cancer
(	-LRB-	punct	O
28	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
40	CD	nummod	O
tumors	NNS	nmod	B-Cancer
(	-LRB-	punct	O
16	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
by	IN	case	O
routine	JJ	compound	O
HE	NN	compound	B-Simple_chemical
staining	NN	nmod	O
(	-LRB-	punct	O
HE	NN	dep	B-Simple_chemical
+	CC	cc	O
)	-RRB-	punct	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
D2	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
40	CD	intj	I-Gene_or_gene_product2
+	CC	cc	O
LVI	NN	conj	O
and	CC	cc	O
age	NN	conj	O
,	,	punct	O
t	NN	compound	O
-	HYPH	punct	O
stage	NN	intj	O
,	,	punct	O
nodal	JJ	amod	O
status	NN	conj	O
,	,	punct	O
grading	NN	compound	O
and	CC	cc	O
hormonreceptor	NN	compound	O
-	HYPH	punct	O
status	NN	nmod	O
.	.	punct	O

Correlation	NN	nsubj	O
between	IN	case	O
D2	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
40	CD	nummod	I-Gene_or_gene_product2
+	CC	cc	O
LVI	NN	conj	O
and	CC	cc	O
menopausal	JJ	amod	O
-	HYPH	punct	O
status	NN	nmod	O
,	,	punct	O
HER2	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	O
status	NN	conj	O
and	CC	cc	O
histological	JJ	amod	O
type	NN	conj	O
was	VBD	cop	O
not	RB	neg	O
significant	JJ	ROOT	O
,	,	punct	O
while	IN	mark	O
there	EX	expl	O
was	VBD	advcl	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
of	IN	case	O
D2	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
40	CD	nmod	I-Gene_or_gene_product2
and	CC	cc	O
so	RB	advmod	O
called	VBN	conj	O
"	``	punct	O
triple	JJ	amod	O
negative	JJ	amod	O
"	''	punct	O
tumors	NNS	oprd	B-Cancer
(	-LRB-	punct	O
ER	NN	appos	B-Gene_or_gene_product2
/	:	punct	O
PR	NN	conj	B-Gene_or_gene_product1
and	CC	cc	O
HER2neu	NNS	compound	B-Gene_or_gene_product1
-	HYPH	punct	O
negative	JJ	conj	O
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
multivariate	JJ	amod	O
analysis	NN	nmod	O
D2	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
40	CD	nummod	I-Gene_or_gene_product2
+	CC	cc	O
was	VBD	cop	O
the	DT	det	O
strongest	JJS	amod	O
predictor	NN	ROOT	O
for	IN	case	O
ALNM	NN	nmod	O
with	IN	case	O
an	DT	det	O
odds	NNS	compound	O
ratio	NN	nmod	O
of	IN	case	O
3	CD	nmod	O
.	.	punct	O
489	CD	nummod	O
and	CC	cc	O
a	DT	det	O
P	NN	compound	O
-	HYPH	punct	O
value	NN	nsubj	O
of	IN	case	O
P	NN	nmod	O
=	JJ	conj	O
0	CD	dobj	O
.	.	punct	O
0003	CD	ROOT	O
,	,	punct	O
followed	VBN	acl	O
only	RB	advmod	O
by	IN	case	O
T	NN	compound	O
-	HYPH	punct	O
stage	NN	nmod	O
and	CC	cc	O
grading	VBG	conj	O
with	IN	prep	O
odds	NNS	compound	O
ratios	NNS	pobj	O
of	IN	prep	O
3	CD	pobj	O
.	.	punct	O
167	CD	nummod	O
and	CC	cc	O
1	CD	conj	O
.	.	punct	O
953	CD	dep	O
and	CC	cc	O
P	NN	conj	O
-	HYPH	punct	O
values	NNS	dep	O
P	NN	nsubj	O
=	JJ	ROOT	O
0	CD	dobj	O
.	.	punct	O
0003	CD	ROOT	O
and	CC	cc	O
P	NN	nsubj	O
=	JJ	conj	O
0	CD	dobj	O
.	.	punct	O
0352	CD	dobj	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
Immunostaining	NN	nsubj	O
with	IN	case	O
D2	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
40	CD	nmod	I-Gene_or_gene_product2
significantly	RB	advmod	O
increased	VBD	ROOT	O
the	DT	det	O
frequency	NN	dobj	O
of	IN	case	O
detection	NN	nmod	O
of	IN	case	O
lymphatic	JJ	amod	B-Multi-tissue_structure
invasion	NN	nmod	O
compared	VBN	prep	O
to	TO	case	O
conventional	JJ	amod	O
H	NN	nmod	B-Simple_chemical
.	.	punct	I-Simple_chemical
E	NNP	compound	I-Simple_chemical
.	.	punct	I-Simple_chemical
-	HYPH	punct	O
staining	NN	ROOT	O
in	IN	case	O
early	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

As	IN	mark	O
LVI	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
strong	JJ	amod	O
predictive	JJ	amod	O
and	CC	cc	O
prognostic	JJ	conj	O
marker	NN	nmod	O
,	,	punct	O
the	DT	det	O
monoclonal	JJ	amod	O
antibody	NN	nsubj	O
D2	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
40	CD	dep	I-Gene_or_gene_product2
has	VBZ	ROOT	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
play	VB	acl	O
a	DT	det	O
significant	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
pathological	JJ	amod	O
routine	JJ	compound	O
workup	NN	nmod	O
of	IN	case	O
breast	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

Further	JJ	amod	O
prospective	JJ	amod	O
studies	NNS	nsubjpass	O
are	VBP	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
prove	VB	xcomp	O
the	DT	det	O
clinical	JJ	amod	O
impact	NN	dobj	O
of	IN	case	O
D2	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
40	CD	nmod	I-Gene_or_gene_product2
.	.	punct	O

N	NNP	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
myc	NN	nsubj	I-Gene_or_gene_product1
augments	VBZ	ROOT	O
death	NN	dobj	O
and	CC	cc	O
attenuates	VBZ	conj	O
protective	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	nmod	I-Gene_or_gene_product2
in	IN	case	O
trophically	RB	advmod	O
stressed	JJ	amod	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

N	NNP	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
myc	NN	nsubj	I-Gene_or_gene_product1
has	VBZ	ROOT	O
proapoptotic	JJ	amod	O
functions	NNS	dobj	O
,	,	punct	O
yet	CC	advmod	O
it	PRP	nsubj	O
acts	VBZ	parataxis	O
as	IN	case	O
an	DT	det	O
oncogene	NN	nmod	O
in	IN	case	O
neuroblastoma	NN	nmod	B-Cancer
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
antiapoptotic	JJ	amod	O
mechanisms	NNS	nsubj	O
have	VBP	ROOT	O
to	TO	mark	O
be	VB	cop	O
operative	JJ	xcomp	O
in	IN	case	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
antagonize	VBP	acl:relcl	O
the	DT	det	O
proapoptotic	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
N	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
myc	NN	nmod	I-Gene_or_gene_product2
.	.	punct	O

We	PRP	nsubj	O
conditionally	RB	advmod	O
activated	VBD	ROOT	O
N	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
myc	NN	dobj	I-Gene_or_gene_product1
in	IN	case	O
SH	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
EP	NN	compound	I-Cell
neuroblastoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
subjected	VBN	acl	O
to	TO	case	O
the	DT	det	O
trophic	JJ	amod	O
stress	NN	nmod	O
of	IN	case	O
serum	NN	compound	B-Organism_substance
or	CC	cc	O
nutrient	JJ	conj	O
deprivation	NN	nmod	O
while	IN	mark	O
changing	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
2	CD	nummod	I-Gene_or_gene_product3
,	,	punct	O
survivin	NN	conj	B-Gene_or_gene_product0
and	CC	cc	O
FLIP	NN	conj	B-Gene_or_gene_product2
(	-LRB-	punct	I-Gene_or_gene_product2
L	NN	appos	I-Gene_or_gene_product2
)	-RRB-	punct	I-Gene_or_gene_product2
,	,	punct	O
antiapoptotic	JJ	amod	O
molecules	NNS	nmod	O
often	RB	advmod	O
overexpressed	VBD	acl	O
in	IN	case	O
poor	JJ	amod	O
prognosis	NN	compound	O
neuroblastomas	NNS	nmod	B-Cancer
.	.	punct	O

Bcl	NN	nsubj	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
protected	VBD	ROOT	O
SH	NN	compound	B-Cell
-	HYPH	punct	I-Cell
EP	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
from	IN	case	O
death	NN	nmod	O
during	IN	case	O
nutritional	JJ	amod	O
deprivation	NN	nmod	O
by	IN	mark	O
activating	VBG	advcl	O
energetically	RB	advmod	O
advantageous	JJ	amod	O
oxidative	JJ	amod	O
phosphorylation	NN	dobj	O
.	.	punct	O

N	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
myc	NN	nsubj	I-Gene_or_gene_product1
overrode	NN	ROOT	O
the	DT	det	O
metabolic	JJ	amod	O
protection	NN	dobj	O
provided	VBN	acl	O
by	IN	agent	O
Bcl	NN	npadvmod	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	npadvmod	I-Gene_or_gene_product2
-	HYPH	punct	O
induced	VBN	amod	O
oxidative	JJ	amod	O
phosphorylation	NN	pobj	O
by	IN	mark	O
reestablishing	VBG	advcl	O
the	DT	det	O
glycolytic	JJ	amod	O
phenotype	NN	dobj	O
and	CC	cc	O
attenuated	VBD	conj	O
the	DT	det	O
antiapoptotic	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
Bcl	NN	nmod	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
during	IN	case	O
metabolic	JJ	amod	O
stress	NN	nmod	O
.	.	punct	O

Survivin	NN	nsubj	B-Gene_or_gene_product1
partially	RB	advmod	O
antagonized	VBD	ROOT	O
the	DT	det	O
growth	NN	compound	O
suppressive	JJ	amod	O
function	NN	dobj	O
of	IN	case	O
N	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
myc	NN	nmod	I-Gene_or_gene_product2
in	IN	case	O
SH	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
EP	NN	compound	I-Cell
neuroblastoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
during	IN	case	O
serum	NN	compound	B-Organism_substance
deprivation	NN	nmod	O
whereas	IN	mark	O
FLIP	NN	nsubj	B-Gene_or_gene_product2
(	-LRB-	punct	I-Gene_or_gene_product2
L	NN	appos	I-Gene_or_gene_product2
)	-RRB-	punct	I-Gene_or_gene_product2
did	VBD	advcl	O
not	RB	neg	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
advance	VBP	ROOT	O
our	PRP$	nmod:poss	O
understanding	NN	dobj	O
of	IN	case	O
the	DT	det	O
functions	NNS	nmod	O
of	IN	case	O
N	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
myc	NN	nmod	I-Gene_or_gene_product2
in	IN	case	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
tyrosine	NN	compound	O
kinase	NN	compound	O
inhibitor	NN	nsubj	O
cediranib	NN	nsubj	B-Simple_chemical
blocks	VBZ	ROOT	O
ligand	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
receptor	NN	compound	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
3	CD	nummod	I-Gene_or_gene_product0
activity	NN	dobj	O
and	CC	cc	O
lymphangiogenesis	NN	conj	O
.	.	punct	O

Solid	JJ	amod	B-Cancer
tumors	NNS	nsubj	I-Cancer
express	VBP	ROOT	O
a	DT	det	O
range	NN	dobj	O
of	IN	case	O
factors	NNS	nmod	O
required	VBN	acl	O
to	TO	mark	O
sustain	VB	xcomp	O
their	PRP$	poss	O
growth	NN	dobj	O
and	CC	cc	O
promote	VB	conj	O
their	PRP$	poss	O
dissemination	NN	dobj	O
.	.	punct	O

Among	IN	case	O
these	DT	nsubj	O
are	VBP	cop	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
A	NN	ROOT	I-Gene_or_gene_product0
(	-LRB-	punct	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
A	NNP	appos	I-Gene_or_gene_product0
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
key	JJ	amod	O
angiogenic	JJ	amod	O
stimulant	NN	appos	O
,	,	punct	O
and	CC	cc	O
VEGF	NNP	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C	NNP	conj	I-Gene_or_gene_product0
,	,	punct	O
a	DT	det	O
primary	JJ	amod	O
mediator	NN	appos	O
of	IN	case	O
lymphangiogenesis	NN	nmod	O
.	.	punct	O

Small	JJ	amod	O
molecule	NN	compound	O
tyrosine	NN	compound	B-Simple_chemical
kinase	NN	compound	I-Simple_chemical
inhibitors	NNS	nsubj	I-Simple_chemical
offer	VBP	ROOT	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
inhibit	VB	acl	O
more	JJR	advmod	O
than	IN	mwe	O
one	CD	nummod	O
kinase	NN	dobj	O
and	CC	cc	O
impede	VBP	conj	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
by	IN	case	O
multiple	JJ	amod	O
mechanisms	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
their	PRP$	poss	O
potency	NN	nsubj	O
toward	IN	prep	O
individual	JJ	amod	O
targets	NNS	pobj	O
can	MD	aux	O
vary	VB	ROOT	O
.	.	punct	O

Cediranib	NN	nsubj	B-Simple_chemical
(	-LRB-	punct	O
RECENTIN	NN	appos	B-Simple_chemical
;	:	punct	O
AZD2171	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
inhibitor	NN	ROOT	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product1
signaling	NN	nmod	O
that	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	acl:relcl	O
in	IN	case	O
experimental	JJ	amod	O
models	NNS	nmod	O
to	TO	mark	O
prevent	VB	xcomp	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
A	NNP	nmod:npmod	I-Gene_or_gene_product0
-	HYPH	punct	O
induced	VBN	amod	O
angiogenesis	NN	dobj	O
and	CC	cc	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
growth	NN	conj	O
,	,	punct	O
yet	CC	cc	O
the	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
cediranib	NN	nmod	B-Simple_chemical
on	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product0
receptor	NN	compound	I-Gene_or_gene_product0
(	-LRB-	punct	I-Gene_or_gene_product0
VEGFR	NN	appos	I-Gene_or_gene_product0
)	-RRB-	punct	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
3	CD	nummod	I-Gene_or_gene_product0
-	HYPH	punct	O
mediated	VBN	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
function	NN	nmod	O
and	CC	cc	O
lymphangiogenesis	NN	conj	O
are	VBP	cop	O
unknown	JJ	parataxis	O
.	.	punct	O

To	TO	mark	O
better	RBR	advmod	O
understand	VB	advcl	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
cediranib	NN	nmod	B-Simple_chemical
against	IN	case	O
VEGFR	NN	compound	B-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
3	CD	nmod	I-Gene_or_gene_product0
and	CC	cc	O
its	PRP$	nmod:poss	O
associated	VBN	amod	O
signaling	NN	compound	O
events	NNS	conj	O
compared	VBN	case	O
with	IN	case	O
its	PRP$	nmod:poss	O
activity	NN	nmod	O
against	IN	case	O
VEGFR	NN	nmod	B-Gene_or_gene_product0
-	,	punct	I-Gene_or_gene_product0
2	CD	nummod	I-Gene_or_gene_product0
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
the	DT	det	O
receptor	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
ligands	NNS	dobj	O
VEGF	NNP	compound	B-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
E	NNP	dep	I-Gene_or_gene_product0
and	CC	cc	O
VEGF	NNP	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C156S	NN	conj	I-Gene_or_gene_product0
.	.	punct	O

In	IN	case	O
human	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
cediranib	NN	aux	B-Simple_chemical
inhibited	VBD	ROOT	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
E	NNP	nmod:npmod	I-Gene_or_gene_product0
-	HYPH	punct	O
induced	VBN	amod	O
phosphorylation	NN	nsubj	O
of	IN	case	O
VEGFR	NN	nmod	B-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
2	CD	nummod	I-Gene_or_gene_product0
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C156S	NN	conj	I-Gene_or_gene_product0
-	HYPH	punct	O
induced	VBN	amod	O
phosphorylation	NN	dobj	O
of	IN	case	O
VEGFR	NN	compound	B-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
3	CD	nmod	I-Gene_or_gene_product0
at	IN	case	O
concentrations	NNS	nmod	O
of	IN	case	O
less	JJR	advmod	O
than	IN	mwe	O
/	:	punct	O
=	JJ	amod	O
1nmol	NN	compound	O
/	:	punct	O
L	NN	nmod	O
and	CC	cc	O
inhibited	VBD	conj	O
activation	NN	dobj	O
of	IN	case	O
downstream	JJ	amod	O
signaling	VBG	amod	O
molecules	NNS	nmod	O
.	.	punct	O

Additionally	RB	advmod	O
,	,	punct	O
cediranib	NN	nsubj	B-Simple_chemical
blocked	VBD	ROOT	O
VEGF	NNP	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C156S	NN	nmod:npmod	I-Gene_or_gene_product0
-	:	punct	O
induced	VBN	amod	O
and	CC	cc	O
VEGF	NNP	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
E	NNP	nmod:npmod	I-Gene_or_gene_product0
-	HYPH	punct	O
induced	VBN	conj	O
proliferation	NN	dobj	O
,	,	punct	O
survival	NN	conj	O
,	,	punct	O
and	CC	cc	O
migration	NN	conj	O
of	IN	case	O
lymphatic	JJ	intj	B-Cell
and	CC	cc	O
blood	NN	compound	B-Cell
vascular	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
cediranib	NN	nsubj	B-Simple_chemical
(	-LRB-	punct	O
6	CD	nummod	O
mg	NN	nummod	O
/	:	punct	O
kg	NN	compound	O
/	:	punct	O
d	NN	appos	O
)	-RRB-	punct	O
prevented	VBD	ROOT	O
angiogenesis	NN	dobj	O
and	CC	cc	O
lymphangiogenesis	NN	conj	O
induced	VBN	acl	O
by	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
E	NNP	dep	I-Gene_or_gene_product0
-	HYPH	punct	O
expressing	VBG	nmod	O
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C156S	NN	compound	I-Gene_or_gene_product0
-	HYPH	punct	O
expressing	VBG	conj	O
adenoviruses	NNS	dep	B-Organism
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Cediranib	NN	nsubj	B-Simple_chemical
(	-LRB-	punct	O
6	CD	nummod	O
mg	NN	compound	O
/	:	punct	O
kg	NN	compound	O
/	:	punct	O
day	NN	appos	O
)	-RRB-	punct	O
also	RB	advmod	O
blocked	VBD	ROOT	O
angiogenesis	NN	dobj	O
and	CC	cc	O
lymphangiogenesis	NN	conj	O
induced	VBN	acl	O
by	IN	case	O
adenoviruses	NNS	nmod	B-Organism
expressing	VBG	acl	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
A	NNP	dobj	I-Gene_or_gene_product0
or	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C	NN	conj	I-Gene_or_gene_product0
and	CC	cc	O
compromised	VBD	conj	O
the	DT	det	O
blood	NN	preconj	B-Organism_substance
and	CC	cc	O
lymphatic	JJ	conj	B-Multi-tissue_structure
vasculatures	NNS	dobj	I-Multi-tissue_structure
of	IN	case	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C	NNP	intj	I-Gene_or_gene_product0
-	HYPH	punct	O
expressing	VBG	amod	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Cediranib	NN	nsubj	B-Simple_chemical
may	MD	aux	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
be	VB	cop	O
an	DT	det	O
effective	JJ	amod	O
means	NNS	ROOT	O
of	IN	mark	O
preventing	VBG	advcl	O
tumor	NN	compound	B-Cancer
progression	NN	dobj	O
,	,	punct	O
not	RB	neg	O
only	RB	cc:preconj	O
by	IN	mark	O
inhibiting	VBG	advcl	O
VEGFR	NN	compound	B-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
2	CD	nummod	I-Gene_or_gene_product0
activity	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
by	IN	mark	O
concomitantly	RB	advmod	O
inhibiting	VBG	conj	O
VEGFR	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
3	CD	nummod	I-Gene_or_gene_product0
activity	NN	dobj	O
and	CC	cc	O
lymphangiogenesis	NN	conj	O
.	.	punct	O

Artemisinin	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
lymphangiogenesis	NN	dobj	O
by	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
C	NN	nmod	I-Gene_or_gene_product0
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
reported	VBN	ROOT	O
that	IN	mark	O
dihydroartemisinin	NN	nsubjpass	B-Simple_chemical
is	VBZ	auxpass	O
found	VBN	ccomp	O
to	TO	mark	O
have	VB	xcomp	O
a	DT	det	O
potent	JJ	amod	O
ability	NN	dobj	O
in	IN	mark	O
influencing	VBG	acl	O
lymphatic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
and	CC	cc	O
tube	NN	compound	B-Tissue
formation	NN	conj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
artemisinin	NN	nmod	B-Simple_chemical
on	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
,	,	punct	O
lymphangiogenesis	NN	conj	O
,	,	punct	O
metastasis	NN	conj	O
and	CC	cc	O
survival	NN	conj	O
in	IN	case	O
mouse	NN	compound	B-Organism
Lewis	NN	compound	B-Cancer
lung	NN	compound	I-Cancer
carcinoma	NN	compound	I-Cancer
(	-LRB-	punct	O
LLC	NN	appos	B-Cancer
)	-RRB-	punct	O
models	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
orally	RB	advmod	B-Organism_subdivision
administered	VBN	amod	O
artemisinin	NN	nsubj	B-Simple_chemical
inhibited	VBD	ccomp	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	dobj	I-Multi-tissue_structure
and	CC	cc	O
lung	NN	compound	B-Organ
metastasis	NN	conj	O
and	CC	cc	O
prolonged	JJ	amod	O
survival	NN	conj	O
without	IN	mark	O
retarding	VBG	advcl	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
the	DT	det	O
decrease	NN	nmod	O
in	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
,	,	punct	O
tumor	NN	compound	B-Cancer
lymphangiogenesis	NN	nsubjpass	O
and	CC	cc	O
expression	NN	conj	O
of	IN	prep	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
C	NN	intj	I-Gene_or_gene_product0
(	-LRB-	punct	O
VEGF	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
C	NN	appos	I-Gene_or_gene_product3
)	-RRB-	punct	O
was	VBD	auxpass	O
significantly	RB	advmod	O
decreased	VBN	ROOT	O
in	IN	case	O
artemisinin	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
mice	NNS	nmod	B-Organism
,	,	punct	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
control	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
IL	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
1beta	NN	nsubj	I-Gene_or_gene_product2
-	:	punct	O
induced	VBN	amod	O
p38	NN	compound	B-Gene_or_gene_product1
mitogen	NN	nmod:npmod	I-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
activated	VBN	amod	I-Gene_or_gene_product1
protein	NN	compound	I-Gene_or_gene_product1
kinase	NN	compound	I-Gene_or_gene_product1
(	-LRB-	punct	O
MAPK	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
activation	NN	nsubjpass	O
and	CC	cc	O
upregulation	NN	conj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C	NN	compound	I-Gene_or_gene_product0
mRNA	NN	nmod	O
and	CC	cc	O
protein	NN	conj	O
in	IN	case	O
LLC	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
was	VBD	auxpass	O
also	RB	advmod	O
suppressed	VBN	ROOT	O
by	IN	case	O
artemisinin	NN	nmod	B-Simple_chemical
or	CC	cc	O
by	IN	case	O
the	DT	det	O
p38	NN	compound	B-Gene_or_gene_product1
MAPK	NN	compound	I-Gene_or_gene_product1
inhibitor	NN	compound	O
SB	NN	conj	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
203580	CD	nummod	I-Simple_chemical
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
p38	NN	compound	B-Gene_or_gene_product1
MAPK	NN	nsubj	I-Gene_or_gene_product1
could	MD	aux	O
serve	VB	ccomp	O
as	IN	case	O
a	DT	det	O
mediator	NN	nmod	O
of	IN	case	O
proinflammatory	JJ	amod	O
cytokine	NN	nmod:npmod	O
-	HYPH	punct	O
induced	VBN	amod	O
VEGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
C	NN	compound	I-Gene_or_gene_product0
expression	NN	nmod	O
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
artemisinin	NN	nsubj	B-Simple_chemical
may	MD	aux	O
be	VB	cop	O
useful	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
prevention	NN	nmod	O
of	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
by	IN	mark	O
downregulating	VBG	advcl	O
VEGF	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
C	NN	dobj	I-Gene_or_gene_product1
and	CC	cc	O
reducing	VBG	conj	O
tumor	NN	compound	B-Cancer
lymphangiogenesis	NN	dobj	O
.	.	punct	O

Bevacizumab	NN	ROOT	B-Simple_chemical
and	CC	cc	O
irinotecan	JJ	conj	B-Simple_chemical
therapy	NN	dep	O
in	IN	case	O
glioblastoma	NN	compound	B-Cancer
multiforme	NN	nmod	I-Cancer
:	:	punct	O
a	DT	det	O
series	NN	dep	O
of	IN	case	O
13	CD	nummod	O
cases	NNS	nmod	O
.	.	punct	O

OBJECT	NN	dep	O
:	:	punct	O
Endothelial	JJ	amod	B-Cell
proliferation	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
recognized	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
marker	NN	nmod	O
of	IN	case	O
high	JJ	amod	O
-	HYPH	punct	O
grade	NN	nmod	O
or	CC	cc	O
aggressive	JJ	amod	O
glioma	NN	conj	B-Cancer
.	.	punct	O

Bevacizumab	NNP	nsubj	B-Simple_chemical
is	VBZ	ROOT	O
a	DT	det	O
humanized	JJ	amod	O
immunoglobulin	NN	compound	B-Gene_or_gene_product3
G1	NN	compound	I-Gene_or_gene_product3
monoclonal	JJ	amod	B-Gene_or_gene_product0
antibody	NN	attr	I-Gene_or_gene_product0
to	TO	case	I-Gene_or_gene_product0
vascular	JJ	amod	I-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	nmod	I-Gene_or_gene_product0
that	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	acl:relcl	O
to	TO	mark	O
have	VB	xcomp	O
activity	NN	dobj	O
in	IN	case	O
malignant	JJ	amod	B-Cancer
gliomas	NNS	nmod	I-Cancer
when	WRB	advmod	O
combined	VBN	advcl	O
with	IN	prep	O
irinotecan	NN	pobj	B-Simple_chemical
.	.	punct	O

The	DT	det	O
authors	NNS	nsubj	O
report	VBP	ROOT	O
on	IN	case	O
a	DT	det	O
case	NN	compound	O
series	NN	nmod	O
of	IN	case	O
13	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
recurrent	JJ	amod	O
heavily	RB	advmod	O
pretreated	JJ	amod	O
malignant	JJ	amod	B-Cancer
glioma	NN	nmod	I-Cancer
that	WDT	nsubjpass	O
was	VBD	auxpass	O
treated	VBN	acl:relcl	O
with	IN	case	O
the	DT	det	O
combination	NN	nmod	O
of	IN	prep	O
bevacizumab	NN	pobj	B-Simple_chemical
and	CC	cc	O
irinotecan	NN	conj	B-Simple_chemical
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Standard	NN	amod	O
therapy	NN	nsubj	O
with	IN	case	O
primary	JJ	amod	O
resection	NN	nmod	O
followed	VBN	acl	O
by	IN	case	O
adjuvant	JJ	amod	O
chemotherapy	NN	nmod	O
and	CC	cc	O
radiation	NN	conj	O
had	VBD	aux	O
failed	VBN	appos	O
in	IN	case	O
all	DT	det	O
patients	NNS	nmod	B-Organism
.	.	punct	O

The	DT	det	O
median	JJ	amod	O
number	NN	nsubj	O
of	IN	case	O
therapies	NNS	nmod	O
applied	VBN	acl	O
,	,	punct	O
including	VBG	case	O
initial	JJ	amod	O
surgery	NN	nmod	O
,	,	punct	O
was	VBD	cop	O
5	CD	nummod	O
(	-LRB-	punct	O
range	NN	dep	O
3	CD	compound	O
-	SYM	punct	O
7	CD	nummod	O
therapies	NNS	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Nine	NN	compound	O
patients	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
started	VBN	ROOT	O
on	IN	case	O
bevacizumab	NN	nmod	B-Simple_chemical
at	IN	case	O
a	DT	det	O
dose	NN	nmod	O
of	IN	case	O
5	CD	nummod	O
mg	NN	nmod	O
/	:	punct	O
m2	NN	appos	O
every	DT	det	O
2	CD	nummod	O
weeks	NNS	dep	O
.	.	punct	O

Four	CD	nummod	O
patients	NNS	nsubj	B-Organism
received	VBD	ROOT	O
bevacizumab	NN	dobj	B-Simple_chemical
at	IN	case	O
a	DT	det	O
dose	NN	nmod	O
of	IN	case	O
10	CD	nummod	O
mg	NN	nmod	O
/	:	punct	O
m2	NN	appos	O
;	:	punct	O
irinotecan	NN	nsubjpass	B-Simple_chemical
was	VBD	auxpass	O
given	VBN	parataxis	O
at	IN	case	O
a	DT	det	O
dose	NN	nmod	O
of	IN	case	O
125	CD	nummod	O
mg	NN	nmod	O
/	:	punct	O
m2	NN	nmod	O
every	DT	det	O
week	NN	npadvmod	O
for	IN	prep	O
3	CD	nummod	O
weeks	NNS	pobj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Of	IN	case	O
the	DT	det	O
13	CD	nummod	O
treated	JJ	amod	O
patients	NNS	nmod	B-Organism
,	,	punct	O
10	CD	appos	O
(	-LRB-	punct	O
77	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
had	VBD	dep	O
a	DT	det	O
radiologically	RB	advmod	O
demonstrated	VBN	amod	O
partial	JJ	amod	O
response	NN	dobj	O
and	CC	cc	O
3	CD	conj	O
(	-LRB-	punct	O
23	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
had	VBD	conj	O
stable	JJ	amod	O
disease	NN	dobj	O
.	.	punct	O

Six	CD	nummod	O
patients	NNS	nsubj	B-Organism
(	-LRB-	punct	O
46	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
had	VBD	ROOT	O
a	DT	det	O
clinical	JJ	amod	O
response	NN	dobj	O
.	.	punct	O

The	DT	det	O
median	JJ	amod	O
time	NN	ROOT	O
to	TO	case	O
disease	NN	compound	O
progression	NN	nmod	O
while	IN	mark	O
on	IN	case	O
treatment	NN	nmod	O
was	VBD	cop	O
24	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

The	DT	det	O
median	JJ	amod	O
overall	JJ	amod	O
survival	NN	nsubj	O
was	VBD	ROOT	O
27	CD	nummod	O
weeks	NNS	attr	O
.	.	punct	O

The	DT	det	O
disease	NN	ROOT	O
progressed	VBN	acl	O
in	IN	case	O
8	CD	nummod	O
patients	NNS	nmod	B-Organism
,	,	punct	O
despite	IN	case	O
an	DT	det	O
initial	JJ	amod	O
response	NN	nmod	O
.	.	punct	O

Five	CD	nummod	O
patients	NNS	nsubj	B-Organism
are	VBP	aux	O
still	RB	advmod	O
responding	VBG	ROOT	O
to	TO	case	O
therapy	NN	nmod	O
.	.	punct	O

Six	CD	ROOT	O
of	IN	case	O
the	DT	det	O
8	CD	nummod	O
patients	NNS	nmod	B-Organism
whose	WP$	nmod:poss	O
disease	NN	nsubj	O
progressed	VBN	acl	O
have	VBP	aux	O
died	VBN	acl:relcl	O
.	.	punct	O

Bevacizumab	NN	nsubjpass	B-Simple_chemical
was	VBD	auxpass	O
discontinued	VBN	ROOT	O
in	IN	case	O
2	CD	nummod	O
patients	NNS	nmod	B-Organism
because	IN	case	O
of	IN	mwe	O
nonfatal	JJ	amod	O
intracranial	JJ	amod	B-Immaterial_anatomical_entity
bleeding	NN	advcl	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
combination	NN	nsubj	O
of	IN	prep	O
bevacizumab	NN	pobj	B-Simple_chemical
and	CC	cc	O
irinotecan	NN	conj	B-Simple_chemical
is	VBZ	appos	O
safe	JJ	acomp	O
and	CC	cc	O
has	VBZ	conj	O
excellent	JJ	amod	O
activity	NN	dobj	O
even	RB	advmod	O
in	IN	case	O
this	DT	det	O
relapsed	NN	amod	O
,	,	punct	O
heavily	RB	advmod	O
pretreated	JJ	amod	O
population	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
high	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
malignant	JJ	amod	B-Cancer
glioma	NN	nmod	I-Cancer
,	,	punct	O
most	JJS	nsubj	O
of	IN	prep	O
whom	WP	pobj	O
would	MD	aux	O
not	RB	neg	O
be	VB	cop	O
candidates	NNS	conj	O
for	IN	case	O
clinical	JJ	amod	O
trials	NNS	nmod	O
.	.	punct	O

Endosialin	NN	compound	B-Gene_or_gene_product2
/	:	punct	O
TEM	NN	appos	B-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
/	:	punct	O
CD248	NN	nsubj	B-Gene_or_gene_product1
is	VBZ	cop	O
a	DT	det	O
pericyte	JJ	compound	B-Cell
marker	NN	ROOT	O
of	IN	case	O
embryonic	JJ	nmod	B-Developing_anatomical_structure
and	CC	cc	O
tumor	NN	conj	B-Cancer
neovascularization	NN	dep	O
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
functional	JJ	amod	O
,	,	punct	O
mature	JJ	dep	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
depends	VBZ	ROOT	O
on	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
between	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
pericytes	NNS	conj	B-Cell
.	.	punct	O

Commonality	NN	nsubj	O
exists	VBZ	ROOT	O
in	IN	prep	O
the	DT	det	O
processes	NNS	pobj	O
involved	VBN	acl	O
in	IN	case	O
vasculature	NN	compound	B-Multi-tissue_structure
development	NN	nmod	O
between	IN	case	O
tissues	NNS	nmod	B-Tissue
whether	IN	mark	O
healthy	JJ	dep	O
or	CC	cc	O
diseased	VBD	conj	O
.	.	punct	O

Endosialin	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
TEM	NN	nsubj	B-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
is	VBZ	cop	O
a	DT	det	O
cell	NN	compound	B-Cellular_component
membrane	NN	compound	I-Cellular_component
protein	NN	ROOT	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
expressed	VBN	acl:relcl	O
in	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
during	IN	case	O
embryogenesis	NN	nmod	O
and	CC	cc	O
tumorigenesis	NN	conj	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
normal	JJ	amod	O
mature	JJ	amod	B-Multi-tissue_structure
vessels	NNS	conj	I-Multi-tissue_structure
.	.	punct	O

Antibodies	NNS	nsubj	O
developed	VBD	ROOT	O
to	TO	case	O
human	JJ	amod	B-Organism
endosialin	NN	nmod	B-Gene_or_gene_product0
were	VBD	auxpass	O
used	VBN	ccomp	O
to	TO	mark	O
investigate	VB	xcomp	O
endosialin	NN	compound	B-Gene_or_gene_product0
expression	NN	dobj	O
and	CC	cc	O
function	NN	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
prenatal	JJ	amod	B-Cell
brain	NN	compound	I-Cell
pericytes	NNS	nmod	I-Cell
and	CC	cc	O
pericytes	NNS	conj	B-Cell
residing	VBG	acl	O
in	IN	prep	O
tumors	NNS	pobj	B-Cancer
.	.	punct	O

Anti	NNP	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
endosialin	NN	nsubj	I-Gene_or_gene_product2
was	VBD	cop	O
capable	JJ	ROOT	O
of	IN	mark	O
preventing	VBG	advcl	O
pericyte	NN	compound	B-Cell
tube	NN	compound	B-Tissue
formation	NN	dobj	O
in	IN	case	O
culture	NN	nmod	B-Cell
and	CC	cc	O
inhibited	VBD	conj	O
migration	NN	dobj	O
.	.	punct	O

Brain	NN	compound	B-Cell
pericytes	NNS	nsubj	I-Cell
in	IN	case	O
culture	NN	nmod	O
had	VBD	ROOT	O
higher	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
endosialin	NN	nmod	B-Gene_or_gene_product2
/	:	punct	O
TEM	NN	appos	B-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
than	IN	case	O
TEMs	NNS	nmod	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
,	,	punct	O
-	SYM	punct	B-Gene_or_gene_product2
3	CD	dep	I-Gene_or_gene_product2
,	,	punct	O
-	SYM	punct	B-Gene_or_gene_product3
4	CD	nummod	I-Gene_or_gene_product3
,	,	punct	O
-	SYM	punct	B-Gene_or_gene_product2
5	CD	conj	I-Gene_or_gene_product2
,	,	punct	O
-	SYM	punct	B-Gene_or_gene_product2
7	CD	conj	I-Gene_or_gene_product2
,	,	punct	O
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product2
8	CD	conj	I-Gene_or_gene_product2
.	.	punct	O

Immunocytochemistry	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
endosialin	NN	nsubj	B-Gene_or_gene_product2
was	VBD	cop	O
present	JJ	ccomp	O
in	IN	case	O
the	DT	det	O
cytoplasmic	JJ	amod	B-Organism_substance
body	NN	nmod	I-Organism_substance
and	CC	cc	O
in	IN	case	O
the	DT	det	O
elongated	VBN	amod	O
extensions	NNS	conj	O
essential	JJ	amod	O
to	TO	case	O
pericyte	NN	compound	B-Cell
function	NN	nmod	O
.	.	punct	O

Transgenic	JJ	amod	O
mice	NNS	nsubj	B-Organism
engineered	VBN	acl	O
to	TO	mark	O
express	VB	xcomp	O
human	JJ	amod	B-Organism
endosialin	NN	dobj	B-Gene_or_gene_product2
bred	VBN	acl	O
on	IN	case	O
an	DT	det	O
immunocompromised	VBN	amod	O
background	NN	nmod	O
allowed	VBD	ROOT	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
tumor	NN	compound	B-Cancer
xenografts	NNS	nmod	I-Cancer
.	.	punct	O

In	IN	case	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cancer
carcinoma	NN	nsubj	I-Cancer
Colo205	NN	dep	I-Cancer
and	CC	cc	O
HT29	NN	conj	B-Cancer
xenografts	NNS	advmod	I-Cancer
grown	VBN	acl	O
in	IN	case	O
human	JJ	amod	B-Organism
endosialin	NN	nmod:npmod	B-Gene_or_gene_product0
-	HYPH	punct	O
transgenic	JJ	amod	O
mice	NNS	nmod	B-Organism
,	,	punct	O
endosialin	NN	compound	B-Gene_or_gene_product0
expression	NN	nsubjpass	O
was	VBD	auxpass	O
largely	RB	advmod	O
confined	VBN	ROOT	O
to	TO	case	O
NG2	NN	nmod:npmod	B-Gene_or_gene_product2
-	HYPH	punct	O
expressing	VBG	amod	O
perivascular	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
not	RB	cc	O
CD31	NN	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
positive	JJ	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

Similar	JJ	amod	O
methods	NNS	nsubj	O
applied	VBN	ROOT	O
to	TO	case	O
human	JJ	amod	B-Organism
ovarian	JJ	amod	B-Cancer
and	CC	cc	O
colon	NN	conj	B-Cancer
tumors	NNS	nmod	I-Cancer
confirmed	VBD	conj	O
endosialin	NN	compound	B-Gene_or_gene_product1
expression	NN	dobj	O
by	IN	case	O
pericytes	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
endosialin	NN	nsubjpass	B-Gene_or_gene_product1
is	VBZ	auxpass	O
strongly	RB	advmod	O
expressed	VBN	ccomp	O
by	IN	case	O
pericytes	NNS	nmod	B-Cell
during	IN	case	O
periods	NNS	nmod	O
of	IN	case	O
active	JJ	amod	O
angiogenesis	NN	nmod	O
during	IN	case	O
embryonic	JJ	nmod	B-Developing_anatomical_structure
and	CC	cc	O
tumor	NN	conj	B-Cancer
development	NN	dep	O
.	.	punct	O

Anti	NNP	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
endosialin	NN	compound	I-Gene_or_gene_product0
antibodies	NNS	nsubj	I-Gene_or_gene_product0
may	MD	aux	O
have	VB	ROOT	O
value	NN	dobj	O
in	IN	mark	O
identifying	VBG	advcl	O
vasculature	NN	dobj	B-Multi-tissue_structure
in	IN	case	O
malignant	JJ	amod	B-Tissue
tissues	NNS	nmod	I-Tissue
.	.	punct	O

With	IN	case	O
the	DT	det	O
appropriate	JJ	amod	O
agent	NN	nsubj	O
,	,	punct	O
targeting	VBG	acl	O
endosialin	NN	dobj	B-Gene_or_gene_product1
may	MD	aux	O
interfere	VB	ROOT	O
with	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
growth	NN	nmod	O
during	IN	case	O
tumor	NN	compound	B-Cancer
development	NN	nmod	O
.	.	punct	O

Efficient	JJ	amod	O
inhibition	NN	ROOT	O
of	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
growth	NN	nmod	O
and	CC	cc	O
prolonged	JJ	amod	O
survival	NN	conj	O
by	IN	case	O
transfection	NN	nmod	O
with	IN	case	O
a	DT	det	O
novel	JJ	amod	O
pro	NN	compound	O
-	HYPH	punct	O
apoptotic	JJ	amod	O
gene	NN	nmod	O
,	,	punct	O
hPNAS	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
4	CD	appos	I-Gene_or_gene_product1
,	,	punct	O
in	IN	case	O
a	DT	det	O
mouse	NN	compound	B-Organism
model	NN	nmod	O
.	.	punct	O

In	FW	compound	O
vivo	FW	advmod	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
results	NNS	ROOT	O
.	.	punct	O

OBJECTIVE	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
transfected	VBD	ROOT	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
and	CC	cc	O
administered	VBN	conj	O
recombinant	JJ	amod	O
plasmid	NN	dobj	O
encoding	VBG	acl	O
hPNAS	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
4	CD	dobj	I-Gene_or_gene_product1
to	TO	mark	O
nude	JJ	xcomp	B-Organism
mice	NNS	dobj	I-Organism
bearing	VBG	acl	O
ovarian	JJ	amod	B-Cancer
cancer	NN	dobj	I-Cancer
,	,	punct	O
aiming	VBG	advcl	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
hPNAS	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
4	CD	nmod	I-Gene_or_gene_product1
against	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
in	FW	compound	O
vitro	FW	advmod	O
and	CC	amod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

METHODS	NNS	dep	O
:	:	punct	O
Ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
SKOV3	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
transfected	VBN	ROOT	O
with	IN	case	O
hPNAS	NN	compound	B-Gene_or_gene_product1
-	SYM	punct	I-Gene_or_gene_product1
4	CD	nummod	I-Gene_or_gene_product1
-	HYPH	punct	O
plasmid	NN	nmod	O
,	,	punct	O
and	CC	cc	O
cell	NN	compound	B-Cell
proliferation	NN	nsubjpass	O
was	VBD	auxpass	O
evaluated	VBN	conj	O
by	IN	case	O
MTT	NN	compound	O
assay	NN	nmod	O
;	:	punct	O
apoptosis	NN	nsubjpass	O
was	VBD	auxpass	O
examined	VBN	parataxis	O
by	IN	case	O
DNA	NN	compound	B-Cellular_component
ladder	NN	nmod	O
,	,	punct	O
Hoechst33258	NN	compound	O
staining	NN	conj	O
and	CC	cc	O
flow	NN	nmod:npmod	O
-	HYPH	punct	O
cytometric	JJ	amod	O
assays	NNS	conj	O
.	.	punct	O

Nude	JJ	compound	B-Organism
mice	NNS	nsubjpass	I-Organism
bearing	VBG	acl	O
ovarian	JJ	amod	B-Cancer
cancers	NNS	dobj	I-Cancer
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
hPNAS	NN	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
4	CD	nummod	I-Gene_or_gene_product2
-	HYPH	punct	O
p	NN	compound	O
/	,	punct	O
liposome	NN	nmod	B-Simple_chemical
.	.	punct	O

Tumor	NN	compound	B-Cancer
growth	NN	nsubjpass	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
and	CC	cc	O
survival	NN	nsubjpass	O
was	VBD	auxpass	O
recorded	VBN	conj	O
.	.	punct	O

TUNEL	NN	compound	O
assay	NN	nsubjpass	O
and	CC	cc	O
microvessel	NN	compound	B-Tissue
density	NN	conj	O
was	VBD	auxpass	O
assessed	VBN	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
apoptosis	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Both	CC	cc:preconj	O
inhibition	NN	nsubjpass	O
of	IN	case	O
proliferation	NN	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
observed	VBN	dep	O
in	IN	case	O
SKOV3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
transfected	VBN	acl	O
with	IN	case	O
hPNAS	NN	compound	B-Gene_or_gene_product1
-	SYM	punct	I-Gene_or_gene_product1
4	CD	nummod	I-Gene_or_gene_product1
-	HYPH	punct	O
p	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

In	IN	case	O
hPNAS	NN	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
4	CD	nummod	I-Gene_or_gene_product2
-	HYPH	punct	O
p	NN	nmod:npmod	O
-	HYPH	punct	O
treated	VBN	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
tumor	NN	compound	B-Cancer
growth	NN	nsubj	O
significantly	RB	advmod	O
decreased	VBD	ROOT	O
,	,	punct	O
while	IN	mark	O
the	DT	det	O
survival	NN	compound	O
time	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
bearing	VBG	amod	O
mice	NNS	nmod	B-Organism
was	VBD	cop	O
prolonged	JJ	advcl	O
compared	VBN	case	O
with	IN	case	O
control	JJ	amod	O
groups	NNS	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

Increased	VBN	amod	O
apoptosis	NN	nsubjpass	O
of	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
decreased	VBD	amod	O
angiogenesis	NN	conj	O
in	IN	case	O
tumor	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
were	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
promising	NN	amod	O
results	NNS	nsubjpass	O
on	IN	case	O
the	DT	det	O
potential	JJ	amod	O
antitumor	JJ	compound	B-Cancer
effects	NNS	nmod	O
of	IN	case	O
hPNAS	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
4	CD	nmod	I-Gene_or_gene_product2
on	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
may	MD	aux	O
be	VB	auxpass	O
explained	VBN	appos	O
,	,	punct	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
by	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
hPNAS	NN	compound	B-Gene_or_gene_product1
-	,	punct	I-Gene_or_gene_product1
4	CD	nsubj	I-Gene_or_gene_product1
has	VBZ	ROOT	O
potential	JJ	dobj	O
as	IN	case	O
a	DT	det	O
new	JJ	amod	O
gene	NN	compound	O
therapy	NN	nmod	O
for	IN	case	O
human	JJ	amod	B-Organism
ovarian	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
properties	NNS	ROOT	O
of	IN	case	O
STX243	NN	nmod	B-Simple_chemical
:	:	punct	O
a	DT	det	O
potent	JJ	amod	O
angiogenesis	NN	compound	O
inhibitor	NN	dep	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
steroidal	NN	amod	O
-	HYPH	punct	O
based	VBN	amod	O
drug	NN	nsubjpass	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
ethyloestradiol	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
3	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
17	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
O	NNP	conj	I-Simple_chemical
,	,	punct	I-Simple_chemical
O	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
bis	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
sulphamate	NN	appos	I-Simple_chemical
(	-LRB-	punct	O
STX243	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
developed	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
potent	JJ	amod	O
antiangiogenic	JJ	amod	O
and	CC	cc	O
antitumour	NN	conj	B-Cancer
compound	NN	nmod	O
.	.	punct	O

The	DT	det	O
objective	NN	nsubj	O
of	IN	case	O
this	DT	det	O
study	NN	nmod	O
was	VBD	ROOT	O
to	TO	mark	O
ascertain	VB	xcomp	O
whether	IN	mark	O
STX243	NN	nsubj	B-Simple_chemical
is	VBZ	cop	O
more	RBR	advmod	O
active	JJ	ccomp	O
in	FW	compound	O
vivo	FW	advmod	O
than	IN	case	O
the	DT	det	O
clinically	RB	advmod	O
relevant	JJ	amod	O
drug	NN	nmod	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methoxyoestradiol	NN	dep	I-Simple_chemical
(	-LRB-	punct	O
2	CD	nummod	B-Simple_chemical
-	:	punct	I-Simple_chemical
MeOE2	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
structurally	RB	advmod	O
similar	JJ	amod	O
compound	NN	conj	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
MeOE2	NN	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
3	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
17	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
O	NNP	appos	I-Simple_chemical
,	,	punct	I-Simple_chemical
O	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
bis	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
sulphamate	NN	appos	I-Simple_chemical
(	-LRB-	punct	O
STX140	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
tumour	NN	compound	B-Cancer
growth	NN	compound	O
inhibition	NN	compound	O
efficacy	NN	nsubjpass	O
,	,	punct	O
antiangiogenic	JJ	amod	O
potential	NN	nsubjpass	O
and	CC	cc	O
pharmacokinetics	NNS	conj	O
of	IN	case	O
STX243	NN	nmod	B-Simple_chemical
were	VBD	auxpass	O
examined	VBN	ROOT	O
using	VBG	xcomp	O
four	CD	nummod	O
in	FW	amod	O
vivo	FW	dep	O
models	NNS	dobj	O
.	.	punct	O

Both	CC	cc:preconj	O
STX243	NN	nsubj	B-Simple_chemical
and	CC	cc	O
STX140	NN	conj	B-Simple_chemical
were	VBD	cop	O
capable	JJ	ROOT	O
of	IN	mark	O
retarding	VBG	advcl	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
MDA	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
MB	NNP	compound	I-Cancer
-	:	punct	I-Cancer
231	CD	nummod	I-Cancer
xenograft	NN	compound	I-Cancer
tumours	NNS	nmod	I-Cancer
(	-LRB-	punct	O
72	CD	nummod	O
and	CC	cc	O
63	CD	conj	O
%	NN	dep	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
no	DT	neg	O
inhibition	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	parataxis	O
for	IN	case	O
animals	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
MeOE2	NN	nmod	I-Simple_chemical
.	.	punct	O

Further	RB	amod	O
tumour	NN	compound	B-Cancer
inhibition	NN	compound	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
STX243	NN	nsubj	B-Simple_chemical
was	VBD	cop	O
also	RB	advmod	O
active	JJ	ccomp	O
against	IN	case	O
MCF	NNP	compound	O
-	HYPH	punct	O
7	CD	nummod	O
paclitaxel	NN	compound	B-Simple_chemical
-	HYPH	punct	O
resistant	JJ	amod	O
tumours	NNS	nmod	O
.	.	punct	O

Using	VBG	advcl	O
a	DT	det	O
Matrigel	NNP	compound	O
plug	NN	npadvmod	O
-	HYPH	punct	O
based	VBN	amod	O
model	NN	dobj	O
,	,	punct	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	nsubj	O
was	VBD	auxpass	O
restricted	JJ	ROOT	O
with	IN	case	O
STX243	NN	nmod	B-Simple_chemical
and	CC	cc	O
STX140	NN	conj	B-Simple_chemical
(	-LRB-	punct	O
50	CD	nummod	O
and	CC	cc	O
72	CD	conj	O
%	NN	dep	O
,	,	punct	O
respectively	RB	advmod	O
,	,	punct	O
using	VBG	xcomp	O
a	DT	det	O
10	CD	compound	O
mg	NN	compound	O
kg	NN	compound	O
(	-LRB-	punct	O
-	SYM	punct	O
1	LS	appos	O
)	-RRB-	punct	O
oral	JJ	amod	O
dose	NN	dobj	O
)	-RRB-	punct	O
,	,	punct	O
thereby	RB	advmod	O
showing	VBG	advcl	O
the	DT	det	O
antiangiogenic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
both	DT	det	O
compounds	NNS	nmod	O
.	.	punct	O

The	DT	det	O
pharmacokinetics	NNS	nsubjpass	O
of	IN	case	O
STX243	NN	nmod	B-Simple_chemical
were	VBD	auxpass	O
examined	VBN	ROOT	O
at	IN	case	O
two	CD	nummod	O
different	JJ	amod	O
doses	NNS	nmod	O
using	VBG	acl	O
adult	JJ	amod	O
female	JJ	amod	O
rats	NNS	dobj	B-Organism
.	.	punct	O

The	DT	det	O
compound	NN	nsubj	O
was	VBD	ROOT	O
orally	RB	advmod	O
bioavailable	JJ	acomp	O
(	-LRB-	punct	O
31	CD	nummod	O
%	NN	npadvmod	O
after	IN	prep	O
a	DT	det	O
single	JJ	amod	O
10	CD	compound	O
mg	NN	compound	O
kg	NN	compound	O
(	-LRB-	punct	O
-	SYM	punct	O
1	LS	nummod	O
)	-RRB-	punct	O
dose	NN	pobj	O
)	-RRB-	punct	O
and	CC	cc	O
resistant	JJ	conj	O
to	TO	case	O
metabolism	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
STX243	NN	nsubj	B-Simple_chemical
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
in	FW	amod	O
vivo	FW	dep	O
drug	NN	ccomp	O
and	CC	cc	O
could	MD	aux	O
be	VB	cop	O
clinically	RB	advmod	O
effective	JJ	conj	O
at	IN	mark	O
treating	VBG	advcl	O
a	DT	det	O
number	NN	dobj	O
of	IN	prep	O
oncological	JJ	amod	O
conditions	NNS	pobj	O
.	.	punct	O

Grape	NN	compound	B-Organism_substance
seed	NN	compound	I-Organism_substance
extract	NN	nsubj	I-Organism_substance
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
via	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
the	DT	det	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
receptor	NN	compound	I-Gene_or_gene_product0
signaling	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

Blockade	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
approach	NN	ROOT	O
for	IN	case	O
cancer	NN	compound	B-Cancer
treatment	NN	nmod	O
and	CC	cc	O
prevention	NN	conj	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	nsubj	I-Gene_or_gene_product0
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
critical	JJ	amod	O
factors	NNS	nmod	O
that	WDT	nsubj	O
induce	VBP	acl:relcl	O
angiogenesis	NN	dobj	O
and	CC	cc	O
has	VBZ	aux	O
thus	RB	advmod	O
become	VBN	conj	O
an	DT	det	O
attractive	JJ	amod	O
target	NN	nsubj	O
for	IN	case	O
antiangiogenesis	NN	compound	O
treatment	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
most	RBS	advmod	O
current	JJ	amod	O
anti	NN	compound	O
-	HYPH	punct	O
VEGF	NNP	compound	B-Gene_or_gene_product1
agents	NNS	nsubj	O
often	RB	advmod	O
cause	VBP	ROOT	O
some	DT	det	O
side	JJ	amod	O
effects	NNS	dobj	O
when	WRB	advmod	O
given	VBN	advcl	O
chronically	RB	advmod	O
.	.	punct	O

Identification	NN	nsubj	O
of	IN	case	O
naturally	RB	advmod	O
occurring	VBG	amod	O
VEGF	NN	compound	B-Gene_or_gene_product1
inhibitors	NNS	nmod	O
derived	VBN	acl	O
from	IN	case	O
diet	NN	nmod	O
would	MD	aux	O
be	VB	cop	O
one	CD	nummod	O
alternative	JJ	amod	O
approach	NN	ROOT	O
with	IN	case	O
an	DT	det	O
advantage	NN	nmod	O
of	IN	case	O
known	JJ	amod	O
safety	NN	nmod	O
.	.	punct	O

Grape	NN	compound	B-Organism_substance
seed	NN	compound	I-Organism_substance
extract	NN	nsubjpass	I-Organism_substance
(	-LRB-	punct	O
GSE	NN	appos	B-Organism_substance
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
widely	RB	advmod	O
used	VBN	amod	O
dietary	JJ	amod	O
supplement	NN	appos	O
,	,	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
antitumor	NN	compound	B-Cancer
activity	NN	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
explored	VBN	ROOT	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
GSE	NN	nmod	B-Organism_substance
on	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product0
receptor	NN	nmod	I-Gene_or_gene_product0
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
GSE	NN	nsubj	B-Organism_substance
could	MD	aux	O
directly	RB	advmod	O
inhibit	VB	ccomp	O
the	DT	det	O
kinase	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
purified	VBN	amod	O
VEGF	NN	compound	B-Gene_or_gene_product0
receptor	NN	nmod	I-Gene_or_gene_product0
2	CD	nummod	I-Gene_or_gene_product0
,	,	punct	O
a	DT	det	O
novel	JJ	amod	O
activity	NN	appos	O
of	IN	case	O
GSE	NN	nmod	B-Organism_substance
that	WDT	nsubjpass	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
characterized	VBN	acl:relcl	O
.	.	punct	O

GSE	NN	nsubj	B-Organism_substance
could	MD	aux	O
also	RB	advmod	O
inhibit	VB	ROOT	O
the	DT	det	O
VEGF	NN	compound	B-Gene_or_gene_product0
receptor	NN	compound	I-Gene_or_gene_product0
/	:	punct	O
mitogen	NN	nmod:npmod	B-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
activated	VBN	amod	I-Gene_or_gene_product0
protein	NN	compound	I-Gene_or_gene_product0
kinase	NN	nmod:npmod	I-Gene_or_gene_product0
-	HYPH	punct	O
mediated	VBN	amod	O
signaling	NN	compound	O
pathway	NN	dobj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

As	IN	case	O
a	DT	det	O
result	NN	nmod	O
,	,	punct	O
GSE	NN	nsubj	B-Organism_substance
could	MD	aux	O
inhibit	VB	ROOT	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
induced	VBN	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
sprout	NN	compound	B-Tissue
formation	NN	conj	O
from	IN	case	O
aorta	NN	compound	B-Multi-tissue_structure
ring	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
assay	NN	nsubj	O
further	RB	advmod	O
showed	VBD	ROOT	O
that	IN	mark	O
GSE	NN	nsubj	B-Organism_substance
could	MD	aux	O
inhibit	VB	ccomp	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	conj	O
of	IN	case	O
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	compound	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
the	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
data	NNS	nmod	O
,	,	punct	O
GSE	NN	compound	B-Organism_substance
treatment	NN	nsubj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
bearing	VBG	amod	O
mice	NNS	nmod	B-Organism
led	VBD	ROOT	O
to	TO	case	O
concomitant	JJ	amod	O
reduction	NN	nmod	O
of	IN	case	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
density	NN	nmod	O
and	CC	cc	O
phosphorylation	NN	conj	O
of	IN	case	O
mitogen	NN	nmod:npmod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
activated	VBN	amod	I-Gene_or_gene_product2
protein	NN	compound	I-Gene_or_gene_product2
kinase	NN	nmod	I-Gene_or_gene_product2
.	.	punct	O

Depletion	NN	nsubj	O
of	IN	case	O
polyphenol	NN	nmod	B-Simple_chemical
with	IN	case	O
polyvinylpyrrolidone	NN	nmod	B-Simple_chemical
abolished	VBD	ROOT	O
the	DT	det	O
antiangiogenic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
GSE	NN	nmod	B-Organism_substance
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
water	NN	nmod:npmod	O
-	HYPH	punct	O
soluble	JJ	amod	O
fraction	NN	nsubj	O
of	IN	case	O
polyphenol	NN	nmod	B-Simple_chemical
in	IN	case	O
GSE	NN	nmod	B-Organism_substance
is	VBZ	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
antiangiogenic	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
this	DT	det	O
study	NN	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
GSE	NN	nsubj	B-Organism_substance
is	VBZ	cop	O
a	DT	det	O
well	RB	advmod	O
-	HYPH	punct	O
tolerated	VBN	amod	O
and	CC	cc	O
inexpensive	JJ	conj	O
natural	JJ	amod	O
VEGF	NN	compound	B-Gene_or_gene_product1
inhibitor	NN	ccomp	O
and	CC	cc	O
could	MD	aux	O
potentially	RB	advmod	O
be	VB	cop	O
useful	JJ	conj	O
in	IN	case	O
cancer	NN	compound	B-Cancer
prevention	NN	nmod	O
or	CC	cc	O
treatment	NN	conj	O
.	.	punct	O

Role	NN	ROOT	O
of	IN	case	O
the	DT	det	O
interferon	NN	nmod:npmod	B-Gene_or_gene_product0
-	HYPH	punct	O
inducible	JJ	amod	O
IFI16	NN	compound	B-Gene_or_gene_product1
gene	NN	nmod	O
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
ICAM	NN	nmod	B-Gene_or_gene_product3
-	,	punct	I-Gene_or_gene_product3
1	CD	dep	I-Gene_or_gene_product3
by	IN	case	O
TNF	NN	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
alpha	NN	nmod	I-Gene_or_gene_product3
.	.	punct	O

The	DT	det	O
Interferon	NN	nmod:npmod	B-Gene_or_gene_product0
-	HYPH	punct	O
inducible	JJ	amod	O
gene	NN	compound	O
IFI16	NN	nsubjpass	B-Gene_or_gene_product1
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
HIN200	NN	compound	B-Gene_or_gene_product2
family	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
oxidative	JJ	amod	O
stress	NN	nmod	O
and	CC	cc	O
cell	NN	compound	B-Cell
density	NN	conj	O
,	,	punct	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
Interferons	NNS	nmod	B-Gene_or_gene_product0
,	,	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
implicated	VBN	conj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
and	CC	cc	O
vessel	NN	compound	B-Multi-tissue_structure
formation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
shown	VBN	ROOT	O
that	IN	mark	O
IFI16	NN	nsubjpass	B-Gene_or_gene_product1
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
proinflammatory	JJ	amod	O
gene	NN	compound	O
stimulation	NN	nmod	O
by	IN	case	O
IFN	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
gamma	NN	nmod	I-Gene_or_gene_product2
through	IN	case	O
the	DT	det	O
NF	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
kappaB	NN	compound	I-Gene_or_gene_product2
complex	NN	nmod	O
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
whether	IN	mark	O
IFI16	NN	compound	B-Gene_or_gene_product1
induction	NN	nsubjpass	O
might	MD	aux	O
be	VB	auxpass	O
extended	VBN	ccomp	O
to	TO	case	O
other	JJ	amod	O
proinflammatory	JJ	amod	O
cytokines	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
tumor	NN	compound	B-Gene_or_gene_product0
necrosis	NN	compound	I-Gene_or_gene_product0
factor	NN	dep	I-Gene_or_gene_product0
(	-LRB-	punct	I-Gene_or_gene_product0
TNF	NN	compound	I-Gene_or_gene_product0
)	-RRB-	punct	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
alpha	NN	nmod	I-Gene_or_gene_product0
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
the	DT	det	O
strategy	NN	dobj	O
of	IN	case	O
the	DT	det	O
RNA	NN	compound	O
interference	NN	nmod	O
to	TO	mark	O
knock	VB	advcl	O
down	RP	prt	O
IFI16	NN	compound	B-Gene_or_gene_product0
expression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
analyze	VB	conj	O
the	DT	det	O
capability	NN	dobj	O
of	IN	case	O
TNF	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
alpha	NN	nmod	I-Gene_or_gene_product3
to	TO	mark	O
stimulate	VB	acl	O
intercellular	JJ	amod	B-Gene_or_gene_product3
adhesion	NN	compound	I-Gene_or_gene_product3
molecule	NN	compound	I-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
(	-LRB-	punct	O
ICAM	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
or	CC	cc	O
CD54	NN	conj	B-Gene_or_gene_product1
)	-RRB-	punct	O
expression	NN	dobj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
functional	JJ	amod	O
IFI16	NN	nmod	B-Gene_or_gene_product0
.	.	punct	O

Our	PRP$	nmod:poss	O
studies	NNS	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
IFI16	NN	nsubj	B-Gene_or_gene_product1
mediates	VBZ	ccomp	O
ICAM	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
stimulation	NN	dobj	O
by	IN	case	O
TNF	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
alpha	NN	nmod	I-Gene_or_gene_product3
through	IN	case	O
the	DT	det	O
NF	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
kappaB	NN	compound	I-Gene_or_gene_product2
pathway	NN	nmod	O
,	,	punct	O
thus	RB	advmod	O
reinforcing	VBG	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
IFI16	NN	compound	B-Gene_or_gene_product1
molecule	NN	nmod	O
in	IN	case	O
the	DT	det	O
inflammation	NN	compound	O
process	NN	nmod	O
.	.	punct	O

Impact	NN	ROOT	O
of	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
VEGF	NN	compound	B-Gene_or_gene_product1
expression	NN	nmod	O
on	IN	case	O
the	DT	det	O
in	FW	amod	O
vivo	FW	dep	O
efficacy	NN	nmod	O
of	IN	case	O
vandetanib	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
ZACTIMA	NN	appos	B-Simple_chemical
;	:	punct	O
ZD6474	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

VEGF	NNP	nsubj	B-Gene_or_gene_product1
is	VBZ	cop	O
the	DT	det	O
key	JJ	amod	O
player	NN	ROOT	O
in	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
the	DT	det	O
impact	NN	nsubjpass	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product1
expression	NN	nmod	O
on	IN	case	O
the	DT	det	O
response	NN	nmod	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
to	TO	case	O
the	DT	det	O
VEGFR2	NN	compound	B-Gene_or_gene_product0
associated	JJ	amod	O
tyrosine	NN	compound	O
kinase	NN	compound	O
inhibitor	NN	compound	O
vandetanib	NN	nmod	B-Simple_chemical
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
.	.	punct	O

MATERIALS	NNS	nsubjpass	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Human	JJ	amod	B-Organism
colon	NN	compound	B-Cancer
carcinoma	NN	nsubjpass	I-Cancer
(	-LRB-	punct	O
HT29	NN	appos	B-Cell
)	-RRB-	punct	O
and	CC	cc	O
murine	JJ	amod	B-Organism
squamous	JJ	amod	B-Cancer
carcinoma	NN	compound	I-Cancer
(	-LRB-	punct	O
SCCVII	NN	compound	B-Cell
)	-RRB-	punct	O
clonal	JJ	amod	O
cell	NN	compound	B-Cell
lines	NNS	conj	I-Cell
expressing	VBG	acl	O
varying	VBG	amod	O
levels	NNS	dobj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product1
were	VBD	auxpass	O
established	VBN	dep	O
and	CC	cc	O
their	PRP$	nmod:poss	O
response	NN	conj	O
to	TO	case	O
vandetanib	NN	nmod	B-Simple_chemical
was	VBD	auxpass	O
assessed	VBN	ROOT	O
in	IN	case	O
tissue	NN	compound	B-Tissue
culture	NN	nmod	O
and	CC	cc	O
as	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	conj	I-Cancer
.	.	punct	O

RESULTS	NNS	nsubj	O
:	:	punct	O
Vandetanib	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
clonogenic	JJ	amod	O
cell	NN	compound	B-Cell
survival	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
but	CC	cc	O
doses	NNS	conj	O
>	NN	dobj	O
or	CC	cc	O
=	JJ	conj	O
10	CD	nummod	O
nM	NN	dobj	O
significantly	RB	advmod	O
reduced	VBD	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
.	.	punct	O

In	FW	compound	O
vivo	FW	advmod	O
,	,	punct	O
tumors	NNS	nsubj	B-Cancer
derived	VBN	acl	O
from	IN	case	O
cell	NN	compound	B-Cell
clones	NNS	nmod	I-Cell
expressing	VBG	acl	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product1
displayed	VBD	ROOT	O
significantly	RB	advmod	O
enhanced	VBN	amod	O
angiogenesis	NN	dobj	O
and	CC	cc	O
more	RBR	advmod	O
aggressive	JJ	amod	O
growth	NN	conj	O
.	.	punct	O

An	DT	det	O
intradermal	JJ	amod	B-Multi-tissue_structure
angiogenesis	NN	compound	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
demonstrate	VB	xcomp	O
that	IN	mark	O
a	DT	det	O
4	CD	nummod	O
-	HYPH	punct	O
day	NN	compound	O
treatment	NN	nsubj	O
with	IN	case	O
vandetanib	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
50	CD	compound	O
mg	NN	dep	O
/	:	punct	O
kg	NN	compound	O
/	:	punct	O
day	NN	appos	O
)	-RRB-	punct	O
was	VBD	cop	O
able	JJ	ccomp	O
to	TO	mark	O
significantly	RB	advmod	O
inhibit	VB	xcomp	O
blood	NN	compound	B-Multi-tissue_structure
vessel	NN	compound	I-Multi-tissue_structure
growth	NN	dobj	O
induced	VBN	acl	O
by	IN	case	O
both	CC	cc:preconj	O
parental	JJ	amod	O
and	CC	cc	O
high	JJ	conj	O
VEGF	NNP	conj	B-Gene_or_gene_product1
-	HYPH	punct	O
expressing	VBG	dep	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
clones	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
the	DT	det	O
HT29	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
model	NN	nmod	O
,	,	punct	O
treatment	NN	compound	O
response	NN	nsubjpass	O
to	TO	case	O
vandetanib	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
50	CD	compound	O
mg	NN	dep	O
/	:	punct	O
kg	NN	nmod	O
/	:	punct	O
day	NN	dobj	O
,	,	punct	O
Monday	NNP	compound	O
-	HYPH	punct	O
Friday	NNP	appos	O
for	IN	prep	O
2	CD	nummod	O
weeks	NNS	pobj	O
)	-RRB-	punct	O
was	VBD	auxpass	O
greatest	JJS	ROOT	O
in	IN	case	O
xenografts	NNS	nmod	B-Cancer
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
highest	JJS	amod	O
VEGF	NNP	dep	B-Gene_or_gene_product1
-	HYPH	punct	O
expressing	VBG	amod	O
cell	NN	compound	B-Cell
clones	NNS	nmod	I-Cell
.	.	punct	O

A	DT	det	O
similar	JJ	amod	O
trend	NN	nsubjpass	O
was	VBD	auxpass	O
noted	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
SCCVII	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
model	NN	nmod	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
vandetanib	NN	compound	B-Simple_chemical
therapy	NN	nsubj	O
effectively	RB	advmod	O
counteracted	VBD	ccomp	O
the	DT	det	O
aggressive	JJ	amod	O
feature	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
resulting	VBG	acl	O
from	IN	case	O
VEGF	NNP	nmod	B-Gene_or_gene_product1
over	IN	advmod	O
-	HYPH	punct	O
expressing	VBG	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
such	JJ	amod	O
tumors	NNS	nsubjpass	B-Cancer
may	MD	aux	O
be	VB	auxpass	O
particularly	RB	advmod	O
well	RB	advmod	O
suited	VBN	ccomp	O
for	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
VEGF	NNP	compound	B-Gene_or_gene_product1
interventions	NNS	nmod	O
.	.	punct	O

c	LS	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
Ski	NN	compound	I-Gene_or_gene_product2
overexpression	NN	nsubj	O
promotes	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
through	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
transforming	VBG	amod	B-Gene_or_gene_product2
growth	NN	compound	I-Gene_or_gene_product2
factor	NN	compound	I-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
beta	NN	compound	I-Gene_or_gene_product2
signaling	NN	nmod	O
in	IN	case	O
diffuse	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

c	LS	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
Ski	NNP	nsubj	I-Gene_or_gene_product2
,	,	punct	O
originally	RB	advmod	O
identified	VBN	acl	O
as	IN	prep	O
a	DT	det	O
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	compound	O
product	NN	pobj	O
,	,	punct	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
negative	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
transforming	VBG	amod	B-Gene_or_gene_product2
growth	NN	compound	I-Gene_or_gene_product2
factor	NN	compound	I-Gene_or_gene_product2
(	-LRB-	punct	I-Gene_or_gene_product2
TGF	NN	compound	I-Gene_or_gene_product2
)	-RRB-	punct	I-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
beta	NN	compound	I-Gene_or_gene_product2
family	NN	compound	O
signaling	NN	nmod	O
through	IN	case	O
interaction	NN	nmod	O
with	IN	case	O
Smad2	NN	nmod	B-Gene_or_gene_product2
,	,	punct	O
Smad3	NN	conj	B-Gene_or_gene_product3
,	,	punct	O
and	CC	cc	O
Smad4	NN	conj	B-Gene_or_gene_product1
.	.	punct	O

High	JJ	amod	O
expression	NN	nsubjpass	O
of	IN	prep	O
c	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
Ski	NNP	pobj	I-Gene_or_gene_product2
has	VBZ	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
some	DT	det	O
cancers	NNS	nmod	B-Cancer
,	,	punct	O
including	VBG	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
showed	VBD	ROOT	O
that	IN	mark	O
disruption	NN	nsubj	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
beta	NN	compound	I-Gene_or_gene_product0
signaling	NN	nmod	O
by	IN	case	O
dominant	JJ	amod	O
-	HYPH	punct	O
negative	JJ	amod	O
TGF	NN	compound	B-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
beta	NN	compound	I-Gene_or_gene_product0
type	NN	compound	I-Gene_or_gene_product0
II	CD	nummod	I-Gene_or_gene_product0
receptor	NN	nmod	I-Gene_or_gene_product0
in	IN	case	O
a	DT	det	O
diffuse	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	compound	I-Cancer
model	NN	nmod	O
accelerated	VBD	ccomp	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
through	IN	case	O
induction	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
by	IN	case	O
decreased	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
anti	JJ	compound	O
-	HYPH	punct	O
angiogenic	JJ	dep	O
factor	NN	compound	O
thrombospondin	NN	dep	B-Gene_or_gene_product3
(	-LRB-	punct	I-Gene_or_gene_product3
TSP	NN	appos	I-Gene_or_gene_product3
)	-RRB-	punct	I-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nmod	I-Gene_or_gene_product3
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
function	NN	dobj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
Ski	NN	nmod	I-Gene_or_gene_product2
in	IN	case	O
human	JJ	amod	B-Organism
diffuse	NN	compound	O
-	HYPH	punct	O
type	NN	compound	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	compound	I-Cancer
OCUM	NN	compound	B-Cell
-	:	punct	I-Cell
2MLN	CD	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	prep	O
c	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
Ski	NNP	pobj	I-Gene_or_gene_product2
inhibited	VBD	ROOT	O
TGF	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
beta	NN	compound	I-Gene_or_gene_product2
signaling	NN	dobj	O
in	IN	case	O
OCUM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
2MLN	CD	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Interestingly	RB	advmod	O
,	,	punct	O
c	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
Ski	NN	compound	I-Gene_or_gene_product2
overexpression	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
extensive	JJ	amod	O
acceleration	NN	nmod	O
of	IN	case	O
the	DT	det	O
growth	NN	nmod	O
of	IN	case	O
subcutaneous	JJ	amod	O
xenografts	NNS	nmod	B-Cancer
in	IN	case	O
BALB	NNP	compound	B-Organism
/	:	punct	I-Organism
c	NN	dep	I-Organism
nu	CC	dep	I-Organism
/	SYM	punct	I-Organism
nu	PRP	dep	I-Organism
female	JJ	amod	I-Organism
mice	NNS	nmod	I-Organism
(	-LRB-	punct	O
6	CD	nummod	O
weeks	NNS	dep	O
of	IN	case	O
age	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Similar	JJ	advmod	O
to	TO	case	O
tumors	NNS	nmod	B-Cancer
expressing	VBG	acl	O
dominant	JJ	amod	O
-	HYPH	punct	O
negative	JJ	amod	O
TGF	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
beta	NN	compound	I-Gene_or_gene_product1
type	NN	compound	I-Gene_or_gene_product1
II	CD	nummod	I-Gene_or_gene_product1
receptor	NN	dobj	I-Gene_or_gene_product1
,	,	punct	O
histochemical	JJ	amod	O
studies	NNS	nsubj	O
revealed	VBD	ROOT	O
less	JJR	amod	O
fibrosis	NN	dobj	O
and	CC	cc	O
increased	VBN	amod	O
angiogenesis	NN	conj	O
in	IN	case	O
xenografted	JJ	amod	O
tumors	NNS	nmod	B-Cancer
expressing	VBG	acl	O
c	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
Ski	NN	dobj	I-Gene_or_gene_product2
compared	VBN	case	O
to	TO	case	O
control	JJ	amod	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
TSP	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
mRNA	NN	nmod	O
by	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
beta	NN	nmod	I-Gene_or_gene_product2
was	VBD	auxpass	O
attenuated	VBN	ROOT	O
by	IN	case	O
c	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
Ski	NNP	nmod	I-Gene_or_gene_product2
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
and	CC	cc	O
expression	NN	nsubjpass	O
of	IN	case	O
TSP	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
mRNA	NN	nmod	O
was	VBD	auxpass	O
decreased	VBN	conj	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
expressing	VBG	acl	O
c	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
Ski	NNP	dobj	I-Gene_or_gene_product2
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
c	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
Ski	NN	compound	I-Gene_or_gene_product2
overexpression	NN	nsubj	O
promotes	VBZ	ccomp	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
diffuse	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
through	IN	case	O
induction	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
Down	NN	compound	B-Gene_or_gene_product3
syndrome	NN	compound	I-Gene_or_gene_product3
critical	JJ	amod	I-Gene_or_gene_product3
region	NN	compound	I-Gene_or_gene_product3
gene	NN	compound	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
short	JJ	amod	O
variant	JJ	amod	O
promoters	NNS	nsubj	O
direct	VBP	ROOT	O
vascular	JJ	amod	B-Multi-tissue_structure
bed	NN	nmod:npmod	I-Multi-tissue_structure
-	HYPH	punct	O
specific	JJ	amod	O
gene	NN	compound	O
expression	NN	dobj	O
during	IN	case	O
inflammation	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Down	NN	compound	B-Gene_or_gene_product3
syndrome	NN	compound	I-Gene_or_gene_product3
critical	JJ	amod	I-Gene_or_gene_product3
region	NN	compound	I-Gene_or_gene_product3
gene	NN	nsubj	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
(	-LRB-	punct	O
DSCR	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
)	-RRB-	punct	O
short	JJ	amod	O
variant	NN	dep	O
(	-LRB-	punct	O
DSCR	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
1s	NN	appos	I-Gene_or_gene_product1
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
inhibitor	NN	ROOT	O
of	IN	case	O
calcineurin	NN	compound	B-Gene_or_gene_product0
/	:	punct	O
NFAT	NN	compound	B-Gene_or_gene_product2
signaling	NN	nmod	O
encoded	VBN	acl	O
by	IN	case	O
exons	NNS	nmod	O
4	CD	nummod	O
-	SYM	punct	O
7	CD	dep	O
of	IN	case	O
DSCR1	NN	nmod	B-Gene_or_gene_product3
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
reported	VBD	ROOT	O
that	IN	mark	O
VEGF	NN	nsubj	B-Gene_or_gene_product1
induces	VBZ	ccomp	O
DSCR	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
1s	NN	compound	I-Gene_or_gene_product2
expression	NN	dobj	O
in	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
in	IN	case	O
turn	NN	nmod	O
negatively	RB	advmod	O
feeds	VBZ	acl:relcl	O
back	RB	advmod	O
to	TO	mark	O
attenuate	VB	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
activation	NN	dobj	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
characterize	VB	advcl	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
promoter	NN	nmod	O
that	WDT	nsubj	O
drives	VBZ	acl:relcl	O
DSCR	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
1s	NN	compound	I-Gene_or_gene_product2
expression	NN	dobj	O
in	IN	mark	O
mediating	VBG	advcl	O
inducible	JJ	amod	O
expression	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
and	CC	cc	O
to	TO	mark	O
determine	VB	conj	O
the	DT	det	O
functional	JJ	amod	O
relevance	NN	dobj	O
of	IN	case	O
DSCR	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
1s	NN	nmod	I-Gene_or_gene_product2
in	IN	case	O
inflammation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
targeted	VBD	ROOT	O
a	DT	det	O
DNA	NN	compound	B-Cellular_component
construct	NN	dobj	O
containing	VBG	acl	O
1	CD	dobj	O
.	.	punct	O
7	CD	nummod	O
kb	NN	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-Organism
DSCR1s	NN	compound	B-Gene_or_gene_product2
promoter	NN	nmod	O
coupled	VBN	acl	O
to	TO	case	O
the	DT	det	O
lacZ	NN	compound	B-Gene_or_gene_product2
reporter	NN	nmod	O
to	TO	case	O
the	DT	det	O
hypoxanthine	NN	compound	B-Gene_or_gene_product0
guanine	NN	compound	I-Gene_or_gene_product0
phosphoribosyl	NN	compound	I-Gene_or_gene_product0
transferase	NN	compound	I-Gene_or_gene_product0
(	-LRB-	punct	O
Hprt	NN	compound	B-Gene_or_gene_product1
)	-RRB-	punct	O
locus	NN	nmod	O
of	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

We	PRP	nsubj	O
determined	VBD	ROOT	O
that	IN	mark	O
lacZ	NN	nsubjpass	B-Gene_or_gene_product2
was	VBD	auxpass	O
uniformly	RB	advmod	O
expressed	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
endothelium	NN	nmod	B-Tissue
of	IN	case	O
transgenic	JJ	amod	B-Developing_anatomical_structure
embryos	NNS	nmod	I-Developing_anatomical_structure
but	CC	cc	O
was	VBD	auxpass	O
markedly	RB	advmod	O
downregulated	VBN	conj	O
postnatally	RB	advmod	O
.	.	punct	O

Systemic	JJ	amod	O
administration	NN	nsubj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product1
or	CC	cc	O
LPS	NN	conj	B-Simple_chemical
in	IN	case	O
adult	JJ	amod	O
mice	NNS	nmod	B-Organism
resulted	VBD	ROOT	O
in	IN	case	O
cyclosporine	NN	compound	B-Simple_chemical
A	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
sensitive	JJ	amod	O
reactivation	NN	nmod	O
of	IN	case	O
the	DT	det	O
DSCR1s	NN	compound	B-Gene_or_gene_product2
promoter	NN	nmod	O
and	CC	cc	O
endogenous	JJ	amod	O
gene	NN	compound	O
expression	NN	conj	O
in	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
organs	NNS	nmod	B-Organ
,	,	punct	O
including	VBG	prep	O
the	DT	det	O
heart	NN	pobj	B-Organ
and	CC	cc	O
brain	NN	conj	B-Organ
.	.	punct	O

The	DT	det	O
DSCR1s	NN	compound	B-Gene_or_gene_product2
promoter	NN	nsubjpass	O
was	VBD	auxpass	O
similarly	RB	advmod	O
induced	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
endothelium	NN	nmod	B-Tissue
of	IN	case	O
tumor	NN	compound	B-Cancer
xenografts	NNS	nmod	I-Cancer
.	.	punct	O

In	IN	case	O
a	DT	det	O
mouse	NN	compound	B-Organism
model	NN	nmod	O
of	IN	case	O
endotoxemia	NN	nmod	O
,	,	punct	O
DSCR	NN	nmod:npmod	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
1s	NNP	nmod:npmod	I-Gene_or_gene_product1
-	HYPH	punct	O
deficient	JJ	amod	O
mice	NNS	conj	B-Organism
demonstrated	VBD	ROOT	O
increased	VBN	amod	O
sepsis	NN	compound	O
mortality	NN	dobj	O
,	,	punct	O
whereas	IN	dep	O
adenovirus	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
DSCR	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
1s	NN	compound	I-Gene_or_gene_product1
overexpression	NN	nsubj	O
protected	VBD	advcl	O
against	IN	case	O
LPS	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
lethality	NN	nmod	O
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
these	DT	det	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
DSCR1s	NN	compound	B-Gene_or_gene_product2
promoter	NN	nsubj	O
directs	VBZ	ccomp	O
vascular	JJ	amod	B-Multi-tissue_structure
bed	NN	nmod:npmod	I-Multi-tissue_structure
-	HYPH	punct	O
specific	JJ	amod	O
expression	NN	dobj	O
in	IN	case	O
activated	VBN	amod	O
endothelium	NN	nmod	B-Tissue
and	CC	cc	O
that	IN	mark	O
DSCR	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
1s	NN	nsubj	I-Gene_or_gene_product2
serves	VBZ	conj	O
to	TO	mark	O
dampen	VB	xcomp	O
the	DT	det	O
host	NN	compound	O
response	NN	dobj	O
to	TO	case	O
infection	NN	nmod	O
.	.	punct	O

Nicked	VBN	amod	B-Gene_or_gene_product2
{	-LRB-	punct	I-Gene_or_gene_product2
beta	NN	nsubj	I-Gene_or_gene_product2
}	-RRB-	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
glycoprotein	NN	appos	I-Gene_or_gene_product2
I	NN	nsubj	I-Gene_or_gene_product2
binds	VBZ	ROOT	O
angiostatin	NN	dobj	B-Gene_or_gene_product0
4	CD	nummod	I-Gene_or_gene_product0
.	.	punct	I-Gene_or_gene_product0
5	CD	ROOT	I-Gene_or_gene_product0
(	-LRB-	punct	O
plasminogen	NN	compound	O
kringle	NN	dep	O
1	CD	nummod	O
-	SYM	punct	O
5	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
attenuates	VBZ	conj	O
its	PRP$	nmod:poss	O
antiangiogenic	JJ	amod	O
property	NN	dobj	O
.	.	punct	O

Angiostatin	NN	nsubjpass	B-Gene_or_gene_product0
was	VBD	auxpass	O
first	RB	advmod	O
discovered	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
plasminogen	NN	compound	B-Gene_or_gene_product1
fragment	NN	nmod	I-Gene_or_gene_product1
with	IN	case	O
antitumor	NN	compound	B-Cancer
/	:	punct	O
antiangiogenic	JJ	amod	O
property	NN	nmod	O
.	.	punct	O

One	CD	ROOT	O
of	IN	case	O
the	DT	det	O
angiostatin	NN	compound	B-Gene_or_gene_product0
isoforms	NNS	nmod	O
,	,	punct	O
that	WDT	nsubj	O
is	VBZ	cop	O
,	,	punct	O
angiostatin	NN	appos	B-Gene_or_gene_product0
4	CD	nummod	I-Gene_or_gene_product0
.	.	punct	I-Gene_or_gene_product0
5	CD	dep	I-Gene_or_gene_product0
(	-LRB-	punct	O
AS4	NN	appos	B-Gene_or_gene_product2
.	.	punct	I-Gene_or_gene_product2
5	CD	nsubjpass	I-Gene_or_gene_product2
)	-RRB-	punct	O
,	,	punct	O
consisting	VBG	acl	O
of	IN	case	O
plasminogen	NN	compound	O
kringle	NN	nmod	O
1	CD	compound	O
to	TO	dep	O
4	CD	dep	O
and	CC	cc	O
a	DT	det	O
most	JJS	amod	O
part	NN	conj	O
of	IN	case	O
kringle	NN	nmod	O
5	CD	nummod	O
,	,	punct	O
is	VBZ	auxpass	O
produced	VBN	ROOT	O
by	IN	case	O
autoproteolysis	NN	nmod	O
and	CC	cc	O
present	JJ	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
plasma	NN	nmod	B-Organism_substance
.	.	punct	O

beta2	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
glycoprotein	NN	nsubjpass	I-Gene_or_gene_product2
I	CD	nummod	I-Gene_or_gene_product2
(	-LRB-	punct	O
beta2GPI	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
is	VBZ	auxpass	O
proteolytically	RB	advmod	O
cleaved	VBN	ROOT	O
by	IN	case	O
plasmin	NN	nmod	B-Gene_or_gene_product1
in	IN	case	O
its	PRP$	nmod:poss	O
domain	NN	compound	O
V	NN	nmod	O
(	-LRB-	punct	O
nicked	VBN	amod	B-Gene_or_gene_product1
beta2GPI	NN	appos	I-Gene_or_gene_product1
)	-RRB-	punct	O
,	,	punct	O
resulting	VBG	xcomp	O
in	IN	case	O
binding	NN	nmod	O
to	TO	case	O
plasminogen	NN	nmod	B-Gene_or_gene_product1
.	.	punct	O

Antiangiogenic	JJ	amod	O
properties	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
recently	RB	advmod	O
reported	VBN	ROOT	O
in	IN	case	O
nicked	VBN	amod	B-Gene_or_gene_product2
beta2GPI	NN	nmod	I-Gene_or_gene_product2
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
intact	JJ	amod	O
beta2GPI	NN	conj	B-Gene_or_gene_product2
at	IN	case	O
higher	JJR	amod	O
concentrations	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
significant	JJ	amod	O
binding	NN	dobj	O
of	IN	case	O
nicked	VBN	amod	B-Gene_or_gene_product2
beta2GPI	NN	nmod	I-Gene_or_gene_product2
to	TO	case	O
AS4	NN	nmod	B-Gene_or_gene_product2
.	.	punct	I-Gene_or_gene_product2
5	CD	nsubj	I-Gene_or_gene_product2
(	-LRB-	punct	O
K	NN	compound	O
(	-LRB-	punct	O
D	NN	appos	O
)	-RRB-	punct	O
=	JJ	ROOT	O
3	CD	dobj	O
.	.	punct	O
27	CD	nummod	O
x	CC	cc	O
10	CD	conj	O
(	-LRB-	punct	O
6	CD	dep	O
)	-RRB-	punct	O
M	NN	ROOT	O
(	-LRB-	punct	O
-	SYM	punct	O
1	CD	appos	O
)	-RRB-	punct	O
)	-RRB-	punct	O
.	.	punct	O

Via	NN	case	O
this	DT	det	O
binding	NN	nmod	O
,	,	punct	O
nicked	VBN	nsubj	B-Gene_or_gene_product2
beta2GPI	NN	nsubj	I-Gene_or_gene_product2
attenuates	VBZ	ROOT	O
the	DT	det	O
antiangiogenic	JJ	amod	O
functions	NNS	dobj	O
of	IN	case	O
AS4	NN	nmod	B-Gene_or_gene_product2
.	.	punct	I-Gene_or_gene_product2
5	CD	ROOT	I-Gene_or_gene_product2
in	IN	case	O
the	DT	det	O
proliferation	NN	nmod	O
of	IN	case	O
arterial	JJ	amod	B-Cell
/	:	punct	O
venous	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
in	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
invasion	NN	nmod	O
and	CC	cc	O
the	DT	det	O
tube	NN	compound	B-Tissue
formation	NN	conj	O
of	IN	case	O
venous	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
and	CC	cc	O
in	FW	amod	O
vivo	FW	dep	O
angiogenesis	NN	conj	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
intact	JJ	advmod	O
beta2GPI	NN	nsubj	B-Gene_or_gene_product2
does	VBZ	aux	O
not	RB	neg	O
bind	VB	ROOT	O
to	TO	case	O
AS4	NN	nmod	B-Gene_or_gene_product2
.	.	punct	I-Gene_or_gene_product2
5	CD	ROOT	I-Gene_or_gene_product2
or	CC	cc	O
inhibit	VBP	conj	O
its	PRP$	nmod:poss	O
antiangiogenic	JJ	amod	O
activity	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
nicked	VBN	nsubj	B-Gene_or_gene_product1
beta2GPI	NN	nsubj	I-Gene_or_gene_product1
exerts	VBZ	ROOT	O
dual	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
that	WDT	nsubj	O
is	VBZ	ccomp	O
,	,	punct	O
nicked	VBN	acomp	B-Gene_or_gene_product1
beta2GPI	NN	nsubj	I-Gene_or_gene_product1
promotes	VBZ	conj	O
angiogenesis	NN	dobj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
AS4	NN	nmod	B-Gene_or_gene_product2
.	.	punct	I-Gene_or_gene_product2
5	CD	dep	I-Gene_or_gene_product2
,	,	punct	O
whereas	IN	dep	O
nicked	VBN	amod	B-Gene_or_gene_product1
beta2GPI	NN	nsubj	I-Gene_or_gene_product1
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
at	IN	case	O
concentrations	NNS	nmod	O
high	JJ	amod	O
enough	RB	amod	O
to	TO	mark	O
neutralize	VB	acl	O
AS4	NN	dobj	B-Gene_or_gene_product2
.	.	punct	I-Gene_or_gene_product2
5	LS	ROOT	I-Gene_or_gene_product2
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
plasmin	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
nicked	VBN	amod	I-Gene_or_gene_product1
beta2GPI	NN	nsubj	I-Gene_or_gene_product1
promotes	VBZ	ccomp	O
angiogenesis	NN	dobj	O
by	IN	prep	O
interacting	VBG	pcomp	O
with	IN	prep	O
plasmin	NN	npadvmod	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
generated	VBN	amod	I-Gene_or_gene_product1
AS4	NN	pobj	I-Gene_or_gene_product1
.	.	punct	I-Gene_or_gene_product1
5	CD	ROOT	I-Gene_or_gene_product1
in	IN	case	O
sites	NNS	nmod	O
of	IN	case	O
increased	VBN	amod	O
fibrinolysis	NN	nmod	O
such	JJ	case	O
as	IN	mwe	O
thrombus	NN	nmod	B-Pathological_formation
.	.	punct	O

[	-LRB-	punct	O
An	DT	det	O
experimental	JJ	amod	O
study	NN	ROOT	O
on	IN	case	O
angiogenesis	NN	nmod	O
of	IN	case	O
non	JJ	advmod	O
-	HYPH	punct	O
vascularized	JJ	amod	O
autogenous	JJ	amod	B-Multi-tissue_structure
bone	NN	compound	I-Multi-tissue_structure
graft	NN	nmod	I-Multi-tissue_structure
with	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
bundle	NN	compound	I-Multi-tissue_structure
implantation	NN	nmod	O
]	-RRB-	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
bundle	NN	compound	I-Multi-tissue_structure
implantation	NN	nmod	O
in	IN	case	O
autogenous	JJ	amod	B-Multi-tissue_structure
bone	NN	compound	I-Multi-tissue_structure
graft	NN	nmod	I-Multi-tissue_structure
on	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Thirty	CD	compound	O
-	HYPH	punct	O
six	CD	nummod	O
New	NNP	compound	B-Organism
Zealand	NNP	compound	I-Organism
white	JJ	amod	I-Organism
rabbits	NNS	nsubjpass	I-Organism
were	VBD	auxpass	O
evaluated	VBN	appos	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
.	.	punct	O

A	DT	det	O
portion	NN	nsubjpass	O
of	IN	case	O
bilateral	JJ	amod	B-Organ
radial	JJ	amod	I-Organ
bones	NNS	nmod	I-Organ
of	IN	case	O
a	DT	det	O
rabbit	NN	nmod	B-Organism
were	VBD	auxpass	O
removed	VBN	ROOT	O
as	IN	mark	O
free	JJ	amod	O
bone	NN	compound	B-Multi-tissue_structure
grafts	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
whose	WP$	poss	O
periostea	NN	nsubjpass	B-Tissue
were	VBD	auxpass	O
peeled	VBN	parataxis	O
off	RP	prt	O
.	.	punct	O

In	IN	prep	O
test	NN	compound	O
group	NN	pobj	O
,	,	punct	O
the	DT	det	O
external	JJ	amod	B-Multi-tissue_structure
maxillary	JJ	amod	I-Multi-tissue_structure
artery	NN	compound	I-Multi-tissue_structure
bundle	NN	nsubjpass	I-Multi-tissue_structure
was	VBD	auxpass	O
passed	VBN	ROOT	O
through	IN	prep	O
the	DT	det	O
marrow	NN	compound	B-Immaterial_anatomical_entity
cavity	NN	pobj	I-Immaterial_anatomical_entity
of	IN	prep	O
the	DT	det	O
bone	NN	pobj	B-Organ
.	.	punct	O

In	IN	prep	O
control	JJ	compound	O
group	NN	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
vascular	JJ	amod	B-Multi-tissue_structure
bundle	NN	compound	I-Multi-tissue_structure
implantation	NN	nsubj	O
.	.	punct	O

Each	DT	det	O
bone	NN	nsubjpass	B-Organ
was	VBD	auxpass	O
placed	VBN	ROOT	O
in	IN	case	O
masseter	NN	compound	B-Organ
muscle	NN	nmod	I-Organ
separately	RB	advmod	O
.	.	punct	O

The	DT	det	O
rabbits	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
sacrificed	VBN	ROOT	O
and	CC	cc	O
the	DT	det	O
specimens	NNS	nsubjpass	B-Multi-tissue_structure
were	VBD	auxpass	O
procured	VBN	conj	O
at	IN	case	O
3	CD	nummod	O
days	NNS	nmod	O
,	,	punct	O
1	CD	nummod	O
,	,	punct	O
2	CD	conj	O
,	,	punct	O
3	CD	conj	O
,	,	punct	O
4	CD	conj	O
and	CC	cc	O
6	CD	conj	O
weeks	NNS	nmod	O
after	IN	case	O
surgery	NN	nmod	O
for	IN	case	O
histological	JJ	amod	O
observation	NN	nmod	O
,	,	punct	O
Chinese	JJ	amod	O
ink	NN	compound	O
perfusion	NN	npadvmod	O
and	CC	cc	O
CD34	NN	compound	B-Gene_or_gene_product1
immunohistochemistry	NN	conj	O
.	.	punct	O

Microvessel	NN	compound	B-Tissue
density	NN	nsubjpass	O
(	-LRB-	punct	O
MVD	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
assessed	VBN	ROOT	O
in	IN	case	O
order	NN	nmod	O
to	TO	mark	O
evaluate	VB	xcomp	O
angiogenesis	NN	dobj	O
of	IN	case	O
autogenous	JJ	amod	B-Multi-tissue_structure
bone	NN	compound	I-Multi-tissue_structure
grafts	NNS	nmod	I-Multi-tissue_structure
.	.	punct	O

RESULTS	NNS	nsubjpass	O
:	:	punct	O
The	DT	det	O
bone	NN	compound	B-Multi-tissue_structure
grafts	NNS	nsubjpass	I-Multi-tissue_structure
were	VBD	auxpass	O
found	VBN	ROOT	O
revascularization	NN	dobj	O
in	IN	case	O
3	CD	nummod	O
days	NNS	nmod	O
after	IN	case	O
surgery	NN	nmod	O
in	IN	case	O
the	DT	det	O
test	NN	compound	O
group	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
at	IN	case	O
2	CD	nummod	O
weeks	NNS	advcl	O
in	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
.	.	punct	O

In	IN	prep	O
3	CD	nummod	O
days	NNS	pobj	O
,	,	punct	O
1	CD	nummod	O
week	NN	npadvmod	O
,	,	punct	O
2	CD	nummod	O
weeks	NNS	appos	O
,	,	punct	O
3	CD	nummod	O
weeks	NNS	conj	O
and	CC	cc	O
4	CD	nummod	O
weeks	NNS	conj	O
after	IN	case	O
surgery	NN	nmod	O
,	,	punct	O
the	DT	det	O
MVD	NN	nsubj	O
of	IN	case	O
test	NN	compound	O
group	NN	nmod	O
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
control	JJ	amod	O
group	NN	nmod	O
.	.	punct	O

In	IN	case	O
4	CD	nummod	O
weeks	NNS	ROOT	O
after	IN	case	O
surgery	NN	nmod	O
,	,	punct	O
angiogenesis	NN	appos	O
of	IN	prep	O
test	NN	compound	O
group	NN	pobj	O
reached	VBD	acl	O
to	TO	aux	O
peak	VB	xcomp	O
.	.	punct	O

CONCLUSION	NN	npadvmod	O
:	:	punct	O
Vascular	JJ	amod	B-Multi-tissue_structure
bundle	NN	compound	I-Multi-tissue_structure
implantation	NN	nsubj	O
improved	VBD	ROOT	O
angiogenesis	NN	dobj	O
in	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
vascularized	JJ	amod	O
autogenous	JJ	amod	B-Multi-tissue_structure
bone	NN	compound	I-Multi-tissue_structure
graft	NN	nmod	I-Multi-tissue_structure
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
.	.	punct	O

Targeting	VBG	ROOT	O
glucose	NN	compound	B-Simple_chemical
consumption	NN	dobj	O
and	CC	cc	O
autophagy	NN	conj	O
in	IN	case	O
myeloma	NN	nmod	B-Cancer
with	IN	case	O
the	DT	det	O
novel	JJ	amod	O
nucleoside	NN	compound	B-Simple_chemical
analogue	NN	nmod	I-Simple_chemical
8	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
aminoadenosine	NN	dep	I-Simple_chemical
.	.	punct	O

Multiple	JJ	amod	O
myeloma	NN	nsubjpass	B-Cancer
,	,	punct	O
an	DT	det	O
incurable	JJ	amod	O
plasma	NN	compound	B-Cancer
cell	NN	compound	I-Cancer
malignancy	NN	appos	I-Cancer
,	,	punct	O
is	VBZ	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
altered	JJ	amod	O
cellular	JJ	amod	B-Cell
metabolism	NN	nmod	O
and	CC	cc	O
resistance	NN	conj	O
to	TO	case	O
apoptosis	NN	nmod	O
.	.	punct	O

Recent	JJ	amod	O
connections	NNS	nsubj	O
between	IN	case	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
and	CC	cc	O
resistance	NN	conj	O
to	TO	case	O
apoptosis	NN	nmod	O
provide	VBP	ROOT	O
a	DT	det	O
compelling	JJ	amod	O
rationale	NN	dobj	O
for	IN	mark	O
targeting	VBG	acl	O
metabolic	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
the	DT	det	O
purine	NN	compound	B-Simple_chemical
analogue	NN	nmod	I-Simple_chemical
8	CD	nummod	I-Simple_chemical
-	:	punct	I-Simple_chemical
aminoadenosine	NN	dep	I-Simple_chemical
to	TO	aux	O
acutely	RB	advmod	O
reduce	VB	acl	O
glucose	NN	compound	B-Simple_chemical
consumption	NN	dobj	O
by	IN	mark	O
regulating	VBG	advcl	O
localization	NN	dobj	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
key	JJ	amod	O
glucose	NN	compound	B-Gene_or_gene_product0
transporters	NNS	nmod	I-Gene_or_gene_product0
.	.	punct	O

Myeloma	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
counteracted	VBD	ROOT	O
the	DT	det	O
metabolic	JJ	amod	O
stress	NN	dobj	O
by	IN	mark	O
activating	VBG	advcl	O
autophagy	NN	dobj	O
.	.	punct	O

Co	NN	compound	O
-	HYPH	punct	O
treatment	NN	ROOT	O
with	IN	case	O
inhibitors	NNS	nmod	O
of	IN	case	O
autophagy	NN	compound	O
results	VBZ	nmod	O
in	IN	case	O
marked	JJ	amod	O
enhancement	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
death	NN	nmod	O
.	.	punct	O

Glucose	NN	compound	B-Simple_chemical
consumption	NN	nsubj	O
by	IN	case	O
drug	NN	compound	O
-	HYPH	punct	O
resistant	JJ	amod	O
myeloma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
was	VBD	aux	O
unaffected	JJ	ROOT	O
by	IN	case	O
8	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
aminoadenosine	NN	nmod	I-Simple_chemical
,	,	punct	O
and	CC	cc	O
accordingly	RB	advmod	O
,	,	punct	O
no	DT	neg	O
activation	NN	nsubjpass	O
of	IN	case	O
autophagy	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
these	DT	det	O
cells	NNS	nsubjpass	B-Cell
can	MD	aux	O
be	VB	auxpass	O
sensitized	VBN	ROOT	O
to	TO	case	O
8	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
aminoadenosine	NN	nmod	I-Simple_chemical
under	IN	prep	O
glucose	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
limiting	VBG	amod	O
conditions	NNS	pobj	O
.	.	punct	O

The	DT	det	O
prosurvival	NN	compound	O
autophagic	JJ	amod	O
response	NN	nsubjpass	O
of	IN	case	O
myeloma	NN	nmod	B-Cancer
to	TO	mark	O
nutrient	JJ	acl	O
deprivation	NN	dobj	O
or	CC	cc	O
to	TO	case	O
nucleoside	NN	compound	B-Simple_chemical
analogue	NN	compound	I-Simple_chemical
treatment	NN	conj	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
described	VBN	ROOT	O
previously	RB	advmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
establishes	VBZ	ROOT	O
the	DT	det	O
potential	NN	dobj	O
of	IN	prep	O
metabolic	JJ	amod	O
targeting	NN	pobj	O
as	IN	prep	O
a	DT	det	O
broader	JJR	amod	O
means	NNS	pobj	O
to	TO	aux	O
kill	VB	acl	O
and	CC	cc	O
sensitize	VB	conj	O
myeloma	NN	dobj	B-Cancer
and	CC	cc	O
identifies	VBZ	conj	O
a	DT	det	O
compound	NN	dobj	O
that	WDT	nsubj	O
can	MD	aux	O
achieve	VB	relcl	O
this	DT	det	O
goal	NN	dobj	O
.	.	punct	O

Dopamine	NN	nsubj	B-Simple_chemical
regulates	VBZ	ROOT	O
phosphorylation	NN	dobj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product0
receptor	NN	nmod	I-Gene_or_gene_product0
2	CD	nummod	I-Gene_or_gene_product0
by	IN	mark	O
engaging	VBG	advcl	O
Src	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
homology	NN	compound	I-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
domain	NN	intj	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
containing	VBG	amod	I-Gene_or_gene_product2
protein	NN	compound	I-Gene_or_gene_product2
tyrosine	NN	compound	I-Gene_or_gene_product2
phosphatase	NN	dobj	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	nmod:npmod	I-Gene_or_gene_product0
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
-	:	punct	O
induced	VBN	amod	O
receptor	NN	compound	O
phosphorylation	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
crucial	JJ	amod	O
step	NN	ROOT	O
for	IN	mark	O
initiating	VBG	advcl	O
downstream	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	dobj	O
that	WDT	nsubj	O
lead	VBP	acl:relcl	O
to	TO	case	O
angiogenesis	NN	nmod	O
or	CC	cc	O
related	JJ	amod	O
pathophysiological	JJ	amod	O
outcomes	NNS	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
previous	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
neurotransmitter	NN	amod	O
dopamine	NN	nsubj	B-Simple_chemical
could	MD	aux	O
inhibit	VB	ccomp	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
induced	VBN	amod	O
phosphorylation	NN	dobj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product0
receptor	NN	nmod	I-Gene_or_gene_product0
2	CD	nummod	I-Gene_or_gene_product0
(	-LRB-	punct	O
VEGFR	NN	compound	B-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
2	CD	nummod	I-Gene_or_gene_product0
)	-RRB-	punct	O
,	,	punct	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	conj	O
,	,	punct	O
migration	NN	conj	O
,	,	punct	O
microvascular	JJ	amod	B-Tissue
permeability	NN	conj	O
,	,	punct	O
and	CC	cc	O
thus	RB	advmod	O
,	,	punct	O
angiogenesis	NN	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
address	VBP	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
VEGFR	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
2	CD	nummod	I-Gene_or_gene_product1
phosphorylation	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
dopamine	NN	nmod	B-Simple_chemical
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
D2	NN	compound	B-Gene_or_gene_product0
dopamine	NN	compound	I-Gene_or_gene_product0
receptor	NN	nsubj	I-Gene_or_gene_product0
(	-LRB-	punct	O
D2DR	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
colocalizes	VBZ	ccomp	O
with	IN	case	O
VEGFR	NN	nmod	B-Gene_or_gene_product3
-	,	punct	I-Gene_or_gene_product3
2	CD	nummod	I-Gene_or_gene_product3
at	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	nmod	I-Cellular_component
.	.	punct	O

Dopamine	NN	compound	B-Simple_chemical
pretreatment	NN	nsubj	O
increases	VBZ	ROOT	O
the	DT	det	O
translocation	NN	dobj	O
and	CC	cc	O
colocalization	NN	conj	O
of	IN	prep	O
Src	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
homology	NN	compound	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
2	CD	nummod	I-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
domain	NN	intj	I-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
containing	VBG	amod	I-Gene_or_gene_product0
protein	NN	compound	I-Gene_or_gene_product0
tyrosine	NN	compound	I-Gene_or_gene_product0
phosphatase	NN	pobj	I-Gene_or_gene_product0
(	-LRB-	punct	O
SHP	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
2	CD	dep	I-Gene_or_gene_product3
)	-RRB-	punct	O
with	IN	case	O
D2DR	NN	nmod	B-Gene_or_gene_product1
at	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	nmod	I-Cellular_component
.	.	punct	O

Dopamine	NN	compound	B-Simple_chemical
administration	NN	nsubj	O
leads	VBZ	ROOT	O
to	TO	case	O
increased	VBN	amod	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
induced	VBN	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
SHP	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
2	CD	nmod	I-Gene_or_gene_product2
and	CC	cc	O
this	DT	det	O
increased	VBN	amod	O
phosphorylation	NN	conj	O
parallels	VBZ	conj	O
the	DT	det	O
increased	VBN	amod	O
phosphatase	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
SHP	NN	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	nmod	I-Gene_or_gene_product2
.	.	punct	O

Active	JJ	amod	O
SHP	NN	nsubj	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
then	RB	advmod	O
dephosphorylates	VBZ	ROOT	O
VEGFR	NN	dobj	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
2	CD	nummod	I-Gene_or_gene_product3
at	IN	case	O
Y951	NN	nmod	O
,	,	punct	O
Y996	NN	conj	O
and	CC	cc	O
Y1059	NN	conj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
Y1175	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
observe	VBP	ROOT	O
that	IN	mark	O
SHP	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
knockdown	NN	nsubj	O
impairs	VBZ	ccomp	O
the	DT	det	O
dopamine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
regulated	VBN	amod	O
inhibition	NN	dobj	O
of	IN	case	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
induced	VBN	amod	O
phosphorylation	NN	nmod	O
of	IN	case	O
VEGFR	NN	nmod	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
2	CD	nummod	I-Gene_or_gene_product3
and	CC	cc	O
,	,	punct	O
subsequently	RB	advmod	O
,	,	punct	O
Src	NN	compound	B-Gene_or_gene_product2
phosphorylation	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
establish	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
SHP	NN	compound	B-Gene_or_gene_product1
-	CC	punct	I-Gene_or_gene_product1
2	CD	nummod	I-Gene_or_gene_product1
phosphatase	NN	nmod	I-Gene_or_gene_product1
in	IN	case	O
the	DT	det	O
dopamine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
mediated	VBN	amod	O
regulation	NN	nmod	O
of	IN	case	O
VEGFR	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
2	CD	nummod	I-Gene_or_gene_product3
phosphorylation	NN	nmod	O
.	.	punct	O

Glioma	NN	compound	B-Cell
tumor	NN	compound	I-Cell
stem	NN	nsubj	I-Cell
-	HYPH	punct	I-Cell
like	JJ	case	I-Cell
cells	NNS	nsubj	I-Cell
promote	VBP	ROOT	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	dobj	O
and	CC	cc	O
vasculogenesis	NN	conj	O
via	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	nmod	I-Gene_or_gene_product0
and	CC	cc	O
stromal	JJ	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
derived	VBN	amod	I-Gene_or_gene_product3
factor	NN	conj	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
.	.	punct	O

Cancer	NN	compound	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
(	-LRB-	punct	O
CSC	NN	appos	B-Cell
)	-RRB-	punct	O
are	VBP	auxpass	O
predicted	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
critical	JJ	amod	O
drivers	NNS	xcomp	O
of	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
due	JJ	case	O
to	TO	mwe	O
their	PRP$	nmod:poss	O
self	NN	compound	O
-	HYPH	punct	O
renewal	NN	compound	O
capacity	NN	nmod	O
and	CC	cc	O
limitless	JJ	amod	O
proliferative	JJ	amod	O
potential	NN	conj	O
.	.	punct	O

An	DT	det	O
emerging	VBG	amod	O
area	NN	nsubj	O
of	IN	prep	O
research	NN	pobj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
CSC	NN	nsubj	B-Cell
may	MD	aux	O
also	RB	advmod	O
support	VB	ccomp	O
tumor	NN	compound	B-Cancer
progression	NN	dobj	O
by	IN	mark	O
promoting	VBG	advcl	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	dobj	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
how	WRB	advmod	O
CSC	NN	nsubj	B-Cell
contribute	VBP	ccomp	O
to	TO	case	O
tumor	NN	compound	B-Multi-tissue_structure
vascular	JJ	amod	I-Multi-tissue_structure
development	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
an	DT	det	O
approach	NN	dobj	O
comparing	VBG	acl	O
tumor	NN	compound	B-Cancer
xenografts	NNS	dobj	I-Cancer
of	IN	case	O
the	DT	det	O
C6	NN	compound	B-Cell
glioma	NN	compound	I-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
containing	VBG	acl	O
either	CC	cc:preconj	O
a	DT	det	O
low	JJ	dobj	O
or	CC	cc	O
a	DT	det	O
high	JJ	amod	O
fraction	NN	conj	O
of	IN	case	O
CSC	NN	nmod	B-Cell
.	.	punct	O

Compared	VBN	case	O
with	IN	case	O
CSC	NN	nmod:npmod	B-Cancer
-	HYPH	punct	I-Cancer
low	JJ	amod	I-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
CSC	NNP	nmod:npmod	B-Cancer
-	HYPH	punct	I-Cancer
high	JJ	amod	I-Cancer
tumors	NNS	nsubj	I-Cancer
exhibited	VBD	ROOT	O
increased	VBN	amod	O
microvessel	NN	compound	B-Tissue
density	NN	dobj	O
and	CC	cc	O
blood	NN	compound	B-Organism_substance
perfusion	NN	conj	O
and	CC	cc	O
induced	VBD	conj	O
increased	VBN	amod	O
mobilization	NN	dobj	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
recruitment	NN	conj	O
of	IN	case	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nmod:npmod	I-Multi-tissue_structure
-	HYPH	punct	O
derived	VBN	amod	O
endothelial	JJ	amod	B-Cell
progenitor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
EPC	NNS	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

CSC	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
high	JJ	amod	I-Cell
C6	NN	compound	I-Cell
cell	NN	compound	I-Cell
cultures	NNS	nsubj	I-Cell
also	RB	advmod	O
induced	VBD	ROOT	O
higher	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
and	CC	cc	O
tubule	NN	compound	B-Tissue
organization	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
compared	VBN	case	O
with	IN	case	O
CSC	NN	nmod:npmod	B-Cell
-	HYPH	punct	I-Cell
low	JJ	amod	I-Cell
cultures	NNS	advcl	I-Cell
.	.	punct	O

CSC	NNP	nmod:npmod	B-Cell
-	HYPH	punct	I-Cell
high	JJ	amod	I-Cell
cultures	NNS	nsubj	I-Cell
and	CC	cc	O
tumors	NNS	conj	B-Cancer
expressed	VBD	ROOT	O
increased	VBN	amod	O
levels	NNS	dobj	O
of	IN	case	O
the	DT	det	O
proangiogenic	JJ	amod	O
factors	NNS	nmod	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	dep	I-Gene_or_gene_product0
and	CC	cc	O
stromal	JJ	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
derived	VBN	amod	I-Gene_or_gene_product3
factor	NN	conj	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
,	,	punct	O
and	CC	cc	O
when	WRB	advmod	O
signaling	NN	nsubjpass	O
by	IN	case	O
either	CC	det	O
factor	NN	nmod	O
was	VBD	auxpass	O
blocked	VBN	advcl	O
,	,	punct	O
all	DT	det	O
aspects	NNS	nsubjpass	O
of	IN	case	O
angiogenesis	NN	nmod	O
observed	VBN	acl	O
in	IN	case	O
CSC	NNP	nmod:npmod	B-Cell
-	HYPH	punct	I-Cell
high	JJ	amod	I-Cell
cultures	NNS	nmod	I-Cell
and	CC	cc	O
tumors	NNS	conj	B-Cancer
,	,	punct	O
including	VBG	case	O
microvessel	NN	compound	B-Tissue
density	NN	nmod	O
,	,	punct	O
perfusion	NN	conj	O
,	,	punct	O
EPC	NN	compound	B-Cell
mobilization	NN	compound	O
/	:	punct	O
recruitment	NN	conj	O
,	,	punct	O
and	CC	cc	O
stimulation	NN	conj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
activity	NN	nmod	O
,	,	punct	O
were	VBD	auxpass	O
reduced	VBN	conj	O
to	TO	case	O
levels	NNS	nmod	O
comparable	JJ	amod	O
with	IN	case	O
those	DT	nmod	O
observed	VBN	acl	O
in	IN	case	O
CSC	NNP	nmod:npmod	B-Cell
-	HYPH	punct	I-Cell
low	JJ	amod	I-Cell
cultures	NNS	nmod	I-Cell
/	:	punct	O
tumors	NNS	conj	B-Cancer
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
CSC	NN	nsubj	B-Cell
contribute	VBP	ccomp	O
to	TO	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
by	IN	mark	O
promoting	VBG	advcl	O
both	CC	cc:preconj	O
local	JJ	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
activity	NN	dobj	O
and	CC	cc	O
systemic	JJ	amod	O
angiogenic	JJ	amod	O
processes	NNS	conj	O
involving	VBG	acl	O
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	compound	I-Multi-tissue_structure
-	HYPH	punct	O
derived	VBN	amod	O
EPC	NN	dobj	B-Cell
in	IN	case	O
a	DT	det	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	dep	I-Gene_or_gene_product0
-	HYPH	punct	O
dependent	JJ	amod	O
and	CC	cc	O
stromal	JJ	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
derived	VBN	conj	I-Gene_or_gene_product3
factor	NN	nmod:npmod	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Inducible	JJ	amod	B-Gene_or_gene_product0
nitric	JJ	amod	I-Gene_or_gene_product0
oxide	NN	compound	I-Gene_or_gene_product0
synthase	NN	nsubj	I-Gene_or_gene_product0
modulates	VBZ	ROOT	O
angiogenesis	NN	dobj	O
in	IN	case	O
ischemic	JJ	amod	O
hindlimb	NN	nmod	B-Organism_subdivision
of	IN	case	O
rat	NN	nmod	B-Organism
.	.	punct	O

BACKGROUND	NN	nsubj	O
:	:	punct	O
Angiogenesis	NN	nsubj	O
plays	VBZ	dep	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
maintaining	VBG	advcl	O
adequate	JJ	amod	O
oxygen	NN	compound	B-Simple_chemical
delivery	NN	dobj	O
,	,	punct	O
and	CC	cc	O
nitric	JJ	amod	B-Simple_chemical
oxide	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
NO	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
potential	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

NO	NN	nsubjpass	B-Simple_chemical
is	VBZ	auxpass	O
synthesized	VBN	ROOT	O
through	IN	case	O
three	CD	nummod	O
isoforms	NNS	nmod	O
of	IN	case	O
NO	NN	compound	B-Gene_or_gene_product2
synthase	NN	nmod	I-Gene_or_gene_product2
(	-LRB-	punct	O
NOS	NN	appos	B-Gene_or_gene_product2
)	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
hypothesized	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
NO	NN	nsubj	B-Simple_chemical
derived	VBN	acl	O
from	IN	case	O
inducible	JJ	amod	B-Gene_or_gene_product2
NOS	NN	nmod	I-Gene_or_gene_product2
(	-LRB-	punct	O
iNOS	NN	appos	B-Gene_or_gene_product2
)	-RRB-	punct	O
may	MD	aux	O
promote	VB	ccomp	O
survival	NN	dobj	O
of	IN	case	O
ischemic	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
through	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

To	TO	mark	O
test	VB	advcl	O
this	DT	det	O
hypothesis	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
iNOS	NN	compound	B-Gene_or_gene_product2
deficiency	NN	nmod	O
(	-LRB-	punct	O
by	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NIL	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
on	IN	case	O
angiogenesis	NN	nmod	O
in	IN	case	O
a	DT	det	O
hindlimb	JJ	compound	B-Organism_subdivision
ischemia	NN	compound	O
model	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Thirty	CD	compound	O
-	HYPH	punct	O
two	CD	nummod	O
male	JJ	amod	O
wistar	NN	compound	B-Organism
rats	NNS	nsubj	I-Organism
randomly	RB	advmod	O
divided	VBN	appos	O
into	IN	prep	O
four	CD	nummod	O
groups	NNS	pobj	O
.	.	punct	O

In	IN	case	O
groups	NNS	nmod	O
1	CD	nummod	O
&	CC	cc	O
2	CD	conj	O
,	,	punct	O
hindlimb	JJ	compound	B-Organism_subdivision
ischemia	NN	nsubjpass	O
was	VBD	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
ligation	NN	nmod	O
of	IN	case	O
femoral	JJ	amod	B-Multi-tissue_structure
artery	NN	nmod	I-Multi-tissue_structure
and	CC	cc	O
they	PRP	nsubj	O
received	VBD	conj	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NIL	NN	dobj	I-Simple_chemical
and	CC	cc	O
saline	NN	conj	B-Simple_chemical
respectively	RB	advmod	O
.	.	punct	O

The	DT	det	O
animals	NNS	nsubj	O
in	IN	case	O
groups	NNS	nmod	O
3	CD	nummod	O
and	CC	cc	O
4	CD	conj	O
also	RB	advmod	O
received	VBD	ROOT	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NIL	NN	dobj	I-Simple_chemical
and	CC	cc	O
saline	NN	conj	B-Simple_chemical
respectively	RB	advmod	O
without	IN	case	O
surgical	JJ	amod	O
procedure	NN	nmod	O
.	.	punct	O

After	IN	prep	O
21	CD	nummod	O
days	NNS	pobj	O
,	,	punct	O
the	DT	det	O
serum	NN	compound	B-Organism_substance
concentration	NN	nsubjpass	O
of	IN	case	O
nitrite	NN	amod	B-Simple_chemical
,	,	punct	O
capillary	JJ	amod	B-Tissue
density	NN	nmod	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
HIF1alpha	NN	nmod	B-Gene_or_gene_product1
were	VBD	auxpass	O
determined	VBN	ROOT	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Serum	NN	compound	B-Organism_substance
nitrite	JJ	amod	B-Simple_chemical
levels	NNS	nsubj	O
were	VBD	cop	O
significantly	RB	advmod	O
lower	JJR	appos	O
in	IN	case	O
L	NNP	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NIL	NN	compound	I-Simple_chemical
groups	NNS	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
capillary	JJ	amod	B-Tissue
density	NN	nsubj	O
in	IN	case	O
group	NN	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
ischemia	NN	dep	O
+	CC	cc	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NIL	NN	conj	I-Simple_chemical
)	-RRB-	punct	O
was	VBD	cop	O
significantly	RB	advmod	O
different	JJ	ROOT	O
from	IN	case	O
group	NN	nmod	O
2	CD	nummod	O
(	-LRB-	punct	O
ischemia	NN	dep	O
+	CC	cc	O
saline	NN	conj	B-Simple_chemical
)	-RRB-	punct	O
;	:	punct	O
group	NN	conj	O
1	CD	nummod	O
:	:	punct	O
360	CD	nummod	O
.	.	punct	O
33	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
77	CD	nummod	O
.	.	punct	O
02	CD	nummod	O
,	,	punct	O
group	NN	ROOT	O
2	CD	nummod	O
:	:	punct	O
549	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
81	CD	nummod	O
.	.	punct	O
85	CD	nummod	O
/	SYM	punct	O
mm2	NN	appos	O
,	,	punct	O
p	NN	compound	O
<	CD	appos	O
0	CD	nummod	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
expression	NN	nsubjpass	O
of	IN	case	O
HIF1alpha	NN	nmod	B-Gene_or_gene_product1
was	VBD	auxpass	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
ischemic	JJ	amod	O
groups	NNS	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Selective	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
iNOS	NN	nmod	B-Gene_or_gene_product2
by	IN	case	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NIL	NNP	nmod	I-Simple_chemical
inhibits	VBZ	appos	O
angiogenesis	NN	dobj	O
in	IN	case	O
a	DT	det	O
hindlimb	JJ	compound	B-Organism_subdivision
ischemic	JJ	amod	O
rat	NN	compound	B-Organism
model	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
ischemia	NN	nsubj	O
induces	VBZ	ROOT	O
expression	NN	dobj	O
of	IN	case	O
HIF1alpha	NN	nmod	B-Gene_or_gene_product1
in	IN	case	O
hypoxic	JJ	amod	B-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

Phenolic	JJ	amod	O
fraction	NN	nsubj	O
of	IN	case	O
tobacco	NN	compound	B-Simple_chemical
smoke	NN	compound	I-Simple_chemical
condensate	NN	nmod	I-Simple_chemical
potentiates	NNS	ROOT	O
benzo	NN	dobj	B-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
a	DT	det	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
pyerene	NN	compound	I-Simple_chemical
diol	NN	compound	I-Simple_chemical
epoxide	NN	dep	I-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
transformation	NN	dep	O
:	:	punct	O
role	NN	dep	O
of	IN	case	O
protein	NN	compound	B-Gene_or_gene_product2
kinase	NN	compound	I-Gene_or_gene_product2
C	NN	nmod	I-Gene_or_gene_product2
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
separated	VBD	ROOT	O
weakly	RB	advmod	O
acidic	JJ	amod	O
phenolic	JJ	amod	O
components	NNS	dobj	O
from	IN	case	O
other	JJ	amod	O
neutral	JJ	amod	O
,	,	punct	O
acidic	JJ	conj	O
and	CC	cc	O
basic	JJ	conj	O
components	NNS	nmod	O
of	IN	case	O
tobacco	NN	compound	B-Simple_chemical
smoke	NN	compound	I-Simple_chemical
condensate	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
TSC	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
observed	VBD	conj	O
that	IN	mark	O
phenolic	JJ	amod	B-Simple_chemical
fraction	NN	nsubj	I-Simple_chemical
of	IN	case	O
TSC	NN	nmod	B-Simple_chemical
significantly	RB	advmod	O
increased	VBD	ccomp	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
colonies	NNS	nmod	O
of	IN	case	O
promotion	NN	nmod:npmod	O
-	HYPH	punct	O
sensitive	JJ	amod	O
JB6	NN	compound	B-Cell
Cl41	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
showed	VBD	acl:relcl	O
anchorage	JJ	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	dobj	O
on	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
BPDE	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
an	DT	det	O
ultimate	JJ	amod	O
carcinogen	NN	dobj	O
produced	VBN	acl	O
by	IN	case	O
metabolic	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
PAH	NN	compound	B-Simple_chemical
benzo	NN	nmod	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
a	DT	det	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
pyrene	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

Anchorage	NNP	nmod:npmod	O
-	HYPH	punct	O
independent	JJ	amod	O
cell	NN	compound	B-Cell
growth	NN	nsubj	O
is	VBZ	cop	O
indicative	JJ	ROOT	O
of	IN	case	O
cell	NN	compound	B-Cell
transformation	NN	nmod	O
resulting	VBG	acl	O
in	IN	case	O
acquisition	NN	nmod	O
of	IN	case	O
tumorigenic	JJ	amod	O
potential	NN	nmod	O
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	dep	O
understand	VB	advcl	O
the	DT	det	O
underlying	VBG	amod	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
TSC	NN	compound	B-Simple_chemical
phenolic	JJ	amod	I-Simple_chemical
fraction	NN	nsubj	I-Simple_chemical
potentiates	VBZ	acl:relcl	O
BPDE	NN	nmod:npmod	B-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
tumorigenicity	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
its	PRP$	nmod:poss	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
two	CD	nummod	O
transcription	NN	compound	O
factors	NNS	compound	O
AP	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	conj	I-Gene_or_gene_product3
and	CC	cc	O
NF	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
kappaB	NN	nmod	I-Gene_or_gene_product2
which	WDT	nsubjpass	O
are	VBP	auxpass	O
known	VBN	acl:relcl	O
to	TO	mark	O
be	VB	auxpass	O
influenced	VBN	xcomp	O
by	IN	case	O
established	JJ	amod	O
tumor	NN	compound	B-Cancer
promoter	NN	compound	O
TPA	NN	nmod	B-Simple_chemical
.	.	punct	O

BPDE	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
caused	VBD	ROOT	O
induction	NN	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
AP	NN	nmod	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	dep	I-Gene_or_gene_product3
and	CC	cc	O
NF	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
kappaB	NN	conj	I-Gene_or_gene_product2
activity	NN	dep	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
luciferase	NN	compound	B-Gene_or_gene_product0
reporter	NN	compound	O
assay	NN	nmod	O
and	CC	cc	O
only	RB	advmod	O
NF	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
kappaB	NN	compound	I-Gene_or_gene_product0
induction	NN	nsubjpass	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
BPDE	NN	nmod	B-Simple_chemical
was	VBD	auxpass	O
significantly	RB	advmod	O
attenuated	VBN	conj	O
by	IN	case	O
TSC	NN	compound	B-Simple_chemical
phenolic	JJ	amod	I-Simple_chemical
fraction	NN	nmod	I-Simple_chemical
whereas	IN	mark	O
AP	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
induction	NN	nsubj	O
remains	VBZ	advcl	O
unaltered	JJ	xcomp	O
.	.	punct	O

Attenuation	NN	nsubjpass	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
kappaB	NN	compound	I-Gene_or_gene_product2
activation	NN	nmod	O
by	IN	case	O
TSC	NN	compound	B-Simple_chemical
phenolic	JJ	amod	I-Simple_chemical
fraction	NN	nmod	I-Simple_chemical
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
significant	JJ	amod	O
decrease	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
PKC	NN	compound	B-Gene_or_gene_product1
substrate	NN	compound	O
phosphorylation	NN	nmod	O
in	IN	case	O
BPDE	NN	compound	B-Simple_chemical
treated	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Non	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
PKC	NN	compound	B-Gene_or_gene_product1
inhibitors	NNS	nsubj	O
staurosporine	NN	dep	B-Simple_chemical
and	CC	cc	O
bisindolylmaleimide	NN	conj	B-Simple_chemical
II	CD	nummod	I-Simple_chemical
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
inhibitors	NNS	conj	O
specific	JJ	amod	O
to	TO	case	O
conventional	JJ	amod	O
PKCs	NNS	nmod	B-Gene_or_gene_product1
(	-LRB-	punct	O
Go6976	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
PKC	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
delta	NN	conj	I-Gene_or_gene_product1
(	-LRB-	punct	O
rottlerin	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
attenuated	VBD	ROOT	O
NF	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
kappaB	NN	compound	I-Gene_or_gene_product2
activation	NN	dobj	O
in	IN	case	O
BPDE	NN	compound	B-Simple_chemical
treated	JJ	amod	O
cells	NNS	nmod	B-Cell
to	TO	case	O
a	DT	det	O
varying	VBG	amod	O
degree	NN	nmod	O
indicating	VBG	acl	O
a	DT	det	O
possible	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
PKC	NN	compound	B-Gene_or_gene_product1
down	RB	nummod	O
-	HYPH	punct	O
regulation	NN	nmod	O
and	CC	cc	O
the	DT	det	O
attenuation	NN	conj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
kappaB	NN	compound	I-Gene_or_gene_product2
activity	NN	nmod	O
by	IN	case	O
TSC	NN	compound	B-Simple_chemical
phenolic	JJ	amod	I-Simple_chemical
fraction	NN	nmod	I-Simple_chemical
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
with	IN	case	O
PKC	NN	compound	B-Gene_or_gene_product1
inhibitors	NNS	nmod	O
also	RB	advmod	O
potentiated	VBD	ROOT	O
anchorage	JJ	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	dobj	O
of	IN	case	O
BPDE	NN	compound	B-Simple_chemical
treated	JJ	amod	O
cells	NNS	nmod	B-Cell
on	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
possible	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
PKC	NN	compound	B-Gene_or_gene_product1
down	RB	nummod	O
-	HYPH	punct	O
regulation	NN	nmod	O
in	IN	case	O
potentiation	NN	nmod	O
of	IN	case	O
BPDE	NN	nmod:npmod	B-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
tumorogenicity	NN	nmod	O
by	IN	case	O
TSC	NN	compound	B-Simple_chemical
phenolic	JJ	amod	I-Simple_chemical
fraction	NN	nmod	I-Simple_chemical
.	.	punct	O

Killing	VBG	ROOT	O
tumor	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
through	IN	case	O
their	PRP$	nmod:poss	O
surface	NN	compound	O
beta	NN	nmod	B-Gene_or_gene_product0
(	-LRB-	punct	I-Gene_or_gene_product0
2	CD	nummod	I-Gene_or_gene_product0
)	-RRB-	punct	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
microglobulin	NN	dep	I-Gene_or_gene_product0
or	CC	cc	O
major	JJ	amod	B-Gene_or_gene_product2
histocompatibility	NN	compound	I-Gene_or_gene_product2
complex	NN	compound	I-Gene_or_gene_product2
class	NN	compound	I-Gene_or_gene_product2
I	CD	nummod	I-Gene_or_gene_product2
molecules	NNS	conj	O
.	.	punct	O

Targeted	VBN	amod	O
antibody	NN	nmod:npmod	O
-	HYPH	punct	O
based	VBN	amod	O
therapy	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
used	VBN	ROOT	O
successfully	RB	advmod	O
to	TO	mark	O
treat	VB	xcomp	O
cancers	NNS	dobj	B-Cancer
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
demonstrated	VBN	ROOT	O
that	IN	mark	O
tumor	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
treated	VBN	acl	O
with	IN	case	O
antibodies	NNS	nmod	O
specific	JJ	amod	O
for	IN	case	O
beta	NN	compound	B-Gene_or_gene_product0
(	-LRB-	punct	I-Gene_or_gene_product0
2	CD	nummod	I-Gene_or_gene_product0
)	-RRB-	punct	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
microglobulin	NN	compound	I-Gene_or_gene_product0
(	-LRB-	punct	O
beta	NN	compound	B-Gene_or_gene_product2
(	-LRB-	punct	I-Gene_or_gene_product2
2	LS	nummod	I-Gene_or_gene_product2
)	-RRB-	punct	I-Gene_or_gene_product2
M	NN	nmod	I-Gene_or_gene_product2
)	-RRB-	punct	O
or	CC	cc	O
major	JJ	amod	B-Gene_or_gene_product2
histocompatibility	NN	compound	I-Gene_or_gene_product2
complex	NN	compound	I-Gene_or_gene_product2
(	-LRB-	punct	I-Gene_or_gene_product2
MHC	NN	compound	I-Gene_or_gene_product2
)	-RRB-	punct	I-Gene_or_gene_product2
class	NN	compound	I-Gene_or_gene_product2
I	CD	nummod	I-Gene_or_gene_product2
molecules	NNS	conj	O
undergo	VBP	ccomp	O
apoptosis	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
(	-LRB-	punct	O
mouse	NN	compound	B-Organism
models	NNS	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Antibodies	NNS	nsubj	O
against	IN	case	O
beta	NN	compound	B-Gene_or_gene_product2
(	-LRB-	punct	I-Gene_or_gene_product2
2	LS	nummod	I-Gene_or_gene_product2
)	-RRB-	punct	I-Gene_or_gene_product2
M	NN	nmod	I-Gene_or_gene_product2
or	CC	cc	O
MHC	NN	compound	B-Gene_or_gene_product1
class	NN	conj	I-Gene_or_gene_product1
I	PRP	nummod	I-Gene_or_gene_product1
induce	VBP	ROOT	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
apoptosis	NN	dobj	O
by	IN	case	O
1	LS	nmod	O
)	-RRB-	punct	O
recruiting	VBG	advcl	O
MHC	NN	compound	B-Gene_or_gene_product1
class	NN	compound	I-Gene_or_gene_product1
I	CD	nummod	I-Gene_or_gene_product1
molecules	NNS	dobj	O
to	TO	case	O
lipid	NN	compound	B-Cellular_component
rafts	NNS	nmod	I-Cellular_component
and	CC	cc	O
activating	VBG	conj	O
LYN	NN	compound	B-Gene_or_gene_product2
kinase	NN	conj	O
and	CC	cc	O
the	DT	det	O
signal	NN	compound	O
-	HYPH	punct	O
transducing	NN	amod	O
enzyme	NN	compound	O
phospholipase	NN	compound	B-Gene_or_gene_product1
C	NN	nmod:npmod	I-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
gamma2	NN	nmod:npmod	I-Gene_or_gene_product1
-	HYPH	punct	O
dependent	JJ	amod	O
c	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
Jun	NNP	compound	I-Gene_or_gene_product2
N	NN	compound	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
terminal	JJ	amod	I-Gene_or_gene_product2
kinase	NN	compound	I-Gene_or_gene_product2
signaling	NN	compound	O
pathway	NN	conj	O
and	CC	cc	O
2	CD	conj	O
)	-RRB-	punct	O
expelling	VBG	advcl	O
interleukin	NN	dobj	B-Gene_or_gene_product2
6	CD	nummod	I-Gene_or_gene_product2
and	CC	cc	O
insulin	NN	conj	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
like	IN	case	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
1	CD	nummod	I-Gene_or_gene_product0
receptors	NNS	nmod	I-Gene_or_gene_product0
out	IN	advmod	O
of	IN	case	O
lipid	NN	compound	B-Cellular_component
rafts	NNS	nmod	I-Cellular_component
and	CC	cc	O
inhibiting	VBG	conj	O
the	DT	dep	O
growth	NN	preconj	O
and	CC	cc	O
survival	NN	conj	O
factor	NN	conj	O
-	:	punct	O
induced	VBN	amod	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
phosphatidylinositol	NN	compound	B-Gene_or_gene_product1
3	CD	nummod	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
kinase	NN	dep	I-Gene_or_gene_product1
/	:	punct	O
Akt	NNP	conj	B-Gene_or_gene_product1
and	CC	cc	O
extracellular	JJ	conj	B-Gene_or_gene_product2
signal	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
related	JJ	amod	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
pathways	NNS	nmod	O
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
mitochondrial	JJ	amod	B-Cellular_component
integrity	NN	nsubjpass	O
is	VBZ	auxpass	O
compromised	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
caspase	NN	nmod:npmod	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
9	CD	npadvmod	I-Gene_or_gene_product2
-	HYPH	punct	O
dependent	JJ	amod	O
cascade	NN	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	conj	O
in	IN	case	O
treated	VBN	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
although	IN	mark	O
beta	NN	compound	B-Gene_or_gene_product2
(	-LRB-	punct	I-Gene_or_gene_product2
2	LS	dep	I-Gene_or_gene_product2
)	-RRB-	punct	I-Gene_or_gene_product2
M	NN	nsubjpass	I-Gene_or_gene_product2
and	CC	cc	O
MHC	NN	compound	B-Gene_or_gene_product1
class	NN	conj	I-Gene_or_gene_product1
I	PRP	nummod	I-Gene_or_gene_product1
are	VBP	auxpass	O
expressed	VBN	advcl	O
on	IN	case	O
normal	JJ	amod	O
hematopoietic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
potential	JJ	amod	O
safety	NN	compound	O
concern	NN	acl:relcl	O
,	,	punct	O
the	DT	det	O
monoclonal	JJ	amod	O
antibodies	NNS	nsubj	O
were	VBD	cop	O
selective	JJ	ROOT	O
to	TO	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
damage	VB	conj	O
normal	JJ	amod	O
cells	NNS	dobj	B-Cell
in	FW	compound	O
vitro	FW	advmod	O
or	CC	advmod	O
in	IN	case	O
human	JJ	conj	B-Organism
-	HYPH	punct	O
like	IN	case	O
mouse	NN	compound	B-Organism
models	NNS	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
targeting	VBG	csubj	O
beta	NN	compound	B-Gene_or_gene_product2
(	-LRB-	punct	I-Gene_or_gene_product2
2	LS	dep	I-Gene_or_gene_product2
)	-RRB-	punct	I-Gene_or_gene_product2
M	NN	dobj	I-Gene_or_gene_product2
or	CC	cc	O
MHC	NN	compound	B-Gene_or_gene_product3
class	NN	conj	I-Gene_or_gene_product3
I	CD	nummod	I-Gene_or_gene_product3
by	IN	mark	O
using	VBG	advcl	O
antibodies	NNS	dobj	O
or	CC	cc	O
other	JJ	amod	O
agents	NNS	conj	O
offers	VBZ	ccomp	O
a	DT	det	O
potential	JJ	amod	O
therapeutic	JJ	amod	O
approach	NN	dobj	O
for	IN	case	O
beta	NN	compound	B-Gene_or_gene_product0
(	-LRB-	punct	I-Gene_or_gene_product0
2	LS	dep	I-Gene_or_gene_product0
)	-RRB-	punct	I-Gene_or_gene_product0
M	NN	dep	I-Gene_or_gene_product0
/	:	punct	O
MHC	NN	compound	B-Gene_or_gene_product3
class	NN	compound	I-Gene_or_gene_product3
I	CD	npadvmod	I-Gene_or_gene_product3
-	HYPH	punct	O
expressing	VBG	amod	O
malignancies	NNS	nmod	O
.	.	punct	O

Cancer	NNP	ROOT	O
2010	CD	nummod	O
.	.	punct	O

(	-LRB-	punct	O
c	LS	ROOT	O
)	-RRB-	punct	O
2010	CD	nummod	O
American	NNP	compound	O
Cancer	NNP	compound	O
Society	NNP	appos	O
.	.	punct	O

Loss	NN	ROOT	O
of	IN	case	O
CDC4	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
FBXW7	NN	nmod	B-Gene_or_gene_product1
in	IN	case	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

BACKGROUND	NN	nsubjpass	O
:	:	punct	O
CDC4	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
FBXW7	NN	appos	B-Gene_or_gene_product1
,	,	punct	O
encoding	VBG	acl	O
a	DT	det	O
ubiquitin	NN	compound	B-Gene_or_gene_product0
ligase	NN	dobj	O
,	,	punct	O
maps	VBZ	appos	O
to	TO	case	O
4q32	NN	nmod	O
and	CC	cc	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	nmod	O
and	CC	cc	O
therapeutic	JJ	amod	O
target	NN	conj	O
in	IN	case	O
many	JJ	amod	O
tumor	NN	compound	B-Cancer
types	NNS	nmod	O
.	.	punct	O

Mutations	NNS	nsubj	O
in	IN	case	O
colonic	JJ	amod	B-Cancer
adenomas	NNS	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
the	DT	det	O
frequent	JJ	amod	O
losses	NNS	conj	O
on	IN	case	O
4q	NN	nmod	B-Cellular_component
described	VBN	acl	O
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
prompt	NN	ROOT	O
speculation	NN	dobj	O
about	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
CDC4	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
FBXW7	NN	nmod	B-Gene_or_gene_product1
in	IN	case	O
gastric	JJ	amod	B-Organ
carcinogenesis	NN	nmod	O
.	.	punct	O

METHODS	NNS	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
assessed	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
CDC4	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
FBXW7	NN	nmod	B-Gene_or_gene_product1
in	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
through	IN	case	O
loss	NN	nmod	O
of	IN	case	O
heterozygosity	NN	nmod	O
(	-LRB-	punct	O
LOH	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
multiplex	NN	amod	O
ligation	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
probe	NN	compound	O
amplification	NN	conj	O
(	-LRB-	punct	O
MLPA	NN	appos	O
)	-RRB-	punct	O
on	IN	case	O
47	CD	nummod	O
flow	NN	npadvmod	O
-	HYPH	punct	O
sorted	VBN	amod	O
gastric	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
including	VBG	case	O
early	RB	amod	B-Cancer
-	HYPH	punct	I-Cancer
onset	NN	compound	I-Cancer
gastric	JJ	amod	I-Cancer
cancers	NNS	nmod	I-Cancer
(	-LRB-	punct	O
EOGC	NN	appos	B-Cancer
)	-RRB-	punct	O
and	CC	cc	O
xenografted	VBN	amod	O
conventional	JJ	amod	O
gastric	JJ	amod	B-Cancer
carcinomas	NNS	conj	I-Cancer
.	.	punct	O

Ploidy	NN	compound	O
analysis	NN	nsubjpass	O
was	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	prt	O
on	IN	case	O
39	CD	nummod	O
EOGCs	NNS	nmod	B-Cancer
and	CC	cc	O
immunohistochemistry	NN	conj	O
of	IN	case	O
CDC4	NN	nmod	B-Gene_or_gene_product1
/	:	punct	O
FBXW7	NN	conj	B-Gene_or_gene_product1
and	CC	cc	O
its	PRP$	nmod:poss	O
substrates	NNS	conj	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
myc	NN	dep	I-Gene_or_gene_product1
,	,	punct	O
c	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
jun	NN	nsubjpass	I-Gene_or_gene_product2
,	,	punct	O
Notch	NN	conj	B-Gene_or_gene_product2
and	CC	cc	O
cyclin	NN	compound	B-Gene_or_gene_product2
E	NN	conj	I-Gene_or_gene_product2
was	VBD	auxpass	O
performed	VBN	conj	O
on	IN	case	O
204	CD	nummod	O
gastric	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
using	VBG	acl	O
tissue	NN	compound	B-Tissue
microarrays	NNS	dobj	O
(	-LRB-	punct	O
TMAs	NNS	appos	O
)	-RRB-	punct	O
.	.	punct	O

Sequence	NN	compound	O
analysis	NN	nsubjpass	O
of	IN	case	O
CDC4	NN	nmod	B-Gene_or_gene_product1
/	:	punct	O
FBXW7	NN	nsubjpass	B-Gene_or_gene_product1
was	VBD	auxpass	O
carried	VBN	ROOT	O
out	RP	advmod	O
on	IN	case	O
gastric	JJ	amod	B-Cell
carcinoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
and	CC	cc	O
xenografts	NNS	conj	B-Cancer
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Loss	NN	nsubj	O
of	IN	case	O
heterozygosity	NN	nmod	O
of	IN	case	O
CDC4	NN	nmod	B-Gene_or_gene_product1
/	:	punct	O
FBXW7	NN	nmod	B-Gene_or_gene_product1
occurred	VBD	appos	O
in	IN	case	O
32	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
EOGCs	NNS	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
loss	NN	nmod	O
of	IN	case	O
expression	NN	nmod	O
in	IN	case	O
26	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

Loss	NN	nsubj	O
of	IN	case	O
expression	NN	nmod	O
was	VBD	cop	O
frequent	JJ	ROOT	O
in	IN	case	O
both	CC	cc:preconj	O
EOGC	NN	nmod	B-Cancer
and	CC	cc	O
conventional	JJ	amod	O
gastric	JJ	amod	B-Cancer
cancers	NNS	conj	I-Cancer
.	.	punct	O

No	DT	neg	O
CDC4	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
FBXW7	NN	compound	B-Gene_or_gene_product1
mutations	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
and	CC	cc	O
loss	NN	nsubj	O
of	IN	case	O
CDC4	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
FBXW7	NN	nmod	B-Gene_or_gene_product1
did	VBD	aux	O
not	RB	neg	O
correlate	VB	conj	O
with	IN	case	O
ploidy	NN	compound	O
status	NN	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
loss	NN	nmod	O
of	IN	case	O
CDC4	NN	nmod	B-Gene_or_gene_product1
/	:	punct	O
FBXW7	NN	conj	B-Gene_or_gene_product1
expression	NN	dep	O
and	CC	cc	O
upregulation	NN	conj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
myc	NN	nmod	I-Gene_or_gene_product1
.	.	punct	O

CONCLUSION	NN	dep	O
:	:	punct	O
Loss	NN	nsubj	O
of	IN	case	O
CDC4	NN	nmod	B-Gene_or_gene_product1
/	:	punct	O
FBXW7	NN	appos	B-Gene_or_gene_product1
appears	VBZ	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
EOGC	NN	nmod	B-Cancer
and	CC	cc	O
conventional	JJ	amod	O
gastric	JJ	amod	B-Organ
carcinogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
myc	NN	compound	I-Gene_or_gene_product1
overexpression	NN	nsubj	O
is	VBZ	cop	O
likely	JJ	conj	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
oncogenic	JJ	amod	O
consequence	NN	xcomp	O
of	IN	case	O
CDC4	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
FBXW7	NN	compound	B-Gene_or_gene_product1
loss	NN	nmod	O
.	.	punct	O

Angiogenesis	NN	compound	O
inhibitors	NNS	ROOT	O
:	:	punct	O
current	JJ	amod	O
strategies	NNS	appos	O
and	CC	cc	O
future	JJ	amod	O
prospects	NNS	conj	O
.	.	punct	O

Angiogenesis	NN	nsubj	O
has	VBZ	aux	O
become	VBN	ROOT	O
an	DT	det	O
attractive	JJ	amod	O
target	NN	attr	O
for	IN	case	O
drug	NN	compound	O
therapy	NN	nmod	O
because	IN	case	O
of	IN	mwe	O
its	PRP$	nmod:poss	O
key	JJ	amod	O
role	NN	advcl	O
in	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
.	.	punct	O

An	DT	det	O
extensive	JJ	amod	O
array	NN	nsubj	O
of	IN	case	O
compounds	NNS	nmod	O
is	VBZ	cop	O
currently	RB	advmod	O
in	IN	case	O
preclinical	JJ	amod	O
development	NN	ROOT	O
,	,	punct	O
with	IN	mark	O
many	JJ	pobj	O
now	RB	advmod	O
entering	VBG	advcl	O
the	DT	det	O
clinic	NN	dobj	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
achieving	VBG	conj	O
approval	NN	dobj	O
from	IN	prep	O
the	DT	det	O
US	NNP	compound	O
Food	NNP	nmod	O
and	CC	cc	O
Drug	NNP	compound	O
Administration	NNP	pobj	O
.	.	punct	O

Several	JJ	amod	O
regulatory	JJ	amod	O
and	CC	cc	O
signaling	VBG	conj	O
molecules	NNS	nsubj	O
governing	VBG	acl	O
angiogenesis	NN	dobj	O
are	VBP	cop	O
of	IN	case	O
interest	NN	ROOT	O
,	,	punct	O
including	VBG	case	O
growth	NN	compound	O
factors	NNS	nmod	O
(	-LRB-	punct	O
eg	FW	dep	O
,	,	punct	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	conj	I-Gene_or_gene_product0
,	,	punct	O
platelet	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
derived	VBN	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	conj	I-Gene_or_gene_product0
,	,	punct	O
fibroblast	NN	compound	B-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	conj	I-Gene_or_gene_product0
,	,	punct	O
and	CC	cc	O
epidermal	JJ	amod	B-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	conj	I-Gene_or_gene_product0
)	-RRB-	punct	O
,	,	punct	O
receptor	NN	compound	O
tyrosine	NN	compound	O
kinases	NNS	conj	O
,	,	punct	O
and	CC	cc	O
transcription	NN	compound	O
factors	NNS	conj	O
such	JJ	case	O
as	IN	mwe	O
hypoxia	NN	compound	B-Gene_or_gene_product0
inducible	JJ	amod	I-Gene_or_gene_product0
factor	NN	nmod	I-Gene_or_gene_product0
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
molecules	NNS	conj	O
involved	VBN	acl	O
in	IN	case	O
mitogen	NN	nmod:npmod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
activated	VBN	amod	I-Gene_or_gene_product2
protein	NN	compound	I-Gene_or_gene_product2
kinase	NN	nmod	I-Gene_or_gene_product2
(	-LRB-	punct	O
MAPK	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
and	CC	cc	O
phosphoinositide	NN	compound	B-Gene_or_gene_product1
3	CD	nummod	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
kinase	NN	compound	I-Gene_or_gene_product1
(	-LRB-	punct	O
PI3K	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
signaling	NN	conj	O
.	.	punct	O

Pharmacologic	JJ	amod	O
agents	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
identified	VBN	ROOT	O
that	WDT	nsubj	O
target	VBP	ccomp	O
these	DT	det	O
pathways	NNS	dobj	O
,	,	punct	O
yet	RB	advmod	O
for	IN	case	O
some	DT	det	O
agents	NNS	nmod	O
(	-LRB-	punct	O
notably	RB	advmod	O
thalidomide	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
understanding	NN	appos	O
of	IN	case	O
the	DT	det	O
specific	JJ	amod	O
mechanisms	NNS	nmod	O
of	IN	case	O
antitumor	JJ	compound	B-Cancer
action	NN	nmod	O
has	VBZ	aux	O
proved	VBN	conj	O
elusive	JJ	xcomp	O
.	.	punct	O

The	DT	det	O
following	JJ	amod	O
review	NN	nsubj	O
describes	VBZ	ROOT	O
key	JJ	amod	O
molecular	JJ	amod	O
mechanisms	NNS	dobj	O
and	CC	cc	O
novel	JJ	amod	O
therapies	NNS	conj	O
that	WDT	nsubj	O
are	VBP	cop	O
on	IN	case	O
the	DT	det	O
horizon	NN	conj	O
for	IN	case	O
antiangiogenic	JJ	amod	O
tumor	NN	compound	B-Cancer
therapy	NN	nmod	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
Bax	NN	compound	B-Gene_or_gene_product3
inhibitor	NN	compound	I-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	pobj	I-Gene_or_gene_product3
(	-LRB-	punct	O
BI	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nmod	I-Gene_or_gene_product3
)	-RRB-	punct	O
induces	VBZ	ROOT	O
cell	NN	compound	B-Cell
transformation	NN	dobj	O
in	IN	case	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

BI	NNP	compound	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
1	CD	nsubj	I-Gene_or_gene_product3
(	-LRB-	punct	O
Bax	NN	compound	B-Gene_or_gene_product3
inhibitor	NN	dep	I-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
)	-RRB-	punct	O
,	,	punct	O
an	DT	det	O
apoptosis	NN	compound	O
-	HYPH	punct	O
inhibiting	VBG	amod	O
gene	NN	appos	O
belonging	VBG	acl	O
to	TO	case	O
the	DT	det	O
Bcl	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
protein	NN	compound	O
family	NN	nmod	O
,	,	punct	O
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
mitochondrial	JJ	amod	B-Cellular_component
apoptosis	NN	compound	O
pathway	NN	nmod	O
to	TO	mark	O
suppress	VB	xcomp	O
Bax	NN	nmod:npmod	B-Gene_or_gene_product2
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	dobj	O
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
potential	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
BI	NN	compound	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
1	CD	nmod	I-Gene_or_gene_product3
in	IN	mark	O
promoting	VBG	acl	O
cell	NN	dobj	B-Cell
growth	NN	dep	O
and	CC	cc	O
tumorigenesis	NN	conj	O
,	,	punct	O
in	IN	case	O
the	DT	det	O
present	JJ	amod	O
study	NN	nmod	O
we	PRP	nsubj	O
overexpressed	VBD	ROOT	O
the	DT	det	O
BI	NNP	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
gene	NN	dobj	O
in	IN	case	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
using	VBG	advcl	O
the	DT	det	O
lentivirus	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
mediated	VBN	amod	O
gene	NN	compound	O
expression	NN	compound	O
system	NN	dobj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
in	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
overexpressing	VBG	acl	O
BI	NN	dobj	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
displayed	VBD	ccomp	O
a	DT	det	O
significantly	RB	advmod	O
higher	JJR	amod	O
growth	NN	compound	O
rate	NN	dobj	O
and	CC	cc	O
formed	VBD	conj	O
more	JJR	amod	O
and	CC	cc	O
larger	JJR	conj	O
colonies	NNS	dobj	O
than	IN	case	O
the	DT	det	O
control	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
in	FW	amod	O
vivo	FW	dep	O
studies	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
lenti	JJ	amod	O
-	HYPH	punct	O
BI	NNP	compound	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
-	HYPH	punct	O
infected	JJ	amod	O
cells	NNS	nsubj	B-Cell
formed	VBD	ccomp	O
obvious	JJ	amod	O
tumours	NNS	dobj	B-Cancer
,	,	punct	O
while	IN	mark	O
no	DT	det	O
tumours	NNS	nsubjpass	B-Cancer
were	VBD	auxpass	O
formed	VBN	advcl	O
by	IN	case	O
the	DT	det	O
control	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
after	IN	mark	O
subcutaneously	RB	advmod	O
injected	VBN	advcl	O
into	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
strongly	RB	advmod	O
suggested	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
BI	NNP	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
gene	NN	nsubj	O
might	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
crucial	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
neoplastic	JJ	amod	O
genesis	NN	nmod	O
and	CC	cc	O
development	NN	conj	O
.	.	punct	O

Anti	NNP	compound	O
-	HYPH	punct	O
metastasis	NN	compound	O
effects	NNS	nsubj	O
of	IN	case	O
gallic	JJ	amod	B-Simple_chemical
acid	NN	nmod	I-Simple_chemical
on	IN	case	O
gastric	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
involves	VBZ	ROOT	O
inhibition	NN	dobj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
kappaB	NN	compound	I-Gene_or_gene_product2
activity	NN	nmod	O
and	CC	cc	O
downregulation	NN	conj	O
of	IN	case	O
PI3K	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
AKT	NN	compound	B-Gene_or_gene_product1
/	SYM	punct	O
small	JJ	amod	B-Gene_or_gene_product2
GTPase	NN	compound	I-Gene_or_gene_product2
signals	NNS	nmod	O
.	.	punct	O

Polyphenols	NNS	nsubj	B-Simple_chemical
are	VBP	ROOT	O
natural	JJ	amod	O
antioxidants	NNS	attr	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
thought	VBN	acl:relcl	O
to	TO	mark	O
contribute	VB	xcomp	O
to	TO	case	O
prevention	NN	nmod	O
of	IN	case	O
cardiovascular	JJ	amod	B-Anatomical_system
disease	NN	nmod	O
and	CC	cc	O
malignancy	NN	conj	O
.	.	punct	O

Although	IN	mark	O
many	JJ	amod	O
studies	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
carried	VBN	advcl	O
out	RP	prt	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
chemopreventive	JJ	amod	O
role	NN	dobj	O
of	IN	case	O
flavonoids	NNS	nmod	B-Simple_chemical
,	,	punct	O
less	JJR	amod	O
attention	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
focused	VBN	ROOT	O
on	IN	case	O
phenolic	JJ	amod	B-Simple_chemical
acids	NNS	nmod	I-Simple_chemical
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
the	DT	det	O
aim	NN	nsubj	O
was	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
phenolic	JJ	amod	B-Simple_chemical
acids	NNS	nmod	I-Simple_chemical
found	VBN	acl	O
abundantly	RB	advmod	O
in	IN	case	O
vegetables	NNS	nmod	B-Organism_subdivision
,	,	punct	O
i	LS	dep	O
.	.	punct	O
e	LS	ROOT	O
.	.	punct	O
gallic	JJ	amod	B-Simple_chemical
acid	NN	ROOT	I-Simple_chemical
(	-LRB-	punct	O
GA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
caffeic	JJ	amod	B-Simple_chemical
acid	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
CA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
protocatechuic	JJ	compound	B-Simple_chemical
acid	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
PCA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
on	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
gastric	JJ	amod	B-Cell
adenocarcinoma	NN	compound	I-Cell
(	-LRB-	punct	I-Cell
AGS	NN	compound	I-Cell
)	-RRB-	punct	I-Cell
cell	NN	compound	I-Cell
metastasis	NN	nmod	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
0	CD	dobj	O
.	.	punct	O
01	CD	nummod	O
mM	NN	amod	O
GA	NN	nsubj	B-Simple_chemical
induced	VBD	ROOT	O
the	DT	det	O
same	JJ	amod	O
level	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
toxicity	NN	nmod	O
as	IN	case	O
4	CD	nmod	O
.	.	punct	O
0mM	CD	compound	O
PCA	NN	ROOT	B-Simple_chemical
.	.	punct	O

Using	VBG	advcl	O
wound	NN	compound	B-Pathological_formation
-	HYPH	punct	O
healing	NN	compound	O
assay	NN	dobj	O
and	CC	cc	O
Boyden	NN	compound	O
chamber	NN	compound	O
assay	NN	conj	O
,	,	punct	O
GA	NN	nsubj	B-Simple_chemical
had	VBD	ROOT	O
potent	JJ	amod	O
inhibitory	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
AGS	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
/	SYM	punct	O
9	CD	nmod	B-Gene_or_gene_product2
of	IN	case	O
AGS	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
by	IN	case	O
2	CD	nmod	O
.	.	punct	O
0	CD	nummod	O
microM	NN	ROOT	O
of	IN	case	O
GA	NNP	nmod	B-Simple_chemical
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
possible	JJ	ROOT	O
that	IN	mark	O
the	DT	det	O
suppressive	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
GA	NN	nmod	B-Simple_chemical
on	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
2	CD	nmod	I-Gene_or_gene_product2
/	SYM	punct	O
9	CD	dep	B-Gene_or_gene_product2
might	MD	aux	O
involve	VB	ccomp	O
the	DT	det	O
inhibition	NN	dobj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
kappaB	NN	compound	I-Gene_or_gene_product2
activity	NN	nmod	O
.	.	punct	O

Multiple	JJ	amod	O
proteins	NNS	nsubjpass	O
involved	VBN	acl	O
in	IN	case	O
metastasis	NN	nmod	O
and	CC	cc	O
the	DT	det	O
cytoskeletal	JJ	amod	B-Cellular_component
reorganization	NN	compound	O
signal	NN	compound	O
pathway	NN	conj	O
,	,	punct	O
including	VBG	case	O
Ras	NN	nmod	B-Gene_or_gene_product2
,	,	punct	O
Cdc42	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
Rac1	NN	conj	B-Gene_or_gene_product3
,	,	punct	O
RhoA	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
RhoB	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
PI3K	NN	conj	B-Gene_or_gene_product1
and	CC	cc	O
p38MAPK	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
were	VBD	auxpass	O
also	RB	advmod	O
inhibited	VBN	ROOT	O
by	IN	case	O
GA	NNP	nmod	B-Simple_chemical
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
immunoreactivity	NN	compound	O
assay	NN	nsubj	O
of	IN	case	O
cytoskeletal	JJ	amod	B-Cellular_component
F	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
actin	NN	nmod	I-Gene_or_gene_product1
demonstrated	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
GA	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
GA	NNP	nsubj	B-Simple_chemical
may	MD	aux	O
have	VB	ROOT	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
effective	JJ	amod	O
agent	NN	xcomp	O
for	IN	case	O
prevention	NN	nmod	O
and	CC	cc	O
treatment	NN	conj	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
metastasis	NN	nmod	O
.	.	punct	O

1	LS	nummod	B-Simple_chemical
,	,	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phenylenebis	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
methylene	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
selenocyanate	NN	nsubj	I-Simple_chemical
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
selenomethionine	NN	conj	B-Simple_chemical
,	,	punct	O
inhibits	VBZ	ROOT	O
androgen	NN	compound	B-Gene_or_gene_product2
receptor	NN	dobj	I-Gene_or_gene_product2
and	CC	cc	O
Akt	NN	compound	B-Gene_or_gene_product1
signaling	NN	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
lack	NN	nsubj	O
of	IN	case	O
treatment	NN	nmod	O
for	IN	case	O
worried	JJ	amod	O
-	HYPH	punct	O
well	JJ	intj	O
patients	NNS	nmod	B-Organism
with	IN	case	O
high	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
prostatic	JJ	amod	B-Pathological_formation
intraepithelial	JJ	amod	I-Pathological_formation
neoplasia	NN	nmod	I-Pathological_formation
combined	VBN	acl	O
with	IN	prep	O
issues	NNS	pobj	O
of	IN	prep	O
recurrence	NN	compound	O
and	CC	cc	O
hormone	NN	conj	O
resistance	NN	pobj	O
in	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
survivors	NNS	nmod	O
remains	VBZ	ROOT	O
a	DT	det	O
major	JJ	amod	O
public	JJ	amod	O
health	NN	compound	O
obstacle	NN	dobj	O
.	.	punct	O

The	DT	det	O
long	JJ	amod	O
latency	NN	nsubj	O
of	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
development	NN	nmod	O
provides	VBZ	ROOT	O
an	DT	det	O
opportunity	NN	dobj	O
to	TO	case	O
intervene	VB	nmod	O
with	IN	case	O
agents	NNS	nmod	O
of	IN	case	O
known	JJ	amod	O
mechanisms	NNS	nmod	O
at	IN	case	O
various	JJ	amod	O
stages	NNS	nmod	O
of	IN	case	O
disease	NN	compound	O
progression	NN	nmod	O
.	.	punct	O

A	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
signaling	NN	compound	O
cascades	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
important	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
development	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
androgen	NN	compound	B-Gene_or_gene_product2
receptor	NN	nmod	I-Gene_or_gene_product2
(	-LRB-	punct	O
AR	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
and	CC	cc	O
phosphatidylinositol	NN	compound	B-Gene_or_gene_product1
3	CD	nummod	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
kinase	NN	dep	I-Gene_or_gene_product1
/	:	punct	O
Akt	DT	compound	B-Gene_or_gene_product1
signaling	NN	compound	O
pathways	NNS	conj	O
.	.	punct	O

Crosstalk	NN	nsubjpass	O
between	IN	case	O
these	DT	det	O
two	CD	nummod	O
pathways	NNS	nmod	O
is	VBZ	auxpass	O
also	RB	advmod	O
thought	VBN	ROOT	O
to	TO	mark	O
contribute	VB	xcomp	O
to	TO	case	O
progression	NN	nmod	O
and	CC	cc	O
hormone	NN	compound	O
-	HYPH	punct	O
refractory	JJ	amod	O
prostate	NN	compound	B-Cancer
disease	NN	conj	I-Cancer
.	.	punct	O

Our	PRP$	nmod:poss	O
initial	JJ	amod	O
investigations	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
naturally	RB	advmod	O
occurring	VBG	amod	O
organoselenium	NN	compound	O
compound	NN	compound	O
selenomethionine	NN	nsubj	B-Simple_chemical
(	-LRB-	punct	O
SM	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
synthetic	JJ	amod	O
1	CD	nmod	B-Simple_chemical
,	,	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phenylenebis	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
methylene	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
selenocyanate	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
p	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
XSC	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
can	MD	aux	O
inhibit	VB	ccomp	O
human	JJ	amod	B-Organism
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
viability	NN	dobj	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
SM	NN	nmod	B-Simple_chemical
,	,	punct	O
p	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
XSC	NN	nsubj	I-Simple_chemical
is	VBZ	cop	O
active	JJ	parataxis	O
at	IN	case	O
physiologically	RB	advmod	O
relevant	JJ	amod	O
doses	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
investigation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
p	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
XSC	NN	nsubj	I-Simple_chemical
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
an	DT	det	O
equivalent	JJ	amod	O
dose	NN	conj	O
of	IN	case	O
SM	NN	nmod	B-Simple_chemical
,	,	punct	O
alters	VBZ	ccomp	O
molecular	JJ	amod	O
targets	NNS	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
apoptosis	NN	dobj	O
in	IN	case	O
androgen	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
responsive	JJ	amod	O
LNCaP	NN	nmod	B-Cell
and	CC	cc	O
androgen	NN	compound	B-Simple_chemical
-	HYPH	punct	O
independent	JJ	amod	O
LNCaP	NN	compound	B-Cell
C4	NN	compound	I-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
human	JJ	amod	I-Cell
prostate	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

p	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
XSC	NN	nsubj	I-Simple_chemical
effectively	RB	advmod	O
inhibits	VBZ	ROOT	O
AR	NN	compound	B-Gene_or_gene_product2
expression	NN	dobj	O
and	CC	cc	O
transcriptional	JJ	amod	O
activity	NN	conj	O
in	IN	case	O
both	DT	det	O
cell	NN	compound	B-Cell
lines	NNS	nmod	I-Cell
.	.	punct	O

p	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
XSC	NN	nsubj	I-Simple_chemical
also	RB	advmod	O
decreases	VBZ	ROOT	O
Akt	JJ	compound	B-Gene_or_gene_product1
phosphorylation	NN	dobj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
Akt	NNP	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
specific	JJ	amod	O
phosphorylation	NN	conj	O
of	IN	case	O
the	DT	det	O
AR	NNS	nmod	B-Gene_or_gene_product2
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
Akt	NNP	nmod	B-Gene_or_gene_product1
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
does	VBZ	aux	O
not	RB	neg	O
fully	RB	advmod	O
attenuate	VB	ROOT	O
p	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
XSC	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
mediated	VBN	amod	O
downregulation	NN	dobj	O
of	IN	case	O
AR	NN	compound	B-Gene_or_gene_product1
activity	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
AR	NN	compound	B-Gene_or_gene_product2
signaling	NN	nmod	O
by	IN	case	O
p	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
XSC	NN	nmod	I-Simple_chemical
does	VBZ	aux	O
not	RB	neg	O
occur	VB	ccomp	O
solely	RB	advmod	O
through	IN	case	O
alterations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
phosphatidylinositol	NN	compound	B-Gene_or_gene_product1
3	CD	nummod	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
kinase	NN	compound	I-Gene_or_gene_product1
/	:	punct	O
Akt	NN	compound	B-Gene_or_gene_product1
survival	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
p	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
XSC	NN	nsubj	I-Simple_chemical
inhibits	VBZ	ccomp	O
multiple	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	dobj	O
in	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
,	,	punct	O
likely	RB	advmod	O
accounting	VBG	advcl	O
for	IN	case	O
the	DT	det	O
downstream	JJ	amod	O
effects	NNS	nmod	O
on	IN	case	O
proliferation	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

Sanguinarine	NN	nsubj	B-Simple_chemical
induces	VBZ	ROOT	O
apoptosis	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
osteosarcoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
the	DT	det	O
extrinsic	JJ	amod	O
and	CC	cc	O
intrinsic	JJ	conj	O
pathways	NNS	nmod	O
.	.	punct	O

The	DT	det	O
quaternary	JJ	amod	O
benzo	NN	compound	B-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
c	LS	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
phenanthridine	NN	compound	I-Simple_chemical
alkaloid	NN	compound	I-Simple_chemical
sanguinarine	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ROOT	O
the	DT	det	O
proliferation	NN	dobj	O
of	IN	case	O
cancerous	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
different	JJ	amod	O
origins	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
lung	NN	nmod	B-Organ
,	,	punct	O
breast	NN	conj	B-Organism_subdivision
,	,	punct	O
pancreatic	JJ	conj	B-Organ
and	CC	cc	O
colon	NN	conj	B-Organ
,	,	punct	O
but	CC	cc	O
nothing	NN	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
effects	NNS	nmod	O
on	IN	case	O
osteosarcoma	NN	nmod	B-Cancer
,	,	punct	O
a	DT	det	O
primary	JJ	amod	B-Cancer
malignant	JJ	amod	I-Cancer
bone	NN	compound	I-Cancer
tumour	NN	appos	I-Cancer
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
sanguinarine	NN	nsubj	B-Simple_chemical
alters	VBZ	ccomp	O
the	DT	det	O
morphology	NN	dobj	O
and	CC	cc	O
reduces	VBZ	conj	O
the	DT	det	O
viability	NN	dobj	O
of	IN	case	O
MG	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
63	CD	nummod	I-Cell
and	CC	cc	O
SaOS	NNP	conj	B-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
human	JJ	amod	I-Cell
osteosarcoma	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
in	IN	case	O
concentration	NN	nmod	O
-	:	punct	O
and	CC	cc	O
time	NN	npadvmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	conj	O
.	.	punct	O

Incubation	NN	nsubj	O
with	IN	case	O
1	CD	nummod	O
micromol	NN	compound	O
/	:	punct	O
L	NN	compound	O
sanguinarine	NN	nmod	B-Simple_chemical
for	IN	case	O
4	CD	nmod	O
and	CC	cc	O
24h	NNS	conj	O
killed	VBD	ROOT	O
more	RBR	advmod	O
efficiently	RB	advmod	O
MG	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
63	CD	nummod	I-Cell
cells	NNS	dobj	I-Cell
than	IN	case	O
SaOS	NNP	compound	B-Cell
-	SYM	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
while	IN	mark	O
incubation	NN	nsubj	O
with	IN	case	O
5	CD	nummod	O
micromol	NN	compound	O
/	:	punct	O
L	NN	compound	O
sanguinarine	NN	nmod	B-Simple_chemical
killed	VBD	advcl	O
almost	RB	advmod	O
100	CD	nummod	O
%	NN	dobj	O
of	IN	case	O
both	DT	det	O
cell	NN	compound	B-Cell
populations	NNS	nmod	I-Cell
within	IN	case	O
24h	NNS	nmod	O
.	.	punct	O

This	DT	det	O
treatment	NN	nsubj	O
also	RB	advmod	O
changed	VBD	ROOT	O
the	DT	det	O
mitochondrial	JJ	amod	B-Cellular_component
membrane	NN	compound	I-Cellular_component
potential	NN	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
MG	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
63	CD	dep	I-Cell
and	CC	cc	O
SaOS	NNP	compound	B-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
within	IN	case	O
1h	NN	nmod	O
,	,	punct	O
caused	VBD	conj	O
chromatin	NN	compound	B-Cellular_component
condensation	NN	dobj	O
and	CC	cc	O
the	DT	det	O
formation	NN	conj	O
of	IN	case	O
apoptotic	JJ	amod	B-Cellular_component
bodies	NNS	nmod	I-Cellular_component
.	.	punct	O

It	PRP	nsubj	O
activated	VBD	ROOT	O
multicaspases	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
increased	VBD	conj	O
the	DT	det	O
activities	NNS	dobj	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
8	CD	nmod	I-Gene_or_gene_product0
and	CC	cc	O
caspase	NN	conj	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
9	CD	dep	I-Gene_or_gene_product3
in	IN	case	O
both	DT	cc:preconj	O
MG	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
63	CD	dep	I-Cell
and	CC	cc	O
SaOS	NNP	compound	B-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
highlight	VBP	ROOT	O
sanguinarine	NN	dobj	B-Simple_chemical
as	IN	case	O
a	DT	det	O
novel	JJ	amod	O
potential	JJ	amod	O
agent	NN	nmod	O
for	IN	case	O
bone	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
therapy	NN	nmod	O
.	.	punct	O

Actin	NNP	compound	B-Gene_or_gene_product2
-	HYPH	punct	O
sequestering	VBG	compound	O
protein	NN	nsubj	O
,	,	punct	O
thymosin	NN	compound	B-Gene_or_gene_product0
beta	NN	conj	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
4	CD	nummod	I-Gene_or_gene_product0
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
novel	JJ	amod	O
hypoxia	NN	compound	O
responsive	JJ	amod	O
regulator	NN	ROOT	O
.	.	punct	O

Angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
soluble	JJ	amod	O
factors	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
vascular	JJ	amod	B-Gene_or_gene_product0
endothelial	JJ	amod	I-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	nmod	I-Gene_or_gene_product0
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
released	VBN	acl	O
from	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
hypoxia	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
enhances	VBZ	ROOT	O
solid	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
growth	NN	dobj	O
and	CC	cc	O
provides	VBZ	conj	O
an	DT	det	O
ability	NN	dobj	O
to	TO	mark	O
establish	VB	acl	O
metastasis	NN	dobj	O
at	IN	case	O
peripheral	JJ	amod	B-Multi-tissue_structure
sites	NNS	nmod	I-Multi-tissue_structure
by	IN	case	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
.	.	punct	O

Thymosin	NN	compound	B-Gene_or_gene_product0
beta	NN	nsubj	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
4	CD	nummod	I-Gene_or_gene_product0
(	-LRB-	punct	O
TB4	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
is	VBZ	cop	O
an	DT	det	O
actin	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	O
sequestering	VBG	compound	O
protein	NN	ROOT	O
to	TO	mark	O
control	VB	acl	O
cytoskeletal	JJ	amod	B-Cellular_component
reorganization	NN	dobj	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
whether	IN	mark	O
angiogenesis	NN	nsubj	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
metastasis	NN	conj	O
are	VBP	cop	O
dependent	JJ	ccomp	O
on	IN	case	O
hypoxia	NN	compound	O
conditioning	NN	compound	O
-	:	punct	O
induced	VBN	amod	O
TB4	NN	compound	B-Gene_or_gene_product1
expression	NN	nmod	O
in	IN	case	O
B16F10	NN	compound	B-Cell
melanoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

TB4	NN	compound	B-Gene_or_gene_product1
expression	NN	nsubjpass	O
in	IN	case	O
B16F10	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
was	VBD	auxpass	O
increased	VBN	ROOT	O
by	IN	case	O
hypoxia	NN	nmod	O
conditioning	NN	acl	O
in	IN	case	O
a	DT	det	O
time	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
an	DT	det	O
increase	NN	dobj	O
of	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
HIF	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
1alpha	NN	conj	I-Gene_or_gene_product1
expression	NN	dep	O
in	IN	case	O
TB4	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	O
transgenic	JJ	amod	O
(	-LRB-	punct	O
Tg	NN	dep	O
)	-RRB-	punct	O
mice	NNS	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
wildtype	JJ	compound	O
mice	NNS	nmod	B-Organism
.	.	punct	O

When	WRB	advmod	O
wound	NN	compound	B-Pathological_formation
healing	NN	compound	O
assay	NN	nsubjpass	O
was	VBD	auxpass	O
used	VBN	advcl	O
to	TO	mark	O
assess	VB	xcomp	O
in	FW	amod	O
vitro	FW	dep	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
,	,	punct	O
hypoxia	NN	nsubj	O
conditioning	NN	acl	O
for	IN	case	O
1	CD	nummod	O
h	NN	nmod	O
enhanced	VBD	ROOT	O
B16F10	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
.	.	punct	O

When	WRB	advmod	O
TB4	NN	compound	B-Gene_or_gene_product1
expression	NN	nsubjpass	O
in	IN	case	O
B16F10	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
was	VBD	auxpass	O
inhibited	VBN	advcl	O
by	IN	case	O
the	DT	det	O
infection	NN	nmod	O
with	IN	case	O
small	JJ	amod	O
hairpin	NN	compound	O
(	-LRB-	punct	O
sh	NN	compound	O
)	-RRB-	punct	O
RNA	NN	nmod	O
of	IN	case	O
TB4	NN	nmod	B-Gene_or_gene_product1
cloned	VBN	acl	O
in	IN	case	O
lentiviral	JJ	amod	B-Organism
vector	NN	nmod	O
,	,	punct	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	nsubjpass	O
was	VBD	auxpass	O
retarded	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
hypoxia	NN	compound	O
conditioning	NN	compound	O
-	:	punct	O
induced	VBN	amod	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	nsubjpass	O
was	VBD	auxpass	O
reduced	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
infection	NN	nmod	O
of	IN	case	O
lentiviral	JJ	amod	B-Organism
shRNA	NN	nmod	O
of	IN	case	O
TB4	NN	nmod	B-Gene_or_gene_product1
.	.	punct	O

HIF	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
1alpha	NN	compound	I-Gene_or_gene_product1
stabilization	NN	nsubjpass	O
and	CC	cc	O
the	DT	det	O
expression	NN	conj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product1
isoform	NN	nmod	O
165	CD	nummod	O
and	CC	cc	O
121	CD	conj	O
in	IN	case	O
hypoxia	NN	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
reduced	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
infection	NN	nmod	O
of	IN	case	O
lentiviral	JJ	amod	B-Organism
shRNA	NN	nmod	O
of	IN	case	O
TB4	NN	nmod	B-Gene_or_gene_product1
in	IN	case	O
B16F10	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
found	VBD	ROOT	O
an	DT	det	O
increase	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
lung	NN	compound	B-Organ
metastasis	NN	conj	O
count	NN	acl	O
in	IN	case	O
TB4	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	O
Tg	NN	compound	O
mice	NNS	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
wildtype	JJ	compound	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Collectively	RB	advmod	O
,	,	punct	O
hypoxia	NN	ROOT	O
conditioning	NN	acl	O
induced	VBD	amod	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
by	IN	case	O
TB4	NN	nmod:npmod	B-Gene_or_gene_product1
expression	NN	nmod:npmod	O
-	:	punct	O
dependent	JJ	amod	O
HIF	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
1alpha	NN	compound	I-Gene_or_gene_product1
stabilization	NN	nmod	O
.	.	punct	O

It	PRP	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
TB4	NN	nsubj	B-Gene_or_gene_product1
could	MD	aux	O
be	VB	cop	O
a	DT	det	O
hypoxia	NN	compound	O
responsive	JJ	amod	O
regulator	NN	ccomp	O
to	TO	mark	O
control	VB	acl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
in	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
metastasis	NN	conj	O
.	.	punct	O

Androgen	NN	nsubj	B-Simple_chemical
stimulates	VBZ	ROOT	O
glycolysis	NN	dobj	O
for	IN	case	O
de	FW	amod	O
novo	FW	dep	O
lipid	NN	compound	B-Simple_chemical
synthesis	NN	nmod	O
by	IN	mark	O
increasing	VBG	advcl	O
the	DT	det	O
activities	NNS	dobj	O
of	IN	case	O
hexokinase	NN	nmod	B-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
and	CC	cc	O
6	CD	conj	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
phosphofructo	NN	compound	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
kinase	NN	compound	I-Gene_or_gene_product2
/	:	punct	I-Gene_or_gene_product2
fructose	NN	compound	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
2	CD	dep	I-Gene_or_gene_product2
,	,	punct	I-Gene_or_gene_product2
6	CD	nummod	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
bisphosphatase	NN	dep	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
in	IN	case	O
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Up	IN	compound	O
-	HYPH	punct	O
regulation	NN	nsubj	O
of	IN	case	O
lipogenesis	NN	nmod	O
by	IN	case	O
androgen	NN	nmod	B-Simple_chemical
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
characteristic	JJ	amod	O
metabolic	JJ	amod	O
features	NNS	nmod	O
of	IN	case	O
LNCaP	NN	compound	B-Cell
prostate	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
study	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
androgen	NN	nsubj	B-Simple_chemical
increases	VBZ	ccomp	O
glucose	NN	compound	B-Simple_chemical
utilization	NN	dobj	O
for	IN	case	O
de	FW	amod	O
novo	FW	dep	O
lipogenesis	NN	nmod	O
in	IN	case	O
LNCaP	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
through	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
HK2	NN	nmod	B-Gene_or_gene_product1
(	-LRB-	punct	O
hexokinase	NN	appos	B-Gene_or_gene_product0
2	CD	nummod	I-Gene_or_gene_product0
)	-RRB-	punct	I-Gene_or_gene_product0
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
the	DT	det	O
cardiac	JJ	amod	B-Organ
isoform	NN	nmod	O
of	IN	case	O
PFKFB2	NN	nmod	B-Gene_or_gene_product1
(	-LRB-	punct	O
6	CD	nummod	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
phosphofructo	NN	compound	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
2	CD	nummod	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
kinase	NN	intj	I-Gene_or_gene_product1
/	:	punct	I-Gene_or_gene_product1
fructose	NN	dep	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
2	CD	dep	I-Gene_or_gene_product1
,	,	punct	I-Gene_or_gene_product1
6	CD	nummod	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
bisphosphatase	NN	dep	I-Gene_or_gene_product1
)	-RRB-	punct	O
.	.	punct	O

Activation	NN	nsubj	O
of	IN	case	O
PKA	NN	nmod	B-Gene_or_gene_product1
(	-LRB-	punct	O
cAMP	NN	nmod:npmod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
dependent	JJ	amod	I-Gene_or_gene_product2
protein	NN	compound	I-Gene_or_gene_product2
kinase	NN	appos	I-Gene_or_gene_product2
)	-RRB-	punct	O
by	IN	case	O
androgen	NN	nmod	B-Simple_chemical
increased	VBD	ROOT	O
phosphorylation	NN	dobj	O
of	IN	case	O
CREB	NN	compound	B-Gene_or_gene_product1
[	-LRB-	punct	O
CRE	NN	compound	B-Gene_or_gene_product2
(	-LRB-	punct	I-Gene_or_gene_product2
cAMP	NN	compound	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
response	NN	compound	I-Gene_or_gene_product2
element	NN	dep	I-Gene_or_gene_product2
)	-RRB-	punct	I-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
binding	NN	compound	I-Gene_or_gene_product2
protein	NN	nmod	I-Gene_or_gene_product2
]	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
in	IN	case	O
turn	NN	nmod	O
bound	VBN	acl:relcl	O
to	TO	case	O
CRE	NN	nmod	O
on	IN	case	O
the	DT	det	O
promoter	NN	nmod	O
of	IN	case	O
the	DT	det	O
HK2	NN	compound	B-Gene_or_gene_product1
gene	NN	nmod	O
resulting	VBG	acl	O
in	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
HK2	NN	compound	B-Gene_or_gene_product1
gene	NN	nmod	O
.	.	punct	O

Up	IN	case	O
-	HYPH	punct	O
regulation	NN	nsubjpass	O
of	IN	case	O
PFKFB2	NN	compound	B-Gene_or_gene_product1
expression	NN	nmod	O
was	VBD	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
direct	JJ	amod	O
binding	NN	nmod	O
of	IN	case	O
ligand	NN	nmod:npmod	O
-	HYPH	punct	O
activated	VBN	amod	O
androgen	NN	compound	B-Simple_chemical
receptor	NN	nmod	O
to	TO	case	O
the	DT	det	O
PFKFB2	NN	compound	B-Gene_or_gene_product1
promoter	NN	nmod	O
.	.	punct	O

The	DT	det	O
activated	VBN	amod	O
PI3K	NN	compound	B-Gene_or_gene_product1
(	-LRB-	punct	O
phosphoinositide	NN	compound	B-Gene_or_gene_product1
3	CD	nummod	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
kinase	NN	appos	I-Gene_or_gene_product1
)	-RRB-	punct	O
/	:	punct	O
Akt	DT	compound	B-Gene_or_gene_product1
signalling	NN	acl	O
pathway	NN	nsubj	O
in	IN	case	O
LNCaP	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
contributes	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
phosphorylation	NN	nmod	O
of	IN	case	O
PFKFB2	NN	nmod	B-Gene_or_gene_product1
at	IN	case	O
Ser466	NN	nmod	B-Amino_acid
and	CC	cc	O
Ser483	NN	conj	B-Amino_acid
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
the	DT	det	O
constitutive	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
PFK	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
2	CD	nummod	I-Gene_or_gene_product1
(	-LRB-	punct	O
6	CD	nummod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
phosphofructo	NN	compound	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
kinase	NN	appos	I-Gene_or_gene_product2
)	-RRB-	punct	O
activity	NN	nmod	O
.	.	punct	O

Glucose	NN	compound	B-Simple_chemical
uptake	NN	nsubjpass	O
and	CC	cc	O
lipogenesis	NN	conj	O
were	VBD	auxpass	O
severely	RB	advmod	O
blocked	VBN	ROOT	O
by	IN	mark	O
knocking	VBG	advcl	O
-	HYPH	punct	O
down	NN	advmod	O
of	IN	case	O
PFKFB2	NN	nmod	B-Gene_or_gene_product1
using	VBG	xcomp	O
siRNA	NN	dobj	O
(	-LRB-	punct	O
small	JJ	amod	O
interfering	VBG	amod	O
RNA	NN	appos	O
)	-RRB-	punct	O
or	CC	cc	O
by	IN	case	O
inhibition	NN	conj	O
of	IN	case	O
PFK	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
2	CD	nummod	I-Gene_or_gene_product1
activity	NN	nmod	O
with	IN	case	O
LY294002	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
de	FW	amod	O
novo	FW	dep	O
lipid	NN	compound	B-Simple_chemical
synthesis	NN	nmod	O
by	IN	case	O
androgen	NN	nmod	B-Simple_chemical
requires	VBZ	ccomp	O
the	DT	det	O
transcriptional	JJ	amod	O
up	RP	dep	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
HK2	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
PFKFB2	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
and	CC	cc	O
phosphorylation	NN	conj	O
of	IN	case	O
PFKFB2	NN	nmod	B-Gene_or_gene_product1
generated	VBN	acl	O
by	IN	case	O
the	DT	det	O
PI3K	NN	compound	B-Gene_or_gene_product1
/	:	punct	O
Akt	DT	nmod	B-Gene_or_gene_product1
signalling	NN	compound	O
pathway	NN	nmod	O
to	TO	mark	O
supply	VB	xcomp	O
the	DT	det	O
source	NN	dobj	O
for	IN	case	O
lipogenesis	NN	nmod	O
from	IN	case	O
glucose	NN	nmod	B-Simple_chemical
in	IN	case	O
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Diallyl	NN	compound	B-Simple_chemical
trisulfide	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
DATS	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
inhibits	VBZ	ROOT	O
mouse	NN	compound	B-Organism
colon	NN	compound	B-Cancer
tumor	NN	dobj	I-Cancer
in	IN	case	O
mouse	NN	compound	B-Organism
CT	NN	compound	B-Cell
-	:	punct	I-Cell
26	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
allograft	NN	xcomp	O
model	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
earlier	JJR	amod	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
DATS	NN	nsubj	B-Simple_chemical
induced	VBD	ccomp	O
apoptosis	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cell
cancer	NN	nmod	I-Cell
HT29	NN	dep	I-Cell
and	CC	cc	O
colo	VBZ	compound	B-Cell
205	CD	nummod	I-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
no	DT	det	O
report	NN	nsubj	O
to	TO	mark	O
show	VB	acl	O
that	IN	mark	O
DATS	NN	nsubj	B-Simple_chemical
induced	VBD	ccomp	O
apoptosis	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
inhibited	VBD	conj	O
CT26	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
in	FW	compound	O
vivo	FW	advmod	O
on	IN	case	O
a	DT	det	O
murine	JJ	amod	B-Organism
allograft	NN	compound	O
animal	NN	compound	O
model	NN	nmod	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
studies	NNS	nmod	O
,	,	punct	O
the	DT	det	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
DATS	NN	nsubj	B-Simple_chemical
induced	VBD	ccomp	O
morphological	JJ	amod	O
changes	NNS	dobj	O
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
in	IN	case	O
CT26	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
studies	NNS	nmod	O
,	,	punct	O
CT26	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nsubjpass	I-Cell
were	VBD	auxpass	O
implanted	VBN	ROOT	O
into	IN	case	O
BALB	NN	compound	B-Organism
/	:	punct	I-Organism
c	NN	compound	I-Organism
mice	NNS	nmod	I-Organism
and	CC	cc	O
groups	NNS	conj	O
of	IN	case	O
mice	NNS	nmod	B-Organism
were	VBD	auxpass	O
treated	VBN	conj	O
with	IN	case	O
vehicle	NN	nmod	O
,	,	punct	O
DATS	NN	compound	B-Simple_chemical
(	-LRB-	punct	O
10	CD	nummod	O
and	CC	cc	O
50	CD	conj	O
mg	NN	compound	O
/	:	punct	O
kg	NN	appos	O
of	IN	case	O
body	NN	compound	B-Organism_subdivision
weight	NN	nmod	O
)	-RRB-	punct	O
.	.	punct	O

DATS	NN	nsubjpass	B-Simple_chemical
were	VBD	auxpass	O
injected	VBN	ROOT	O
once	RB	case	O
per	IN	case	O
four	CD	nummod	O
days	NNS	nmod	O
intraperitoneally	RB	advmod	B-Immaterial_anatomical_entity
(	-LRB-	punct	O
i	LS	dep	O
.	.	punct	O
p	NN	ROOT	O
.	.	punct	O
)	-RRB-	punct	O
,	,	punct	O
with	IN	case	O
treatment	NN	nmod	O
starting	VBG	acl	O
4	CD	nummod	O
weeks	NNS	dobj	O
prior	RB	amod	O
to	TO	mwe	O
cells	NNS	compound	B-Cell
inoculation	NN	dep	O
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	prep	O
vehicle	NN	pobj	O
or	CC	cc	O
with	IN	case	O
10	CD	nummod	O
and	CC	cc	O
50	CD	conj	O
mg	NN	compound	O
/	:	punct	O
kg	NN	nsubj	O
of	IN	case	O
DATS	NN	nmod	B-Simple_chemical
resulted	VBD	ROOT	O
in	IN	case	O
a	DT	det	O
reduction	NN	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cancer
volume	NN	nmod	O
and	CC	cc	O
weight	NN	conj	O
.	.	punct	O

Tumor	NN	compound	B-Cancer
volume	NN	nsubj	O
and	CC	cc	O
total	JJ	amod	O
hemoglobin	NN	conj	B-Gene_or_gene_product0
in	IN	case	O
allograft	NN	compound	O
mice	NNS	nmod	B-Organism
treated	VBN	acl	O
with	IN	case	O
50	CD	compound	O
mg	NN	compound	O
/	:	punct	O
kg	NN	compound	O
DATS	NN	nmod	B-Simple_chemical
were	VBD	cop	O
significantly	RB	advmod	O
smaller	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
in	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
DATS	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ccomp	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
in	IN	case	O
an	DT	det	O
allograft	NN	compound	O
animal	NN	compound	O
model	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
DATS	NN	nsubj	B-Simple_chemical
may	MD	aux	O
represent	VB	ROOT	O
a	DT	det	O
colon	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
preventive	JJ	amod	O
agent	NN	dobj	O
and	CC	cc	O
can	MD	aux	O
be	VB	auxpass	O
used	VBN	conj	O
in	IN	prep	O
the	DT	det	O
future	NN	pobj	O
.	.	punct	O

High	NNP	amod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
mobility	NN	compound	I-Gene_or_gene_product2
group	NN	compound	I-Gene_or_gene_product2
A2	NN	compound	I-Gene_or_gene_product2
protein	NN	nsubj	O
modulates	VBZ	ROOT	O
hTERT	NN	compound	B-Gene_or_gene_product1
transcription	NN	dobj	O
to	TO	mark	O
promote	VB	xcomp	O
tumorigenesis	NN	dobj	O
.	.	punct	O

The	DT	det	O
high	JJ	amod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
mobility	NN	compound	I-Gene_or_gene_product2
group	NN	compound	I-Gene_or_gene_product2
A2	NN	compound	I-Gene_or_gene_product2
gene	NN	nsubj	O
(	-LRB-	punct	O
HMGA2	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
is	VBZ	cop	O
one	CD	ROOT	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
frequently	RB	advmod	O
amplified	VBD	amod	O
genes	NNS	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
functions	NNS	nsubjpass	O
of	IN	case	O
HMGA2	NN	nmod	B-Gene_or_gene_product1
in	IN	case	O
tumorigenesis	NN	nmod	O
are	VBP	auxpass	O
not	RB	neg	O
fully	RB	advmod	O
understood	VBN	ROOT	O
due	JJ	case	O
to	TO	case	O
limited	JJ	amod	O
knowledge	NN	nmod	O
of	IN	case	O
its	PRP$	nmod:poss	O
targets	NNS	nmod	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Our	PRP$	nmod:poss	O
study	NN	nsubj	O
reveals	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
HMGA2	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
the	DT	det	O
regulation	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Organism
telomerase	NN	compound	B-Gene_or_gene_product0
reverse	JJ	compound	I-Gene_or_gene_product0
transcriptase	NN	nmod	I-Gene_or_gene_product0
(	-LRB-	punct	O
hTERT	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
catalytic	JJ	amod	O
subunit	NN	appos	O
of	IN	case	O
telomerase	NN	nmod	B-Gene_or_gene_product0
,	,	punct	O
which	WDT	nsubj	O
offers	VBZ	acl:relcl	O
critical	JJ	amod	O
insight	NN	dobj	O
into	IN	mark	O
how	WRB	advmod	O
HMGA2	NN	nsubj	B-Gene_or_gene_product1
contributes	VBZ	advcl	O
to	TO	case	O
tumorigenesis	NN	nmod	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
HMGA2	NN	nmod	B-Gene_or_gene_product1
modulates	VBZ	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
hTERT	NN	nmod	B-Gene_or_gene_product1
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
cells	NNS	nmod	B-Cell
with	IN	case	O
enhanced	VBN	amod	O
telomerase	NN	compound	B-Gene_or_gene_product0
activities	NNS	nmod	O
and	CC	cc	O
increased	VBD	amod	O
telomere	RB	compound	B-Cellular_component
length	NN	conj	O
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
suberoylanilide	NN	amod	B-Simple_chemical
hydroxamide	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
SAHA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
histone	NN	compound	B-Gene_or_gene_product0
deacetylase	NN	compound	I-Gene_or_gene_product0
(	-LRB-	punct	O
HDAC	NN	compound	B-Gene_or_gene_product1
)	-RRB-	punct	O
inhibitor	NN	appos	O
,	,	punct	O
causes	VBZ	ROOT	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
hTERT	NN	compound	B-Gene_or_gene_product1
reporter	NN	compound	O
activation	NN	dobj	O
,	,	punct	O
mimicking	VBG	advcl	O
HMGA2	NN	compound	B-Gene_or_gene_product1
overexpression	NN	dobj	O
.	.	punct	O

By	IN	mark	O
interacting	VBG	advcl	O
with	IN	case	O
Sp1	NN	nmod	B-Gene_or_gene_product3
,	,	punct	O
HMGA2	NN	nsubj	B-Gene_or_gene_product1
interferes	VBZ	ROOT	O
with	IN	case	O
the	DT	det	O
recruitment	NN	nmod	O
of	IN	case	O
HDAC2	NN	nmod	B-Gene_or_gene_product1
to	TO	case	O
the	DT	det	O
hTERT	NN	compound	B-Gene_or_gene_product1
proximal	JJ	amod	O
promoter	NN	nmod	O
,	,	punct	O
enhancing	VBG	xcomp	O
localized	JJ	amod	O
histone	NN	compound	B-Gene_or_gene_product2
H3	NN	compound	I-Gene_or_gene_product2
-	:	punct	O
K9	NN	compound	O
acetylation	NN	dobj	O
and	CC	cc	O
thereby	RB	advmod	O
stimulating	VBG	conj	O
hTERT	NN	compound	B-Gene_or_gene_product1
expression	NN	dobj	O
and	CC	cc	O
telomerase	NN	compound	B-Gene_or_gene_product2
activity	NN	conj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
HMGA2	NN	compound	B-Gene_or_gene_product1
knockdown	NN	nsubj	O
by	IN	case	O
short	JJ	amod	O
hairpin	NN	compound	O
HMGA2	NN	nmod	B-Gene_or_gene_product1
in	IN	case	O
HepG2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
leads	VBZ	ROOT	O
to	TO	case	O
progressive	VB	amod	O
telomere	RB	compound	B-Cellular_component
shortening	VBG	nmod	O
and	CC	cc	O
a	DT	det	O
concurrent	JJ	amod	O
decrease	NN	conj	O
of	IN	case	O
steady	JJ	amod	O
-	HYPH	punct	O
state	NN	compound	O
hTERT	NN	compound	B-Gene_or_gene_product1
mRNA	NN	compound	O
levels	NNS	nmod	O
,	,	punct	O
attenuating	VBG	xcomp	O
their	PRP$	nmod:poss	O
ability	NN	dobj	O
to	TO	aux	O
form	VB	acl	O
colonies	NNS	dobj	O
in	IN	prep	O
soft	JJ	amod	O
agar	NN	pobj	O
.	.	punct	O

Importantly	RB	advmod	O
,	,	punct	O
HMGA2	NN	nsubj	B-Gene_or_gene_product1
partially	RB	advmod	O
replaces	VBZ	ROOT	O
the	DT	det	O
function	NN	dobj	O
of	IN	case	O
hTERT	NN	nmod	B-Gene_or_gene_product1
during	IN	case	O
the	DT	det	O
tumorigenic	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
are	VBP	cop	O
potentially	RB	advmod	O
clinically	RB	advmod	O
relevant	JJ	ROOT	O
,	,	punct	O
because	IN	mark	O
HMGA2	NN	compound	B-Gene_or_gene_product1
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
reported	VBN	advcl	O
to	TO	mark	O
be	VB	auxpass	O
upregulated	VBN	xcomp	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
as	IN	case	O
telomere	RB	compound	B-Cellular_component
maintenance	NN	nmod	O
is	VBZ	cop	O
essential	JJ	conj	O
for	IN	case	O
tumorigenesis	NN	nmod	O
.	.	punct	O

Hedgehog	JJ	amod	B-Gene_or_gene_product2
signaling	NN	ROOT	O
:	:	punct	O
networking	VBG	dep	O
to	TO	mark	O
nurture	VB	xcomp	O
a	DT	det	O
promalignant	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
microenvironment	NN	dobj	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
to	TO	case	O
its	PRP$	nmod:poss	O
role	NN	nmod	O
in	IN	case	O
embryonic	JJ	amod	B-Developing_anatomical_structure
development	NN	nmod	O
,	,	punct	O
the	DT	det	O
Hedgehog	NNP	compound	B-Gene_or_gene_product2
pathway	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
active	JJ	amod	O
participant	NN	xcomp	O
in	IN	case	O
cancer	NN	compound	B-Cancer
development	NN	nmod	O
,	,	punct	O
progression	NN	conj	O
,	,	punct	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

Although	IN	mark	O
this	DT	det	O
pathway	NN	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	advcl	O
by	IN	case	O
autocrine	JJ	amod	O
signaling	NN	nmod	O
by	IN	case	O
Hedgehog	JJ	compound	B-Gene_or_gene_product2
ligands	NNS	nmod	O
,	,	punct	O
it	PRP	nsubj	O
can	MD	aux	O
also	RB	advmod	O
initiate	VB	ROOT	O
paracrine	NN	amod	O
signaling	NN	dobj	O
with	IN	case	O
cells	NNS	nmod	B-Cell
in	IN	case	O
the	DT	det	O
microenvironment	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
creates	VBZ	ROOT	O
a	DT	det	O
network	NN	dobj	O
of	IN	prep	O
Hedgehog	NNP	compound	B-Gene_or_gene_product2
signaling	NN	pobj	O
that	WDT	nsubj	O
determines	VBZ	relcl	O
the	DT	det	O
malignant	JJ	amod	O
behavior	NN	dobj	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

As	IN	case	O
a	DT	det	O
result	NN	nmod	O
of	IN	case	O
paracrine	NN	amod	O
signal	NN	compound	O
transmission	NN	nmod	O
,	,	punct	O
the	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
Hedgehog	JJ	compound	B-Gene_or_gene_product1
signaling	NN	nmod	O
most	RBS	advmod	O
profoundly	RB	advmod	O
influence	VBP	ROOT	O
the	DT	det	O
stromal	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
that	WDT	nsubj	O
constitute	VBP	acl:relcl	O
the	DT	det	O
tumor	NN	compound	B-Cancer
microenvironment	NN	dobj	O
.	.	punct	O

The	DT	det	O
stromal	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
in	IN	case	O
turn	NN	nmod	O
produce	VBP	ROOT	O
factors	NNS	dobj	O
that	WDT	nsubj	O
nurture	VBP	acl:relcl	O
the	DT	det	O
tumor	NN	dobj	B-Cancer
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
such	PDT	predet	O
a	DT	det	O
resonating	NN	amod	O
cross	NN	compound	O
-	HYPH	punct	O
talk	NN	nsubj	O
can	MD	aux	O
amplify	VB	ROOT	O
Hedgehog	JJ	compound	B-Gene_or_gene_product2
signaling	NN	dobj	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
molecular	JJ	amod	O
chatter	NN	nmod	O
that	WDT	nsubj	O
overall	RB	advmod	O
promotes	VBZ	acl:relcl	O
tumor	NN	compound	B-Cancer
progression	NN	dobj	O
.	.	punct	O

Inhibitors	NNS	nsubj	O
of	IN	case	O
Hedgehog	JJ	compound	B-Gene_or_gene_product2
signaling	NN	nmod	O
have	VBP	aux	O
been	VBN	cop	O
the	DT	det	O
subject	NN	ROOT	O
of	IN	prep	O
intense	JJ	amod	O
research	NN	pobj	O
.	.	punct	O

Several	JJ	nsubjpass	O
of	IN	case	O
these	DT	det	O
inhibitors	NNS	nmod	O
are	VBP	auxpass	O
currently	RB	advmod	O
being	VBG	auxpass	O
evaluated	VBN	ROOT	O
in	IN	case	O
clinical	JJ	amod	O
trials	NNS	nmod	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
review	VBP	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
the	DT	det	O
Hedgehog	NNP	compound	B-Gene_or_gene_product2
pathway	NN	nmod	O
in	IN	case	O
the	DT	det	O
signature	NN	amod	O
characteristics	NNS	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
determine	VBP	acl:relcl	O
tumor	NN	compound	B-Cancer
development	NN	dobj	O
,	,	punct	O
progression	NN	conj	O
,	,	punct	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

This	DT	det	O
review	NN	nsubj	O
condenses	VBZ	ROOT	O
the	DT	det	O
latest	JJS	amod	O
findings	NNS	dobj	O
on	IN	case	O
the	DT	det	O
signaling	NN	compound	O
pathways	NNS	nmod	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
activated	VBN	acl:relcl	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
regulated	VBN	conj	O
by	IN	case	O
molecules	NNS	nmod	O
generated	VBN	acl	O
from	IN	case	O
Hedgehog	JJ	compound	B-Gene_or_gene_product1
signaling	NN	nmod	O
in	IN	case	O
cancer	NN	nmod	B-Cancer
and	CC	cc	O
cites	NNS	conj	O
promising	VBG	acl	O
clinical	JJ	amod	O
interventions	NNS	dobj	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
discuss	VBP	ROOT	O
future	JJ	amod	O
directions	NNS	dobj	O
for	IN	mark	O
identifying	VBG	acl	O
the	DT	det	O
appropriate	JJ	amod	O
patients	NNS	dobj	B-Organism
for	IN	case	O
therapy	NN	nmod	O
,	,	punct	O
developing	VBG	advcl	O
reliable	JJ	amod	O
markers	NNS	dobj	O
of	IN	case	O
efficacy	NN	nmod	O
of	IN	case	O
treatment	NN	nmod	O
,	,	punct	O
and	CC	cc	O
combating	VBG	conj	O
resistance	NN	dobj	O
to	IN	prep	O
Hedgehog	NN	compound	B-Gene_or_gene_product2
pathway	NN	compound	O
inhibitors	NNS	pobj	O
.	.	punct	O

Analysis	NN	ROOT	O
of	IN	case	O
molecular	JJ	amod	O
aberrations	NNS	nmod	O
of	IN	case	O
Wnt	NN	compound	B-Gene_or_gene_product2
pathway	NN	compound	O
gladiators	NNS	nmod	O
in	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
in	IN	case	O
the	DT	det	O
Kashmiri	NNP	compound	O
population	NN	nmod	O
.	.	punct	O

The	DT	det	O
development	NN	nsubj	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
(	-LRB-	punct	O
CRC	NN	appos	B-Cancer
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
multi	NN	amod	O
-	HYPH	punct	O
step	NN	compound	O
process	NN	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
Wnt	NN	compound	B-Gene_or_gene_product2
pathways	NNS	nsubj	O
with	IN	case	O
its	PRP$	nmod:poss	O
two	CD	nummod	O
molecular	JJ	amod	O
gladiators	NNS	compound	O
adenomatous	JJ	amod	B-Gene_or_gene_product1
polyposis	NN	compound	I-Gene_or_gene_product1
coli	NN	nmod	I-Gene_or_gene_product1
(	-LRB-	punct	O
APC	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
catenin	NN	conj	I-Gene_or_gene_product0
plays	VBZ	conj	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
transforming	VBG	advcl	O
a	DT	det	O
normal	JJ	amod	B-Tissue
tissue	NN	dobj	I-Tissue
into	IN	case	O
a	DT	det	O
malignant	JJ	amod	B-Cancer
one	CD	nmod	I-Cancer
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
aimed	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
aberrations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
APC	NN	compound	B-Gene_or_gene_product1
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
catenin	NN	conj	I-Gene_or_gene_product0
genes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
CRC	NN	nmod	B-Cancer
in	IN	case	O
the	DT	det	O
Kashmir	NN	compound	O
valley	NN	nmod	O
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
correlate	VB	conj	O
it	PRP	dobj	O
with	IN	case	O
various	JJ	amod	O
clinicopathological	JJ	amod	O
variables	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
paired	JJ	amod	O
tumour	NN	dobj	B-Cancer
and	CC	cc	O
normal	JJ	amod	O
-	HYPH	punct	O
tissue	NN	compound	B-Tissue
specimens	NNS	conj	I-Tissue
of	IN	case	O
86	CD	nummod	O
CRC	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
for	IN	case	O
the	DT	det	O
occurrence	NN	nmod	O
of	IN	case	O
aberrations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
mutation	NN	compound	O
cluster	NN	compound	O
region	NN	nmod	O
(	-LRB-	punct	O
MCR	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
APC	NN	compound	B-Gene_or_gene_product1
gene	NN	nmod	O
and	CC	cc	O
exon	NN	conj	O
3	CD	nummod	O
of	IN	case	O
the	DT	det	O
beta	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
catenin	NN	compound	I-Gene_or_gene_product0
gene	NN	nmod	O
by	IN	case	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	compound	O
-	HYPH	punct	O
single	JJ	amod	O
-	HYPH	punct	O
strand	NN	compound	O
conformation	NN	compound	O
polymorphism	NN	nmod	O
(	-LRB-	punct	O
PCR	NN	compound	O
-	:	punct	O
SSCP	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
PCR	NN	compound	O
-	HYPH	punct	O
direct	JJ	amod	O
sequencing	NN	conj	O
.	.	punct	O

Analysis	NN	nsubjpass	O
of	IN	case	O
promoter	NN	compound	O
hypermethylation	NN	nmod	O
of	IN	case	O
the	DT	det	O
APC	NN	compound	B-Gene_or_gene_product1
gene	NN	nmod	O
was	VBD	auxpass	O
also	RB	advmod	O
carried	VBN	ROOT	O
out	RP	prt	O
using	VBG	xcomp	O
methylation	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
PCR	NN	dobj	O
(	-LRB-	punct	O
MS	NN	compound	O
-	:	punct	O
PCR	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
overall	JJ	amod	O
mutation	NN	compound	O
rate	NN	nsubj	O
of	IN	case	O
the	DT	det	O
MCR	NN	nmod	O
of	IN	case	O
the	DT	det	O
APC	NN	compound	B-Gene_or_gene_product1
gene	NN	nmod	O
among	IN	case	O
86	CD	nummod	O
CRC	NN	compound	B-Cancer
cases	NNS	nmod	O
was	VBD	cop	O
12	CD	ROOT	O
.	.	punct	O
8	CD	ROOT	O
per	IN	case	O
cent	JJ	nmod	O
(	-LRB-	punct	O
11	CD	dep	O
of	IN	advmod	O
86	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

Promoter	NN	compound	O
hypermethylation	NN	nsubjpass	O
of	IN	case	O
APC	NN	nmod	B-Gene_or_gene_product1
was	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
54	CD	nmod	O
.	.	punct	O
65	CD	dep	O
per	IN	case	O
cent	JJ	nmod	O
(	-LRB-	punct	O
47	CD	compound	O
of	IN	advmod	O
86	CD	dep	O
)	-RRB-	punct	O
of	IN	case	O
cases	NNS	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
association	NN	dobj	O
between	IN	case	O
tumour	NN	compound	B-Cancer
location	NN	nmod	O
,	,	punct	O
tumour	NN	compound	B-Cancer
grade	NN	compound	O
and	CC	cc	O
node	NN	conj	B-Multi-tissue_structure
status	NN	conj	O
and	CC	cc	O
the	DT	det	O
methylation	NN	compound	O
status	NN	conj	O
of	IN	case	O
the	DT	det	O
APC	NN	compound	B-Gene_or_gene_product1
gene	NN	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	:	nsubj	O
=	JJ	advcl	O
0	CD	dobj	O
.	.	punct	O
05	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
number	NN	nsubj	O
of	IN	case	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
APC	NN	compound	B-Gene_or_gene_product1
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
catenin	NN	conj	I-Gene_or_gene_product0
genes	NNS	nmod	O
in	IN	case	O
our	PRP$	nmod:poss	O
CRC	NN	compound	B-Cancer
cases	NNS	nmod	O
was	VBD	cop	O
very	RB	advmod	O
low	JJ	advcl	O
,	,	punct	O
the	DT	det	O
study	NN	nsubj	O
confirms	VBZ	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
epigenetic	JJ	amod	O
gene	NN	compound	O
silencing	NN	nmod	O
of	IN	case	O
the	DT	det	O
pivotal	JJ	amod	O
molecular	JJ	amod	O
gladiator	NN	nmod	O
,	,	punct	O
APC	NN	appos	B-Gene_or_gene_product1
,	,	punct	O
of	IN	case	O
the	DT	det	O
Wnt	NN	compound	B-Gene_or_gene_product2
pathway	NN	nmod	O
in	IN	case	O
the	DT	det	O
development	NN	nmod	O
of	IN	case	O
CRC	NN	nmod	B-Cancer
in	IN	case	O
the	DT	det	O
Kashmiri	NNP	compound	O
population	NN	nmod	O
.	.	punct	O

Aglycon	NN	nsubj	B-Simple_chemical
of	IN	prep	O
rhizochalin	NN	pobj	B-Simple_chemical
from	IN	prep	O
the	DT	det	O
Rhizochalina	NNP	compound	B-Organism
incrustata	NN	pobj	I-Organism
induces	VBZ	ROOT	O
apoptosis	NN	dobj	O
via	IN	case	O
activation	NN	nmod	O
of	IN	case	O
AMP	NN	nmod:npmod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
activated	VBN	amod	I-Gene_or_gene_product2
protein	NN	compound	I-Gene_or_gene_product2
kinase	NN	nmod	I-Gene_or_gene_product2
in	IN	case	O
HT	NN	compound	B-Cell
-	HYPH	punct	I-Cell
29	CD	nummod	I-Cell
colon	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Rhizochalin	NNP	nsubj	B-Simple_chemical
is	VBZ	ROOT	O
a	DT	det	O
two	CD	nummod	O
-	HYPH	punct	O
headed	VBN	amod	O
sphingolipid	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
like	NN	prep	O
compound	NN	pobj	O
isolated	VBN	acl	O
from	IN	prep	O
the	DT	det	O
sponge	JJ	compound	O
Rhizochalina	NNP	compound	B-Organism
incrustata	NNS	pobj	I-Organism
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
reported	VBN	ROOT	O
that	IN	mark	O
rhizocalin	NN	nsubj	B-Simple_chemical
and	CC	cc	O
its	PRP$	nmod:poss	O
derivates	NNS	conj	O
have	VBP	ccomp	O
a	DT	det	O
chemopreventive	JJ	amod	O
and	CC	cc	O
chemotherapeutic	JJ	conj	O
effect	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
molecular	JJ	amod	O
mechanism	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
effects	NNS	nmod	O
is	VBZ	auxpass	O
not	RB	neg	O
understood	VBN	ROOT	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
aglycon	NN	nsubj	B-Simple_chemical
of	IN	case	O
rhizochalin	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
AglRhz	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
from	IN	case	O
the	DT	det	O
Rhizochalina	NNP	compound	B-Organism
incrustata	NN	nmod	I-Organism
induces	VBZ	ccomp	O
AMP	NN	nmod:npmod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
activated	VBN	amod	I-Gene_or_gene_product2
protein	NN	compound	I-Gene_or_gene_product2
kinase	NN	compound	I-Gene_or_gene_product2
(	-LRB-	punct	O
AMPK	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
phosphorylation	NN	dobj	O
,	,	punct	O
and	CC	cc	O
thereby	RB	advmod	O
inhibits	VBZ	conj	O
mammalian	JJ	amod	B-Gene_or_gene_product0
target	NN	dobj	I-Gene_or_gene_product0
of	IN	case	I-Gene_or_gene_product0
rapamycin	NN	compound	I-Gene_or_gene_product0
(	-LRB-	punct	O
mTOR	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
-	:	punct	O
p70S6	NN	compound	B-Gene_or_gene_product1
kinase	NN	nmod:npmod	I-Gene_or_gene_product1
-	HYPH	punct	O
extracellular	JJ	amod	B-Gene_or_gene_product2
signal	NN	nmod:npmod	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
regulated	VBN	amod	I-Gene_or_gene_product2
kinase	NN	compound	I-Gene_or_gene_product2
(	-LRB-	punct	O
ERK	NN	appos	B-Gene_or_gene_product2
)	-RRB-	punct	O
signaling	NN	nmod	O
and	CC	cc	O
activator	NN	compound	B-Gene_or_gene_product3
protein	NN	conj	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
(	-LRB-	punct	O
AP	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	appos	I-Gene_or_gene_product3
)	-RRB-	punct	O
activity	NN	conj	O
via	IN	case	O
phosphorylation	NN	nmod	O
of	IN	case	O
Raptor	NN	nmod	B-Gene_or_gene_product2
in	IN	case	O
HT	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
29	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
AglRhz	NN	nsubj	B-Simple_chemical
induced	VBD	ROOT	O
activation	NN	dobj	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
3	CD	nummod	I-Gene_or_gene_product3
and	CC	cc	O
poly	NN	conj	B-Gene_or_gene_product1
(	-LRB-	punct	I-Gene_or_gene_product1
ADP	NN	compound	I-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
ribose	NN	amod	I-Gene_or_gene_product1
)	-RRB-	punct	I-Gene_or_gene_product1
polymerase	NN	nmod	I-Gene_or_gene_product1
(	-LRB-	punct	O
PARP	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
DNA	NN	compound	B-Cellular_component
fragmentation	NN	dep	O
in	IN	case	O
HT	NN	compound	B-Cell
-	HYPH	punct	I-Cell
29	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
leads	VBZ	conj	O
to	TO	case	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
suppression	NN	conj	O
of	IN	case	O
tumorigenicity	NN	nmod	O
of	IN	case	O
HT	NN	compound	B-Cell
-	HYPH	punct	I-Cell
29	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Notably	RB	advmod	O
,	,	punct	O
AglRhz	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ROOT	O
insulin	NN	dobj	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
like	IN	case	I-Gene_or_gene_product3
growth	NN	compound	I-Gene_or_gene_product3
factor	NN	pobj	I-Gene_or_gene_product3
(	-LRB-	punct	I-Gene_or_gene_product3
IGF	NN	appos	I-Gene_or_gene_product3
)	-RRB-	punct	I-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
-	HYPH	punct	O
induced	VBN	amod	O
AP	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
activity	NN	nmod	O
and	CC	cc	O
cell	NN	compound	B-Cell
transformation	NN	conj	O
in	IN	case	O
JB6	NN	compound	B-Cell
Cl41	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Overall	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
findings	NNS	nsubj	O
identify	VBP	ROOT	O
AMPK	NN	dobj	B-Gene_or_gene_product1
as	IN	case	O
an	DT	det	O
important	JJ	amod	O
target	NN	compound	O
protein	NN	nmod	O
for	IN	mark	O
mediating	VBG	acl	O
the	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
properties	NNS	dobj	O
of	IN	case	O
AglRhz	NN	nmod	B-Simple_chemical
in	IN	case	O
HT	NN	compound	B-Cell
-	HYPH	punct	I-Cell
29	CD	nummod	I-Cell
colon	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
have	VBP	conj	O
important	JJ	amod	O
implication	NN	dobj	O
for	IN	case	O
sponges	NNS	nmod	O
,	,	punct	O
the	DT	det	O
most	RBS	advmod	O
important	JJ	amod	O
marine	NN	compound	O
source	NN	dobj	O
,	,	punct	O
in	IN	case	O
colon	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Expression	NN	ROOT	O
of	IN	case	O
thymidylate	JJ	compound	B-Gene_or_gene_product0
synthase	NN	nmod	I-Gene_or_gene_product0
and	CC	cc	O
dihydropyrimidine	NN	compound	B-Gene_or_gene_product0
dehydrogenase	NN	conj	I-Gene_or_gene_product0
in	IN	case	O
primary	JJ	amod	B-Cancer
oral	JJ	amod	I-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nmod	I-Cancer
and	CC	cc	O
corresponding	JJ	amod	O
metastases	NNS	conj	O
in	IN	case	O
cervical	JJ	amod	B-Multi-tissue_structure
lymph	NN	compound	I-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
:	:	punct	O
association	NN	dep	O
with	IN	case	O
the	DT	det	O
metastasis	NN	compound	O
suppressor	NN	compound	O
CD82	NN	nmod	B-Gene_or_gene_product1
.	.	punct	O

Thymidylate	NN	compound	B-Gene_or_gene_product0
synthase	NN	nsubj	I-Gene_or_gene_product0
(	-LRB-	punct	O
TS	NN	appos	B-Gene_or_gene_product2
)	-RRB-	punct	O
and	CC	cc	O
dihydropyrimidine	NN	compound	B-Gene_or_gene_product0
dehydrogenase	NN	conj	I-Gene_or_gene_product0
(	-LRB-	punct	O
DPD	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
are	VBP	cop	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
fluorouracil	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	appos	I-Simple_chemical
)	-RRB-	punct	O
metabolizing	JJ	compound	O
enzymes	NNS	ROOT	O
and	CC	cc	O
are	VBP	auxpass	O
involved	VBN	conj	O
in	IN	case	O
the	DT	det	O
sensitivity	NN	nmod	O
of	IN	case	O
carcinoma	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
to	IN	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	nmod	I-Simple_chemical
.	.	punct	O

Although	IN	mark	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	nsubjpass	I-Simple_chemical
is	VBZ	auxpass	O
often	RB	advmod	O
used	VBN	advcl	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
oral	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
,	,	punct	O
there	EX	expl	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	ROOT	O
any	DT	det	O
investigation	NN	nsubj	O
into	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
these	DT	det	O
enzymes	NNS	nmod	O
in	IN	case	O
metastatic	JJ	amod	B-Multi-tissue_structure
lymph	NN	compound	I-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
or	CC	cc	O
of	IN	case	O
their	PRP$	nmod:poss	O
roles	NNS	conj	O
in	IN	case	O
the	DT	det	O
effectiveness	NN	nmod	O
of	IN	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	nmod	I-Simple_chemical
in	IN	mark	O
treating	VBG	advcl	O
lymph	NN	compound	B-Cancer
node	NN	nmod:npmod	I-Cancer
-	HYPH	punct	I-Cancer
metastatic	JJ	amod	I-Cancer
cancer	NN	dobj	I-Cancer
.	.	punct	O

Oral	JJ	amod	B-Cancer
squamous	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	nsubj	I-Cancer
(	-LRB-	punct	O
OSCC	NN	appos	B-Cancer
)	-RRB-	punct	O
often	RB	advmod	O
metastasizes	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
and	CC	cc	O
these	DT	det	O
enzymes	NNS	nsubj	O
may	MD	aux	O
be	VB	cop	O
significant	JJ	conj	O
in	IN	case	O
the	DT	det	O
survival	NN	nmod	O
of	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
this	DT	det	O
disease	NN	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
TS	NN	nmod	B-Gene_or_gene_product2
and	CC	cc	O
DPD	NN	conj	B-Gene_or_gene_product1
in	IN	case	O
cervical	JJ	amod	B-Multi-tissue_structure
lymph	NN	compound	I-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
relationship	NN	conj	O
with	IN	case	O
primary	JJ	amod	B-Cancer
OSCC	NN	nmod	I-Cancer
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
interaction	NN	conj	O
between	IN	case	O
these	DT	det	O
enzymes	NNS	nmod	O
and	CC	cc	O
Kangai	NN	compound	B-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
(	-LRB-	punct	O
KAI1	NN	compound	B-Gene_or_gene_product3
/	:	punct	O
CD82	NN	conj	B-Gene_or_gene_product1
)	-RRB-	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
metastasis	NN	compound	O
suppressor	NN	compound	O
protein	NN	acl:relcl	O
.	.	punct	O

Surgical	JJ	amod	O
specimens	NNS	nsubjpass	B-Multi-tissue_structure
from	IN	case	O
20	CD	nummod	O
cases	NNS	nmod	O
of	IN	case	O
OSCC	NN	nmod	B-Cancer
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
,	,	punct	O
20	CD	nummod	O
cases	NNS	nsubjpass	O
of	IN	case	O
OSCC	NN	nmod	B-Cancer
without	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
10	CD	nummod	O
cases	NNS	nsubjpass	O
of	IN	case	O
normal	JJ	amod	O
mucosa	NN	nmod	B-Multi-tissue_structure
were	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
.	.	punct	O

The	DT	det	O
relationship	NN	nsubjpass	O
between	IN	case	O
TS	NN	nmod	B-Gene_or_gene_product2
and	CC	cc	O
DPD	NN	compound	B-Gene_or_gene_product1
expression	NN	conj	O
and	CC	cc	O
clinicopathological	JJ	amod	O
data	NNS	conj	O
was	VBD	auxpass	O
analyzed	VBN	ROOT	O
.	.	punct	O

TS	NN	nsubjpass	B-Gene_or_gene_product2
and	CC	cc	O
DPD	NN	compound	B-Gene_or_gene_product1
proteins	NNS	conj	O
were	VBD	auxpass	O
overexpressed	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	B-Cancer
OSCC	NN	nmod	I-Cancer
compared	VBN	case	O
to	TO	case	O
that	DT	nmod	O
in	IN	case	O
normal	JJ	amod	O
mucosa	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

TS	NN	compound	B-Gene_or_gene_product2
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
primary	JJ	amod	O
oral	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
the	DT	det	O
group	NN	nmod	O
with	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
was	VBD	cop	O
higher	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
those	DT	nmod	O
without	IN	advmod	O
.	.	punct	O

DPD	NN	compound	B-Gene_or_gene_product1
expression	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
significantly	RB	advmod	O
correlate	VB	ROOT	O
with	IN	case	O
the	DT	det	O
occurrence	NN	nmod	O
of	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
,	,	punct	O
nor	CC	cc	O
was	VBD	cop	O
it	PRP	nsubj	O
different	JJ	conj	O
between	IN	case	O
primary	JJ	amod	O
oral	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
cervical	JJ	amod	B-Multi-tissue_structure
metastases	NNS	conj	O
.	.	punct	O

CD82	NN	compound	B-Gene_or_gene_product1
expression	NN	nsubjpass	O
was	VBD	auxpass	O
significantly	RB	advmod	O
reduced	VBN	ROOT	O
in	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
TS	NN	nsubj	B-Gene_or_gene_product2
and	CC	cc	O
CD82	NN	conj	B-Gene_or_gene_product1
may	MD	aux	O
be	VB	cop	O
of	IN	case	O
great	JJ	amod	O
value	NN	ccomp	O
in	IN	mark	O
assessing	VBG	advcl	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	dobj	O
of	IN	case	O
OSCC	NN	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
could	MD	aux	O
be	VB	auxpass	O
taken	VBN	conj	O
as	IN	case	O
new	JJ	amod	O
targets	NNS	nmod	O
for	IN	case	O
therapy	NN	nmod	O
of	IN	case	O
metastatic	JJ	amod	O
OSCC	NN	nmod	B-Cancer
.	.	punct	O

Impaired	JJ	amod	O
CK1	NN	compound	B-Gene_or_gene_product2
delta	NN	compound	I-Gene_or_gene_product2
activity	NN	nsubj	O
attenuates	VBZ	ROOT	O
SV40	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
induced	VBN	amod	O
cellular	JJ	amod	B-Cell
transformation	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
mouse	NN	compound	B-Organism
mammary	JJ	amod	B-Organ
carcinogenesis	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Simian	JJ	amod	B-Organism
virus	NN	nsubj	I-Organism
40	CD	nummod	I-Organism
(	-LRB-	punct	O
SV40	NN	appos	B-Organism
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
powerful	JJ	amod	O
tool	NN	ROOT	O
to	TO	mark	O
study	VB	acl	O
cellular	JJ	amod	B-Cell
transformation	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
tumor	NN	compound	B-Cancer
development	NN	conj	O
and	CC	cc	O
progression	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Various	JJ	amod	O
cellular	JJ	amod	B-Cell
kinases	NNS	nsubj	O
,	,	punct	O
among	IN	case	O
them	PRP	nmod	O
members	NNS	dep	O
of	IN	case	O
the	DT	det	O
CK1	NN	compound	B-Gene_or_gene_product3
family	NN	nmod	O
,	,	punct	O
play	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
modulating	VBG	advcl	O
the	DT	det	O
transforming	NN	amod	O
activity	NN	dobj	O
of	IN	case	O
SV40	NN	nmod	B-Organism
,	,	punct	O
including	VBG	case	O
the	DT	det	O
transforming	NN	amod	O
activity	NN	nmod	O
of	IN	case	O
T	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
Ag	NN	nmod	I-Gene_or_gene_product1
,	,	punct	O
the	DT	det	O
major	JJ	amod	O
transforming	VBG	amod	O
protein	NN	appos	O
of	IN	case	O
SV40	NN	nmod	B-Organism
,	,	punct	O
itself	PRP	appos	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
characterized	VBD	ROOT	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
mutant	JJ	amod	O
CK1delta	NN	compound	B-Gene_or_gene_product1
variants	NNS	nmod	O
with	IN	case	O
impaired	JJ	amod	O
kinase	NN	compound	O
activity	NN	nmod	O
on	IN	case	O
SV40	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
transformation	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
and	CC	cc	O
on	IN	case	O
SV40	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
induced	VBN	amod	O
mammary	JJ	amod	B-Organ
carcinogenesis	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
in	IN	case	O
a	DT	det	O
transgenic	JJ	amod	B-Organism
/	SYM	punct	I-Organism
bi	JJ	advmod	I-Organism
-	HYPH	punct	I-Organism
transgenic	JJ	amod	I-Organism
mouse	NN	compound	I-Organism
model	NN	nmod	O
.	.	punct	O

CK1delta	NN	compound	B-Gene_or_gene_product1
mutants	NNS	nsubj	O
exhibited	VBD	ROOT	O
a	DT	det	O
reduced	VBN	amod	O
kinase	NN	compound	O
activity	NN	dobj	O
compared	VBN	case	O
to	TO	case	O
wtCK1delta	NN	nmod	B-Gene_or_gene_product0
in	IN	case	O
in	FW	amod	O
vitro	FW	dep	O
kinase	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

Molecular	JJ	amod	O
modeling	NN	compound	O
studies	NNS	nsubj	O
suggested	VBD	ROOT	O
that	IN	mark	O
mutation	NN	compound	O
N172D	NN	nsubj	O
,	,	punct	O
located	JJ	amod	O
within	IN	case	O
the	DT	det	O
substrate	NN	compound	O
binding	NN	compound	O
region	NN	nmod	O
,	,	punct	O
is	VBZ	cop	O
mainly	RB	advmod	O
responsible	JJ	ccomp	O
for	IN	case	O
impaired	JJ	amod	O
mutCK1delta	NN	compound	B-Gene_or_gene_product1
activity	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
stably	RB	advmod	O
over	RB	advmod	O
-	HYPH	punct	O
expressed	VBN	advcl	O
in	IN	case	O
maximal	JJ	amod	O
transformed	VBN	amod	O
SV	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
52	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
CK1delta	NN	compound	B-Gene_or_gene_product1
mutants	NNS	nsubj	O
induced	VBD	ROOT	O
reversion	NN	dobj	O
to	TO	case	O
a	DT	det	O
minimal	JJ	amod	O
transformed	VBN	amod	O
phenotype	NN	nmod	O
by	IN	case	O
dominant	JJ	amod	O
-	HYPH	punct	O
negative	JJ	amod	O
interference	NN	nmod	O
with	IN	case	O
endogenous	JJ	amod	O
wtCK1delta	NN	nmod	B-Gene_or_gene_product1
.	.	punct	O

To	TO	mark	O
characterize	VB	advcl	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
CK1delta	NN	nmod	B-Gene_or_gene_product1
on	IN	case	O
SV40	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
induced	VBN	amod	O
mammary	JJ	amod	B-Organ
carcinogenesis	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
generated	VBD	ROOT	O
transgenic	JJ	amod	B-Organism
mice	NNS	dobj	I-Organism
expressing	VBG	acl	O
mutant	JJ	amod	O
CK1delta	NN	dobj	B-Gene_or_gene_product1
under	IN	case	O
the	DT	det	O
control	NN	nmod	O
of	IN	case	O
the	DT	det	O
whey	JJ	compound	B-Gene_or_gene_product0
acidic	JJ	amod	I-Gene_or_gene_product0
protein	NN	compound	I-Gene_or_gene_product0
(	-LRB-	punct	O
WAP	NN	compound	B-Gene_or_gene_product2
)	-RRB-	punct	O
gene	NN	compound	O
promoter	NN	nmod	O
,	,	punct	O
and	CC	cc	O
crossed	VBD	conj	O
them	PRP	dobj	O
with	IN	case	O
SV40	NN	compound	B-Organism
transgenic	JJ	amod	O
WAP	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
T	NN	compound	I-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
antigen	NN	compound	I-Gene_or_gene_product0
(	-LRB-	punct	O
WAP	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
T	NN	appos	I-Gene_or_gene_product2
)	-RRB-	punct	O
mice	NNS	nmod	O
.	.	punct	O

Both	CC	cc:preconj	O
WAP	NNP	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
T	NN	compound	I-Gene_or_gene_product2
mice	NNS	nsubj	B-Organism
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
WAP	NNP	compound	B-Gene_or_gene_product2
-	HYPH	punct	O
mutCK1delta	NN	nmod:npmod	B-Gene_or_gene_product1
/	:	punct	O
WAP	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
T	NNP	nmod:npmod	I-Gene_or_gene_product0
bi	IN	advmod	O
-	HYPH	punct	O
transgenic	JJ	amod	O
mice	NNS	conj	O
developed	VBD	ROOT	O
breast	NN	compound	B-Cancer
cancer	NN	dobj	I-Cancer
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
tumor	NN	compound	B-Cancer
incidence	NN	nsubj	O
was	VBD	cop	O
lower	JJR	ROOT	O
and	CC	cc	O
life	NN	compound	O
span	NN	dep	O
was	VBD	cop	O
significantly	RB	advmod	O
longer	JJR	conj	O
in	IN	case	O
WAP	NNP	compound	B-Gene_or_gene_product2
-	HYPH	punct	O
mutCK1delta	NN	nmod:npmod	B-Gene_or_gene_product1
/	:	punct	O
WAP	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	O
T	NNP	nmod:npmod	O
bi	IN	advmod	O
-	HYPH	punct	O
transgenic	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O

The	DT	det	O
reduced	VBN	amod	O
CK1delta	NN	compound	B-Gene_or_gene_product1
activity	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
early	JJ	amod	O
lesion	NN	compound	B-Pathological_formation
formation	NN	dobj	O
during	IN	case	O
tumorigenesis	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
impaired	JJ	amod	O
CK1delta	NN	compound	B-Gene_or_gene_product1
activity	NN	nsubj	O
reduces	VBZ	ccomp	O
the	DT	det	O
probability	NN	dobj	O
for	IN	case	O
outgrowth	NN	nmod	O
of	IN	case	O
in	FW	amod	B-Cancer
situ	FW	dep	I-Cancer
carcinomas	NNS	nmod	I-Cancer
to	TO	case	O
invasive	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
different	JJ	amod	O
tumorigenic	JJ	amod	O
potential	NN	nsubjpass	O
of	IN	case	O
SV40	NN	nmod	B-Organism
in	IN	case	O
WAP	NNP	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
T	NN	compound	I-Gene_or_gene_product2
and	CC	cc	O
WAP	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	O
mutCK1delta	NN	conj	B-Gene_or_gene_product1
/	:	punct	O
WAP	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
T	NN	compound	I-Gene_or_gene_product2
tumors	NNS	nsubjpass	B-Cancer
was	VBD	auxpass	O
also	RB	advmod	O
reflected	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
significantly	RB	advmod	O
different	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
various	JJ	amod	O
genes	NNS	nmod	O
known	VBN	acl	O
to	TO	mark	O
be	VB	auxpass	O
involved	VBN	xcomp	O
in	IN	case	O
tumor	NN	compound	B-Cancer
progression	NN	nmod	O
,	,	punct	O
specifically	RB	advmod	O
of	IN	case	O
those	DT	nmod	O
involved	VBN	acl	O
in	IN	case	O
wnt	NN	amod	B-Gene_or_gene_product2
-	HYPH	punct	O
signaling	NN	nmod	O
and	CC	cc	O
DNA	NN	compound	B-Cellular_component
repair	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	dobj	O
inactivating	VBG	amod	O
mutations	NNS	nmod	O
in	IN	case	O
CK1delta	NN	compound	B-Gene_or_gene_product1
impair	VBP	compound	O
SV40	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
induced	VBN	amod	O
cellular	JJ	amod	B-Cell
transformation	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
mouse	NN	compound	B-Organism
mammary	JJ	amod	B-Organ
carcinogenesis	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Osteonectin	NN	compound	B-Gene_or_gene_product0
transcript	NN	ROOT	O
and	CC	cc	O
metastatic	JJ	amod	O
behavior	NN	conj	O
in	IN	case	O
v	CD	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
Ki	NN	compound	I-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
ras	NN	compound	I-Gene_or_gene_product0
transformed	JJ	amod	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

Osteonectin	NNP	nsubj	B-Gene_or_gene_product0
is	VBZ	ROOT	O
one	CD	attr	O
of	IN	prep	O
the	DT	det	O
major	JJ	amod	O
non	JJ	amod	O
-	HYPH	punct	O
collagenous	JJ	amod	O
proteins	NNS	pobj	O
of	IN	case	O
bone	NN	nmod	B-Tissue
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
its	PRP$	nmod:poss	O
transcript	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
many	JJ	amod	O
soft	JJ	amod	B-Tissue
,	,	punct	I-Tissue
extracellular	JJ	dep	I-Tissue
matrix	NN	compound	I-Tissue
-	HYPH	punct	I-Tissue
producing	VBG	dep	I-Tissue
tissues	NNS	nmod	I-Tissue
;	:	punct	O
an	DT	det	O
osteonectin	NN	nmod:npmod	B-Gene_or_gene_product0
-	HYPH	punct	O
related	JJ	amod	O
protein	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	parataxis	O
in	IN	case	O
tumor	NN	compound	B-Cellular_component
basement	NN	compound	I-Cellular_component
membrane	NN	nmod	I-Cellular_component
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
osteonectin	NN	amod	B-Gene_or_gene_product0
gene	NN	nmod	O
in	IN	case	O
fresh	JJ	amod	O
BALB	NN	compound	B-Cell
/	:	punct	I-Cell
c	NN	compound	I-Cell
fibroblasts	NNS	nmod	I-Cell
transformed	VBN	acl	O
by	IN	case	O
v	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
Ki	NN	compound	I-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
ras	NN	nmod	I-Gene_or_gene_product0
.	.	punct	O

Transformed	VBN	amod	O
cells	NNS	nsubj	B-Cell
exhibited	VBD	ROOT	O
lower	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
RNA	NN	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
with	IN	case	O
normal	JJ	amod	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
transformed	VBN	amod	O
cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
cloned	VBN	ROOT	O
after	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
tumorigenic	JJ	amod	O
assay	NN	nmod	O
,	,	punct	O
and	CC	cc	O
4	CD	nummod	O
clones	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
analyzed	VBN	conj	O
for	IN	case	O
osteonectin	NN	amod	B-Gene_or_gene_product0
expression	NN	nmod	O
by	IN	case	O
Northern	NN	compound	O
blots	NNS	nmod	O
.	.	punct	O

Two	CD	nsubjpass	O
of	IN	case	O
them	PRP	nmod	O
were	VBD	auxpass	O
selected	VBN	ROOT	O
for	IN	case	O
high	JJ	nmod	O
or	CC	cc	O
low	JJ	conj	O
osteonectin	NN	dep	B-Gene_or_gene_product0
expression	NN	dep	O
and	CC	cc	O
tested	VBN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
in	IN	case	O
spontaneous	JJ	amod	O
and	CC	cc	O
artificial	JJ	conj	O
metastasis	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

High	JJ	amod	O
osteonectin	NN	amod	B-Gene_or_gene_product0
expression	NN	nsubjpass	O
was	VBD	auxpass	O
correlated	VBN	ROOT	O
with	IN	case	O
high	JJ	amod	O
lung	NN	compound	B-Organ
colonization	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
10	CD	nummod	O
(	-LRB-	punct	O
5	CD	dep	O
)	-RRB-	punct	O
cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
injected	VBN	ROOT	O
i	LS	dobj	B-Immaterial_anatomical_entity
.	.	punct	I-Immaterial_anatomical_entity
v	LS	ccomp	I-Immaterial_anatomical_entity
.	.	punct	I-Immaterial_anatomical_entity
,	,	punct	O
median	JJ	amod	O
colony	NN	compound	B-Cell
value	NN	nsubj	O
was	VBD	ROOT	O
55	CD	attr	O
and	CC	cc	O
20	CD	conj	O
in	IN	case	O
higher	JJR	amod	O
expressor	NN	nmod	O
vs	CC	cc	O
.	.	punct	O
lower	JJR	amod	O
expressor	NN	ROOT	O
respectively	RB	advmod	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
005	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Spontaneous	JJ	amod	O
metastasis	NN	nsubj	O
indicates	VBZ	ROOT	O
a	DT	det	O
possible	JJ	amod	O
reverse	JJ	amod	O
correlation	NN	dobj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
align	NN	ROOT	O
osteonectin	NN	dobj	B-Gene_or_gene_product0
with	IN	case	O
other	JJ	amod	O
matrix	NN	compound	B-Cellular_component
-	HYPH	punct	O
components	NNS	nmod	O
and	CC	cc	O
adhesion	NN	compound	O
molecules	NNS	conj	O
in	IN	mark	O
affecting	VBG	advcl	O
potential	JJ	amod	O
metastatic	JJ	amod	O
spreading	NN	dobj	O
of	IN	case	O
transformed	VBN	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

[	-LRB-	punct	O
Intraepithelial	JJ	amod	B-Cancer
neoplasm	NN	ROOT	I-Cancer
of	IN	case	O
the	DT	det	O
uterine	NN	amod	B-Multi-tissue_structure
cervix	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
angiogenesis	NN	conj	O
:	:	punct	O
morphologic	JJ	amod	O
study	NN	dep	O
]	-RRB-	punct	O

Thirty	CD	nummod	O
uterine	JJ	amod	B-Multi-tissue_structure
cervix	NNS	compound	I-Multi-tissue_structure
specimens	NNS	nsubjpass	I-Multi-tissue_structure
sampled	VBN	acl	O
following	VBG	case	O
conization	NN	nmod	O
or	CC	cc	O
total	JJ	amod	O
hysterectomy	NN	conj	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
histology	NN	dobj	O
,	,	punct	O
histoenzymology	NN	conj	O
(	-LRB-	punct	O
vessel	NN	compound	B-Multi-tissue_structure
phosphatase	NN	compound	O
alkaline	NN	compound	O
activity	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
(	-LRB-	punct	O
demonstration	NN	dep	O
of	IN	case	O
laminin	NN	nmod	B-Gene_or_gene_product0
and	CC	cc	O
type	NN	compound	B-Gene_or_gene_product2
IV	CD	nummod	I-Gene_or_gene_product2
collagen	NN	conj	I-Gene_or_gene_product2
in	IN	case	O
epithelium	NN	nmod	B-Tissue
and	CC	cc	O
vessel	NN	conj	B-Cellular_component
basement	NN	compound	I-Cellular_component
membranes	NNS	dep	I-Cellular_component
)	-RRB-	punct	O
.	.	punct	O

Pathologic	JJ	amod	O
conditions	NNS	nsubj	O
included	VBD	ROOT	O
dystrophia	NN	dobj	O
,	,	punct	O
moderate	JJ	amod	O
dysplasia	NN	conj	O
,	,	punct	O
severe	JJ	amod	O
dysplasia	NN	conj	O
,	,	punct	O
and	CC	cc	O
intraepithelial	JJ	amod	B-Cancer
carcinoma	NN	conj	I-Cancer
.	.	punct	O

Results	NNS	nsubjpass	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
to	TO	case	O
findings	NNS	nmod	O
in	IN	case	O
a	DT	det	O
control	JJ	amod	O
group	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
severity	NN	nsubj	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
abnormalities	NNS	nmod	O
correlated	VBD	ccomp	O
positively	RB	advmod	O
with	IN	case	O
the	DT	det	O
severity	NN	nmod	O
of	IN	case	O
histologic	JJ	amod	O
epithelial	JJ	amod	B-Pathological_formation
lesions	NNS	nmod	I-Pathological_formation
;	:	punct	O
this	DT	det	O
finding	NN	nsubj	O
is	VBZ	cop	O
consistent	JJ	parataxis	O
with	IN	case	O
colposcopic	JJ	amod	O
results	NNS	nmod	O
.	.	punct	O

Anarchic	JJ	amod	O
angiogenesis	NN	nsubjpass	O
with	IN	prep	O
large	JJ	amod	O
,	,	punct	O
moniliform	NN	pobj	O
,	,	punct	O
tortuous	JJ	amod	O
vessels	NNS	nsubjpass	B-Multi-tissue_structure
was	VBD	auxpass	O
seen	VBN	ROOT	O
in	IN	case	O
severe	JJ	amod	O
dysplasias	NNS	nmod	O
and	CC	cc	O
carcinomas	NNS	conj	B-Cancer
.	.	punct	O

The	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
anomalies	NNS	nsubj	O
seem	VBP	ROOT	O
to	TO	mark	O
precede	VB	xcomp	O
the	DT	det	O
development	NN	dobj	O
of	IN	prep	O
histologic	JJ	amod	B-Pathological_formation
lesions	NNS	pobj	I-Pathological_formation
in	IN	prep	O
some	DT	det	O
instances	NNS	pobj	O
.	.	punct	O

Histogenesis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
abnormal	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
may	MD	aux	O
involve	VB	ROOT	O
production	NN	dobj	O
of	IN	case	O
an	DT	det	O
angiogenic	JJ	amod	O
factor	NN	nmod	O
by	IN	case	O
the	DT	det	O
cancerized	VBN	amod	B-Tissue
epithelia	NN	nmod	I-Tissue
.	.	punct	O

Glycolysis	NN	nsubj	O
and	CC	cc	O
glutaminolysis	NN	conj	O
in	IN	case	O
perifused	VBN	amod	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	ROOT	I-Cell
tumour	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

A	DT	det	O
perifusion	NN	compound	O
system	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	ROOT	O
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
study	VB	advcl	O
glucose	NN	nsubj	B-Simple_chemical
and	CC	cc	O
glutamine	NN	compound	B-Amino_acid
metabolism	NN	conj	O
by	IN	case	O
freshly	RB	advmod	O
harvested	VBN	amod	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	conj	I-Cell
tumour	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
in	IN	case	O
steady	JJ	amod	O
state	NN	compound	O
conditions	NNS	nmod	O
.	.	punct	O

Cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
perifused	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
5	CD	compound	O
mM	NN	amod	O
glucose	NN	nmod	B-Simple_chemical
,	,	punct	O
0	CD	appos	O
.	.	punct	O
5	CD	nummod	O
mM	NN	amod	O
glutamine	NN	ROOT	B-Amino_acid
or	CC	cc	O
5	CD	compound	O
mM	NN	amod	O
glucose	NN	conj	B-Simple_chemical
and	CC	cc	O
0	CD	conj	O
.	.	punct	O
5	CD	nummod	O
mM	NN	amod	O
glutamine	NN	ROOT	B-Amino_acid
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
in	IN	case	O
steady	JJ	amod	O
state	NN	nmod	O
reveal	VBP	ROOT	O
that	IN	mark	O
both	DT	det	O
substrates	NNS	ccomp	O
glucose	NN	nsubjpass	B-Simple_chemical
and	CC	cc	O
glutamine	NN	conj	B-Amino_acid
are	VBP	auxpass	O
continuously	RB	advmod	O
wasted	VBN	dep	O
by	IN	case	O
tumour	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
excreting	VBG	xcomp	O
two	CD	nummod	O
moles	NNS	dobj	O
of	IN	prep	O
lactate	NN	pobj	B-Simple_chemical
per	IN	case	O
mol	NN	nmod	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
and	CC	cc	O
one	CD	nummod	O
mol	NN	conj	O
of	IN	case	O
glutamate	NN	nmod	B-Amino_acid
and	CC	cc	O
ammonia	NN	conj	B-Simple_chemical
per	IN	case	O
mol	NN	nmod	O
of	IN	case	O
glutamine	NN	nmod	B-Amino_acid
consumed	VBN	acl	O
into	IN	case	O
the	DT	det	O
medium	NN	nmod	O
.	.	punct	O

Glutamine	NN	compound	B-Amino_acid
consumption	NN	nsubj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
was	VBD	cop	O
higher	JJR	ROOT	O
than	IN	case	O
with	IN	case	O
glutamine	NN	nmod	B-Amino_acid
alone	RB	advmod	O
.	.	punct	O

Multi	NNP	compound	O
-	HYPH	punct	O
step	NN	compound	O
neoplastic	JJ	amod	O
transformation	NN	ROOT	O
of	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
fibroblasts	NNS	nmod	B-Cell
by	IN	case	O
Co	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
60	CD	nummod	I-Simple_chemical
gamma	NN	compound	O
rays	NNS	nmod	O
and	CC	cc	O
Ha	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	compound	I-Gene_or_gene_product2
oncogenes	NNS	conj	O
.	.	punct	O

As	IN	mark	O
reported	VBN	advcl	O
previously	RB	advmod	O
(	-LRB-	punct	O
Namba	NNP	dep	O
et	FW	dep	O
al	FW	conj	O
.	NNP	punct	O
,	,	punct	O
1985	CD	appos	O
;	:	punct	O
Namba	NNP	conj	O
,	,	punct	O
1985	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
fibroblasts	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
transformed	VBN	ROOT	O
into	IN	case	O
immortal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
abnormal	JJ	amod	O
karyotypes	NNS	nmod	O
by	IN	case	O
Co	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
60	CD	nummod	I-Simple_chemical
gamma	NN	compound	O
-	HYPH	punct	O
ray	NN	compound	O
irradiation	NN	nmod	O
.	.	punct	O

These	DT	det	O
immortally	RB	advmod	O
transformed	VBN	amod	O
cells	NNS	nsubj	B-Cell
(	-LRB-	punct	O
KMST	NN	dep	B-Cell
-	:	punct	I-Cell
6	CD	nummod	I-Cell
)	-RRB-	punct	O
showed	VBD	ROOT	O
no	DT	neg	O
clonability	NN	dobj	O
in	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
and	CC	cc	O
were	VBD	cop	O
not	RB	neg	O
tumorigenic	JJ	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
by	IN	case	O
treatment	NN	nmod	O
with	IN	case	O
Ha	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	compound	I-Gene_or_gene_product2
oncogenes	NNS	nmod	O
derived	VBN	acl	O
from	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
lung	NN	compound	I-Organism
carcinoma	NN	nmod	I-Organism
or	CC	cc	O
Harvey	NN	compound	B-Organism
murine	JJ	amod	I-Organism
sarcoma	NN	compound	I-Organism
virus	NN	conj	I-Organism
,	,	punct	O
the	DT	det	O
KMST	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
6	CD	nummod	I-Cell
cells	NNS	nsubj	I-Cell
acquired	VBD	ROOT	O
elevated	JJ	amod	O
clonability	NN	dobj	O
in	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
and	CC	cc	O
transplantability	NN	conj	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

All	PDT	predet	O
the	DT	det	O
tumors	NNS	nsubj	B-Cancer
produced	VBD	acl	O
grew	VBD	ROOT	O
progressively	RB	advmod	O
without	IN	mark	O
showing	VBG	advcl	O
regression	NN	dobj	O
and	CC	cc	O
killed	VBD	conj	O
the	DT	det	O
mice	NNS	dobj	B-Organism
.	.	punct	O

The	DT	det	O
tumors	NNS	nsubj	B-Cancer
were	VBD	cop	O
also	RB	advmod	O
serially	RB	advmod	O
transplantable	JJ	ROOT	O
into	IN	case	O
other	JJ	amod	O
mice	NNS	nmod	B-Organism
.	.	punct	O

The	DT	det	O
Ha	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	compound	I-Gene_or_gene_product2
oncogene	NN	nsubj	O
alone	RB	advmod	O
did	VBD	aux	O
not	RB	neg	O
convert	VB	ROOT	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
fibroblasts	NNS	dobj	B-Cell
into	IN	case	O
either	CC	cc:preconj	O
immortal	JJ	nmod	B-Cell
or	CC	cc	O
tumorigenic	JJ	conj	B-Cell
cells	NNS	dep	I-Cell
.	.	punct	O

Our	PRP$	nmod:poss	O
current	JJ	amod	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
gamma	NN	compound	O
rays	NNS	nsubj	O
worked	VBD	ccomp	O
as	IN	case	O
an	DT	det	O
initiator	NN	nmod	O
of	IN	case	O
carcinogenesis	NN	nmod	O
in	IN	case	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
cells	NNS	nmod	B-Cell
,	,	punct	O
giving	VBG	xcomp	O
rise	NN	dobj	O
to	TO	case	O
chromosome	NN	compound	B-Cellular_component
aberrations	NNS	nmod	O
and	CC	cc	O
immortality	NN	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
Ha	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	compound	I-Gene_or_gene_product2
oncogene	NN	nsubj	O
played	VBD	conj	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
the	DT	det	O
immortally	RB	advmod	O
transformed	VBN	amod	O
cell	NN	compound	B-Cell
population	NN	nmod	O
to	TO	case	O
a	DT	det	O
neoplastic	JJ	amod	O
one	CD	nmod	O
showing	VBG	acl	O
enhanced	VBN	amod	O
colony	NN	compound	O
formation	NN	dobj	O
in	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
and	CC	cc	O
tumorigenicity	NN	conj	O
in	IN	case	O
nude	JJ	amod	B-Organism
mice	NNS	nmod	I-Organism
.	.	punct	O

New	JJ	amod	O
functions	NNS	ROOT	O
of	IN	case	O
epidermal	JJ	amod	B-Gene_or_gene_product0
growth	NN	compound	I-Gene_or_gene_product0
factor	NN	nmod	I-Gene_or_gene_product0
:	:	punct	O
stimulation	NN	dep	O
of	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
and	CC	cc	O
matrix	NN	nmod:npmod	B-Cellular_component
dependent	JJ	amod	O
proliferation	NN	conj	O
.	.	punct	O

The	DT	det	O
proliferative	JJ	amod	O
response	NN	nsubj	O
of	IN	case	O
bovine	JJ	amod	B-Organism
retinal	JJ	amod	B-Cell
capillary	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
EGF	NN	nmod	B-Gene_or_gene_product1
is	VBZ	cop	O
dependent	JJ	ROOT	O
upon	IN	mark	O
attaching	VBG	advcl	O
the	DT	det	O
cells	NNS	dobj	B-Cell
to	TO	case	O
a	DT	det	O
matrix	NN	nmod	B-Cellular_component
of	IN	case	O
fibronectin	NN	nmod	B-Gene_or_gene_product0
.	.	punct	O

Bovine	JJ	amod	B-Organism
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nsubjpass	I-Cell
are	VBP	auxpass	O
also	RB	advmod	O
stimulated	VBN	ROOT	O
to	TO	mark	O
actively	RB	advmod	O
migrate	VB	xcomp	O
when	WRB	advmod	O
exposed	VBN	advcl	O
to	TO	case	O
EGF	NN	nmod	B-Gene_or_gene_product1
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

These	DT	det	O
activities	NNS	nsubj	O
provide	VBP	ROOT	O
an	DT	det	O
explanation	NN	dobj	O
for	IN	case	O
the	DT	det	O
angiogenic	JJ	amod	O
properties	NNS	nmod	O
of	IN	case	O
EGF	NN	nmod	B-Gene_or_gene_product1
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Capillary	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nsubjpass	O
and	CC	cc	O
proliferation	NN	conj	O
are	VBP	auxpass	O
proposed	VBN	ROOT	O
as	IN	case	O
sensitive	JJ	amod	O
quantifiable	JJ	amod	O
bioassays	NNS	nmod	O
to	TO	mark	O
explore	VB	xcomp	O
the	DT	det	O
functional	JJ	amod	O
domains	NNS	dobj	O
of	IN	case	O
the	DT	det	O
EGF	NN	compound	B-Gene_or_gene_product1
molecule	NN	nmod	O
.	.	punct	O

Studies	NNS	nsubj	O
on	IN	case	O
the	DT	det	O
inactivation	NN	nmod	O
of	IN	case	O
these	DT	det	O
properties	NNS	nmod	O
of	IN	case	O
EGF	NN	nmod	B-Gene_or_gene_product1
by	IN	case	O
specific	JJ	amod	O
cleavage	NN	nmod	O
of	IN	case	O
the	DT	det	O
molecule	NN	nmod	O
with	IN	case	O
CNBr	NN	nmod	B-Simple_chemical
or	CC	cc	O
proteases	NNS	conj	O
suggest	VBP	ROOT	O
that	IN	mark	O
an	DT	det	O
intact	JJ	amod	O
loop	NN	nsubj	O
composed	VBN	acl	O
in	IN	case	O
part	NN	nmod	O
by	IN	case	O
amino	NN	compound	O
acid	NN	compound	O
residues	NNS	nmod	O
20	CD	dep	O
to	TO	dep	O
31	CD	nummod	O
is	VBZ	cop	O
essential	JJ	ccomp	O
for	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
some	DT	det	O
functions	NNS	nmod	O
.	.	punct	O

Angiogenesis	NN	ROOT	O
:	:	punct	O
initiation	NN	dep	O
and	CC	cc	O
control	NN	conj	O
.	.	punct	O

From	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
experiments	NNS	nmod	O
using	VBG	acl	O
new	JJ	amod	O
methods	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
rabbit	NN	compound	B-Organism
cornea	NN	nmod	B-Multi-tissue_structure
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	aux	O
now	RB	advmod	O
becoming	VBG	ROOT	O
clear	JJ	xcomp	O
that	IN	mark	O
the	DT	det	O
growth	NN	nsubj	O
of	IN	prep	O
a	DT	det	O
capillary	JJ	pobj	B-Tissue
involves	VBZ	ccomp	O
an	DT	det	O
ordered	VBN	amod	O
sequence	NN	dobj	O
of	IN	case	O
events	NNS	nmod	O
that	WDT	nsubj	O
includes	VBZ	acl:relcl	O
lysis	NN	dobj	O
of	IN	case	O
the	DT	det	O
basement	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
of	IN	case	O
a	DT	det	O
parent	NN	compound	O
venule	NN	nmod	B-Multi-tissue_structure
,	,	punct	O
directional	JJ	amod	O
migration	NN	appos	O
of	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
toward	IN	case	O
the	DT	det	O
angiogenic	JJ	amod	O
stimulus	NN	nmod	O
,	,	punct	O
lumen	NN	compound	B-Immaterial_anatomical_entity
formation	NN	conj	O
,	,	punct	O
development	NN	appos	O
of	IN	case	O
branches	NNS	nmod	B-Tissue
,	,	punct	O
and	CC	cc	O
anastomosis	NN	conj	O
of	IN	case	O
the	DT	det	O
tip	NN	nmod	O
of	IN	case	O
one	CD	nummod	O
tube	NN	nmod	B-Tissue
with	IN	prep	O
another	DT	pobj	O
to	TO	aux	O
form	VB	acl	O
a	DT	det	O
loop	NN	dobj	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
also	RB	advmod	O
clear	JJ	ROOT	O
that	IN	mark	O
diffusible	JJ	amod	O
angiogenic	JJ	amod	O
stimuli	NNS	nsubjpass	O
can	MD	aux	O
be	VB	auxpass	O
released	VBN	ccomp	O
not	RB	neg	O
only	RB	cc:preconj	O
from	IN	case	O
most	JJS	advmod	O
solid	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
,	,	punct	O
but	CC	cc	O
also	RB	advmod	O
from	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
three	CD	nummod	O
non	JJ	amod	B-Cell
-	HYPH	punct	I-Cell
neoplastic	JJ	amod	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

These	DT	nsubj	O
include	VBP	ROOT	O
activated	VBN	amod	O
macrophages	NNS	dobj	B-Cell
,	,	punct	O
sensitized	VBN	amod	O
lymphocytes	NNS	conj	B-Cell
,	,	punct	O
and	CC	cc	O
adipocytes	NNS	conj	B-Cell
.	.	punct	O

Other	JJ	amod	O
normal	JJ	amod	B-Tissue
tissues	NNS	nsubj	I-Tissue
can	MD	aux	O
also	RB	advmod	O
stimulate	VB	ROOT	O
angiogenesis	NN	dobj	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
type	NN	nsubj	O
of	IN	case	O
cell	NN	compound	B-Cell
giving	NN	compound	O
rise	NN	nmod	O
to	TO	case	O
the	DT	det	O
angiogenic	JJ	amod	O
stimulus	NN	nmod	O
is	VBZ	cop	O
unknown	JJ	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
period	NN	nsubj	O
of	IN	case	O
angiogenic	JJ	amod	O
stimulation	NN	nmod	O
is	VBZ	cop	O
brief	JJ	conj	O
.	.	punct	O

With	IN	case	O
the	DT	det	O
recent	JJ	amod	O
ability	NN	nmod	O
to	TO	case	O
clone	NN	compound	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
to	TO	mark	O
carry	VB	conj	O
them	PRP	dobj	O
in	IN	prep	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
culture	NN	pobj	O
,	,	punct	O
it	PRP	nsubj	O
has	VBZ	aux	O
been	VBN	cop	O
possible	JJ	ROOT	O
to	TO	mark	O
further	RB	advmod	O
delineate	VB	xcomp	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
capillary	JJ	amod	B-Tissue
growth	NN	nmod	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
mast	NN	compound	B-Cell
cell	NN	nsubj	I-Cell
seems	VBZ	ccomp	O
to	TO	mark	O
behave	VB	xcomp	O
as	IN	case	O
a	DT	det	O
helper	NN	compound	B-Cell
cell	NN	nmod	I-Cell
for	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
in	IN	case	O
some	DT	det	O
way	NN	nmod	O
speeding	VBG	acl	O
up	RP	prt	O
their	PRP$	poss	O
rate	NN	dobj	O
of	IN	prep	O
directional	JJ	amod	O
migration	NN	pobj	O
.	.	punct	O

At	IN	case	O
this	DT	det	O
writing	NN	nmod	O
,	,	punct	O
heparin	NN	nsubj	B-Simple_chemical
appears	VBZ	ROOT	O
to	TO	mark	O
be	VB	cop	O
the	DT	det	O
principal	JJ	amod	O
mast	NN	compound	B-Cell
cell	NN	compound	I-Cell
factor	NN	xcomp	O
responsible	JJ	amod	O
for	IN	case	O
this	DT	det	O
effect	NN	nmod	O
on	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

One	CD	nummod	O
theoretical	JJ	amod	O
possibility	NN	nsubj	O
is	VBZ	ROOT	O
that	IN	mark	O
mast	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
may	MD	aux	O
prepare	VB	ccomp	O
the	DT	det	O
matrix	NN	dobj	B-Cellular_component
,	,	punct	O
perhaps	RB	advmod	O
by	IN	case	O
slow	JJ	amod	O
release	NN	nmod	O
of	IN	case	O
heparin	NN	nmod	B-Simple_chemical
,	,	punct	O
so	IN	advmod	O
that	IN	mark	O
capillary	JJ	amod	B-Tissue
sprouts	NNS	nsubj	I-Tissue
can	MD	aux	O
more	RBR	advmod	O
easily	RB	advmod	O
move	VB	advcl	O
through	IN	case	O
it	PRP	nmod	O
toward	IN	case	O
their	PRP$	nmod:poss	O
angiogenic	JJ	amod	O
target	NN	nmod	O
.	.	punct	O

While	IN	mark	O
the	DT	det	O
study	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
as	IN	case	O
a	DT	det	O
phenomenon	NN	nmod	O
is	VBZ	cop	O
still	RB	advmod	O
in	IN	case	O
an	DT	det	O
early	JJ	amod	O
phase	NN	advcl	O
,	,	punct	O
it	PRP	nsubj	O
has	VBZ	aux	O
become	VBN	ROOT	O
possible	JJ	acomp	O
,	,	punct	O
by	IN	mark	O
using	VBG	advcl	O
a	DT	det	O
combination	NN	dobj	O
of	IN	case	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	nmod	O
in	FW	amod	O
vivo	FW	dep	O
techniques	NNS	conj	O
,	,	punct	O
to	TO	mark	O
more	RBR	advmod	O
thoroughly	RB	advmod	O
understand	VB	conj	O
the	DT	det	O
initiation	NN	dobj	O
and	CC	cc	O
control	NN	conj	O
of	IN	case	O
capillary	JJ	amod	B-Tissue
growth	NN	nmod	O
.	.	punct	O

Protection	NN	ROOT	O
from	IN	case	O
experimental	JJ	amod	O
ocular	JJ	amod	O
herpetic	JJ	amod	O
keratitis	NN	nmod	O
by	IN	case	O
a	DT	det	O
heat	NN	npadvmod	O
-	HYPH	punct	O
killed	VBN	amod	O
virus	NN	compound	O
vaccine	NN	nmod	O
.	.	punct	O

New	NNP	compound	B-Organism
Zealand	NNP	compound	I-Organism
white	JJ	amod	I-Organism
rabbits	NNS	nsubjpass	I-Organism
were	VBD	auxpass	O
given	VBN	ROOT	O
limbal	JJ	amod	O
inoculations	NNS	dobj	O
of	IN	case	O
a	DT	det	O
heat	NN	npadvmod	O
-	HYPH	punct	O
killed	VBN	amod	O
suspension	NN	nmod	O
of	IN	case	O
herpes	NN	compound	B-Organism
simplex	NN	compound	I-Organism
virus	NN	nmod	I-Organism
(	-LRB-	punct	O
HSV	NN	appos	B-Organism
)	-RRB-	punct	O
in	IN	case	O
a	DT	det	O
lysate	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
embryonic	JJ	amod	B-Cell
kidney	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

At	IN	prep	O
intervals	NNS	pobj	O
of	IN	prep	O
four	CD	quantmod	O
to	TO	quantmod	O
14	CD	nummod	O
days	NNS	pobj	O
,	,	punct	O
the	DT	det	O
animals	NNS	nsubjpass	O
were	VBD	auxpass	O
challenged	VBN	ROOT	O
by	IN	case	O
intrastromal	JJ	amod	O
inoculation	NN	nmod	O
with	IN	case	O
10	CD	compound	O
,	,	punct	O
000	CD	nummod	O
plaque	NN	compound	O
-	HYPH	punct	O
forming	VBG	amod	O
units	NNS	nmod	O
of	IN	case	O
viable	JJ	amod	O
HSV	NN	nmod	B-Organism
.	.	punct	O

Epithelial	JJ	amod	B-Tissue
keratitis	NN	ROOT	O
,	,	punct	O
disciform	NN	compound	B-Pathological_formation
edema	NN	conj	I-Pathological_formation
,	,	punct	O
and	CC	cc	O
necrotizing	VBG	conj	O
keratitis	NN	dobj	O
with	IN	case	O
neovascularization	NN	nmod	O
of	IN	case	O
the	DT	det	O
cornea	NN	nmod	B-Multi-tissue_structure
developed	VBN	acl	O
in	IN	case	O
control	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O

Epithelial	JJ	amod	B-Tissue
keratitis	NN	nsubj	O
and	CC	cc	O
corneal	NN	compound	B-Pathological_formation
edema	NN	conj	I-Pathological_formation
also	RB	advmod	O
developed	VBD	ROOT	O
in	IN	prep	O
the	DT	det	O
immunized	JJ	amod	O
animals	NNS	pobj	O
during	IN	case	O
the	DT	det	O
first	JJ	amod	O
week	NN	nmod	O
after	IN	case	O
virus	NN	compound	O
challenge	NN	nmod	O
,	,	punct	O
but	CC	cc	O
these	DT	det	O
symptoms	NNS	nsubj	O
rapidly	RB	advmod	O
resolved	VBD	conj	O
during	IN	prep	O
the	DT	det	O
following	VBG	amod	O
weeks	NNS	pobj	O
.	.	punct	O

The	DT	det	O
absence	NN	nsubj	O
of	IN	case	O
iritis	NN	nmod	O
,	,	punct	O
neovascularization	NN	conj	O
,	,	punct	O
and	CC	cc	O
necrotizing	JJ	conj	O
keratitis	NN	conj	O
in	IN	case	O
the	DT	det	O
corneas	NNS	nmod	B-Multi-tissue_structure
of	IN	case	O
the	DT	det	O
immunized	JJ	amod	O
animals	NNS	nmod	O
was	VBD	ROOT	O
particularly	RB	advmod	O
striking	JJ	acomp	O
.	.	punct	O

Protein	NN	compound	O
kinase	NN	compound	O
activities	NNS	ROOT	O
in	IN	case	O
immune	JJ	amod	O
complexes	NNS	nmod	O
of	IN	case	O
simian	JJ	amod	B-Organism
virus	NN	compound	I-Organism
40	CD	nummod	I-Organism
large	JJ	amod	B-Gene_or_gene_product0
T	NN	compound	I-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
antigen	NN	intj	I-Gene_or_gene_product0
and	CC	cc	O
transformation	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
cellular	JJ	amod	B-Cell
p53	NN	compound	B-Gene_or_gene_product1
protein	NN	nmod	O
.	.	punct	O

Immune	JJ	amod	O
complex	NN	compound	O
kinase	NN	compound	O
assays	NNS	nsubjpass	O
in	IN	case	O
the	DT	det	O
simian	JJ	amod	B-Organism
virus	NN	compound	I-Organism
40	CD	nummod	I-Organism
system	NN	nmod	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
by	IN	case	O
incubation	NN	nmod	O
of	IN	case	O
immunoprecipitates	NNS	nmod	O
containing	VBG	acl	O
tumor	NN	compound	B-Cancer
antigens	NNS	dobj	O
with	IN	case	O
[	-LRB-	punct	B-Simple_chemical
gamma	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
32P	NN	compound	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
ATP	NN	nmod	I-Simple_chemical
,	,	punct	O
followed	VBN	acl	O
by	IN	case	O
analysis	NN	nmod	O
of	IN	case	O
any	DT	det	O
phosphoacceptor	NN	compound	O
proteins	NNS	nmod	O
.	.	punct	O

These	DT	det	O
assays	NNS	nsubj	O
yielded	VBD	ROOT	O
mainly	RB	advmod	O
the	DT	det	O
viral	JJ	amod	B-Organism
large	JJ	amod	B-Gene_or_gene_product2
T	NN	compound	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
antigen	NN	dobj	I-Gene_or_gene_product2
and	CC	cc	O
,	,	punct	O
in	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
the	DT	det	O
associated	VBN	amod	O
cellular	JJ	amod	B-Cell
p53	NN	appos	B-Gene_or_gene_product1
as	IN	case	O
endogenous	JJ	amod	O
substrates	NNS	nmod	O
.	.	punct	O

The	DT	det	O
nature	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
substrates	NNS	nmod	O
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
proteolysis	NN	compound	O
techniques	NNS	nmod	O
.	.	punct	O

Under	IN	case	O
specific	JJ	amod	O
conditions	NNS	nmod	O
,	,	punct	O
casein	NN	nsubjpass	B-Gene_or_gene_product2
could	MD	aux	O
be	VB	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
an	DT	det	O
exogenous	JJ	amod	O
substrate	NN	nmod	O
as	RB	advmod	O
well	RB	mwe	O
.	.	punct	O

The	DT	det	O
kinase	NN	compound	O
reactions	NNS	nsubj	O
showed	VBD	ROOT	O
preference	NN	dobj	O
for	IN	case	O
ATP	NN	nmod	B-Simple_chemical
and	CC	cc	O
MgCl2	NN	conj	B-Simple_chemical
instead	RB	advmod	O
of	IN	case	O
GTP	NN	nmod	B-Simple_chemical
or	CC	cc	O
MnCl2	NN	conj	B-Simple_chemical
.	.	punct	O

Both	CC	cc:preconj	O
phosphoserine	NN	nsubjpass	B-Amino_acid
and	CC	cc	O
phosphothreonine	NN	conj	B-Amino_acid
,	,	punct	O
but	CC	cc	O
in	IN	case	O
no	DT	neg	O
case	NN	compound	O
phosphotyrosine	NN	conj	B-Amino_acid
,	,	punct	O
were	VBD	auxpass	O
detected	VBN	ROOT	O
after	IN	case	O
an	DT	det	O
immune	JJ	amod	O
complex	NN	compound	O
kinase	NN	compound	O
reaction	NN	nmod	O
.	.	punct	O

Apparently	RB	advmod	O
,	,	punct	O
several	JJ	amod	O
in	FW	amod	O
vivo	FW	dep	O
phosphorylation	NN	compound	O
sites	NNS	nsubjpass	O
were	VBD	auxpass	O
recognized	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
in	IN	case	O
both	CC	cc:preconj	O
large	JJ	amod	B-Gene_or_gene_product2
T	NN	compound	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
antigen	NN	nmod	I-Gene_or_gene_product2
and	CC	cc	O
p53	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
but	CC	cc	O
the	DT	det	O
presence	NN	nsubjpass	O
of	IN	case	O
some	DT	det	O
artifactual	JJ	amod	O
sites	NNS	nmod	O
could	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
completely	RB	advmod	O
excluded	VBN	conj	O
.	.	punct	O

Although	IN	mark	O
contaminating	VBG	amod	O
kinases	NNS	nsubj	O
were	VBD	cop	O
detectable	JJ	advcl	O
in	IN	case	O
the	DT	det	O
immune	JJ	amod	O
complexes	NNS	nmod	O
,	,	punct	O
at	IN	case	O
least	JJS	mwe	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product1
molecules	NNS	nsubjpass	O
were	VBD	auxpass	O
phosphorylated	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
in	IN	case	O
a	DT	det	O
more	RBR	advmod	O
specific	JJ	amod	O
way	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
followed	VBD	ROOT	O
from	IN	case	O
several	JJ	amod	O
characteristics	NNS	nmod	O
of	IN	case	O
the	DT	det	O
immune	JJ	amod	O
complex	NN	compound	O
kinase	NN	compound	O
reactions	NNS	nmod	O
and	CC	cc	O
especially	RB	advmod	O
from	IN	case	O
the	DT	det	O
strong	JJ	amod	O
inhibition	NN	conj	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product1
phosphorylation	NN	nmod	O
by	IN	case	O
two	CD	nummod	O
anti	JJ	amod	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
large	JJ	amod	I-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
T	NN	compound	I-Gene_or_gene_product0
monoclonal	JJ	amod	I-Gene_or_gene_product0
antibodies	NNS	nmod	I-Gene_or_gene_product0
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
large	JJ	amod	B-Gene_or_gene_product2
T	NN	compound	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
antigen	NN	nsubj	I-Gene_or_gene_product2
showed	VBD	ccomp	O
associated	VBN	amod	O
kinase	NN	compound	O
activity	NN	dobj	O
,	,	punct	O
although	IN	mark	O
none	NN	nsubj	O
of	IN	case	O
our	PRP$	nmod:poss	O
results	NNS	nmod	O
could	MD	aux	O
unambiguously	RB	advmod	O
demonstrate	VB	advcl	O
an	DT	det	O
intrinsic	JJ	amod	O
kinase	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
.	.	punct	O

Finally	RB	advmod	O
,	,	punct	O
anti	JJ	amod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
p53	NN	compound	I-Gene_or_gene_product2
monoclonal	JJ	amod	I-Gene_or_gene_product2
antibodies	NNS	nsubj	I-Gene_or_gene_product2
only	RB	advmod	O
slightly	RB	advmod	O
affected	VBN	ROOT	O
in	FW	amod	O
vitro	FW	dep	O
phosphorylation	NN	compound	O
reactions	NNS	dobj	O
,	,	punct	O
whereas	IN	dep	O
a	DT	det	O
p53	NN	compound	B-Gene_or_gene_product1
molecule	NN	nsubjpass	O
from	IN	case	O
a	DT	det	O
simian	JJ	amod	B-Organism
virus	NN	nmod	I-Organism
40	CD	nummod	I-Organism
-	HYPH	punct	O
free	JJ	amod	O
,	,	punct	O
chemically	RB	advmod	O
transformed	VBN	amod	O
human	JJ	amod	B-Organism
cell	NN	compound	B-Cell
line	NN	appos	I-Cell
was	VBD	auxpass	O
not	RB	neg	O
phosphorylated	VBN	parataxis	O
in	FW	compound	O
vitro	FW	advmod	O
under	IN	case	O
any	DT	det	O
condition	NN	nmod	O
tested	VBN	acl	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
highly	RB	advmod	O
unlikely	JJ	ROOT	O
that	IN	mark	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product1
molecule	NN	nsubj	O
per	FW	compound	O
se	FW	advmod	O
carries	VBZ	ccomp	O
intrinsic	JJ	amod	O
or	CC	cc	O
even	RB	advmod	O
associated	VBN	amod	O
kinase	NN	compound	O
activities	NNS	dobj	O
.	.	punct	O

Molecular	JJ	amod	O
mediators	NNS	ROOT	O
of	IN	case	O
interactions	NNS	nmod	O
with	IN	case	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
components	NNS	nmod	I-Cellular_component
in	IN	case	O
metastasis	NN	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Metastasis	NN	nsubj	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	conj	O
are	VBP	cop	O
invasive	JJ	amod	O
phenomena	NNS	ROOT	O
and	CC	cc	O
share	VB	conj	O
many	JJ	amod	O
common	JJ	amod	O
properties	NNS	dobj	O
at	IN	case	O
the	DT	det	O
physiological	JJ	amod	O
level	NN	nmod	O
and	CC	cc	O
some	DT	det	O
similarities	NNS	conj	O
at	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

Each	DT	nsubj	O
consists	VBZ	ROOT	O
of	IN	case	O
repetitive	JJ	amod	O
cycles	NNS	nmod	O
of	IN	case	O
interaction	NN	nmod	O
with	IN	case	O
adjacent	JJ	amod	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
components	NNS	nmod	I-Cellular_component
by	IN	mark	O
mediating	VBG	advcl	O
cellular	JJ	amod	B-Cell
adhesion	NN	dobj	O
,	,	punct	O
matrix	NN	compound	B-Cellular_component
dissolution	NN	conj	O
,	,	punct	O
and	CC	cc	O
cellular	JJ	amod	B-Cell
motility	NN	conj	O
to	TO	mark	O
achieve	VB	advcl	O
metastasis	NN	dobj	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
or	CC	cc	O
neovascularization	NN	dobj	O
of	IN	case	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Molecular	JJ	amod	O
factors	NNS	nsubjpass	O
which	WDT	nsubj	O
implement	VBP	acl:relcl	O
this	DT	det	O
triad	NN	dobj	O
of	IN	case	O
events	NNS	nmod	O
are	VBP	auxpass	O
reviewed	VBN	ROOT	O
,	,	punct	O
as	IN	mark	O
are	VBP	cop	O
several	JJ	amod	O
signal	NN	compound	O
transduction	NN	compound	O
components	NNS	nmod	O
which	WDT	nsubj	O
may	MD	aux	O
regulate	VB	acl:relcl	O
them	PRP	dobj	O
.	.	punct	O

Some	DT	mark	O
potentially	RB	advmod	O
promising	JJ	acl	O
prognostic	JJ	amod	O
,	,	punct	O
diagnostic	JJ	conj	O
,	,	punct	O
and	CC	cc	O
therapeutic	JJ	conj	O
modalities	NNS	nsubjpass	O
for	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
and	CC	cc	O
metastatic	JJ	amod	O
disease	NN	conj	O
are	VBP	auxpass	O
also	RB	advmod	O
discussed	VBN	ROOT	O
.	.	punct	O

Suppressed	VBN	amod	O
transformation	NN	ROOT	O
and	CC	cc	O
induced	VBD	amod	O
differentiation	NN	conj	O
of	IN	case	O
HER	NN	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	intj	I-Gene_or_gene_product2
/	:	punct	O
neu	NN	npadvmod	B-Gene_or_gene_product1
-	HYPH	punct	O
overexpressing	VBG	amod	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	case	O
emodin	NN	nmod	B-Simple_chemical
.	.	punct	O

The	DT	det	O
amplification	NN	nsubjpass	O
and	CC	cc	O
overexpression	NN	conj	O
of	IN	case	O
the	DT	det	O
HER	NNP	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
/	:	punct	O
neu	NN	compound	B-Gene_or_gene_product1
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
encodes	VBZ	acl:relcl	O
the	DT	det	O
tyrosine	NN	compound	B-Amino_acid
kinase	NN	compound	O
receptor	NN	compound	O
p185neu	NN	dobj	B-Gene_or_gene_product1
,	,	punct	O
have	VBP	aux	O
been	VBN	auxpass	O
observed	VBN	ROOT	O
frequently	RB	advmod	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
from	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
and	CC	cc	O
are	VBP	auxpass	O
correlated	VBN	conj	O
with	IN	case	O
poor	JJ	amod	O
prognosis	NN	nmod	O
.	.	punct	O

To	TO	mark	O
explore	VB	advcl	O
the	DT	det	O
potential	NN	dobj	O
of	IN	case	O
chemotherapy	NN	nmod	O
directed	VBN	acl	O
at	IN	case	O
the	DT	det	O
tyrosine	NN	compound	B-Amino_acid
kinase	NN	nmod	O
of	IN	case	O
p185neu	NN	nmod	B-Gene_or_gene_product1
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
found	VBN	ROOT	O
that	IN	mark	O
emodin	NN	nsubj	B-Simple_chemical
(	-LRB-	punct	O
3	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
1	CD	dep	I-Simple_chemical
,	,	punct	I-Simple_chemical
6	CD	conj	I-Simple_chemical
,	,	punct	I-Simple_chemical
8	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
trihydroxyanthraquinone	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
tyrosine	NN	compound	B-Gene_or_gene_product0
kinase	NN	compound	I-Gene_or_gene_product0
inhibitor	NN	appos	O
,	,	punct	O
suppresses	VBZ	ccomp	O
autophosphorylation	NN	dobj	O
and	CC	cc	O
transphosphorylation	NN	compound	O
activities	NNS	conj	O
of	IN	case	O
HER	NN	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
/	:	punct	O
neu	NN	compound	B-Gene_or_gene_product1
tyrosine	NN	compound	B-Amino_acid
kinase	NN	nmod	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
tyrosine	NN	compound	B-Amino_acid
hypophosphorylation	NN	nmod	O
of	IN	case	O
p185neu	NN	nmod	B-Gene_or_gene_product1
in	IN	case	O
HER	NNP	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
/	:	punct	O
neu	NN	npadvmod	B-Gene_or_gene_product1
-	HYPH	punct	O
overexpressing	VBG	amod	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Emodin	NNP	nsubj	B-Simple_chemical
,	,	punct	O
at	IN	case	O
a	DT	det	O
40	CD	nummod	O
-	HYPH	punct	O
microM	NN	amod	O
concentration	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
repressed	VBD	acl:relcl	O
tyrosine	NN	compound	B-Amino_acid
kinase	NN	dobj	O
of	IN	case	O
p185neu	NN	nmod	B-Gene_or_gene_product1
,	,	punct	O
efficiently	RB	advmod	O
inhibited	VBD	ROOT	O
both	CC	cc:preconj	O
anchorage	JJ	amod	O
-	HYPH	punct	O
dependent	JJ	amod	O
and	CC	cc	O
anchorage	JJ	nmod:npmod	O
-	HYPH	punct	O
independent	JJ	conj	O
growth	NN	dobj	O
of	IN	case	O
HER	NN	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	intj	I-Gene_or_gene_product2
/	:	punct	O
neu	NN	npadvmod	B-Gene_or_gene_product1
-	HYPH	punct	O
overexpressing	VBG	amod	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
inhibition	NN	nsubj	O
was	VBD	cop	O
much	RB	advmod	O
less	RBR	advmod	O
effective	JJ	ROOT	O
for	IN	case	O
those	DT	det	O
cells	NNS	nmod	B-Cell
expressing	VBG	acl	O
basal	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
p185neu	NN	nmod	B-Gene_or_gene_product1
under	IN	case	O
the	DT	det	O
same	JJ	amod	O
conditions	NNS	nmod	O
.	.	punct	O

Emodin	NN	nsubj	B-Simple_chemical
also	RB	advmod	O
induced	VBD	ROOT	O
differentiation	NN	dobj	O
of	IN	case	O
HER	NN	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	intj	I-Gene_or_gene_product2
/	:	punct	O
neu	NN	npadvmod	B-Gene_or_gene_product1
-	HYPH	punct	O
overexpressing	VBG	amod	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	mark	O
exhibiting	VBG	advcl	O
a	DT	det	O
morphological	JJ	amod	O
maturation	NN	compound	O
property	NN	dobj	O
of	IN	case	O
large	JJ	amod	O
lacy	JJ	compound	O
nuclei	NNS	nmod	B-Cellular_component
surrounded	VBN	acl	O
by	IN	case	O
sizable	JJ	amod	O
flat	JJ	compound	B-Organism_substance
cytoplasm	NN	nmod	I-Organism_substance
and	CC	cc	O
by	IN	mark	O
showing	VBG	advcl	O
a	DT	det	O
measurable	JJ	amod	O
production	NN	dobj	O
of	IN	case	O
large	JJ	amod	O
lipid	NN	compound	B-Simple_chemical
droplets	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
marker	NN	acl:relcl	O
of	IN	case	O
mature	JJ	amod	B-Cell
breast	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Therefore	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
emodin	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ccomp	O
HER	NN	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
/	:	punct	O
neu	NN	compound	B-Gene_or_gene_product1
tyrosine	NN	compound	B-Amino_acid
kinase	NN	compound	O
activity	NN	dobj	O
and	CC	cc	O
preferentially	RB	advmod	O
suppresses	VBZ	conj	O
growth	NN	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
differentiation	NN	dobj	O
of	IN	case	O
HER	NN	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	intj	I-Gene_or_gene_product2
/	:	punct	O
neu	NN	npadvmod	B-Gene_or_gene_product1
-	HYPH	punct	O
overexpressing	VBG	amod	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
may	MD	aux	O
have	VB	ROOT	O
chemotherapeutic	JJ	amod	O
implications	NNS	dobj	O
for	IN	mark	O
using	VBG	advcl	O
emodin	NN	dobj	B-Simple_chemical
to	TO	mark	O
target	VB	xcomp	O
HER	NN	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
/	:	punct	O
neu	NN	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
overexpressing	VBG	amod	O
cancer	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

Metastatic	JJ	amod	O
NIH	NN	compound	B-Cell
3T3	NN	compound	I-Cell
x	NN	cc	I-Cell
LTA	NN	compound	I-Cell
cell	NN	compound	I-Cell
hybrids	NNS	nsubj	I-Cell
express	VBP	ROOT	O
72	CD	nummod	B-Gene_or_gene_product2
kDa	NN	compound	I-Gene_or_gene_product2
type	NN	compound	I-Gene_or_gene_product2
IV	CD	nummod	I-Gene_or_gene_product2
collagenase	NN	dobj	I-Gene_or_gene_product2
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
reported	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
murine	JJ	amod	B-Organism
fibroblast	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	compound	I-Cell
LTA	NN	nsubj	I-Cell
is	VBZ	cop	O
tumorigenic	JJ	ccomp	O
but	CC	cc	O
non	JJ	conj	O
-	HYPH	punct	O
metastatic	JJ	conj	O
,	,	punct	O
and	CC	cc	O
is	VBZ	cop	O
non	JJ	advmod	O
-	HYPH	punct	O
responsive	JJ	conj	O
to	TO	case	O
a	DT	det	O
transfected	VBN	amod	O
H	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
ras	NN	compound	I-Gene_or_gene_product1
oncogene	NN	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
NIH	NN	compound	B-Cell
3T3	NN	compound	I-Cell
cells	NNS	nsubj	I-Cell
are	VBP	cop	O
non	JJ	amod	O
-	HYPH	punct	O
tumorigenic	JJ	ROOT	O
but	CC	cc	O
are	VBP	conj	O
ras	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	O
responsive	JJ	acomp	O
and	CC	cc	O
become	VB	conj	O
metastatic	JJ	acomp	O
when	WRB	advmod	O
transfected	VBN	advcl	O
with	IN	case	O
ras	NN	nmod	B-Gene_or_gene_product2
.	.	punct	O

Somatic	JJ	amod	B-Cell
cell	NN	compound	I-Cell
hybrids	NNS	nsubj	I-Cell
between	IN	case	O
LTA	NN	nmod	B-Cell
and	CC	cc	O
NIH	NN	compound	B-Cell
3T3	NN	compound	I-Cell
cells	NNS	conj	I-Cell
are	VBP	cop	O
tumorigenic	JJ	ROOT	O
,	,	punct	O
metastatic	JJ	conj	O
and	CC	cc	O
ras	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	O
responsive	JJ	conj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
expression	NN	dobj	O
of	IN	case	O
type	NN	compound	B-Gene_or_gene_product2
IV	CD	nummod	I-Gene_or_gene_product2
collagenases	NNS	nmod	I-Gene_or_gene_product2
in	IN	case	O
parental	JJ	amod	O
LTA	NN	nmod	B-Cell
and	CC	cc	O
NIH	NN	compound	B-Cell
3T3	NN	compound	I-Cell
cells	NNS	conj	I-Cell
(	-LRB-	punct	O
with	IN	nmod	O
and	CC	cc	O
without	IN	case	O
ras	NN	appos	B-Gene_or_gene_product2
)	-RRB-	punct	O
and	CC	cc	O
four	CD	nummod	O
metastatic	JJ	amod	O
LTA	NN	conj	B-Cell
x	CC	cc	I-Cell
NIH	NN	compound	I-Cell
3T3	NN	compound	I-Cell
hybrids	NNS	conj	I-Cell
(	-LRB-	punct	O
also	RB	advmod	O
with	IN	nmod	O
and	CC	cc	O
without	IN	case	O
ras	NN	appos	B-Gene_or_gene_product0
)	-RRB-	punct	O
.	.	punct	O

Parental	JJ	amod	O
NIH	NNP	compound	B-Cell
3T3	NN	npadvmod	I-Cell
-	:	punct	I-Cell
derived	VBN	amod	I-Cell
cells	NNS	nsubj	I-Cell
had	VBD	ROOT	O
both	CC	cc:preconj	O
72	CD	nummod	B-Gene_or_gene_product1
kDa	NN	dobj	I-Gene_or_gene_product1
and	CC	cc	O
92	CD	nummod	B-Gene_or_gene_product0
kDa	NN	compound	I-Gene_or_gene_product0
gelatinase	NN	compound	I-Gene_or_gene_product0
activities	NNS	conj	O
,	,	punct	O
and	CC	cc	O
LTA	NNP	nmod:npmod	B-Cell
-	HYPH	punct	O
derived	VBN	amod	O
cells	NNS	conj	B-Cell
had	VBD	aux	O
either	CC	cc:preconj	O
aberrantly	RB	advmod	O
sized	VBN	conj	O
approximately	RB	advmod	O
90	CD	nummod	B-Gene_or_gene_product1
kDa	NN	compound	I-Gene_or_gene_product1
activity	NN	dobj	O
alone	RB	advmod	O
or	CC	cc	O
neither	CC	cc:preconj	O
enzyme	NN	compound	O
activity	NN	conj	O
.	.	punct	O

All	DT	det	O
four	CD	nummod	O
metastatic	JJ	amod	O
hybrids	NNS	nsubj	B-Cell
expressed	VBD	ROOT	O
60	CD	nummod	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
72	CD	nummod	I-Gene_or_gene_product2
kDa	NN	compound	I-Gene_or_gene_product2
gelatinase	NN	compound	I-Gene_or_gene_product2
activity	NN	dobj	O
,	,	punct	O
while	IN	mark	O
three	CD	nsubj	O
of	IN	case	O
them	PRP	nmod	O
also	RB	advmod	O
had	VBD	advcl	O
92	CD	nummod	B-Gene_or_gene_product2
kDa	NN	compound	I-Gene_or_gene_product2
activity	NN	dobj	O
and	CC	cc	O
one	CD	nsubj	O
had	VBD	conj	O
only	RB	advmod	O
minimal	JJ	amod	O
92	CD	compound	B-Gene_or_gene_product1
kDa	NN	compound	I-Gene_or_gene_product1
activity	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
the	DT	det	O
metastatic	JJ	amod	O
phenotype	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
hybrids	NNS	nmod	B-Cell
was	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
expression	NN	nmod	O
of	IN	case	O
72	CD	nummod	B-Gene_or_gene_product2
kDa	NN	compound	I-Gene_or_gene_product2
gelatinase	NN	nmod	I-Gene_or_gene_product2
.	.	punct	O

Levels	NNS	nsubj	O
of	IN	case	O
RNA	NN	nmod	O
for	IN	case	O
tissue	NN	compound	B-Tissue
inhibitors	NNS	nmod	O
of	IN	case	O
metalloproteinases	NNS	nmod	O
(	-LRB-	punct	O
TIMP	NN	compound	B-Gene_or_gene_product3
-	SYM	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
,	,	punct	O
TIMP	NN	conj	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
2	CD	nummod	I-Gene_or_gene_product3
)	-RRB-	punct	O
were	VBD	cop	O
relatively	RB	advmod	O
constant	JJ	ROOT	O
,	,	punct	O
suggesting	VBG	advcl	O
independent	JJ	amod	O
regulation	NN	dobj	O
of	IN	case	O
type	NN	compound	B-Gene_or_gene_product2
IV	CD	nummod	I-Gene_or_gene_product2
collagenases	NNS	nmod	I-Gene_or_gene_product2
and	CC	cc	O
their	PRP$	nmod:poss	O
inhibitors	NNS	conj	O
.	.	punct	O

Southern	NN	compound	O
blotting	NN	nsubj	O
and	CC	cc	O
probing	VBG	conj	O
with	IN	case	O
PCR	NN	nmod:npmod	O
-	HYPH	punct	O
synthesized	VBN	amod	O
cDNA	NN	compound	O
fragments	NNS	nmod	O
of	IN	case	O
the	DT	det	O
mouse	NN	compound	B-Organism
72	CD	nummod	B-Gene_or_gene_product2
kDa	NN	compound	I-Gene_or_gene_product2
type	NN	compound	I-Gene_or_gene_product2
IV	CD	nummod	I-Gene_or_gene_product2
collagenase	NN	compound	I-Gene_or_gene_product2
gene	NN	nmod	O
showed	VBD	ROOT	O
that	IN	mark	O
this	DT	det	O
gene	NN	nsubj	O
was	VBD	cop	O
present	JJ	ccomp	O
in	IN	case	O
all	DT	det	O
cells	NNS	nmod	B-Cell
although	IN	mark	O
the	DT	det	O
structure	NN	nsubj	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
in	IN	case	O
one	CD	nmod	O
of	IN	case	O
the	DT	det	O
three	CD	nummod	O
LTA	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
differed	VBD	advcl	O
from	IN	case	O
that	DT	nmod	O
of	IN	case	O
the	DT	det	O
other	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
key	JJ	amod	O
change	NN	nsubj	O
in	IN	case	O
the	DT	det	O
metastatic	JJ	amod	O
hybrids	NNS	nmod	B-Cell
,	,	punct	O
relative	JJ	case	O
to	TO	case	O
non	JJ	advmod	O
-	HYPH	punct	O
metastatic	JJ	amod	O
parental	JJ	amod	O
LTA	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
is	VBZ	cop	O
induction	NN	ccomp	O
of	IN	case	O
expression	NN	nmod	O
of	IN	case	O
72	CD	nummod	B-Gene_or_gene_product2
kDa	NN	compound	I-Gene_or_gene_product2
type	NN	compound	I-Gene_or_gene_product2
IV	CD	nummod	I-Gene_or_gene_product2
collagenase	NN	nmod	I-Gene_or_gene_product2
.	.	punct	O

Neoplastic	JJ	amod	O
progression	NN	nsubjpass	O
of	IN	case	O
human	JJ	amod	B-Organism
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
the	DT	det	O
stromelysin	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
3	CD	dep	I-Gene_or_gene_product2
and	CC	cc	O
BM	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
40	CD	nummod	I-Gene_or_gene_product2
/	SYM	punct	O
SPARC	NN	compound	B-Gene_or_gene_product2
genes	NNS	nmod	O
.	.	punct	O

The	DT	det	O
interaction	NN	nsubj	O
of	IN	case	O
neoplastic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
is	VBZ	cop	O
a	DT	det	O
critical	JJ	amod	O
event	NN	ROOT	O
for	IN	case	O
the	DT	det	O
initiation	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cancer
invasion	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
potential	JJ	amod	O
implication	NN	dobj	O
of	IN	case	O
stromelysin	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
3	CD	nmod	I-Gene_or_gene_product2
(	-LRB-	punct	O
ST3	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
newly	RB	advmod	O
identified	VBN	amod	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
matrix	NN	compound	O
-	HYPH	punct	O
degrading	VBG	amod	O
metalloproteinase	NN	compound	O
family	NN	nmod	O
,	,	punct	O
and	CC	cc	O
of	IN	case	O
BM	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
40	CD	nummod	I-Gene_or_gene_product2
/	SYM	punct	O
SPARC	NNP	conj	B-Gene_or_gene_product2
,	,	punct	O
a	DT	det	O
glycoprotein	NN	appos	O
associated	VBN	acl	O
with	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
,	,	punct	O
during	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
colorectal	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

We	PRP	nsubj	O
analyzed	VBD	ROOT	O
the	DT	det	O
relative	JJ	amod	O
abundance	NN	dobj	O
of	IN	case	O
ST3	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
BM	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
40	CD	conj	I-Gene_or_gene_product2
/	SYM	punct	O
SPARC	NN	compound	B-Gene_or_gene_product2
transcripts	NNS	nmod	O
by	IN	case	O
Northern	NN	compound	O
blot	NN	nmod	O
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
distribution	NN	conj	O
by	IN	case	O
in	FW	amod	O
situ	FW	dep	O
hybridization	NN	nmod	O
,	,	punct	O
in	IN	case	O
normal	JJ	amod	O
mucosa	NN	nmod	B-Multi-tissue_structure
,	,	punct	O
benign	JJ	amod	B-Pathological_formation
adenomas	NNS	conj	I-Pathological_formation
,	,	punct	O
and	CC	cc	O
primary	JJ	amod	O
colorectal	JJ	amod	B-Cancer
adenocarcinomas	NNS	conj	I-Cancer
and	CC	cc	O
their	PRP$	nmod:poss	O
liver	NN	compound	B-Organ
metastases	NNS	conj	O
.	.	punct	O

The	DT	det	O
ST3	NN	compound	B-Gene_or_gene_product1
and	CC	cc	O
BM	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
40	CD	conj	I-Gene_or_gene_product2
/	SYM	punct	O
SPARC	NN	compound	B-Gene_or_gene_product2
transcripts	NNS	nsubjpass	O
were	VBD	auxpass	O
overexpressed	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
colorectal	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
their	PRP$	nmod:poss	O
liver	NN	compound	B-Organ
metastases	NNS	conj	O
compared	VBN	prep	O
to	TO	case	O
non	JJ	advmod	O
-	HYPH	punct	O
neoplastic	JJ	amod	O
mucosa	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

These	DT	det	O
transcripts	NNS	nsubj	O
were	VBD	auxpass	O
localized	JJ	ROOT	O
in	IN	case	O
stromal	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
adjacent	JJ	amod	O
to	TO	case	O
the	DT	det	O
neoplastic	JJ	amod	O
foci	NNS	nmod	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	case	O
ST3	NN	nmod	B-Gene_or_gene_product1
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
colorectal	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
toward	IN	case	O
local	JJ	amod	O
invasion	NN	nmod	O
and	CC	cc	O
liver	NN	compound	B-Organ
metastasis	NN	conj	O
.	.	punct	O

Induction	NN	nsubj	O
of	IN	case	O
these	DT	det	O
genes	NNS	nmod	O
also	RB	advmod	O
occurred	VBD	ROOT	O
in	IN	case	O
diverticulitis	NN	nmod	O
and	CC	cc	O
digestive	JJ	amod	O
neoplasms	NNS	conj	B-Cancer
such	JJ	case	O
as	IN	mwe	O
gastric	JJ	amod	B-Cancer
and	CC	cc	O
esophageal	JJ	conj	B-Cancer
carcinomas	NNS	nmod	I-Cancer
.	.	punct	O

Down	NN	compound	O
-	HYPH	punct	O
regulation	NN	ROOT	O
of	IN	case	O
collagen	NN	compound	B-Gene_or_gene_product2
XII	NN	nmod	I-Gene_or_gene_product2
in	IN	case	O
transformed	VBN	amod	O
mesenchymal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Collagen	NN	compound	B-Gene_or_gene_product2
XII	NN	nsubj	I-Gene_or_gene_product2
is	VBZ	cop	O
a	DT	det	O
complex	JJ	amod	O
multidomain	NN	amod	O
protein	NN	ROOT	O
associated	VBN	acl	O
with	IN	case	O
the	DT	det	O
surface	NN	nmod	O
of	IN	case	O
interstitial	JJ	amod	B-Organ
collagen	NN	compound	B-Gene_or_gene_product0
fibrils	NNS	nmod	B-Cellular_component
.	.	punct	O

This	DT	det	O
protein	NN	nsubjpass	O
is	VBZ	auxpass	O
produced	VBN	ROOT	O
in	IN	case	O
large	JJ	amod	O
amounts	NNS	nmod	O
by	IN	case	O
fibroblasts	NNS	nmod	B-Cell
cultivated	VBN	acl	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	cop	O
completely	RB	advmod	O
absent	JJ	ROOT	O
from	IN	case	O
cells	NNS	nmod	B-Cell
transformed	VBN	acl	O
by	IN	case	O
the	DT	det	O
oncogene	NN	compound	O
v	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
myc	NN	nmod	I-Gene_or_gene_product0
or	CC	cc	O
v	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
src	NN	conj	I-Gene_or_gene_product0
and	CC	cc	O
from	IN	case	O
cells	NNS	conj	B-Cell
derived	VBN	acl	O
from	IN	case	O
a	DT	det	O
methylcholanthrene	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
fibrosarcoma	NN	nmod	B-Cancer
.	.	punct	O

Since	IN	mark	O
all	PDT	det:predet	O
these	DT	det	O
cells	NNS	nsubj	B-Cell
lack	VBP	advcl	O
any	DT	det	O
mRNA	NN	dobj	O
for	IN	case	O
collagen	NN	nmod	B-Gene_or_gene_product2
,	,	punct	I-Gene_or_gene_product2
XII	NN	appos	I-Gene_or_gene_product2
,	,	punct	O
it	PRP	nsubj	O
seems	VBZ	ROOT	O
likely	JJ	xcomp	O
that	IN	mark	O
the	DT	det	O
synthesis	NN	nsubjpass	O
is	VBZ	auxpass	O
blocked	VBN	ccomp	O
at	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

Experiments	NNS	nsubj	O
with	IN	case	O
a	DT	det	O
temperature	NN	nmod:npmod	O
-	HYPH	punct	O
sensitive	JJ	amod	O
mutant	NN	nmod	O
of	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
demonstrated	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
single	JJ	amod	O
oncogene	NN	compound	O
product	NN	nsubj	O
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
inhibit	VB	xcomp	O
the	DT	det	O
synthesis	NN	dobj	O
.	.	punct	O

A	DT	det	O
reduction	NN	nsubj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
collagen	NN	compound	B-Gene_or_gene_product2
XII	NN	nmod	I-Gene_or_gene_product2
might	MD	aux	O
have	VB	ROOT	O
profound	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
the	DT	det	O
stability	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
of	IN	case	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Comparative	JJ	amod	O
NMR	NN	compound	O
study	NN	ROOT	O
of	IN	case	O
a	DT	det	O
differentiated	VBN	amod	O
rat	NN	compound	B-Organism
hepatoma	NN	nmod	B-Cancer
and	CC	cc	O
its	PRP$	nmod:poss	O
dedifferentiated	VBN	amod	O
subclone	NN	conj	B-Cell
cultured	VBN	acl	O
as	IN	case	O
spheroids	NNS	nmod	B-Cell
and	CC	cc	O
as	IN	case	O
implanted	VBN	amod	O
tumors	NNS	conj	B-Cancer
.	.	punct	O

H4IIEC3	NN	nsubjpass	B-Cell
(	-LRB-	punct	O
H4	NN	appos	B-Cell
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
differentiated	VBN	amod	O
rat	NN	compound	B-Organism
hepatoma	NN	compound	B-Cell
line	NN	appos	I-Cell
and	CC	cc	O
H5	NN	conj	B-Cell
,	,	punct	O
its	PRP$	nmod:poss	O
dedifferentiated	VBN	amod	O
subclone	NN	appos	B-Cell
,	,	punct	O
were	VBD	auxpass	O
investigated	VBN	ROOT	O
as	IN	case	O
proliferating	VBG	amod	O
spheroids	NNS	nmod	B-Cell
and	CC	cc	O
as	IN	case	O
implanted	VBN	amod	O
subcutaneous	JJ	amod	B-Cancer
tumors	NNS	conj	I-Cancer
in	IN	case	O
juvenile	JJ	amod	B-Organism
rats	NNS	nmod	I-Organism
.	.	punct	O

H4	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
formed	VBD	ROOT	O
tight	JJ	dobj	O
,	,	punct	O
round	VB	conj	O
spheroids	NNS	dobj	B-Cell
whereas	IN	mark	O
H5	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
formed	VBD	advcl	O
loose	JJ	dobj	O
,	,	punct	O
grape	NN	compound	B-Cell
-	HYPH	punct	I-Cell
like	IN	case	I-Cell
structures	NNS	conj	I-Cell
.	.	punct	O

31P	CD	compound	B-Simple_chemical
MR	NN	compound	O
spectra	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
phosphocreatine	NN	nsubj	B-Simple_chemical
was	VBD	cop	O
present	JJ	ccomp	O
in	IN	case	O
H5	NN	compound	B-Cell
spheroids	NNS	nmod	I-Cell
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
H4	NN	conj	B-Cell
spheroids	NNS	dep	I-Cell
or	CC	cc	O
tumors	NNS	conj	B-Cancer
.	.	punct	O

[	-LRB-	punct	B-Simple_chemical
13C	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
Lactate	NN	compound	I-Simple_chemical
production	NN	nsubj	O
from	IN	prep	O
[	-LRB-	punct	B-Simple_chemical
13C	NN	nummod	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
glucose	NN	pobj	I-Simple_chemical
,	,	punct	O
with	IN	case	O
no	DT	neg	O
detectable	JJ	amod	O
uptake	NN	nmod	O
of	IN	case	O
[	-LRB-	punct	B-Simple_chemical
13C	NN	nummod	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
alanine	NN	nmod	I-Simple_chemical
,	,	punct	O
indicated	VBD	ROOT	O
that	IN	mark	O
energy	NN	compound	O
production	NN	nsubj	O
in	IN	case	O
H5	NN	compound	B-Cell
spheroids	NNS	nmod	I-Cell
was	VBD	cop	O
primarily	RB	advmod	O
via	IN	case	O
glycolysis	NN	ccomp	O
.	.	punct	O

No	DT	dep	O
[	-LRB-	punct	B-Simple_chemical
13C	NN	nsubjpass	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
glucose	NN	compound	I-Simple_chemical
utilization	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
H4	NN	compound	B-Cell
spheroids	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
uptake	NN	nsubj	O
of	IN	case	O
alanine	NN	nmod	B-Amino_acid
and	CC	cc	O
accumulation	NN	conj	O
of	IN	case	O
labeled	VBN	amod	O
lactate	NN	nmod	B-Simple_chemical
,	,	punct	O
glutamate	NN	conj	B-Amino_acid
and	CC	cc	O
glutamine	NN	conj	B-Amino_acid
indicated	VBD	conj	O
oxidation	NN	dobj	O
via	IN	case	O
the	DT	det	O
tricarboxylic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
TCA	NN	compound	B-Simple_chemical
)	-RRB-	punct	O
cycle	NN	nmod	O
.	.	punct	O

Tumors	NNS	nsubjpass	B-Cancer
of	IN	case	O
H4	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
were	VBD	auxpass	O
well	RB	advmod	O
perfused	VBN	ROOT	O
,	,	punct	O
unlike	IN	case	O
tumors	NNS	nmod	B-Cancer
of	IN	case	O
H5	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
which	WDT	nsubj	O
were	VBD	cop	O
highly	RB	advmod	O
necrotic	JJ	acl:relcl	O
.	.	punct	O

Following	VBG	ROOT	O
i	LS	dobj	O
.	.	punct	O
v	LS	ROOT	O
.	.	punct	O
infusion	NN	nsubjpass	O
with	IN	case	O
[	-LRB-	punct	B-Simple_chemical
13C	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
alanine	NN	nmod	I-Simple_chemical
,	,	punct	O
[	-LRB-	punct	B-Simple_chemical
13C	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
lactate	NN	conj	I-Simple_chemical
and	CC	cc	O
glutamate	NN	conj	B-Amino_acid
,	,	punct	O
evidence	NN	conj	O
of	IN	case	O
oxidation	NN	nmod	O
via	IN	case	O
the	DT	det	O
TCA	NN	compound	B-Simple_chemical
cycle	NN	nmod	O
,	,	punct	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
H4	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

Thus	RB	advmod	O
the	DT	det	O
results	NNS	nsubj	O
obtained	VBN	acl	O
by	IN	case	O
31P	NN	nmod	B-Simple_chemical
and	CC	cc	O
13C	NN	conj	B-Simple_chemical
MRS	NN	conj	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
differentiation	NN	compound	O
state	NN	nmod	O
of	IN	case	O
H4	NN	nmod	B-Cell
and	CC	cc	O
H5	NN	conj	B-Cell
spheroids	NNS	dep	I-Cell
and	CC	cc	O
tumors	NNS	conj	B-Cancer
.	.	punct	O

[	-LRB-	punct	O
The	DT	det	O
erbB	NN	compound	B-Gene_or_gene_product1
gene	NN	compound	O
family	NN	ROOT	O
:	:	punct	O
significance	NN	dep	O
for	IN	case	O
tumor	NN	compound	B-Cancer
development	NN	nmod	O
,	,	punct	O
prognosis	NN	conj	O
and	CC	cc	O
new	JJ	amod	O
therapeutic	JJ	amod	O
modalities	NNS	conj	O
]	-RRB-	punct	O
.	.	punct	O

RNA	NN	nsubj	B-Organism
and	CC	cc	O
DNA	NN	compound	B-Organism
viruses	NNS	conj	I-Organism
can	MD	aux	O
be	VB	aux	O
transforming	VBG	ROOT	O
and	CC	cc	O
tumourigenic	JJ	amod	O
agents	NNS	conj	O
.	.	punct	O

The	DT	det	O
transformation	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
consequence	NN	ROOT	O
of	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
viruses	NNS	nmod	B-Organism
to	TO	mark	O
integrate	VB	acl	O
into	IN	case	O
the	DT	det	O
host	NN	compound	B-Cell
cell	NN	compound	I-Cell
'	''	punct	O
s	NNS	nmod	O
DNA	NN	dep	B-Cellular_component
and	CC	cc	O
to	TO	mark	O
produce	VB	conj	O
transforming	VBG	amod	O
proteins	NNS	dobj	O
.	.	punct	O

These	DT	det	O
proteins	NNS	nsubjpass	O
are	VBP	auxpass	O
mainly	RB	advmod	O
produced	VBN	ROOT	O
by	IN	case	O
specific	JJ	amod	O
integral	JJ	amod	O
parts	NNS	nmod	O
of	IN	case	O
the	DT	det	O
viral	JJ	amod	B-Organism
genome	NN	nmod	O
,	,	punct	O
the	DT	det	O
oncogenes	NNS	dobj	O
.	.	punct	O

Comparison	NN	nsubj	O
between	IN	case	O
RNA	NN	compound	O
/	:	punct	O
DNA	NN	compound	B-Cellular_component
sequence	NN	nmod	O
of	IN	case	O
viral	JJ	amod	B-Organism
oncogenes	NNS	nmod	O
and	CC	cc	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
genome	NN	conj	O
of	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
revealed	VBD	ROOT	O
high	JJ	amod	O
sequence	NN	compound	O
similarities	NNS	dobj	O
in	IN	case	O
specific	JJ	amod	O
genomic	JJ	amod	O
areas	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
named	VBN	acl:relcl	O
cellular	JJ	amod	B-Cell
proto	NN	compound	O
-	:	punct	O
oncogens	NNS	oprd	O
.	.	punct	O

They	PRP	nsubj	O
are	VBP	ROOT	O
important	JJ	amod	O
components	NNS	attr	O
of	IN	case	O
the	DT	det	O
growth	NN	compound	O
regulatory	JJ	amod	O
pathways	NNS	nmod	O
in	IN	case	O
normal	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
accumulation	NN	nsubj	O
of	IN	case	O
genetic	JJ	amod	O
alterations	NNS	nmod	O
of	IN	case	O
some	DT	det	O
proto	NN	compound	O
-	HYPH	punct	O
oncogens	NNS	nmod	O
,	,	punct	O
like	IN	case	O
the	DT	det	O
erbB	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	O
family	NN	nmod	O
,	,	punct	O
may	MD	aux	O
be	VB	cop	O
part	NN	ROOT	O
of	IN	case	O
the	DT	det	O
mechanism	NN	nmod	O
,	,	punct	O
by	IN	case	O
which	WDT	nmod	O
malignant	JJ	amod	B-Cell
cells	NNS	nsubj	I-Cell
can	MD	aux	O
acquire	VB	acl:relcl	O
a	DT	det	O
selective	JJ	amod	O
growth	NN	compound	O
advantage	NN	dobj	O
.	.	punct	O

The	DT	det	O
epidermal	JJ	amod	B-Gene_or_gene_product1
growth	NN	compound	I-Gene_or_gene_product1
factor	NN	compound	I-Gene_or_gene_product1
receptor	NN	nsubj	I-Gene_or_gene_product1
(	-LRB-	punct	O
EGF	NN	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
R	NN	dep	I-Gene_or_gene_product3
,	,	punct	O
c	NN	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
erbB1	NNP	appos	I-Gene_or_gene_product3
)	-RRB-	punct	O
,	,	punct	O
Her	PRP$	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
/	:	punct	O
neu	NN	compound	B-Gene_or_gene_product1
(	-LRB-	punct	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
erbB2	NN	appos	I-Gene_or_gene_product1
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
erbB3	NNP	conj	I-Gene_or_gene_product1
are	VBP	ROOT	O
members	NNS	attr	O
of	IN	prep	O
the	DT	det	O
erbB	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	O
family	NN	pobj	O
.	.	punct	O

The	DT	det	O
detection	NN	nsubj	O
of	IN	case	O
increased	VBN	amod	O
abundance	NN	nmod	O
of	IN	case	O
EGF	NN	compound	B-Gene_or_gene_product1
-	:	punct	I-Gene_or_gene_product1
R	NN	nmod	I-Gene_or_gene_product1
or	CC	cc	O
Her	PRP$	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
/	:	punct	O
neu	NN	compound	B-Gene_or_gene_product2
proteins	NNS	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
tumours	NNS	nmod	B-Cancer
can	MD	aux	O
provide	VB	ROOT	O
additional	JJ	amod	O
information	NN	dobj	O
on	IN	case	O
the	DT	det	O
disease	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	nmod	O
and	CC	cc	O
overall	JJ	amod	O
survival	NN	conj	O
for	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
breast	NN	nmod	B-Cancer
,	,	punct	O
ovarian	JJ	conj	B-Cancer
,	,	punct	O
endometrial	JJ	conj	B-Cancer
or	CC	cc	O
cervical	JJ	conj	B-Cancer
cancer	NN	conj	I-Cancer
.	.	punct	O

Molecular	JJ	amod	O
and	CC	cc	O
cell	NN	nmod:npmod	B-Cell
-	HYPH	punct	O
physiological	JJ	conj	O
analyses	NNS	nsubj	O
have	VBP	aux	O
improved	VBN	ROOT	O
the	DT	det	O
understanding	NN	dobj	O
of	IN	case	O
tumour	NN	compound	B-Cancer
biology	NN	nmod	O
and	CC	cc	O
provide	VBP	conj	O
the	DT	det	O
opportunity	NN	dobj	O
for	IN	case	O
new	JJ	amod	O
therapeutic	JJ	amod	O
approaches	NNS	nmod	O
.	.	punct	O

Monoclonal	JJ	amod	O
antibody	NN	compound	O
targeted	VBD	amod	O
therapy	NN	ROOT	O
directed	VBN	acl	O
against	IN	case	O
EGF	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
R	NN	nmod	I-Gene_or_gene_product1
or	CC	cc	O
Her	PRP$	compound	B-Gene_or_gene_product2
-	SYM	punct	I-Gene_or_gene_product2
2	CD	nummod	I-Gene_or_gene_product2
/	:	punct	O
neu	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
the	DT	det	O
use	NN	appos	O
of	IN	prep	O
anti	JJ	amod	O
-	HYPH	punct	O
sense	NN	amod	O
oligonucleotides	NNS	pobj	O
and	CC	cc	O
oligodeoxynucleotides	NNS	conj	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
application	NN	nsubjpass	O
of	IN	case	O
tyrosine	NN	compound	B-Gene_or_gene_product0
kinase	NN	nmod	I-Gene_or_gene_product0
and	CC	cc	O
protein	NN	compound	B-Gene_or_gene_product2
C	NN	compound	I-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
kinase	NN	compound	I-Gene_or_gene_product2
inhibitors	NNS	conj	O
are	VBP	auxpass	O
currently	RB	advmod	O
being	VBG	auxpass	O
investigated	VBN	conj	O
.	.	punct	O

Human	JJ	amod	B-Organism
cytomegalovirus	NN	nsubj	I-Organism
elevates	NNS	ROOT	O
levels	NNS	dobj	O
of	IN	case	O
the	DT	det	O
cellular	JJ	amod	B-Cell
protein	NN	compound	O
p53	NN	nmod	B-Gene_or_gene_product1
in	IN	case	O
infected	JJ	amod	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

Human	JJ	amod	B-Organism
cytomegalovirus	NN	nsubj	I-Organism
(	-LRB-	punct	O
HCMV	NN	appos	B-Organism
)	-RRB-	punct	O
,	,	punct	O
like	IN	case	O
other	JJ	amod	O
DNA	NN	compound	B-Cellular_component
tumor	NN	compound	B-Cancer
viruses	NNS	nmod	O
,	,	punct	O
induces	VBZ	ROOT	O
morphological	JJ	amod	O
transformation	NN	dobj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
stimulates	VBZ	conj	O
host	NN	compound	O
cell	NN	compound	B-Cell
macromolecular	JJ	amod	O
synthesis	NN	dobj	O
in	IN	case	O
infected	JJ	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Since	IN	mark	O
other	JJ	amod	O
DNA	NN	compound	B-Cellular_component
tumor	NN	compound	B-Cancer
viruses	NNS	nsubjpass	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
simian	JJ	amod	B-Organism
virus	NN	nmod	I-Organism
40	CD	nummod	I-Organism
and	CC	cc	O
adenovirus	NN	conj	B-Organism
,	,	punct	O
have	VBP	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	advcl	O
to	TO	mark	O
interact	VB	xcomp	O
with	IN	case	O
cellular	JJ	amod	B-Cell
protein	NN	compound	O
p53	NN	nmod	B-Gene_or_gene_product1
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
whether	IN	mark	O
infection	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
by	IN	case	O
HCMV	NN	nmod	B-Organism
would	MD	aux	O
modulate	VB	ccomp	O
cellular	JJ	amod	B-Cell
p53	NN	compound	B-Gene_or_gene_product1
levels	NNS	dobj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
HCMV	NN	nsubj	B-Organism
elevates	VBZ	ccomp	O
cellular	JJ	amod	B-Cell
p53	NN	compound	B-Gene_or_gene_product1
levels	NNS	dobj	O
on	IN	case	O
the	DT	det	O
order	NN	nmod	O
of	IN	case	O
10	CD	nummod	O
-	HYPH	punct	O
to	IN	quantmod	O
20	CD	nummod	O
-	HYPH	punct	O
fold	JJ	nmod	O
in	IN	case	O
infected	JJ	amod	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
elevated	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product1
levels	NNS	nmod	O
was	VBD	cop	O
dependent	JJ	ROOT	O
upon	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
active	JJ	amod	O
virus	NN	nmod	O
and	CC	cc	O
was	VBD	auxpass	O
prevented	VBN	conj	O
by	IN	case	O
neutralizing	VBG	amod	O
antibody	NN	nmod	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubjpass	O
of	IN	case	O
elevated	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product1
levels	NNS	nmod	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
not	RB	neg	O
to	TO	mark	O
be	VB	cop	O
due	JJ	case	O
to	TO	mwe	O
virus	NN	compound	O
-	HYPH	punct	O
receptor	NN	compound	O
interactions	NNS	nmod	O
or	CC	cc	O
HCMV	NN	compound	B-Organism
late	JJ	amod	O
events	NNS	conj	O
.	.	punct	O

The	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
elevated	JJ	amod	O
p53	NN	compound	B-Gene_or_gene_product1
levels	NNS	nmod	O
commenced	VBN	ROOT	O
at	IN	case	O
immediate	JJ	amod	O
-	HYPH	punct	O
early	JJ	amod	O
times	NNS	nmod	O
of	IN	case	O
the	DT	det	O
HCMV	NN	compound	B-Organism
multiplication	NN	compound	O
cycle	NN	nmod	O
(	-LRB-	punct	O
6	CD	nummod	O
h	NN	compound	O
postinfection	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
reached	VBD	conj	O
maximal	JJ	amod	O
levels	NNS	dobj	O
by	IN	case	O
24	CD	nummod	O
h	NN	compound	O
postinfection	NN	nmod	O
,	,	punct	O
before	IN	case	O
most	JJS	nsubjpass	O
of	IN	case	O
the	DT	det	O
HCMV	NN	compound	B-Organism
DNA	NN	compound	B-Cellular_component
synthesis	NN	nmod	O
was	VBD	auxpass	O
initiated	VBN	advcl	O
.	.	punct	O

HCMV	NN	compound	B-Organism
immediate	JJ	amod	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
early	JJ	amod	I-Gene_or_gene_product2
proteins	NNS	nsubjpass	I-Gene_or_gene_product2
were	VBD	auxpass	O
clearly	RB	advmod	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	cop	O
responsible	JJ	xcomp	O
for	IN	mark	O
elevating	VBG	advcl	O
p53	NN	compound	B-Gene_or_gene_product1
levels	NNS	dobj	O
in	IN	case	O
infected	JJ	amod	O
fibroblasts	NNS	nmod	B-Cell
;	:	punct	O
expression	NN	nsubj	O
of	IN	case	O
HCMV	NN	compound	B-Organism
immediate	JJ	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
early	JJ	amod	I-Gene_or_gene_product3
region	NN	nmod	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
and	CC	cc	O
2	CD	conj	B-Gene_or_gene_product2
proteins	NNS	dep	O
resulted	VBD	parataxis	O
in	IN	case	O
elevation	NN	nmod	O
of	IN	case	O
p53	NN	compound	B-Gene_or_gene_product1
levels	NNS	nmod	O
in	IN	case	O
transfected	VBN	amod	O
human	JJ	amod	B-Organism
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

This	DT	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
first	JJ	amod	O
report	NN	attr	O
of	IN	case	O
increased	VBN	amod	O
p53	NN	compound	B-Gene_or_gene_product1
levels	NNS	nmod	O
caused	VBN	acl	O
by	IN	case	O
HCMV	NN	nmod	B-Organism
in	IN	case	O
infected	JJ	amod	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

H	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	compound	I-Gene_or_gene_product2
mutations	NNS	ROOT	O
in	IN	case	O
human	JJ	amod	B-Organism
pituitary	JJ	amod	B-Cancer
carcinoma	NN	compound	I-Cancer
metastases	NNS	nmod	O
.	.	punct	O

Molecular	JJ	amod	O
mechanisms	NNS	nsubjpass	O
of	IN	case	O
pituitary	JJ	amod	B-Organ
tumorigenesis	NN	nmod	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
Polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	compound	O
-	HYPH	punct	O
single	JJ	dobj	O
stranded	JJ	xcomp	O
conformational	JJ	amod	O
polymorphism	NN	dobj	O
with	IN	case	O
DNA	NN	compound	O
sequencing	NN	nmod	O
to	TO	mark	O
identify	VB	xcomp	O
potential	JJ	amod	O
mutations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
ras	NN	compound	B-Gene_or_gene_product2
protooncogenes	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	compound	O
p53	NN	conj	B-Gene_or_gene_product1
in	IN	case	O
invasive	JJ	amod	B-Cancer
pituitary	JJ	amod	I-Cancer
adenomas	NNS	nmod	I-Cancer
and	CC	cc	O
carcinomas	NNS	conj	B-Cancer
.	.	punct	O

Sequencing	NN	nsubj	O
of	IN	case	O
exons	NNS	nmod	O
5	CD	nummod	O
through	IN	case	O
8	CD	nmod	O
of	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product1
gene	NN	nmod	O
revealed	VBD	ROOT	O
no	DT	neg	O
mutations	NNS	dobj	O
,	,	punct	O
nor	CC	cc	O
were	VBD	conj	O
mutations	NNS	nsubj	O
detected	VBN	acl	O
in	IN	case	O
the	DT	det	O
N	NN	compound	B-Gene_or_gene_product2
-	:	punct	I-Gene_or_gene_product2
or	CC	cc	O
K	NNP	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	conj	I-Gene_or_gene_product2
protooncogenes	NNS	nmod	O
in	IN	case	O
four	CD	nmod	O
of	IN	case	O
the	DT	det	O
carcinomas	NNS	nmod	B-Cancer
and	CC	cc	O
their	PRP$	nmod:poss	O
respective	JJ	amod	O
metastatic	JJ	amod	O
deposits	NNS	conj	B-Cancer
.	.	punct	O

Point	NN	compound	O
mutations	NNS	nsubjpass	O
of	IN	case	O
H	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
ras	NN	nmod	I-Gene_or_gene_product1
however	RB	advmod	O
,	,	punct	O
were	VBD	auxpass	O
identified	VBN	ROOT	O
in	IN	case	O
three	CD	nummod	O
distant	JJ	amod	O
metastatic	JJ	amod	O
pituitary	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
secondaries	NNS	nmod	I-Cancer
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
their	PRP$	nmod:poss	O
respective	JJ	amod	O
primary	JJ	amod	B-Cancer
pituitary	JJ	amod	I-Cancer
carcinomas	NNS	conj	I-Cancer
,	,	punct	O
or	CC	cc	O
in	IN	case	O
six	CD	nummod	O
invasive	JJ	amod	O
adenomas	NNS	conj	B-Cancer
.	.	punct	O

Two	CD	nsubj	O
of	IN	case	O
the	DT	det	O
mutations	NNS	nmod	O
included	VBD	ROOT	O
a	DT	det	O
G	NN	compound	B-Simple_chemical
to	TO	case	O
C	NN	compound	B-Simple_chemical
substitution	NN	dobj	O
at	IN	case	O
codon	NN	nmod	O
12	CD	nummod	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
G	NN	conj	B-Simple_chemical
to	TO	case	O
A	NN	compound	B-Simple_chemical
substitution	NN	nmod	O
at	IN	case	O
codon	NN	nmod	O
18	CD	nummod	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
a	DT	det	O
glycine	NN	nmod	B-Amino_acid
to	TO	case	O
arginine	NN	nmod	B-Amino_acid
,	,	punct	O
and	CC	cc	O
an	DT	det	O
alanine	NN	conj	B-Amino_acid
to	TO	case	O
threonine	NN	compound	B-Amino_acid
change	NN	nmod	O
at	IN	case	O
these	DT	det	O
amino	NN	compound	B-Amino_acid
acids	NNS	nmod	I-Amino_acid
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

A	DT	det	O
third	JJ	amod	O
mutation	NN	nsubj	O
involved	VBD	ROOT	O
a	DT	det	O
single	JJ	amod	O
base	NN	compound	O
pair	NN	compound	O
(	-LRB-	punct	O
adenine	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
deletion	NN	dobj	O
in	IN	case	O
codon	NN	nmod	O
3	CD	nummod	O
of	IN	case	O
H	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	nmod	I-Gene_or_gene_product2
which	WDT	nsubj	O
causes	VBZ	acl:relcl	O
a	DT	det	O
frame	NN	compound	O
shift	NN	dobj	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
a	DT	det	O
termination	NN	compound	O
signal	NN	nmod	O
at	IN	case	O
codon	NN	nmod	O
19	CD	nummod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
point	NN	compound	O
mutations	NNS	nsubjpass	O
in	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
ras	NN	conj	B-Gene_or_gene_product2
are	VBP	auxpass	O
not	RB	neg	O
associated	VBN	ccomp	O
with	IN	case	O
pituitary	JJ	amod	B-Organ
tumorigenesis	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
point	NN	compound	O
mutations	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
H	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
ras	NN	compound	I-Gene_or_gene_product2
gene	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
important	JJ	parataxis	O
in	IN	case	O
the	DT	det	O
formation	NN	nmod	O
and	CC	cc	O
or	CC	cc	O
growth	NN	conj	O
of	IN	case	O
pituitary	JJ	amod	B-Cancer
metastases	NNS	nmod	I-Cancer
.	.	punct	O

This	DT	det	O
observed	VBN	amod	O
genomic	JJ	amod	O
instability	NN	nsubj	O
will	MD	aux	O
be	VB	ROOT	O
of	IN	prep	O
value	NN	pobj	O
in	IN	mark	O
predicting	VBG	advcl	O
the	DT	det	O
potential	JJ	amod	O
metastatic	JJ	amod	O
behavior	NN	dobj	O
of	IN	case	O
these	DT	det	O
aggressive	JJ	amod	O
pituitary	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

Overexpression	NN	ROOT	O
of	IN	case	O
Glut	NNP	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
glucose	NN	compound	B-Simple_chemical
transporter	NN	nmod	O
in	IN	case	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

An	DT	det	O
immunohistochemical	JJ	amod	O
study	NN	ROOT	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Breast	NN	compound	B-Cancer
cancers	NNS	nsubj	I-Cancer
have	VBP	appos	O
higher	JJR	dobj	O
than	IN	case	O
normal	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
metabolism	NN	nmod	O
,	,	punct	O
but	CC	cc	O
the	DT	det	O
mechanism	NN	nsubjpass	O
of	IN	case	O
glucose	NN	compound	B-Simple_chemical
entry	NN	nmod	O
into	IN	case	O
these	DT	det	O
tumors	NNS	nmod	B-Cancer
is	VBZ	auxpass	O
not	RB	neg	O
well	RB	advmod	O
understood	VBN	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
five	CD	nummod	O
facilitative	JJ	amod	O
glucose	NN	compound	B-Simple_chemical
transporters	NNS	nmod	O
,	,	punct	O
Glut	NNP	compound	B-Gene_or_gene_product3
-	,	punct	I-Gene_or_gene_product3
1	CD	appos	I-Gene_or_gene_product3
(	-LRB-	punct	O
erythrocyte	NN	compound	B-Cell
type	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
Glut	NN	compound	B-Gene_or_gene_product3
-	,	punct	I-Gene_or_gene_product3
2	CD	appos	I-Gene_or_gene_product3
(	-LRB-	punct	O
liver	NN	compound	B-Organ
type	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
Glut	NN	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
3	CD	appos	I-Gene_or_gene_product3
(	-LRB-	punct	O
brain	NN	compound	B-Organ
type	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
Glut	NN	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
4	CD	nummod	I-Gene_or_gene_product3
(	-LRB-	punct	O
muscle	NN	compound	B-Organ
/	:	punct	O
fat	NN	compound	B-Tissue
type	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
Glut	NN	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
5	CD	nummod	I-Gene_or_gene_product2
(	-LRB-	punct	O
small	JJ	amod	B-Organ
intestine	NN	compound	I-Organ
type	NN	conj	O
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
studied	VBN	dep	O
by	IN	case	O
immunohistochemistry	NN	nmod	O
of	IN	case	O
paraffin	NN	amod	B-Simple_chemical
sections	NNS	nmod	B-Tissue
from	IN	case	O
12	CD	nummod	O
primary	JJ	amod	O
human	JJ	amod	B-Organism
breast	NN	compound	B-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
8	CD	nummod	O
lymph	NN	compound	B-Cancer
node	NN	compound	I-Cancer
metastases	NNS	conj	I-Cancer
from	IN	case	O
2	CD	nummod	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Rat	NN	compound	B-Organism
tissues	NNS	nsubjpass	B-Tissue
known	VBN	acl	O
to	TO	mark	O
express	VB	xcomp	O
these	DT	det	O
glucose	NN	compound	B-Simple_chemical
transporters	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
All	PDT	det:predet	O
the	DT	det	O
primary	JJ	amod	O
breast	NN	compound	B-Cancer
cancers	NNS	nsubj	I-Cancer
and	CC	cc	O
the	DT	det	O
lymph	NN	compound	B-Cancer
node	NN	compound	I-Cancer
metastases	NNS	conj	I-Cancer
were	VBD	cop	O
positive	JJ	appos	O
for	IN	prep	O
Glut	NNP	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	pobj	I-Gene_or_gene_product3
.	.	punct	O

This	DT	det	O
transporter	NN	nsubjpass	O
was	VBD	auxpass	O
expressed	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
and	CC	cc	O
in	IN	case	O
the	DT	det	O
cytoplasm	NN	conj	B-Organism_substance
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
exhibited	VBD	conj	O
marked	JJ	amod	O
intratumoral	JJ	amod	B-Cancer
and	CC	cc	O
intertumoral	JJ	conj	B-Cancer
variability	NN	dobj	O
in	IN	case	O
the	DT	det	O
proportions	NNS	nmod	O
of	IN	case	O
positive	JJ	amod	O
cells	NNS	nmod	B-Cell
and	CC	cc	O
the	DT	det	O
intensity	NN	conj	O
of	IN	case	O
staining	NN	nmod	O
.	.	punct	O

Staining	NN	nsubj	O
of	IN	case	O
the	DT	det	O
normal	JJ	amod	O
mammary	JJ	amod	B-Tissue
epithelium	NN	nmod	I-Tissue
,	,	punct	O
if	IN	mark	O
present	JJ	advcl	O
,	,	punct	O
was	VBD	cop	O
much	RB	advmod	O
lower	JJR	ROOT	O
than	IN	mark	O
observed	VBN	advcl	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
the	DT	det	O
same	JJ	amod	O
patient	NN	nmod	B-Organism
.	.	punct	O

Glut	NN	compound	B-Gene_or_gene_product2
-	,	punct	I-Gene_or_gene_product2
2	CD	nsubjpass	I-Gene_or_gene_product2
was	VBD	auxpass	O
expressed	VBN	ROOT	O
in	IN	case	O
all	DT	nmod	O
of	IN	case	O
the	DT	det	O
tumors	NNS	nmod	B-Cancer
,	,	punct	O
but	CC	cc	O
the	DT	det	O
intensity	NN	nsubj	O
of	IN	case	O
staining	NN	nmod	O
was	VBD	cop	O
not	RB	neg	O
consistently	RB	advmod	O
stronger	JJR	conj	O
than	IN	case	O
that	DT	nmod	O
seen	VBN	acl	O
in	IN	case	O
healthy	JJ	amod	B-Tissue
breast	NN	nmod	I-Tissue
.	.	punct	O

Clusters	NNS	nsubjpass	O
of	IN	case	O
Glut	NNP	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
4	CD	npadvmod	I-Gene_or_gene_product2
-	HYPH	punct	O
positive	JJ	amod	O
granule	NN	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
cells	NNS	nmod	B-Cell
in	IN	case	O
six	CD	nmod	O
of	IN	case	O
the	DT	det	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

None	NN	nsubj	O
of	IN	case	O
the	DT	det	O
tumors	NNS	nmod	B-Cancer
or	CC	cc	O
the	DT	det	O
healthy	JJ	amod	B-Tissue
breast	NN	conj	I-Tissue
in	IN	case	O
the	DT	det	O
tissues	NNS	nmod	B-Tissue
studied	VBN	acl	O
expressed	VBD	ROOT	O
Glut	NNP	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
3	CD	dobj	I-Gene_or_gene_product3
or	CC	cc	O
Glut	NNP	compound	B-Gene_or_gene_product2
-	HYPH	punct	I-Gene_or_gene_product2
5	CD	conj	I-Gene_or_gene_product2
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Higher	JJR	amod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
transporter	NN	compound	O
Glut	NN	compound	B-Gene_or_gene_product3
-	,	punct	I-Gene_or_gene_product3
1	CD	nmod	I-Gene_or_gene_product3
by	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
healthy	JJ	amod	B-Tissue
breast	NN	compound	I-Tissue
tissue	NN	nmod	I-Tissue
is	VBZ	cop	O
common	JJ	appos	O
.	.	punct	O

Increased	VBN	amod	O
glucose	NN	compound	B-Simple_chemical
transporter	NN	compound	O
protein	NN	compound	O
expression	NN	nsubj	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
increased	VBN	amod	O
uptake	NN	nmod	O
of	IN	case	O
2	CD	nummod	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
18F	NN	nummod	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
fluoro	NNS	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
D	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glucose	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
FDG	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
by	IN	case	O
these	DT	det	O
tumors	NNS	nmod	B-Cancer
observed	VBN	acl	O
by	IN	case	O
positron	NN	compound	O
emission	NN	compound	O
tomography	NN	nmod	O
(	-LRB-	punct	O
PET	NN	appos	O
)	-RRB-	punct	O
imaging	NN	acl	O
.	.	punct	O

High	JJ	amod	O
density	NN	ROOT	O
of	IN	case	O
somatostatin	NN	compound	B-Gene_or_gene_product0
receptors	NNS	nmod	I-Gene_or_gene_product0
in	IN	case	O
veins	NNS	nmod	B-Multi-tissue_structure
surrounding	VBG	acl	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Tissue
tissue	NN	dobj	I-Tissue
:	:	punct	O
role	NN	dep	O
in	IN	case	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
host	NN	compound	O
interaction	NN	nmod	O
?	.	punct	O

Somatostatin	NN	compound	B-Gene_or_gene_product0
receptors	NNS	nsubjpass	I-Gene_or_gene_product0
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
peritumoral	JJ	amod	B-Multi-tissue_structure
veins	NNS	nmod	I-Multi-tissue_structure
of	IN	case	O
various	JJ	amod	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
specimens	NNS	nmod	I-Tissue
.	.	punct	O

Vascular	JJ	amod	B-Tissue
and	CC	cc	O
neoplastic	JJ	conj	B-Tissue
tissue	NN	nsubjpass	I-Tissue
from	IN	case	O
14	CD	nummod	O
colonic	JJ	amod	B-Cancer
adenocarcinomas	NNS	nmod	I-Cancer
,	,	punct	O
13	CD	nummod	O
carcinoids	NNS	appos	B-Cancer
,	,	punct	O
6	CD	nummod	O
renal	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	appos	I-Cancer
and	CC	cc	O
7	CD	nummod	O
malignant	JJ	amod	B-Cancer
lymphomas	NNS	nsubjpass	I-Cancer
were	VBD	auxpass	O
analyzed	VBN	ROOT	O
for	IN	case	O
somatostatin	NN	compound	B-Gene_or_gene_product0
receptors	NNS	nmod	I-Gene_or_gene_product0
by	IN	case	O
use	NN	nmod	O
of	IN	case	O
quantitative	JJ	amod	O
receptor	NN	compound	O
autoradiography	NN	nmod	O
.	.	punct	O

In	IN	case	O
colonic	JJ	amod	B-Cancer
carcinoma	NN	compound	I-Cancer
specimens	NNS	nmod	I-Cancer
,	,	punct	O
the	DT	det	O
peritumoral	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nsubj	I-Multi-tissue_structure
expressed	VBD	ROOT	O
a	DT	det	O
high	JJ	amod	O
density	NN	dobj	O
of	IN	case	O
somatostatin	NN	compound	B-Gene_or_gene_product0
receptors	NNS	nmod	I-Gene_or_gene_product0
,	,	punct	O
whereas	IN	dep	O
the	DT	det	O
neoplastic	JJ	amod	B-Tissue
tissue	NN	nsubj	I-Tissue
itself	PRP	dep	O
was	VBD	cop	O
receptor	NN	compound	O
-	HYPH	punct	O
negative	JJ	parataxis	O
in	IN	case	O
many	JJ	amod	O
cases	NNS	nmod	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
incidence	NN	nsubj	O
and	CC	cc	O
density	NN	conj	O
of	IN	case	O
somatostatin	NN	compound	B-Gene_or_gene_product0
receptors	NNS	nmod	I-Gene_or_gene_product0
in	IN	case	O
peritumoral	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
was	VBD	cop	O
low	JJ	ROOT	O
in	IN	case	O
well	RB	advmod	O
-	HYPH	punct	O
differentiated	VBN	amod	O
gastrointestinal	JJ	amod	B-Cancer
and	CC	cc	O
bronchial	JJ	conj	B-Cancer
carcinoids	NNS	nmod	I-Cancer
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
the	DT	det	O
high	JJ	amod	O
density	NN	nmod	O
of	IN	case	O
such	JJ	amod	O
receptors	NNS	nmod	O
in	IN	case	O
the	DT	det	O
carcinoid	JJ	amod	B-Tissue
tumor	NN	compound	I-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

Autochthonous	JJ	amod	O
vessels	NNS	nsubj	B-Multi-tissue_structure
surrounding	VBG	acl	O
other	JJ	amod	O
tumors	NNS	dobj	B-Cancer
such	JJ	case	O
as	IN	mwe	O
renal	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
or	CC	cc	O
malignant	JJ	amod	B-Cancer
lymphomas	NNS	conj	I-Cancer
also	RB	advmod	O
frequently	RB	advmod	O
expressed	VBD	ROOT	O
somatostatin	NN	compound	B-Gene_or_gene_product0
receptors	NNS	dobj	I-Gene_or_gene_product0
.	.	punct	O

In	IN	case	O
all	DT	det	O
cases	NNS	nmod	O
,	,	punct	O
the	DT	det	O
somatostatin	NN	compound	B-Gene_or_gene_product0
receptors	NNS	nsubj	I-Gene_or_gene_product0
were	VBD	aux	O
localized	JJ	ROOT	O
in	IN	case	O
veins	NNS	nmod	B-Multi-tissue_structure
,	,	punct	O
particularly	RB	advmod	O
in	IN	case	O
the	DT	det	O
smooth	NN	amod	B-Tissue
-	HYPH	punct	I-Tissue
muscle	NN	compound	I-Tissue
cell	NN	compound	I-Tissue
layer	NN	appos	I-Tissue
.	.	punct	O

They	PRP	nsubj	O
exhibited	VBD	ROOT	O
specific	JJ	amod	O
and	CC	cc	O
high	JJ	conj	O
-	HYPH	punct	O
affinity	NN	dep	O
binding	NN	dobj	O
of	IN	case	O
somatostatin	NN	nmod	B-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
14	CD	compound	I-Gene_or_gene_product0
,	,	punct	O
somatostatin	NN	conj	B-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
28	CD	dep	I-Gene_or_gene_product0
and	CC	cc	O
octreotide	NN	conj	B-Simple_chemical
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
preferential	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
the	DT	det	O
SSTR2	NN	compound	B-Gene_or_gene_product0
receptor	NN	compound	I-Gene_or_gene_product0
subtype	NN	nmod	O
.	.	punct	O

Since	IN	ROOT	O
the	DT	det	O
vessels	NNS	pobj	B-Multi-tissue_structure
of	IN	case	O
normal	JJ	amod	O
non	JJ	amod	O
-	HYPH	punct	O
neoplastic	JJ	amod	O
human	JJ	amod	B-Organism
tissues	NNS	nmod	B-Tissue
,	,	punct	O
e	NN	appos	O
.	.	punct	O
g	NN	nsubj	O
.	.	punct	O
of	IN	case	O
intestine	NN	nmod	B-Organ
or	CC	cc	O
lymphatic	JJ	amod	B-Organ
organs	NNS	conj	I-Organ
,	,	punct	O
have	VBP	ROOT	O
few	JJ	amod	O
somatostatin	NN	compound	B-Gene_or_gene_product0
receptors	NNS	dobj	I-Gene_or_gene_product0
,	,	punct	O
the	DT	det	O
increased	VBN	amod	O
somatostatin	NN	compound	B-Gene_or_gene_product0
receptor	NN	compound	I-Gene_or_gene_product0
expression	NN	nsubjpass	O
in	IN	case	O
peritumoral	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
observed	VBN	acl	O
in	IN	case	O
this	DT	det	O
study	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
linked	VBN	parataxis	O
to	TO	case	O
the	DT	det	O
neoplastic	JJ	amod	O
process	NN	nmod	O
itself	PRP	dep	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
somatostatin	NN	nsubj	B-Gene_or_gene_product0
and	CC	cc	O
somatostatin	NN	compound	B-Gene_or_gene_product0
receptors	NNS	conj	I-Gene_or_gene_product0
may	MD	aux	O
play	VB	ccomp	O
a	DT	det	O
regulatory	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
hemodynamic	JJ	amod	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
host	NN	compound	O
interactions	NNS	nmod	O
,	,	punct	O
possibly	RB	advmod	O
involving	VBG	advcl	O
tumor	NN	compound	B-Tissue
stroma	NN	compound	I-Tissue
generation	NN	dobj	O
,	,	punct	O
tumor	NN	compound	B-Cancer
environment	NN	conj	O
,	,	punct	O
angiogenesis	NN	conj	O
and	CC	cc	O
,	,	punct	O
particularly	RB	advmod	O
,	,	punct	O
vascular	JJ	amod	B-Multi-tissue_structure
drainage	NN	dobj	O
of	IN	case	O
poorly	RB	advmod	O
differentiated	VBN	amod	O
neoplasms	NNS	nmod	B-Cancer
.	.	punct	O

Syndecan	NNP	compound	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
expression	NN	nsubj	O
in	IN	case	O
mammary	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
is	VBZ	cop	O
E	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
cadherin	NN	nmod:npmod	I-Gene_or_gene_product0
-	HYPH	punct	O
dependent	JJ	ROOT	O
.	.	punct	O

E	NNP	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
cadherin	NN	nsubj	I-Gene_or_gene_product0
is	VBZ	cop	O
a	DT	det	O
Ca	NN	ROOT	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
+	CC	cc	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	O
dependent	JJ	amod	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
adhesion	NN	compound	O
molecule	NN	appos	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
mainly	RB	advmod	O
expressed	VBN	acl:relcl	O
in	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Recent	JJ	amod	O
studies	NNS	nsubj	O
have	VBP	aux	O
shown	VBN	ROOT	O
that	IN	mark	O
E	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
cadherin	NN	nsubj	I-Gene_or_gene_product0
has	VBZ	ccomp	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
as	IN	case	O
an	DT	det	O
invasion	NN	compound	O
suppressor	NN	compound	O
molecule	NN	nmod	O
in	IN	case	O
epithelial	JJ	amod	B-Cell
tumor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Syndecan	NNP	compound	B-Gene_or_gene_product3
-	,	punct	I-Gene_or_gene_product3
1	CD	nsubj	I-Gene_or_gene_product3
is	VBZ	cop	O
a	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	compound	I-Cellular_component
proteoglycan	NN	ROOT	O
that	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
functions	NNS	nmod	O
including	VBG	case	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
adhesion	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
matrix	NN	compound	B-Cellular_component
anchorage	NN	conj	O
and	CC	cc	O
growth	NN	compound	B-Gene_or_gene_product0
factor	NN	compound	I-Gene_or_gene_product0
presentation	NN	conj	O
for	IN	case	O
signalling	NN	amod	O
receptors	NNS	nmod	O
.	.	punct	O

Its	PRP$	nmod:poss	O
suppression	NN	nsubjpass	O
has	VBZ	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
be	VB	auxpass	O
associated	VBN	xcomp	O
with	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	dep	O
better	RBR	advmod	O
understand	VB	advcl	O
the	DT	det	O
coordinated	VBN	amod	O
regulation	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
and	CC	cc	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
matrix	NN	conj	B-Cellular_component
interactions	NNS	nmod	O
during	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
studied	VBN	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
syndecan	NN	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	nmod	I-Gene_or_gene_product3
in	IN	case	O
malignant	JJ	amod	B-Cell
mammary	JJ	amod	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
genetically	RB	advmod	O
manipulated	VBD	acl	O
for	IN	case	O
E	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
cadherin	NN	compound	I-Gene_or_gene_product0
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
invasive	JJ	amod	O
NM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
e	NN	compound	I-Cell
-	HYPH	punct	I-Cell
ras	NN	compound	I-Cell
-	HYPH	punct	I-Cell
MAC1	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
where	WRB	advmod	O
E	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
cadherin	NN	nsubjpass	I-Gene_or_gene_product0
was	VBD	auxpass	O
partially	RB	advmod	O
downregulated	VBN	acl:relcl	O
by	IN	case	O
specific	JJ	amod	O
antisense	JJ	amod	O
RNA	NN	nmod	O
,	,	punct	O
syndecan	NN	amod	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
expression	NN	nsubjpass	O
was	VBD	auxpass	O
suppressed	VBN	ROOT	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
transfection	NN	nsubj	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
cadherin	NN	compound	I-Gene_or_gene_product1
cDNA	NN	nmod	I-Gene_or_gene_product1
into	IN	case	O
invasive	JJ	amod	O
NM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
f	NN	compound	I-Cell
-	HYPH	punct	I-Cell
ras	NN	compound	I-Cell
-	HYPH	punct	I-Cell
TD	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
upregulation	NN	nmod	O
of	IN	case	O
syndecan	NN	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
expression	NN	nmod	O
in	IN	case	O
association	NN	nmod	O
with	IN	case	O
decreased	VBN	amod	O
invasiveness	NN	nmod	O
.	.	punct	O

In	IN	case	O
both	DT	det	O
cases	NNS	nmod	O
,	,	punct	O
regulation	NN	nsubj	O
of	IN	case	O
syndecan	NN	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	nmod	I-Gene_or_gene_product3
occurred	VBD	ROOT	O
post	NN	dobj	O
-	HYPH	punct	O
transcriptionally	RB	advmod	O
,	,	punct	O
since	IN	mark	O
syndecan	JJ	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
mRNA	NN	compound	O
levels	NNS	nsubj	O
remained	VBD	advcl	O
unchanged	JJ	xcomp	O
.	.	punct	O

Instead	RB	advmod	O
,	,	punct	O
a	DT	det	O
translational	JJ	amod	O
regulation	NN	nsubjpass	O
is	VBZ	auxpass	O
suggested	VBN	ROOT	O
,	,	punct	O
since	IN	mark	O
syndecan	JJ	amod	B-Gene_or_gene_product3
-	HYPH	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
core	NN	compound	O
protein	NN	compound	O
synthesis	NN	nsubj	O
was	VBD	cop	O
E	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
cadherin	NN	nmod:npmod	I-Gene_or_gene_product0
dependent	JJ	advcl	O
.	.	punct	O

Another	DT	det	O
cell	NN	compound	B-Cell
adhesion	NN	compound	O
protein	NN	nsubjpass	O
,	,	punct	O
beta	NN	compound	B-Gene_or_gene_product0
1	CD	nummod	I-Gene_or_gene_product0
-	:	punct	I-Gene_or_gene_product0
integrin	NN	nsubjpass	I-Gene_or_gene_product0
was	VBD	auxpass	O
not	RB	neg	O
affected	VBN	ROOT	O
by	IN	case	O
E	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
cadherin	NN	compound	I-Gene_or_gene_product0
expression	NN	nmod	O
.	.	punct	O

The	DT	det	O
data	NNS	nsubj	O
provide	VBP	ROOT	O
an	DT	det	O
example	NN	dobj	O
of	IN	case	O
coordinated	VBN	amod	O
changes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
two	CD	nummod	O
cell	NN	compound	B-Cell
adhesion	NN	compound	O
molecules	NNS	nmod	O
,	,	punct	O
syndecan	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
and	CC	cc	O
E	NN	conj	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
cadherin	NN	appos	I-Gene_or_gene_product0
during	IN	case	O
epithelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
transformation	NN	nmod	O
.	.	punct	O

Metastasis	NN	nmod:npmod	O
-	HYPH	punct	O
associated	VBN	amod	O
5T4	NN	compound	B-Gene_or_gene_product2
antigen	NN	nsubj	O
disrupts	VBZ	ROOT	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
contacts	NNS	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
cellular	JJ	amod	B-Cell
motility	NN	dobj	O
in	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
5T4	NN	compound	B-Gene_or_gene_product1
antigen	NN	nsubjpass	O
is	VBZ	auxpass	O
defined	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
monoclonal	JJ	amod	O
antibody	NN	nmod	O
(	-LRB-	punct	O
MAb	NN	appos	O
)	-RRB-	punct	O
specific	JJ	amod	O
for	IN	case	O
human	JJ	amod	B-Organism
trophoblast	NN	nmod	B-Cell
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
also	RB	advmod	O
expressed	VBN	ROOT	O
by	IN	case	O
many	JJ	amod	O
types	NNS	nmod	O
of	IN	case	O
tumour	NN	compound	B-Cell
cell	NN	nmod	I-Cell
and	CC	cc	O
has	VBZ	aux	O
been	VBN	auxpass	O
associated	VBN	conj	O
with	IN	case	O
metastasis	NN	nmod	O
and	CC	cc	O
poor	JJ	amod	O
clinical	JJ	amod	O
outcome	NN	conj	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

This	DT	det	O
pattern	NN	nsubj	O
of	IN	case	O
expression	NN	nmod	O
is	VBZ	cop	O
consistent	JJ	ROOT	O
with	IN	case	O
a	DT	det	O
mechanistic	JJ	amod	O
involvement	NN	nmod	O
of	IN	case	O
5T4	NN	compound	B-Gene_or_gene_product1
molecules	NNS	nmod	O
in	IN	case	O
the	DT	det	O
spread	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
5T4	NN	compound	B-Gene_or_gene_product2
antigen	NN	nsubj	O
is	VBZ	cop	O
a	DT	det	O
transmembrane	JJ	amod	B-Cellular_component
glycoprotein	NN	ROOT	O
with	IN	case	O
a	DT	det	O
310	CD	nummod	O
amino	NN	compound	B-Amino_acid
acid	NN	compound	I-Amino_acid
extracellular	JJ	amod	B-Immaterial_anatomical_entity
domain	NN	nmod	O
and	CC	cc	O
a	DT	det	O
44	CD	nummod	O
amino	NN	compound	B-Amino_acid
acid	NN	compound	I-Amino_acid
cytoplasmic	JJ	amod	B-Organism_substance
domain	NN	conj	O
.	.	punct	O

Transfection	NN	nsubj	O
of	IN	case	O
full	JJ	amod	O
-	HYPH	punct	O
length	NN	compound	O
5T4	NN	compound	B-Gene_or_gene_product1
cDNA	NN	nmod	O
into	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
alters	VBZ	ROOT	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
contacts	NNS	dobj	O
and	CC	cc	O
cellular	JJ	amod	B-Cell
motility	NN	conj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
in	IN	case	O
5T4	NN	nmod:npmod	B-Gene_or_gene_product1
-	HYPH	punct	O
transfected	VBN	amod	O
CL	NN	compound	B-Cell
-	HYPH	punct	I-Cell
S1	NN	compound	I-Cell
murine	JJ	amod	I-Cell
mammary	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
5T4	NN	compound	B-Gene_or_gene_product1
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
dendritic	JJ	amod	B-Cell
morphology	NN	nmod	O
,	,	punct	O
accompanied	VBN	advcl	O
by	IN	case	O
abrogation	NN	nmod	O
of	IN	case	O
actin	NN	compound	B-Gene_or_gene_product0
/	:	punct	O
cadherin	NN	appos	B-Gene_or_gene_product0
-	HYPH	punct	O
containing	VBG	amod	O
contacts	NNS	nmod	O
and	CC	cc	O
increased	VBN	amod	O
motility	NN	conj	O
.	.	punct	O

In	IN	case	O
transfected	VBN	amod	O
MDCK	NN	compound	B-Cell
canine	NN	compound	I-Cell
kidney	NN	compound	I-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
5T4	NN	compound	B-Gene_or_gene_product1
over	IN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
also	RB	advmod	O
results	VBZ	ROOT	O
in	IN	case	O
increased	VBN	amod	O
motility	NN	nmod	O
,	,	punct	O
but	CC	cc	O
disruption	NN	nsubjpass	O
of	IN	case	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
contacts	NNS	nmod	O
,	,	punct	O
either	CC	appos	O
by	IN	mark	O
culturing	VBG	advcl	O
cells	NNS	dobj	B-Cell
in	IN	case	O
low	JJ	amod	O
calcium	NN	compound	B-Simple_chemical
medium	NN	nmod	O
or	CC	cc	O
by	IN	case	O
addition	NN	conj	O
of	IN	case	O
HGF	NN	nmod	B-Gene_or_gene_product1
/	:	punct	O
SF	NN	conj	B-Gene_or_gene_product1
,	,	punct	O
is	VBZ	auxpass	O
needed	VBN	conj	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
5T4	NN	compound	B-Gene_or_gene_product1
expression	NN	nmod	O
on	IN	case	O
morphology	NN	nmod	O
and	CC	cc	O
motility	NN	conj	O
are	VBP	cop	O
separable	JJ	ROOT	O
since	IN	mark	O
cells	NNS	nsubj	B-Cell
transfected	VBN	acl	O
with	IN	case	O
a	DT	det	O
truncated	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
5T4	NN	compound	B-Gene_or_gene_product1
cDNA	NN	nmod	O
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
cytoplasmic	JJ	amod	B-Organism_substance
domain	NN	nsubjpass	O
is	VBZ	auxpass	O
deleted	VBN	acl:relcl	O
reveal	VBP	advcl	O
that	IN	mark	O
the	DT	det	O
latter	JJ	nsubj	O
is	VBZ	cop	O
necessary	JJ	ccomp	O
to	TO	mark	O
abrogate	VB	xcomp	O
actin	NN	compound	B-Gene_or_gene_product0
/	:	punct	O
cadherin	NN	appos	B-Gene_or_gene_product0
-	HYPH	punct	O
containing	VBG	amod	O
contacts	NNS	dobj	O
but	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
influence	VB	conj	O
the	DT	det	O
effects	NNS	dobj	O
on	IN	case	O
motility	NN	nmod	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
5T4	NN	compound	B-Gene_or_gene_product1
molecules	NNS	nsubj	O
can	MD	aux	O
deliver	VB	ROOT	O
signals	NNS	dobj	O
through	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
extracellular	JJ	nmod	B-Immaterial_anatomical_entity
and	CC	cc	O
intracellular	JJ	conj	B-Immaterial_anatomical_entity
domains	NNS	dep	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
resultant	JJ	amod	O
effects	NNS	nsubj	O
are	VBP	cop	O
consistent	JJ	conj	O
with	IN	case	O
a	DT	det	O
role	NN	nmod	O
for	IN	case	O
5T4	NN	compound	B-Gene_or_gene_product1
molecules	NNS	nmod	O
in	IN	case	O
invasion	NN	compound	O
processes	NNS	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Effects	NNS	ROOT	O
of	IN	case	O
carcinostatic	JJ	amod	O
agents	NNS	nmod	O
in	IN	case	O
the	DT	det	O
hematogenous	JJ	amod	O
metastasis	NN	nmod	O
of	IN	case	O
cancer	NN	nmod	B-Cancer
]	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
experimental	JJ	amod	O
studies	NNS	nsubjpass	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
carcinostatic	JJ	amod	O
agents	NNS	nmod	O
in	IN	case	O
the	DT	det	O
adhesion	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Certain	JJ	amod	O
carcinostatic	JJ	amod	O
agents	NNS	nsubj	O
induce	VBP	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product1
-	HYPH	punct	I-Gene_or_gene_product1
selectin	NN	nmod	I-Gene_or_gene_product1
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
enhance	VBP	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
carbohydrate	NN	amod	B-Simple_chemical
ligands	NNS	nmod	O
on	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
increased	VBN	amod	O
adhesion	NN	nsubjpass	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
was	VBD	auxpass	O
observed	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
carcinostatic	JJ	amod	O
agents	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
trans	JJ	nmod:npmod	B-Immaterial_anatomical_entity
-	HYPH	punct	I-Immaterial_anatomical_entity
splenic	JJ	amod	I-Immaterial_anatomical_entity
hepatic	JJ	amod	B-Organ
metastasis	NN	compound	O
model	NN	nmod	O
using	VBG	acl	O
nude	JJ	amod	B-Organism
mice	NNS	dobj	I-Organism
,	,	punct	O
the	DT	det	O
augmentation	NN	nsubjpass	O
of	IN	case	O
cancer	NN	compound	B-Cancer
metastasis	NN	nmod	O
was	VBD	auxpass	O
observed	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
carcinostatic	JJ	amod	O
agents	NNS	nmod	O
.	.	punct	O

From	IN	prep	O
the	DT	det	O
above	JJ	pobj	O
,	,	punct	O
we	PRP	nsubj	O
concluded	VBD	ROOT	O
that	IN	mark	O
carcinostatic	JJ	amod	O
agents	NNS	nsubj	O
may	MD	aux	O
increase	VB	ccomp	O
the	DT	det	O
metastatic	JJ	amod	O
ability	NN	dobj	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

Changes	NNS	ROOT	O
in	IN	case	O
plasminogen	NN	compound	B-Gene_or_gene_product3
activator	NN	compound	I-Gene_or_gene_product3
inhibitor	NN	compound	I-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
levels	NNS	nmod	O
in	IN	case	O
non	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
small	JJ	amod	I-Cancer
cell	NN	compound	I-Cancer
lung	NN	compound	I-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Increased	VBN	amod	O
urokinase	NN	compound	B-Gene_or_gene_product0
plasminogen	NN	compound	I-Gene_or_gene_product0
activator	NN	compound	I-Gene_or_gene_product0
(	-LRB-	punct	O
uPA	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
levels	NNS	nsubjpass	O
are	VBP	auxpass	O
increased	VBN	ROOT	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
malignancies	NNS	nmod	B-Cancer
and	CC	cc	O
have	VBP	aux	O
been	VBN	auxpass	O
correlated	VBN	conj	O
with	IN	case	O
decreased	VBN	amod	O
disease	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
interval	NN	nmod	O
and	CC	cc	O
decreased	VBD	conj	O
overall	JJ	amod	O
survival	NN	dobj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	ROOT	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
examined	VBN	parataxis	O
components	NNS	dobj	O
of	IN	case	O
this	DT	det	O
plasminogen	NN	compound	B-Gene_or_gene_product1
activating	NN	compound	O
system	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
Non	NNP	compound	B-Cancer
-	HYPH	punct	I-Cancer
Small	NNP	compound	I-Cancer
Cell	NNP	compound	I-Cancer
Lung	NNP	compound	I-Cancer
Cancer	NNP	nmod	I-Cancer
(	-LRB-	punct	O
NSCLC	NN	appos	B-Cancer
)	-RRB-	punct	O
.	.	punct	O

Levels	NNS	nsubjpass	O
of	IN	case	O
uPA	NN	compound	B-Gene_or_gene_product1
,	,	punct	O
urokinase	NN	compound	B-Gene_or_gene_product0
-	HYPH	punct	I-Gene_or_gene_product0
plasminogen	NN	compound	I-Gene_or_gene_product0
activator	NN	compound	I-Gene_or_gene_product0
receptor	NN	nmod	I-Gene_or_gene_product0
(	-LRB-	punct	O
uPAR	NN	appos	B-Gene_or_gene_product1
)	-RRB-	punct	O
and	CC	cc	O
plasminogen	NN	compound	B-Gene_or_gene_product3
activator	NN	compound	I-Gene_or_gene_product3
inhibitor	NN	conj	I-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
(	-LRB-	punct	O
PAI	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
)	-RRB-	punct	O
were	VBD	auxpass	O
measured	VBN	ROOT	O
semiquantitatively	RB	advmod	O
in	IN	case	O
paraffin	NN	amod	O
sections	NNS	nmod	B-Cancer
of	IN	case	O
tumours	NNS	nmod	B-Cancer
from	IN	case	O
147	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
NSCLC	NN	nmod	B-Cancer
.	.	punct	O

Immunohistochemically	RB	advmod	O
stained	JJ	ROOT	O
sections	NNS	nsubjpass	B-Cancer
of	IN	prep	O
tumour	NN	pobj	B-Cancer
were	VBD	auxpass	O
allocated	VBN	ccomp	O
a	DT	det	O
score	NN	dobj	O
for	IN	case	O
stain	NN	compound	O
intensity	NN	nmod	O
and	CC	cc	O
results	NNS	nsubj	O
correlated	VBD	conj	O
to	IN	nmod	O
:	:	punct	O
survival	NN	dobj	O
;	:	punct	O
tumour	NN	compound	B-Cancer
stage	NN	conj	O
(	-LRB-	punct	O
T	NN	appos	O
)	-RRB-	punct	O
;	:	punct	O
nodal	JJ	amod	B-Multi-tissue_structure
stage	NN	conj	O
(	-LRB-	punct	O
N	NN	appos	O
)	-RRB-	punct	O
;	:	punct	O
stage	NN	compound	O
grouping	NN	conj	O
(	-LRB-	punct	O
I	PRP	dep	O
to	TO	case	O
IIIb	NNS	nmod	O
)	-RRB-	punct	O
,	,	punct	O
survival	NN	compound	O
status	NN	conj	O
and	CC	cc	O
sex	NN	conj	O
.	.	punct	O

Increased	VBN	amod	O
levels	NNS	nsubjpass	O
of	IN	case	O
PAI	NN	nmod	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
were	VBD	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
a	DT	det	O
decreased	VBN	amod	O
survival	NN	nmod	O
in	IN	case	O
squamous	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinoma	NN	compound	I-Cancer
(	-LRB-	punct	O
SCC	NN	compound	B-Cancer
)	-RRB-	punct	O
X2	NN	nmod	O
=	JJ	amod	O
5	CD	dobj	O
.	.	punct	O
72	CD	dep	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	ROOT	O
0	CD	dobj	O
.	.	punct	O
017	CD	ROOT	O
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
74	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
positive	JJ	amod	O
relationship	NN	nsubj	O
between	IN	case	O
PAI	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
levels	NNS	nmod	O
and	CC	cc	O
N	NN	compound	O
-	HYPH	punct	O
stage	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	advcl	O
<	SYM	dobj	O
0	CD	nummod	O
.	.	punct	O
05	CD	nsubj	O
)	-RRB-	punct	O
,	,	punct	O
presence	NN	dep	O
of	IN	case	O
nodal	JJ	amod	B-Multi-tissue_structure
metastases	NNS	nmod	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
<	SYM	dobj	O
0	CD	nummod	O
.	.	punct	O
05	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
stage	NN	compound	O
grouping	NN	attr	O
(	-LRB-	punct	O
p	NN	dep	O
=	JJ	amod	O
<	SYM	dobj	O
0	CD	nummod	O
.	.	punct	O
01	CD	nsubj	O
)	-RRB-	punct	O
and	CC	cc	O
extent	NN	conj	O
of	IN	case	O
disease	NN	nmod	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
<	SYM	dobj	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
total	JJ	amod	O
group	NN	nmod	O
and	CC	cc	O
the	DT	det	O
SCC	NN	compound	B-Cancer
subgroup	NN	conj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
adenocarcinoma	NN	conj	B-Cancer
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
positive	JJ	amod	O
relationship	NN	nsubj	O
between	IN	case	O
PAI	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	nummod	I-Gene_or_gene_product3
levels	NNS	nmod	O
and	CC	cc	O
T	NN	compound	O
-	HYPH	punct	O
stage	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	acl	O
<	SYM	dobj	O
0	CD	nummod	O
.	.	punct	O
05	CD	attr	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
total	JJ	amod	O
group	NN	nmod	O
,	,	punct	O
and	CC	cc	O
survival	NN	compound	O
status	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
<	SYM	dobj	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
SCC	NN	compound	B-Cancer
subgroup	NN	nmod	O
alone	RB	advmod	O
.	.	punct	O

uPA	NN	amod	B-Gene_or_gene_product2
and	CC	cc	O
uPAR	NN	conj	B-Gene_or_gene_product2
levels	NNS	nsubjpass	O
were	VBD	auxpass	O
not	RB	neg	O
significantly	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
tumour	NN	compound	B-Cancer
staging	NN	nmod	O
or	CC	cc	O
survival	NN	conj	O
.	.	punct	O

We	PRP	nsubj	O
conclude	VBP	ROOT	O
that	IN	nsubj	O
increased	VBN	amod	O
PAI	NN	compound	B-Gene_or_gene_product3
-	:	punct	I-Gene_or_gene_product3
1	CD	dep	I-Gene_or_gene_product3
antigen	NN	compound	O
levels	NNS	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
associated	VBN	ccomp	O
with	IN	case	O
a	DT	det	O
decreased	VBN	amod	O
survival	NN	nmod	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
SCC	NN	nmod	B-Cancer
.	.	punct	O

Potential	JJ	amod	O
roles	NNS	ROOT	O
for	IN	case	O
focal	JJ	amod	B-Gene_or_gene_product2
adhesion	NN	compound	I-Gene_or_gene_product2
kinase	NN	nmod	I-Gene_or_gene_product2
in	IN	case	O
development	NN	nmod	O
.	.	punct	O

Focal	JJ	amod	B-Gene_or_gene_product2
adhesion	NN	compound	I-Gene_or_gene_product2
kinase	NN	nsubj	I-Gene_or_gene_product2
(	-LRB-	punct	O
pp125FAK	NN	dep	B-Gene_or_gene_product1
or	CC	cc	O
FAK	NN	conj	B-Gene_or_gene_product1
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
protein	NN	compound	B-Gene_or_gene_product2
tyrosine	NN	compound	I-Gene_or_gene_product2
kinase	NN	ROOT	I-Gene_or_gene_product2
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	acl:relcl	O
with	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
signalling	NN	amod	O
cascades	NNS	nmod	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
initiated	VBN	acl:relcl	O
when	WRB	advmod	O
the	DT	det	O
integrin	NN	compound	B-Gene_or_gene_product0
family	NN	nsubj	O
of	IN	case	O
cell	NN	compound	B-Gene_or_gene_product0
adhesion	NN	compound	I-Gene_or_gene_product0
molecules	NNS	nmod	I-Gene_or_gene_product0
engage	VBP	advcl	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
molecules	NNS	dobj	O
.	.	punct	O

In	IN	case	O
cultured	VBN	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
this	DT	det	O
molecule	NN	nsubjpass	O
is	VBZ	auxpass	O
physically	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
focal	JJ	amod	B-Cellular_component
adhesions	NNS	nmod	I-Cellular_component
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
well	RB	advmod	O
-	HYPH	punct	O
defined	VBN	amod	O
regions	NNS	acl:relcl	O
of	IN	case	O
intimate	JJ	amod	O
cell	NN	compound	B-Cell
-	:	punct	O
to	TO	advmod	O
-	HYPH	punct	O
substratum	NN	amod	O
adhesion	NN	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
location	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
interacts	VBZ	ROOT	O
with	IN	case	O
other	JJ	amod	O
proteins	NNS	nmod	O
of	IN	case	O
the	DT	det	O
focal	JJ	amod	B-Cellular_component
adhesion	NN	nmod	I-Cellular_component
to	TO	mark	O
activate	VB	acl	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
signalling	NN	amod	O
events	NNS	dobj	O
associated	VBN	acl	O
with	IN	case	O
cell	NN	compound	B-Cell
adhesion	NN	nmod	O
.	.	punct	O

The	DT	det	O
in	FW	amod	O
vitro	FW	dep	O
expression	NN	nsubj	O
of	IN	case	O
FAK	NN	nmod	B-Gene_or_gene_product1
and	CC	cc	O
its	PRP$	nmod:poss	O
level	NN	conj	O
of	IN	case	O
phosphorylation	NN	nmod	O
appear	VBP	ROOT	O
to	TO	mark	O
be	VB	cop	O
related	JJ	xcomp	O
to	TO	case	O
several	JJ	amod	O
physiological	JJ	amod	O
phenomena	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
cell	NN	compound	B-Cell
spreading	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
differentiation	NN	conj	O
,	,	punct	O
cell	NN	compound	B-Cell
locomotion	NN	conj	O
and	CC	cc	O
cell	NN	compound	B-Cell
death	NN	conj	O
.	.	punct	O

Because	IN	mark	O
these	DT	det	O
phenomena	NNS	nsubj	O
are	VBP	cop	O
all	DT	ROOT	O
of	IN	case	O
critical	JJ	amod	O
importance	NN	nmod	O
during	IN	case	O
morphogenesis	NN	nmod	O
,	,	punct	O
and	CC	cc	O
because	IN	mark	O
FAK	NN	nsubjpass	B-Gene_or_gene_product1
is	VBZ	auxpass	O
expressed	VBN	advcl	O
in	IN	case	O
embryonic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
evidence	NN	nsubj	O
has	VBZ	aux	O
been	VBN	aux	O
accumulating	VBG	conj	O
to	TO	aux	O
indicate	VB	xcomp	O
that	IN	mark	O
FAK	NN	nsubj	B-Gene_or_gene_product1
may	MD	aux	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
modulator	NN	ccomp	O
of	IN	case	O
developmental	JJ	amod	O
processes	NNS	nmod	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
review	NN	nmod	O
,	,	punct	O
this	DT	det	O
evidence	NN	nsubjpass	O
is	VBZ	auxpass	O
surveyed	VBN	ROOT	O
together	RB	advmod	O
with	IN	prep	O
evidence	NN	pobj	O
from	IN	prep	O
analogous	JJ	amod	O
situations	NNS	pobj	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
tumour	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
and	CC	cc	O
invasiveness	NN	conj	O
.	.	punct	O

Although	IN	mark	O
evidence	NN	nsubj	O
suggesting	VBG	acl	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
FAK	NN	nmod	B-Gene_or_gene_product1
in	IN	case	O
morphogenesis	NN	nmod	O
is	VBZ	aux	O
accumulating	VBG	advcl	O
,	,	punct	O
current	JJ	amod	O
uncertainties	NNS	appos	O
regarding	VBG	case	O
its	PRP$	nmod:poss	O
cytoplasmic	JJ	amod	B-Organism_substance
location	NN	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
molecular	JJ	amod	O
interactions	NNS	conj	O
in	FW	compound	O
vivo	FW	advmod	O
make	VB	ROOT	O
it	PRP	nsubj	O
difficult	JJ	ccomp	O
to	TO	mark	O
reach	VB	xcomp	O
definitive	JJ	amod	O
conclusions	NNS	dobj	O
regarding	VBG	prep	O
the	DT	det	O
significance	NN	pobj	O
of	IN	prep	O
its	PRP$	poss	O
contributions	NNS	pobj	O
to	TO	prep	O
developmental	JJ	amod	O
processes	NNS	pobj	O
.	.	punct	O

